##ANALYSISTYPE=GERMLINE_SINGLESAMPLE
##PIPELINE=megSAP 0.2-486-gc928f885
##SAMPLE=<ID=NA12878_03,Gender=n/a,ExternalSampleName=131036,IsTumor=no,IsFFPE=no,DiseaseGroup=Diseases of the nervous system,DiseaseStatus=affected>
##FILTER=off-target=Variant marked as 'off-target'.
##FILTER=low_conf_region=Variant marked as 'low_conf_region'.
##DESCRIPTION=NA12878_03=Genotype of variant in sample.
##DESCRIPTION=filter=Annotations for filtering and ranking variants.
##DESCRIPTION=quality=Quality parameters - variant quality (QUAL), depth (DP), allele frequency (AF), mean mapping quality of alternate allele (MQM), probability of strand bias for alternate bases as phred score (SAP), probability of allele ballance as phred score (ABP)
##DESCRIPTION=gene=Affected gene list (comma-separated).
##DESCRIPTION=variant_type=Variant type.
##DESCRIPTION=coding_and_splicing=Coding and splicing details (Gene, ENST number, type, impact, exon/intron number, HGVS.c, HGVS.p, Pfam domain).
##DESCRIPTION=coding_and_splicing_refseq=Coding and splicing details based on RefSeq (Gene, RefSeq id, type, impact, exon/intron number, HGVS.c, HGVS.p, Pfam domain).
##DESCRIPTION=regulatory=Regulatory consequence details.
##DESCRIPTION=OMIM=OMIM database annotation.
##DESCRIPTION=ClinVar=ClinVar database annotation.
##DESCRIPTION=HGMD=HGMD database annotation.
##DESCRIPTION=RepeatMasker=RepeatMasker annotation.
##DESCRIPTION=dbSNP=Identifier in dbSNP database.
##DESCRIPTION=1000g=Allele frequency in 1000 genomes project.
##DESCRIPTION=gnomAD=Allele frequency in gnomAD project.
##DESCRIPTION=gnomAD_hom_hemi=Homoyzgous counts and hemizygous counts of gnomAD project (genome data).
##DESCRIPTION=gnomAD_sub=Sub-population allele frequenciens (AFR,AMR,EAS,NFE,SAS) in gnomAD project.
##DESCRIPTION=phyloP=phyloP (100way vertebrate) annotation. Deleterious threshold > 1.6.
##DESCRIPTION=Sift=Sift effect prediction and score for each transcript: D=damaging, T=tolerated.
##DESCRIPTION=PolyPhen=PolyPhen (humVar) effect prediction and score for each transcript: D=probably damaging, P=possibly damaging, B=benign.
##DESCRIPTION=fathmm-MKL=fathmm-MKL score (for coding/non-coding regions). Deleterious threshold > 0.5.
##DESCRIPTION=CADD=CADD pathogenicity prediction scores (scaled phred-like). Deleterious threshold > 10-20.
##DESCRIPTION=REVEL=REVEL pathogenicity prediction score. Deleterious threshold > 0.5.
##DESCRIPTION=MaxEntScan=MaxEntScan splicing prediction (reference bases score/alternate bases score).
##DESCRIPTION=dbscSNV=dbscSNV splicing prediction (ADA/RF score).
##DESCRIPTION=COSMIC=COSMIC somatic variant database anntotation.
##DESCRIPTION=MMSplice_DeltaLogitPSI=MMsplice delta Logit PSI score: variant's effect on the exon inclusion - positive score shows higher exon inclusion, negative higher exclusion rate. A score greater than 2 or less than -2 can be considered strong.
##DESCRIPTION=MMSplice_pathogenicity=MMsplice pathogenicity score: probability of pathogenic effect of the variant on splicing
##DESCRIPTION=SpliceAI=SpliceAI prediction of splice-site variations. Probability of the variant being splice-altering (range from 0-1). The score is the maximum value of acceptor/donor gain/loss of all effected genes.
##DESCRIPTION=NGSD_hom=Homozygous variant count in NGSD.
##DESCRIPTION=NGSD_het=Heterozygous variant count in NGSD.
##DESCRIPTION=NGSD_group=Homozygous / heterozygous variant count in NGSD with the same disease group.
##DESCRIPTION=classification=Classification from the NGSD.
##DESCRIPTION=classification_comment=Classification comment from the NGSD.
##DESCRIPTION=validation=Validation information from the NGSD. Validation results of other samples are listed in brackets!
##DESCRIPTION=comment=Variant comments from the NGSD.
##DESCRIPTION=gene_info=Gene information from NGSD (inheritance mode, gnomAD o/e scores).
##FILTER=low_conf_region=Low confidence region for small variant calling based on gnomAD AC0/RF filters and IMGAG trio/twin data.
#chr	start	end	ref	obs	NA12878_03	filter	quality	gene	variant_type	coding_and_splicing	coding_and_splicing_refseq	regulatory	OMIM	ClinVar	HGMD	RepeatMasker	dbSNP	1000g	gnomAD	gnomAD_hom_hemi	gnomAD_sub	phyloP	Sift	PolyPhen	fathmm-MKL	CADD	REVEL	MaxEntScan	dbscSNV	COSMIC	MMSplice_DeltaLogitPSI	MMSplice_pathogenicity	SpliceAI	NGSD_hom	NGSD_het	NGSD_group	classification	classification_comment	validation	comment	gene_info
chr1	12062205	12062205	A	G	het	off-target	QUAL=897;DP=111;AF=0.39;MQM=60;SAP=80;ABP=15	MFN2	intron	MFN2:ENST00000235329.5:intron_variant:MODIFIER:intron11/18:c.1160+45A>G::,MFN2:ENST00000444836.1:intron_variant:MODIFIER:intron10/17:c.1160+45A>G::	MFN2:NM_001127660.1:intron_variant:MODIFIER:intron10/17:c.1160+45A>G::,MFN2:NM_014874.4:intron_variant:MODIFIER:intron11/18:c.1160+45A>G::		608507 [GENE=MFN2 PHENOS=Hereditary motor and sensory neuropathy VIA,601152,Autosomal dominant/Charcot-Marie-Tooth disease,axonal,type 2A2B,617087,Autosomal recessive/Charcot-Marie-Tooth disease,axonal,type 2A2A,609260,Autosomal dominant];				rs2236057	0.6579	0.6615	6882,.	0.6479,0.5317,0.6765,0.6679,0.7034	-2.0590			0.01,0.11	3.53					-0.0379	0.4507	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)				some%20text%20for%20testing	MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	12071680	12071680	A	G	het	off-target	QUAL=774;DP=65;AF=0.51;MQM=60;SAP=11;ABP=3	MFN2	3'UTR	MFN2:ENST00000235329.5:3_prime_UTR_variant:MODIFIER:exon19/19:c.*58A>G::,MFN2:ENST00000444836.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*58A>G::	MFN2:NM_001127660.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*58A>G::,MFN2:NM_014874.4:3_prime_UTR_variant:MODIFIER:exon19/19:c.*58A>G::		608507 [GENE=MFN2 PHENOS=Hereditary motor and sensory neuropathy VIA,601152,Autosomal dominant/Charcot-Marie-Tooth disease,axonal,type 2A2B,617087,Autosomal recessive/Charcot-Marie-Tooth disease,axonal,type 2A2A,609260,Autosomal dominant];	292381 [benign DISEASE=Charcot-Marie-Tooth disease, type 2,Hereditary motor and sensory neuropathy with optic atrophy,not specified];			rs1042842	0.7324	0.7195	8238,.		-0.8580			0.04,0.13	0.76					0.0086	0.9418	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	43393245	43393245	-	GGTGAGAAAT	het	off-target	QUAL=1722;DP=173;AF=0.52;MQM=60;SAP=73;ABP=4	SLC2A1	intron	SLC2A1:ENST00000426263.3:intron_variant:MODIFIER:intron9/9:c.1278+30_1278+31insATTTCTCACC::	SLC2A1:NM_006516.3:intron_variant:MODIFIER:intron9/9:c.1278+30_1278+31insATTTCTCACC::		138140 [GENE=SLC2A1 PHENOS=Dystonia 9,601042,Autosomal dominant/GLUT1 deficiency syndrome 1,infantile onset,severe,606777,Autosomal recessive,Autosomal dominant/Stomatin-deficient cryohydrocytosis with neurologic defects,608885,Autosomal dominant/GLUT1 deficiency syndrome 2,childhood onset,612126,Autosomal dominant/Epilepsy,idiopathic generalized,susceptibility to,12,614847,Autosomal dominant];				rs3831326		0.5517	4915,.						2.73					0.1492	0.1156	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC2A1 (inh=AR+AD oe_syn=0.99 oe_mis=0.53 oe_lof=0.05)
chr1	114443035	114443035	C	G	hom	off-target	QUAL=5773;DP=175;AF=1.00;MQM=60;SAP=7;ABP=0	AP4B1,AP4B1-AS1	intron,non_coding_transcript_exon	AP4B1:ENST00000256658.4:intron_variant:MODIFIER:intron5/10:c.618-13G>C::,AP4B1:ENST00000369566.3:intron_variant:MODIFIER:intron2/2:c.339-13G>C::,AP4B1:ENST00000369567.1:intron_variant:MODIFIER:intron1/6:c.114-13G>C::,AP4B1:ENST00000369569.1:intron_variant:MODIFIER:intron4/9:c.618-13G>C::,AP4B1-AS1:ENST00000419536.1:non_coding_transcript_exon_variant:MODIFIER:exon5/5:n.910C>G::	AP4B1:NM_001253852.3:intron_variant:MODIFIER:intron4/9:c.618-13G>C::,AP4B1:NM_001253853.3:intron_variant:MODIFIER:intron5/10:c.321-13G>C::,AP4B1:NM_001308312.2:intron_variant:MODIFIER:intron1/6:c.114-13G>C::,AP4B1:NM_006594.5:intron_variant:MODIFIER:intron5/10:c.618-13G>C::,AP4B1-AS1:NR_037864.1:non_coding_transcript_exon_variant:MODIFIER:exon5/5:n.910C>G::,AP4B1-AS1:NR_125965.1:non_coding_transcript_exon_variant:MODIFIER:exon5/5:n.1078C>G::	regulatory_region_variant:promoter_flanking_region	607245 [GENE=AP4B1 PHENOS=Spastic paraplegia 47,autosomal recessive,614066,Autosomal recessive];	157725 [benign/likely benign DISEASE=not specified];			rs3789613	0.3656	0.3864	2160,.	0.1239,0.5214,0.7729,0.3596,0.2495	0.0420			0.01,0.14	2.51		6.10>6.68			0.597	0.8954	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AP4B1-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), AP4B1 (inh=AR oe_syn=1.01 oe_mis=0.98 oe_lof=0.57), DCLRE1B (inh=n/a oe_syn=0.95 oe_mis=0.91 oe_lof=0.20)
chr1	114443899	114443899	G	A	het		QUAL=1317;DP=144;AF=0.40;MQM=60;SAP=8;ABP=17	AP4B1	synonymous,intron	AP4B1:ENST00000256658.4:synonymous_variant:LOW:exon5/11:c.576C>T:p.Gly192=:PF01602 [Adaptin N terminal region],AP4B1:ENST00000369566.3:intron_variant:MODIFIER:intron2/2:c.339-877C>T::,AP4B1:ENST00000369567.1:intron_variant:MODIFIER:intron1/6:c.114-877C>T::,AP4B1:ENST00000369569.1:synonymous_variant:LOW:exon4/10:c.576C>T:p.Gly192=:PF01602 [Adaptin N terminal region]	AP4B1:NM_001253852.3:synonymous_variant:LOW:exon4/10:c.576C>T:p.Gly192=:,AP4B1:NM_001253853.3:synonymous_variant:LOW:exon5/11:c.279C>T:p.Gly93=:,AP4B1:NM_001308312.2:intron_variant:MODIFIER:intron1/6:c.114-877C>T::,AP4B1:NM_006594.5:synonymous_variant:LOW:exon5/11:c.576C>T:p.Gly192=:		607245 [GENE=AP4B1 PHENOS=Spastic paraplegia 47,autosomal recessive,614066,Autosomal recessive];	157723 [benign DISEASE=History of neurodevelopmental disorder,not specified];			rs17464525	0.1224	0.1695	514,.	0.0891,0.0919,0.1826,0.1933,0.1185	-1.5830			0.04,0.44	11.87					-0.0819	0.6594	0.18	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AP4B1-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), AP4B1 (inh=AR oe_syn=1.01 oe_mis=0.98 oe_lof=0.57), DCLRE1B (inh=n/a oe_syn=0.95 oe_mis=0.91 oe_lof=0.20)
chr1	155205669	155205669	G	T	hom	off-target	QUAL=1609;DP=56;AF=1.00;MQM=54;SAP=3;ABP=0	GBA	intron	GBA:ENST00000327247.5:intron_variant:MODIFIER:intron9/11:c.1225-34C>A::,GBA:ENST00000368373.3:intron_variant:MODIFIER:intron8/10:c.1225-34C>A::,GBA:ENST00000427500.3:intron_variant:MODIFIER:intron7/9:c.1078-34C>A::,GBA:ENST00000428024.3:intron_variant:MODIFIER:intron7/9:c.964-34C>A::,GBA:ENST00000536770.1:intron_variant:MODIFIER:intron6/8:c.886-34C>A::	GBA:NM_000157.4:intron_variant:MODIFIER:intron8/10:c.1225-34C>A::,GBA:NM_001005741.3:intron_variant:MODIFIER:intron9/11:c.1225-34C>A::,GBA:NM_001005742.3:intron_variant:MODIFIER:intron9/11:c.1225-34C>A::,GBA:NM_001171811.2:intron_variant:MODIFIER:intron7/9:c.964-34C>A::,GBA:NM_001171812.2:intron_variant:MODIFIER:intron7/9:c.1078-34C>A::	regulatory_region_variant:promoter_flanking_region	606463 [GENE=GBA PHENOS=Gaucher disease,type III,231000,Autosomal recessive/Parkinson disease,late-onset,susceptibility to,168600,Multifactorial,Autosomal dominant/Gaucher disease,type IIIC,231005,Autosomal recessive/Gaucher disease,type I,230800,Autosomal recessive/Gaucher disease,perinatal lethal,608013,Autosomal recessive/Gaucher disease,type II,230900,Autosomal recessive/Lewy body dementia,susceptibility to,127750,Autosomal dominant];	256871 [benign DISEASE=Gaucher disease,not specified,not provided];			rs3115534		0.9866	14293,.	0.8399,0.9923,0.9996,0.9975,0.9983	0.6620			0.00,0.04	7.96					-0.1359	0.2207	0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTX1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), GBA (inh=AR oe_syn=1.05 oe_mis=0.81 oe_lof=0.51)
chr1	155207387	155207387	A	T	het	off-target	QUAL=1506;DP=129;AF=0.50;MQM=52;SAP=31;ABP=3	GBA	intron	GBA:ENST00000327247.5:intron_variant:MODIFIER:intron7/11:c.762-18T>A::,GBA:ENST00000368373.3:intron_variant:MODIFIER:intron6/10:c.762-18T>A::,GBA:ENST00000427500.3:intron_variant:MODIFIER:intron5/9:c.615-18T>A::,GBA:ENST00000428024.3:intron_variant:MODIFIER:intron5/9:c.501-18T>A::,GBA:ENST00000536770.1:intron_variant:MODIFIER:intron4/8:c.423-18T>A::	GBA:NM_000157.4:intron_variant:MODIFIER:intron6/10:c.762-18T>A::,GBA:NM_001005741.3:intron_variant:MODIFIER:intron7/11:c.762-18T>A::,GBA:NM_001005742.3:intron_variant:MODIFIER:intron7/11:c.762-18T>A::,GBA:NM_001171811.2:intron_variant:MODIFIER:intron5/9:c.501-18T>A::,GBA:NM_001171812.2:intron_variant:MODIFIER:intron5/9:c.615-18T>A::		606463 [GENE=GBA PHENOS=Gaucher disease,type III,231000,Autosomal recessive/Parkinson disease,late-onset,susceptibility to,168600,Multifactorial,Autosomal dominant/Gaucher disease,type IIIC,231005,Autosomal recessive/Gaucher disease,type I,230800,Autosomal recessive/Gaucher disease,perinatal lethal,608013,Autosomal recessive/Gaucher disease,type II,230900,Autosomal recessive/Lewy body dementia,susceptibility to,127750,Autosomal dominant];	198756 [benign DISEASE=not specified,not provided];			rs140335079	0.0018	0.0090	2,.	0.0026,0.0034,0.0001,0.0130,0.0014	-0.0700			0.03,0.11	6.51		10.84>7.92			-1.0984	0.8734	0.03	2	420	1 / 139					MTX1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), GBA (inh=AR oe_syn=1.05 oe_mis=0.81 oe_lof=0.51)
chr1	173819421	173819421	-	A	het	off-target;low_conf_region	QUAL=287;DP=22;AF=0.59;MQM=60;SAP=5;ABP=5	DARS2	intron	DARS2:ENST00000239457.5:intron_variant:MODIFIER:intron12/15:c.-63-29dup::,DARS2:ENST00000361951.4:intron_variant:MODIFIER:intron12/16:c.1192-29dup::	DARS2:NM_001365212.1:intron_variant:MODIFIER:intron12/15:c.1192-3051dup::,DARS2:NM_001365213.2:intron_variant:MODIFIER:intron12/13:c.1192-29dup::,DARS2:NM_018122.5:intron_variant:MODIFIER:intron12/16:c.1192-29dup::		610956 [GENE=DARS2 PHENOS=Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation,611105,Autosomal recessive];				rs199872112		0.3904	1164,.	0.3896,0.3553,0.3950,0.3300,0.3684					0.79					-0.0581	0.3293	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DARS2 (inh=AR oe_syn=0.89 oe_mis=0.82 oe_lof=0.66)
chr2	75425623	75425623	G	A	het	off-target	QUAL=2664;DP=192;AF=0.57;MQM=60;SAP=10;ABP=11	TACR1	intron	TACR1:ENST00000305249.5:intron_variant:MODIFIER:intron1/4:c.389+49C>T::,TACR1:ENST00000409848.3:intron_variant:MODIFIER:intron1/3:c.389+49C>T::	TACR1:NM_001058.4:intron_variant:MODIFIER:intron1/4:c.389+49C>T::,TACR1:NM_015727.3:intron_variant:MODIFIER:intron1/3:c.389+49C>T::						rs2024512	0.5409	0.5451	4975,.	0.8042,0.4415,0.4058,0.4642,0.3919	-0.9380			0.00,0.10	5.03					0.1816	0.4221	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TACR1 (inh=n/a oe_syn=0.99 oe_mis=0.90 oe_lof=0.50)
chr2	75425728	75425728	A	G	het		QUAL=2756;DP=238;AF=0.48;MQM=60;SAP=17;ABP=4	TACR1	synonymous	TACR1:ENST00000305249.5:synonymous_variant:LOW:exon1/5:c.333T>C:p.Phe111=:PF00001 [7 transmembrane receptor (rhodopsin family)],TACR1:ENST00000409848.3:synonymous_variant:LOW:exon1/4:c.333T>C:p.Phe111=:PF00001 [7 transmembrane receptor (rhodopsin family)]	TACR1:NM_001058.4:synonymous_variant:LOW:exon1/5:c.333T>C:p.Phe111=:,TACR1:NM_015727.3:synonymous_variant:LOW:exon1/4:c.333T>C:p.Phe111=:						rs6715729	0.5651	0.5683	5509,.	0.8609,0.4565,0.4070,0.4755,0.4001	1.1620			0.19,0.96	14.08					0.001	0.4239	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TACR1 (inh=n/a oe_syn=0.99 oe_mis=0.90 oe_lof=0.50)
chr2	86479035	86479035	A	G	het	off-target	QUAL=1895;DP=114;AF=0.64;MQM=60;SAP=3;ABP=23	REEP1	intron	REEP1:ENST00000165698.5:intron_variant:MODIFIER:intron5/6:c.417+45T>C::,REEP1:ENST00000535845.1:intron_variant:MODIFIER:intron4/5:c.336+45T>C::,REEP1:ENST00000538924.1:intron_variant:MODIFIER:intron5/6:c.438+45T>C::,REEP1:ENST00000540790.1:intron_variant:MODIFIER:intron6/7:c.354+45T>C::,REEP1:ENST00000541910.1:intron_variant:MODIFIER:intron3/4:c.182+12053T>C::	REEP1:NM_001164730.2:intron_variant:MODIFIER:intron5/6:c.438+45T>C::,REEP1:NM_001164731.2:intron_variant:MODIFIER:intron4/5:c.336+45T>C::,REEP1:NM_001164732.2:intron_variant:MODIFIER:intron3/4:c.182+12053T>C::,REEP1:NM_001371279.1:intron_variant:MODIFIER:intron5/8:c.417+45T>C::,REEP1:NM_001371280.1:intron_variant:MODIFIER:intron5/5:c.417+45T>C::,REEP1:NM_022912.3:intron_variant:MODIFIER:intron5/6:c.417+45T>C::		609139 [GENE=REEP1 PHENOS=Spastic paraplegia 31,autosomal dominant,610250,Autosomal dominant/Neuronopathy,distal hereditary motor,type VB,614751,Autosomal dominant];				rs12988844	0.4339	0.5042	3107,.	0.1457,0.6257,0.6642,0.4870,0.4965	-0.8200			0.00,0.10	4.44					-0.0964	0.8857	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					REEP1 (inh=AD oe_syn=1.06 oe_mis=0.66 oe_lof=0.00)
chr2	86481835	86481835	C	T	het		QUAL=359;DP=42;AF=0.38;MQM=60;SAP=5;ABP=8	REEP1	synonymous,intron	REEP1:ENST00000165698.5:synonymous_variant:LOW:exon4/7:c.285G>A:p.Thr95=:PF03134 [TB2/DP1 HVA22 family],REEP1:ENST00000535845.1:synonymous_variant:LOW:exon3/6:c.204G>A:p.Thr68=:PF03134 [TB2/DP1 HVA22 family],REEP1:ENST00000538924.1:synonymous_variant:LOW:exon4/7:c.306G>A:p.Thr102=:PF03134 [TB2/DP1 HVA22 family],REEP1:ENST00000540790.1:synonymous_variant:LOW:exon5/8:c.222G>A:p.Thr74=:PF03134 [TB2/DP1 HVA22 family],REEP1:ENST00000541910.1:intron_variant:MODIFIER:intron3/4:c.182+9253G>A::	REEP1:NM_001164730.2:synonymous_variant:LOW:exon4/7:c.306G>A:p.Thr102=:,REEP1:NM_001164731.2:synonymous_variant:LOW:exon3/6:c.204G>A:p.Thr68=:,REEP1:NM_001164732.2:intron_variant:MODIFIER:intron3/4:c.182+9253G>A::,REEP1:NM_001371279.1:synonymous_variant:LOW:exon4/9:c.285G>A:p.Thr95=:,REEP1:NM_001371280.1:synonymous_variant:LOW:exon4/6:c.285G>A:p.Thr95=:,REEP1:NM_022912.3:synonymous_variant:LOW:exon4/7:c.285G>A:p.Thr95=:	regulatory_region_variant:promoter_flanking_region	609139 [GENE=REEP1 PHENOS=Spastic paraplegia 31,autosomal dominant,610250,Autosomal dominant/Neuronopathy,distal hereditary motor,type VB,614751,Autosomal dominant];	130108 [benign DISEASE=Spastic paraplegia 31, autosomal dominant,not specified];			rs2276625	0.4287	0.4749	2734,.	0.2195,0.6190,0.6072,0.4496,0.4544	-2.8240			0.02,0.13	0.39					-0.1984	0.306	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					REEP1 (inh=AD oe_syn=1.06 oe_mis=0.66 oe_lof=0.00)
chr2	86509267	86509267	G	A	het	off-target	QUAL=147;DP=15;AF=0.53;MQM=60;SAP=20;ABP=3	REEP1	intron	REEP1:ENST00000165698.5:intron_variant:MODIFIER:intron2/6:c.105+26C>T::,REEP1:ENST00000535845.1:intron_variant:MODIFIER:intron1/5:c.25-18103C>T::,REEP1:ENST00000538924.1:intron_variant:MODIFIER:intron2/6:c.126+26C>T::,REEP1:ENST00000540790.1:intron_variant:MODIFIER:intron2/7:c.-92+26C>T::,REEP1:ENST00000541910.1:intron_variant:MODIFIER:intron2/4:c.105+26C>T::	REEP1:NM_001164730.2:intron_variant:MODIFIER:intron2/6:c.126+26C>T::,REEP1:NM_001164731.2:intron_variant:MODIFIER:intron1/5:c.25-18103C>T::,REEP1:NM_001164732.2:intron_variant:MODIFIER:intron2/4:c.105+26C>T::,REEP1:NM_001371279.1:intron_variant:MODIFIER:intron2/8:c.105+26C>T::,REEP1:NM_001371280.1:intron_variant:MODIFIER:intron2/5:c.105+26C>T::,REEP1:NM_022912.3:intron_variant:MODIFIER:intron2/6:c.105+26C>T::		609139 [GENE=REEP1 PHENOS=Spastic paraplegia 31,autosomal dominant,610250,Autosomal dominant/Neuronopathy,distal hereditary motor,type VB,614751,Autosomal dominant];				rs1863058	0.4054	0.4692	2620,.	0.1563,0.6246,0.5927,0.4473,0.4537	0.4650			0.03,0.17	3.43					0.1868	0.3335	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					REEP1 (inh=AD oe_syn=1.06 oe_mis=0.66 oe_lof=0.00)
chr2	86509388	86509388	T	G	het	off-target	QUAL=1415;DP=94;AF=0.57;MQM=60;SAP=6;ABP=8	REEP1	intron	REEP1:ENST00000165698.5:intron_variant:MODIFIER:intron1/6:c.33-23A>C::,REEP1:ENST00000535845.1:intron_variant:MODIFIER:intron1/5:c.25-18224A>C::,REEP1:ENST00000538924.1:intron_variant:MODIFIER:intron1/6:c.54-23A>C::,REEP1:ENST00000540790.1:intron_variant:MODIFIER:intron1/7:c.-164-23A>C::,REEP1:ENST00000541910.1:intron_variant:MODIFIER:intron1/4:c.33-23A>C::	REEP1:NM_001164730.2:intron_variant:MODIFIER:intron1/6:c.54-23A>C::,REEP1:NM_001164731.2:intron_variant:MODIFIER:intron1/5:c.25-18224A>C::,REEP1:NM_001164732.2:intron_variant:MODIFIER:intron1/4:c.33-23A>C::,REEP1:NM_001371279.1:intron_variant:MODIFIER:intron1/8:c.33-23A>C::,REEP1:NM_001371280.1:intron_variant:MODIFIER:intron1/5:c.33-23A>C::,REEP1:NM_022912.3:intron_variant:MODIFIER:intron1/6:c.33-23A>C::		609139 [GENE=REEP1 PHENOS=Spastic paraplegia 31,autosomal dominant,610250,Autosomal dominant/Neuronopathy,distal hereditary motor,type VB,614751,Autosomal dominant];				rs1863059		0.5401	4525,.	0.5857,0.6578,0.6512,0.4864,0.5263	0.0320			0.01,0.13	1.89					0.1297	0.0766	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					REEP1 (inh=AD oe_syn=1.06 oe_mis=0.66 oe_lof=0.00)
chr2	171702480	171702480	C	T	hom	off-target	QUAL=2653;DP=80;AF=1.00;MQM=60;SAP=27;ABP=0	GAD1	intron	GAD1:ENST00000358196.3:intron_variant:MODIFIER:intron9/16:c.948-39C>T::	GAD1:NM_000817.3:intron_variant:MODIFIER:intron9/16:c.948-39C>T::		605363 [GENE=GAD1 PHENOS=Cerebral palsy,spastic quadriplegic,1,603513,Autosomal recessive/Developmental and epileptic encephalopathy 89,619124,Autosomal recessive];				rs701492	0.2929	0.2975	1221,.	0.2617,0.3250,0.2845,0.2771,0.3824	0.9850			0.02,0.35	12.55					0.0684	0.036	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GAD1 (inh=AR oe_syn=0.97 oe_mis=0.64 oe_lof=0.27)
chr2	171705158	171705158	T	-	het	off-target	QUAL=107;DP=79;AF=0.18;MQM=60;SAP=3;ABP=75	GAD1	intron	GAD1:ENST00000358196.3:intron_variant:MODIFIER:intron11/16:c.1120-628del::	GAD1:NM_000817.3:intron_variant:MODIFIER:intron11/16:c.1120-628del::	regulatory_region_variant:open_chromatin_region	605363 [GENE=GAD1 PHENOS=Cerebral palsy,spastic quadriplegic,1,603513,Autosomal recessive/Developmental and epileptic encephalopathy 89,619124,Autosomal recessive];				rs35403424		0.5261	2000,.	0.2575,0.5159,0.3730,0.5626,0.5309	0.3650				0.87					0.0774	0.5751	0.05	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GAD1 (inh=AR oe_syn=0.97 oe_mis=0.64 oe_lof=0.27)
chr2	198362018	198362018	T	C	het		QUAL=1578;DP=122;AF=0.49;MQM=60;SAP=10;ABP=3	HSPD1	synonymous	HSPD1:ENST00000345042.2:synonymous_variant:LOW:exon3/12:c.273A>G:p.Lys91=:PF00118 [TCP-1/cpn60 chaperonin family],HSPD1:ENST00000388968.3:synonymous_variant:LOW:exon3/12:c.273A>G:p.Lys91=:PF00118 [TCP-1/cpn60 chaperonin family],HSPD1:ENST00000544407.1:synonymous_variant:LOW:exon3/3:c.273A>G:p.Lys91=:PF00118 [TCP-1/cpn60 chaperonin family]	HSPD1:NM_002156.5:synonymous_variant:LOW:exon3/12:c.273A>G:p.Lys91=:,HSPD1:NM_199440.1:synonymous_variant:LOW:exon3/12:c.273A>G:p.Lys91=:	regulatory_region_variant:promoter	118190 [GENE=HSPD1 PHENOS=Spastic paraplegia 13,autosomal dominant,605280,Autosomal dominant/Leukodystrophy,hypomyelinating,4,612233,Autosomal recessive];	129241 [benign DISEASE=Spastic paraplegia,Hereditary spastic paraplegia 13,not specified];			rs8539	0.6546	0.6454	6578,.	0.7151,0.4896,0.5121,0.6797,0.6948	0.7910			0.65,0.89	12.52					0.5213	0.938	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPD1 (inh=AR+AD oe_syn=1.00 oe_mis=0.64 oe_lof=0.09), HSPE1 (inh=n/a oe_syn=1.35 oe_mis=0.44 oe_lof=0.00), HSPE1-MOB4 (inh=n/a oe_syn=1.04 oe_mis=0.32 oe_lof=0.07)
chr2	202570232	202570232	A	G	hom	off-target	QUAL=1182;DP=36;AF=1.00;MQM=60;SAP=7;ABP=0	ALS2	intron	ALS2:ENST00000264276.6:intron_variant:MODIFIER:intron29/33:c.4581-48T>C::,ALS2:ENST00000457679.2:intron_variant:MODIFIER:intron21/25:c.*929-48T>C::	ALS2:NM_020919.4:intron_variant:MODIFIER:intron29/33:c.4581-48T>C::		606352 [GENE=ALS2 PHENOS=Primary lateral sclerosis,juvenile,606353,Autosomal recessive/Amyotrophic lateral sclerosis 2,juvenile,205100,Autosomal recessive/Spastic paralysis,infantile onset ascending,607225,Autosomal recessive];	261379 [benign DISEASE=not specified];			rs3219170	0.9059	0.9231	12722,.	0.8205,0.8930,0.9857,0.9211,0.9599	0.0080			0.00,0.07	7.38					-0.1175	0.188	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALS2 (inh=AR oe_syn=0.97 oe_mis=0.82 oe_lof=0.39)
chr2	202575821	202575821	G	A	hom		QUAL=2960;DP=95;AF=1.00;MQM=60;SAP=4;ABP=0	ALS2	synonymous,3'UTR	ALS2:ENST00000264276.6:synonymous_variant:LOW:exon26/34:c.4015C>T:p.Leu1339=:,ALS2:ENST00000457679.2:3_prime_UTR_variant:MODIFIER:exon18/26:c.*363C>T::	ALS2:NM_020919.4:synonymous_variant:LOW:exon26/34:c.4015C>T:p.Leu1339=:		606352 [GENE=ALS2 PHENOS=Primary lateral sclerosis,juvenile,606353,Autosomal recessive/Amyotrophic lateral sclerosis 2,juvenile,205100,Autosomal recessive/Spastic paralysis,infantile onset ascending,607225,Autosomal recessive];	261377 [benign DISEASE=Amyotrophic lateral sclerosis type 2,ALS2-Related Disorders,not specified,not provided];			rs3219168	0.9053	0.9230	12721,.	0.8194,0.8924,0.9857,0.9214,0.9598	-1.9240			0.05,0.18	4.67					-0.1707	0.3773	0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALS2 (inh=AR oe_syn=0.97 oe_mis=0.82 oe_lof=0.39)
chr2	202580370	202580370	G	A	hom	off-target	QUAL=4184;DP=129;AF=1.00;MQM=60;SAP=6;ABP=0	ALS2	intron	ALS2:ENST00000264276.6:intron_variant:MODIFIER:intron25/33:c.4004+25C>T::,ALS2:ENST00000457679.2:intron_variant:MODIFIER:intron17/25:c.*352+25C>T::	ALS2:NM_020919.4:intron_variant:MODIFIER:intron25/33:c.4004+25C>T::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	606352 [GENE=ALS2 PHENOS=Primary lateral sclerosis,juvenile,606353,Autosomal recessive/Amyotrophic lateral sclerosis 2,juvenile,205100,Autosomal recessive/Spastic paralysis,infantile onset ascending,607225,Autosomal recessive];	261375 [benign DISEASE=not specified];			rs3219167	0.8041	0.8312	10466,.	0.7816,0.8578,0.7491,0.8345,0.8424	-1.3460			0.13,0.27	3.46					0.1582	0.1886	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALS2 (inh=AR oe_syn=0.97 oe_mis=0.82 oe_lof=0.39)
chr2	202593929	202593929	-	A	het	off-target	QUAL=17;DP=18;AF=0.22;MQM=60;SAP=12;ABP=15	ALS2	intron	ALS2:ENST00000264276.6:intron_variant:MODIFIER:intron13/33:c.2581-24dup::,ALS2:ENST00000457679.2:intron_variant:MODIFIER:intron4/25:c.517-24dup::	ALS2:NM_020919.4:intron_variant:MODIFIER:intron13/33:c.2581-24dup::		606352 [GENE=ALS2 PHENOS=Primary lateral sclerosis,juvenile,606353,Autosomal recessive/Amyotrophic lateral sclerosis 2,juvenile,205100,Autosomal recessive/Spastic paralysis,infantile onset ascending,607225,Autosomal recessive];				rs113406595		0.0439	0,.	0.0358,0.0529,0.0392,0.0389,0.0567					3.49					0.0233	0.0431	0.01	1	54	1 / 35					ALS2 (inh=AR oe_syn=0.97 oe_mis=0.82 oe_lof=0.39)
chr2	202598113	202598113	C	T	hom		QUAL=4814;DP=151;AF=1.00;MQM=60;SAP=25;ABP=0	ALS2	synonymous	ALS2:ENST00000264276.6:synonymous_variant:LOW:exon13/34:c.2466G>A:p.Val822=:PF00621 [RhoGEF domain],ALS2:ENST00000457679.2:synonymous_variant:LOW:exon4/26:c.402G>A:p.Val134=:PF00621 [RhoGEF domain]	ALS2:NM_020919.4:synonymous_variant:LOW:exon13/34:c.2466G>A:p.Val822=:		606352 [GENE=ALS2 PHENOS=Primary lateral sclerosis,juvenile,606353,Autosomal recessive/Amyotrophic lateral sclerosis 2,juvenile,205100,Autosomal recessive/Spastic paralysis,infantile onset ascending,607225,Autosomal recessive];	261368 [benign DISEASE=Amyotrophic lateral sclerosis type 2,ALS2-Related Disorders,not specified,not provided];			rs2276615	0.3724	0.5391	4060,.	0.1530,0.6662,0.3476,0.6126,0.3990	-0.0680			0.53,0.90	12.29					-0.2054	0.3739	0.14	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALS2 (inh=AR oe_syn=0.97 oe_mis=0.82 oe_lof=0.39)
chr2	202625615	202625615	C	T	hom		QUAL=5634;DP=166;AF=1.00;MQM=60;SAP=3;ABP=0	ALS2	missense	ALS2:ENST00000264276.6:missense_variant:MODERATE:exon4/34:c.1102G>A:p.Val368Met:,ALS2:ENST00000467448.1:missense_variant:MODERATE:exon4/4:c.1102G>A:p.Val368Met:	ALS2:NM_001135745.2:missense_variant:MODERATE:exon4/4:c.1102G>A:p.Val368Met:,ALS2:NM_020919.4:missense_variant:MODERATE:exon4/34:c.1102G>A:p.Val368Met:		606352 [GENE=ALS2 PHENOS=Primary lateral sclerosis,juvenile,606353,Autosomal recessive/Amyotrophic lateral sclerosis 2,juvenile,205100,Autosomal recessive/Spastic paralysis,infantile onset ascending,607225,Autosomal recessive];	261364 [benign DISEASE=Amyotrophic lateral sclerosis type 2,ALS2-Related Disorders,not specified,not provided];			rs3219156	0.8966	0.9133	11918,.	0.7825,0.9342,0.9998,0.9006,0.9506	-2.3590	T(0.15),T(0.16)	B(0.00),B(0.01)	0.06,0.17	0.05	0.02				0.0005	0.936	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALS2 (inh=AR oe_syn=0.97 oe_mis=0.82 oe_lof=0.39)
chr2	241659368	241659368	C	A	hom	off-target	QUAL=3795;DP=124;AF=1.00;MQM=60;SAP=3;ABP=0	KIF1A	intron	KIF1A:ENST00000320389.7:intron_variant:MODIFIER:intron43/46:c.4566-25G>T::,KIF1A:ENST00000498729.2:intron_variant:MODIFIER:intron45/49:c.4869-25G>T::	KIF1A:NM_001244008.1:intron_variant:MODIFIER:intron45/48:c.4869-25G>T::,KIF1A:NM_001320705.2:intron_variant:MODIFIER:intron44/47:c.4593-25G>T::,KIF1A:NM_001330289.2:intron_variant:MODIFIER:intron45/48:c.4620-25G>T::,KIF1A:NM_001330290.2:intron_variant:MODIFIER:intron44/47:c.4668-25G>T::,KIF1A:NM_004321.7:intron_variant:MODIFIER:intron43/46:c.4566-25G>T::		601255 [GENE=KIF1A PHENOS=NESCAV syndrome,614255,Autosomal dominant/Spastic paraplegia 30,autosomal dominant,610357,Autosomal recessive,Autosomal dominant/Neuropathy,hereditary sensory,type IIC,614213,Autosomal recessive/Spastic paraplegia 30,autosomal recessive,610357,Autosomal recessive,Autosomal dominant];	670495 [benign DISEASE=not provided];			rs6437368		0.7885	9706,.	0.8324,0.8088,0.9064,0.7484,0.7619	-1.2010			0.01,0.09	0.62					0.0284	0.2744	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1A (inh=AR+AD oe_syn=1.00 oe_mis=0.57 oe_lof=0.07)
chr2	241674222	241674222	T	C	het	off-target	QUAL=1204;DP=67;AF=0.70;MQM=60;SAP=3;ABP=27	KIF1A	intron	KIF1A:ENST00000320389.7:intron_variant:MODIFIER:intron36/46:c.3704+2258A>G::,KIF1A:ENST00000498729.2:intron_variant:MODIFIER:intron38/49:c.4007+2258A>G::	KIF1A:NM_001244008.1:intron_variant:MODIFIER:intron38/48:c.4007+2258A>G::,KIF1A:NM_001320705.2:intron_variant:MODIFIER:intron37/47:c.3731+2258A>G::,KIF1A:NM_001330289.2:intron_variant:MODIFIER:intron37/48:c.3732-60A>G::,KIF1A:NM_001330290.2:intron_variant:MODIFIER:intron37/47:c.3806+2258A>G::,KIF1A:NM_004321.7:intron_variant:MODIFIER:intron36/46:c.3704+2258A>G::		601255 [GENE=KIF1A PHENOS=NESCAV syndrome,614255,Autosomal dominant/Spastic paraplegia 30,autosomal dominant,610357,Autosomal recessive,Autosomal dominant/Neuropathy,hereditary sensory,type IIC,614213,Autosomal recessive/Spastic paraplegia 30,autosomal recessive,610357,Autosomal recessive,Autosomal dominant];			G-rich (Low_complexity)	rs3755533		0.7776	9513,.		-0.0140			0.00,0.05	0.13					-0.0188	0.3696	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1A (inh=AR+AD oe_syn=1.00 oe_mis=0.57 oe_lof=0.07)
chr2	241680633	241680633	G	T	het	off-target	QUAL=1253;DP=87;AF=0.57;MQM=60;SAP=12;ABP=7	KIF1A	intron	KIF1A:ENST00000320389.7:intron_variant:MODIFIER:intron33/46:c.3446+53C>A::,KIF1A:ENST00000498729.2:intron_variant:MODIFIER:intron35/49:c.3749+53C>A::	KIF1A:NM_001244008.1:intron_variant:MODIFIER:intron35/48:c.3749+53C>A::,KIF1A:NM_001320705.2:intron_variant:MODIFIER:intron34/47:c.3473+53C>A::,KIF1A:NM_001330289.2:intron_variant:MODIFIER:intron34/48:c.3473+53C>A::,KIF1A:NM_001330290.2:intron_variant:MODIFIER:intron34/47:c.3548+53C>A::,KIF1A:NM_004321.7:intron_variant:MODIFIER:intron33/46:c.3446+53C>A::		601255 [GENE=KIF1A PHENOS=NESCAV syndrome,614255,Autosomal dominant/Spastic paraplegia 30,autosomal dominant,610357,Autosomal recessive,Autosomal dominant/Neuropathy,hereditary sensory,type IIC,614213,Autosomal recessive/Spastic paraplegia 30,autosomal recessive,610357,Autosomal recessive,Autosomal dominant];	670535 [benign DISEASE=not provided];			rs4414678	0.4914	0.4235	2886,.		-3.2840			0.01,0.06	0.01					-0.0276	0.2212	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1A (inh=AR+AD oe_syn=1.00 oe_mis=0.57 oe_lof=0.07)
chr2	241680802	241680802	G	A	het		QUAL=1469;DP=125;AF=0.48;MQM=60;SAP=5;ABP=3	KIF1A	splice_region&intron	KIF1A:ENST00000320389.7:splice_region_variant&intron_variant:LOW:intron32/46:c.3338-8C>T::,KIF1A:ENST00000498729.2:splice_region_variant&intron_variant:LOW:intron34/49:c.3641-8C>T::	KIF1A:NM_001244008.1:splice_region_variant&intron_variant:LOW:intron34/48:c.3641-8C>T::,KIF1A:NM_001320705.2:splice_region_variant&intron_variant:LOW:intron33/47:c.3365-8C>T::,KIF1A:NM_001330289.2:splice_region_variant&intron_variant:LOW:intron33/48:c.3365-8C>T::,KIF1A:NM_001330290.2:splice_region_variant&intron_variant:LOW:intron33/47:c.3440-8C>T::,KIF1A:NM_004321.7:splice_region_variant&intron_variant:LOW:intron32/46:c.3338-8C>T::		601255 [GENE=KIF1A PHENOS=NESCAV syndrome,614255,Autosomal dominant/Spastic paraplegia 30,autosomal dominant,610357,Autosomal recessive,Autosomal dominant/Neuropathy,hereditary sensory,type IIC,614213,Autosomal recessive/Spastic paraplegia 30,autosomal recessive,610357,Autosomal recessive,Autosomal dominant];	129391 [benign DISEASE=Spastic paraplegia 30, autosomal recessive,not specified];			rs56024577	0.2909	0.3473	1120,.	0.0590,0.5092,0.4530,0.2773,0.4830	1.9570			0.08,0.22	3.07		11.38>10.45	0.000/0.008		-0.0901	0.2516	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1A (inh=AR+AD oe_syn=1.00 oe_mis=0.57 oe_lof=0.07)
chr2	241696841	241696843	TCC	-	het	low_conf_region	QUAL=652;DP=106;AF=0.33;MQM=60;SAP=17;ABP=30	KIF1A	intron,inframe_deletion	KIF1A:ENST00000320389.7:intron_variant:MODIFIER:intron25/46:c.2555+934_2555+936del::,KIF1A:ENST00000498729.2:inframe_deletion:MODERATE:exon27/50:c.2751_2753del:p.Glu917del:	KIF1A:NM_001244008.1:inframe_deletion:MODERATE:exon27/49:c.2751_2753del:p.Glu917del:,KIF1A:NM_001320705.2:intron_variant:MODIFIER:intron26/47:c.2582+934_2582+936del::,KIF1A:NM_001330289.2:intron_variant:MODIFIER:intron26/48:c.2582+934_2582+936del::,KIF1A:NM_001330290.2:intron_variant:MODIFIER:intron26/47:c.2657+934_2657+936del::,KIF1A:NM_004321.7:intron_variant:MODIFIER:intron25/46:c.2555+934_2555+936del::		601255 [GENE=KIF1A PHENOS=NESCAV syndrome,614255,Autosomal dominant/Spastic paraplegia 30,autosomal dominant,610357,Autosomal recessive,Autosomal dominant/Neuropathy,hereditary sensory,type IIC,614213,Autosomal recessive/Spastic paraplegia 30,autosomal recessive,610357,Autosomal recessive,Autosomal dominant];	284274 [benign DISEASE=not specified];		(TCC)n (Simple_repeat)	rs10594016		0.6662	5941,.	0.7732,0.4491,0.6456,0.5382,0.4386	1.3570				17.50					-0.03	0.4892	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1A (inh=AR+AD oe_syn=1.00 oe_mis=0.57 oe_lof=0.07)
chr2	241702561	241702561	T	A	het	off-target	QUAL=613;DP=46;AF=0.59;MQM=60;SAP=4;ABP=6	KIF1A	intron	KIF1A:ENST00000320389.7:intron_variant:MODIFIER:intron20/46:c.1922+22A>T::,KIF1A:ENST00000498729.2:intron_variant:MODIFIER:intron21/49:c.1949+22A>T::	KIF1A:NM_001244008.1:intron_variant:MODIFIER:intron21/48:c.1949+22A>T::,KIF1A:NM_001320705.2:intron_variant:MODIFIER:intron21/47:c.1949+22A>T::,KIF1A:NM_001330289.2:intron_variant:MODIFIER:intron21/48:c.1949+22A>T::,KIF1A:NM_001330290.2:intron_variant:MODIFIER:intron21/47:c.2024+22A>T::,KIF1A:NM_004321.7:intron_variant:MODIFIER:intron20/46:c.1922+22A>T::		601255 [GENE=KIF1A PHENOS=NESCAV syndrome,614255,Autosomal dominant/Spastic paraplegia 30,autosomal dominant,610357,Autosomal recessive,Autosomal dominant/Neuropathy,hereditary sensory,type IIC,614213,Autosomal recessive/Spastic paraplegia 30,autosomal recessive,610357,Autosomal recessive,Autosomal dominant];	671033 [benign DISEASE=not provided];			rs11688298		0.5891	5494,.	0.6882,0.3966,0.6637,0.5612,0.4066	-0.3070			0.02,0.11	0.62					0.0064	0.1142	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1A (inh=AR+AD oe_syn=1.00 oe_mis=0.57 oe_lof=0.07)
chr2	241708675	241708675	C	T	het	off-target	QUAL=929;DP=74;AF=0.49;MQM=60;SAP=3;ABP=3	KIF1A	intron	KIF1A:ENST00000320389.7:intron_variant:MODIFIER:intron15/46:c.1395-50G>A::,KIF1A:ENST00000498729.2:intron_variant:MODIFIER:intron16/49:c.1422-50G>A::	KIF1A:NM_001244008.1:intron_variant:MODIFIER:intron16/48:c.1422-50G>A::,KIF1A:NM_001320705.2:intron_variant:MODIFIER:intron16/47:c.1422-50G>A::,KIF1A:NM_001330289.2:intron_variant:MODIFIER:intron16/48:c.1422-50G>A::,KIF1A:NM_001330290.2:intron_variant:MODIFIER:intron16/47:c.1497-50G>A::,KIF1A:NM_004321.7:intron_variant:MODIFIER:intron15/46:c.1395-50G>A::		601255 [GENE=KIF1A PHENOS=NESCAV syndrome,614255,Autosomal dominant/Spastic paraplegia 30,autosomal dominant,610357,Autosomal recessive,Autosomal dominant/Neuropathy,hereditary sensory,type IIC,614213,Autosomal recessive/Spastic paraplegia 30,autosomal recessive,610357,Autosomal recessive,Autosomal dominant];	682837 [benign DISEASE=not provided];			rs2288753	0.3353	0.2858	1322,.	0.2629,0.2411,0.5476,0.2792,0.2583	0.5240			0.06,0.19	6.32					-0.0516	0.1668	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1A (inh=AR+AD oe_syn=1.00 oe_mis=0.57 oe_lof=0.07)
chr2	241713646	241713646	A	G	het		QUAL=747;DP=86;AF=0.43;MQM=60;SAP=46;ABP=7	KIF1A	synonymous	KIF1A:ENST00000320389.7:synonymous_variant:LOW:exon12/47:c.991T>C:p.Leu331=:PF00225 [Kinesin motor domain],KIF1A:ENST00000498729.2:synonymous_variant:LOW:exon12/50:c.991T>C:p.Leu331=:PF00225 [Kinesin motor domain]	KIF1A:NM_001244008.1:synonymous_variant:LOW:exon12/49:c.991T>C:p.Leu331=:,KIF1A:NM_001320705.2:synonymous_variant:LOW:exon12/48:c.991T>C:p.Leu331=:,KIF1A:NM_001330289.2:synonymous_variant:LOW:exon12/49:c.991T>C:p.Leu331=:,KIF1A:NM_001330290.2:synonymous_variant:LOW:exon12/48:c.991T>C:p.Leu331=:,KIF1A:NM_004321.7:synonymous_variant:LOW:exon12/47:c.991T>C:p.Leu331=:		601255 [GENE=KIF1A PHENOS=NESCAV syndrome,614255,Autosomal dominant/Spastic paraplegia 30,autosomal dominant,610357,Autosomal recessive,Autosomal dominant/Neuropathy,hereditary sensory,type IIC,614213,Autosomal recessive/Spastic paraplegia 30,autosomal recessive,610357,Autosomal recessive,Autosomal dominant];	129396 [benign DISEASE=Spastic paraplegia 30, autosomal recessive,History of neurodevelopmental disorder,not specified];			rs1063353	0.5136	0.4482	3521,.	0.6824,0.3037,0.5880,0.3509,0.3156	6.4660			0.05,0.95	11.10					-0.0673	0.0754	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1A (inh=AR+AD oe_syn=1.00 oe_mis=0.57 oe_lof=0.07)
chr2	241722445	241722445	G	A	het		QUAL=2673;DP=147;AF=0.71;MQM=60;SAP=4;ABP=62	KIF1A	intron	KIF1A:ENST00000320389.7:intron_variant:MODIFIER:intron9/46:c.864+16C>T::,KIF1A:ENST00000498729.2:intron_variant:MODIFIER:intron9/49:c.864+16C>T::	KIF1A:NM_001244008.1:intron_variant:MODIFIER:intron9/48:c.864+16C>T::,KIF1A:NM_001320705.2:intron_variant:MODIFIER:intron9/47:c.864+16C>T::,KIF1A:NM_001330289.2:intron_variant:MODIFIER:intron9/48:c.864+16C>T::,KIF1A:NM_001330290.2:intron_variant:MODIFIER:intron9/47:c.864+16C>T::,KIF1A:NM_004321.7:intron_variant:MODIFIER:intron9/46:c.864+16C>T::		601255 [GENE=KIF1A PHENOS=NESCAV syndrome,614255,Autosomal dominant/Spastic paraplegia 30,autosomal dominant,610357,Autosomal recessive,Autosomal dominant/Neuropathy,hereditary sensory,type IIC,614213,Autosomal recessive/Spastic paraplegia 30,autosomal recessive,610357,Autosomal recessive,Autosomal dominant];	283505 [benign DISEASE=not specified];			rs2288750	0.2883	0.2714	1334,.	0.4426,0.2630,0.3270,0.2003,0.1058	-0.9150			0.01,0.11	0.80					0.1276	0.0264	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1A (inh=AR+AD oe_syn=1.00 oe_mis=0.57 oe_lof=0.07)
chr2	241726646	241726646	A	G	het	off-target	QUAL=2117;DP=172;AF=0.47;MQM=60;SAP=3;ABP=4	KIF1A	intron	KIF1A:ENST00000320389.7:intron_variant:MODIFIER:intron5/46:c.429+22T>C::,KIF1A:ENST00000498729.2:intron_variant:MODIFIER:intron5/49:c.429+22T>C::	KIF1A:NM_001244008.1:intron_variant:MODIFIER:intron5/48:c.429+22T>C::,KIF1A:NM_001320705.2:intron_variant:MODIFIER:intron5/47:c.429+22T>C::,KIF1A:NM_001330289.2:intron_variant:MODIFIER:intron5/48:c.429+22T>C::,KIF1A:NM_001330290.2:intron_variant:MODIFIER:intron5/47:c.429+22T>C::,KIF1A:NM_004321.7:intron_variant:MODIFIER:intron5/46:c.429+22T>C::		601255 [GENE=KIF1A PHENOS=NESCAV syndrome,614255,Autosomal dominant/Spastic paraplegia 30,autosomal dominant,610357,Autosomal recessive,Autosomal dominant/Neuropathy,hereditary sensory,type IIC,614213,Autosomal recessive/Spastic paraplegia 30,autosomal recessive,610357,Autosomal recessive,Autosomal dominant];	673387 [benign DISEASE=not provided];			rs2288746	0.4832	0.4921	4074,.	0.7088,0.3868,0.4291,0.4251,0.2886	-2.4950			0.00,0.10	6.76					-0.4019	0.0906	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1A (inh=AR+AD oe_syn=1.00 oe_mis=0.57 oe_lof=0.07)
chr2	241737017	241737017	C	A	hom	off-target	QUAL=3248;DP=99;AF=1.00;MQM=60;SAP=4;ABP=0	KIF1A	intron	KIF1A:ENST00000320389.7:intron_variant:MODIFIER:intron2/46:c.106+47G>T::,KIF1A:ENST00000498729.2:intron_variant:MODIFIER:intron2/49:c.106+47G>T::	KIF1A:NM_001244008.1:intron_variant:MODIFIER:intron2/48:c.106+47G>T::,KIF1A:NM_001320705.2:intron_variant:MODIFIER:intron2/47:c.106+47G>T::,KIF1A:NM_001330289.2:intron_variant:MODIFIER:intron2/48:c.106+47G>T::,KIF1A:NM_001330290.2:intron_variant:MODIFIER:intron2/47:c.106+47G>T::,KIF1A:NM_004321.7:intron_variant:MODIFIER:intron2/46:c.106+47G>T::		601255 [GENE=KIF1A PHENOS=NESCAV syndrome,614255,Autosomal dominant/Spastic paraplegia 30,autosomal dominant,610357,Autosomal recessive,Autosomal dominant/Neuropathy,hereditary sensory,type IIC,614213,Autosomal recessive/Spastic paraplegia 30,autosomal recessive,610357,Autosomal recessive,Autosomal dominant];	682824 [benign DISEASE=not provided];			rs10167412	0.3221	0.3448	1882,.	0.3689,0.2964,0.3975,0.3160,0.2258	-0.4920			0.03,0.18	4.92					-0.0955	0.1274	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1A (inh=AR+AD oe_syn=1.00 oe_mis=0.57 oe_lof=0.07)
chr3	33055688	33055688	T	C	het		QUAL=2060;DP=164;AF=0.51;MQM=60;SAP=3;ABP=3	GLB1	missense	GLB1:ENST00000307363.5:missense_variant:MODERATE:exon15/16:c.1594A>G:p.Ser532Gly:,GLB1:ENST00000307377.8:missense_variant:MODERATE:exon12/13:c.1201A>G:p.Ser401Gly:,GLB1:ENST00000399402.3:missense_variant:MODERATE:exon15/16:c.1504A>G:p.Ser502Gly:,GLB1:ENST00000445488.2:missense_variant:MODERATE:exon16/17:c.1738A>G:p.Ser580Gly:	GLB1:NM_000404.4:missense_variant:MODERATE:exon15/16:c.1594A>G:p.Ser532Gly:,GLB1:NM_001079811.2:missense_variant:MODERATE:exon15/16:c.1504A>G:p.Ser502Gly:,GLB1:NM_001135602.2:missense_variant:MODERATE:exon12/13:c.1201A>G:p.Ser401Gly:,GLB1:NM_001317040.1:missense_variant:MODERATE:exon16/17:c.1738A>G:p.Ser580Gly:		611458 [GENE=GLB1 PHENOS=GM1-gangliosidosis,type III,230650,Autosomal recessive/GM1-gangliosidosis,type I,230500,Autosomal recessive/Mucopolysaccharidosis type IVB (Morquio),253010,Autosomal recessive/GM1-gangliosidosis,type II,230600,Autosomal recessive];	92899 [benign/likely benign DISEASE=Mucopolysaccharidosis, MPS-IV-B,GM1 gangliosidosis,not specified,not provided];	CM074252 [CLASS=FP MUT=ALT PHEN="Reduced activity" GENE=GLB1];		rs73826339	0.0349	0.0475	42,.	0.0310,0.0404,0.0001,0.0647,0.0111	-0.4420	T(0.37),T(0.42),T(0.41),T(0.31)	B(0.00),B(0.00),B(0.00),B(0.01)	0.02,0.12	0.07	0.20				0.105	0.8527	0	78	1909	20 / 563					GLB1 (inh=AR oe_syn=0.95 oe_mis=0.88 oe_lof=0.59)
chr3	33055721	33055721	A	G	hom		QUAL=5211;DP=163;AF=1.00;MQM=60;SAP=3;ABP=0	GLB1	missense	GLB1:ENST00000307363.5:missense_variant:MODERATE:exon15/16:c.1561T>C:p.Cys521Arg:,GLB1:ENST00000307377.8:missense_variant:MODERATE:exon12/13:c.1168T>C:p.Cys390Arg:,GLB1:ENST00000399402.3:missense_variant:MODERATE:exon15/16:c.1471T>C:p.Cys491Arg:,GLB1:ENST00000445488.2:missense_variant:MODERATE:exon16/17:c.1705T>C:p.Cys569Arg:	GLB1:NM_000404.4:missense_variant:MODERATE:exon15/16:c.1561T>C:p.Cys521Arg:,GLB1:NM_001079811.2:synonymous_variant:LOW:exon15/16:c.1471T>C:p.Arg491=:,GLB1:NM_001135602.2:synonymous_variant:LOW:exon12/13:c.1168T>C:p.Arg390=:,GLB1:NM_001317040.1:synonymous_variant:LOW:exon16/17:c.1705T>C:p.Arg569=:		611458 [GENE=GLB1 PHENOS=GM1-gangliosidosis,type III,230650,Autosomal recessive/GM1-gangliosidosis,type I,230500,Autosomal recessive/Mucopolysaccharidosis type IVB (Morquio),253010,Autosomal recessive/GM1-gangliosidosis,type II,230600,Autosomal recessive];	167145 [benign DISEASE=not specified,not provided];			rs4302331	0.9271	0.9831	13949,.	0.7762,0.9867,1.0000,0.9984,0.9992	0.3470	T(0.60),T(0.85),T(0.59),T(0.59)	B(0.00),B(0.00),B(0.00),B(0.00)	0.01,0.13	12.54	0.13				0.0601	0.8519	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GLB1 (inh=AR oe_syn=0.95 oe_mis=0.88 oe_lof=0.59)
chr3	33063050	33063050	A	G	het		QUAL=1377;DP=91;AF=0.58;MQM=60;SAP=3;ABP=8	GLB1	splice_region&intron	GLB1:ENST00000307363.5:splice_region_variant&intron_variant:LOW:intron12/15:c.1233+8T>C::,GLB1:ENST00000307377.8:splice_region_variant&intron_variant:LOW:intron9/12:c.840+8T>C::,GLB1:ENST00000399402.3:splice_region_variant&intron_variant:LOW:intron12/15:c.1143+8T>C::,GLB1:ENST00000445488.2:splice_region_variant&intron_variant:LOW:intron13/16:c.1377+8T>C::	GLB1:NM_000404.4:splice_region_variant&intron_variant:LOW:intron12/15:c.1233+8T>C::,GLB1:NM_001079811.2:splice_region_variant&intron_variant:LOW:intron12/15:c.1143+8T>C::,GLB1:NM_001135602.2:splice_region_variant&intron_variant:LOW:intron9/12:c.840+8T>C::,GLB1:NM_001317040.1:splice_region_variant&intron_variant:LOW:intron13/16:c.1377+8T>C::		611458 [GENE=GLB1 PHENOS=GM1-gangliosidosis,type III,230650,Autosomal recessive/GM1-gangliosidosis,type I,230500,Autosomal recessive/Mucopolysaccharidosis type IVB (Morquio),253010,Autosomal recessive/GM1-gangliosidosis,type II,230600,Autosomal recessive];	92894 [benign/likely benign DISEASE=Mucopolysaccharidosis, MPS-IV-B,GM1 gangliosidosis,not specified,not provided];			rs13093698	0.1635	0.2140	762,.	0.2209,0.1931,0.0569,0.2195,0.1569	2.5660			0.04,0.26	10.82			0.000/0.030		0.0751	0.9122	0.08	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GLB1 (inh=AR oe_syn=0.95 oe_mis=0.88 oe_lof=0.59)
chr3	33093190	33093190	T	C	hom	off-target	QUAL=875;DP=31;AF=1.00;MQM=60;SAP=19;ABP=0	GLB1	intron	GLB1:ENST00000307363.5:intron_variant:MODIFIER:intron9/15:c.955+60A>G::,GLB1:ENST00000307377.8:intron_variant:MODIFIER:intron6/12:c.562+60A>G::,GLB1:ENST00000399402.3:intron_variant:MODIFIER:intron9/15:c.865+60A>G::,GLB1:ENST00000445488.2:intron_variant:MODIFIER:intron10/16:c.1099+60A>G::	GLB1:NM_000404.4:intron_variant:MODIFIER:intron9/15:c.955+60A>G::,GLB1:NM_001079811.2:intron_variant:MODIFIER:intron9/15:c.865+60A>G::,GLB1:NM_001135602.2:intron_variant:MODIFIER:intron6/12:c.562+60A>G::,GLB1:NM_001317040.1:intron_variant:MODIFIER:intron10/16:c.1099+60A>G::		611458 [GENE=GLB1 PHENOS=GM1-gangliosidosis,type III,230650,Autosomal recessive/GM1-gangliosidosis,type I,230500,Autosomal recessive/Mucopolysaccharidosis type IVB (Morquio),253010,Autosomal recessive/GM1-gangliosidosis,type II,230600,Autosomal recessive];	678119 [benign DISEASE=not provided];			rs12632196		0.7587	9564,.		-0.8290			0.01,0.15	5.76					0.0703	0.1926	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GLB1 (inh=AR oe_syn=0.95 oe_mis=0.88 oe_lof=0.59)
chr3	33138544	33138544	A	G	hom		QUAL=534;DP=17;AF=1.00;MQM=60;SAP=3;ABP=0	GLB1	synonymous	GLB1:ENST00000307363.5:synonymous_variant:LOW:exon1/16:c.34T>C:p.Leu12=:,GLB1:ENST00000307377.8:synonymous_variant:LOW:exon1/13:c.34T>C:p.Leu12=:,GLB1:ENST00000445488.2:synonymous_variant:LOW:exon1/17:c.34T>C:p.Leu12=:	GLB1:NM_000404.4:synonymous_variant:LOW:exon1/16:c.34T>C:p.Leu12=:,TMPPE:NM_001039770.3:5_prime_UTR_variant:MODIFIER:exon1/2:c.-442T>C::,GLB1:NM_001135602.2:synonymous_variant:LOW:exon1/13:c.34T>C:p.Leu12=:,TMPPE:NM_001136238.2:5_prime_UTR_variant:MODIFIER:exon1/2:c.-338T>C::,GLB1:NM_001317040.1:synonymous_variant:LOW:exon1/17:c.34T>C:p.Leu12=:	regulatory_region_variant:promoter,TF_binding_site_variant	611458 [GENE=GLB1 PHENOS=GM1-gangliosidosis,type III,230650,Autosomal recessive/GM1-gangliosidosis,type I,230500,Autosomal recessive/Mucopolysaccharidosis type IVB (Morquio),253010,Autosomal recessive/GM1-gangliosidosis,type II,230600,Autosomal recessive];	92905 [benign DISEASE=Mucopolysaccharidosis, MPS-IV-B,GM1 gangliosidosis,not specified,not provided];			rs7614776	0.9277	0.9088	12149,.	0.8660,0.9592,0.9997,0.8792,0.9536	1.0070			0.00,0.16	8.13					0.3527	0.1883	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GLB1 (inh=AR oe_syn=0.95 oe_mis=0.88 oe_lof=0.59), TMPPE (inh=n/a oe_syn=0.97 oe_mis=0.82 oe_lof=0.62)
chr3	33138549	33138549	G	A	het		QUAL=28;DP=18;AF=0.22;MQM=60;SAP=3;ABP=15	GLB1	missense	GLB1:ENST00000307363.5:missense_variant:MODERATE:exon1/16:c.29C>T:p.Pro10Leu:,GLB1:ENST00000307377.8:missense_variant:MODERATE:exon1/13:c.29C>T:p.Pro10Leu:,GLB1:ENST00000445488.2:missense_variant:MODERATE:exon1/17:c.29C>T:p.Pro10Leu:	GLB1:NM_000404.4:missense_variant:MODERATE:exon1/16:c.29C>T:p.Pro10Leu:,TMPPE:NM_001039770.3:5_prime_UTR_variant:MODIFIER:exon1/2:c.-447C>T::,GLB1:NM_001135602.2:missense_variant:MODERATE:exon1/13:c.29C>T:p.Pro10Leu:,TMPPE:NM_001136238.2:5_prime_UTR_variant:MODIFIER:exon1/2:c.-343C>T::,GLB1:NM_001317040.1:missense_variant:MODERATE:exon1/17:c.29C>T:p.Pro10Leu:	regulatory_region_variant:promoter,TF_binding_site_variant	611458 [GENE=GLB1 PHENOS=GM1-gangliosidosis,type III,230650,Autosomal recessive/GM1-gangliosidosis,type I,230500,Autosomal recessive/Mucopolysaccharidosis type IVB (Morquio),253010,Autosomal recessive/GM1-gangliosidosis,type II,230600,Autosomal recessive];	92904 [benign DISEASE=Mucopolysaccharidosis, MPS-IV-B,GM1 gangliosidosis,not specified,not provided];	CM055955 [CLASS=R MUT=ALT PHEN="Gangliosidosis GM1" GENE=GLB1];		rs7637099	0.4319	0.5674	4377,.	0.1385,0.5452,0.5134,0.6218,0.5773	0.1970	T(0.67),T(0.66),D(0.00)	B(0.00),B(0.00),B(0.00)	0.10,0.32	7.87	0.36				0.2484	0.1851	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GLB1 (inh=AR oe_syn=0.95 oe_mis=0.88 oe_lof=0.59), TMPPE (inh=n/a oe_syn=0.97 oe_mis=0.82 oe_lof=0.62)
chr3	155551206	155551206	C	T	het	off-target	QUAL=154;DP=26;AF=0.38;MQM=60;SAP=25;ABP=6	SLC33A1	intron	SLC33A1:ENST00000359479.3:intron_variant:MODIFIER:intron4/6:c.1266+51G>A::,SLC33A1:ENST00000392845.3:intron_variant:MODIFIER:intron4/5:c.1266+51G>A::	SLC33A1:NM_001190992.1:intron_variant:MODIFIER:intron4/6:c.1266+51G>A::,SLC33A1:NM_001363883.1:intron_variant:MODIFIER:intron2/3:c.960+440G>A::,SLC33A1:NM_004733.4:intron_variant:MODIFIER:intron4/5:c.1266+51G>A::	regulatory_region_variant:promoter_flanking_region	603690 [GENE=SLC33A1 PHENOS=Spastic paraplegia 42,autosomal dominant,612539,Autosomal dominant/Congenital cataracts,hearing loss,and neurodegeneration,614482,Autosomal recessive];				rs7649631	0.4768	0.3997	3027,.	0.6969,0.4577,0.3336,0.2836,0.4397	0.2350			0.00,0.09	6.49					0.0106	0.1147	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC33A1 (inh=AR+AD oe_syn=1.04 oe_mis=0.67 oe_lof=0.48)
chr3	193334991	193334991	G	A	het		QUAL=843;DP=92;AF=0.39;MQM=60;SAP=3;ABP=12	OPA1	intron,missense	OPA1:ENST00000361150.2:intron_variant:MODIFIER:intron3/28:c.448+1432G>A::,OPA1:ENST00000361510.2:missense_variant:MODERATE:exon4/31:c.473G>A:p.Ser158Asn:,OPA1:ENST00000361715.2:intron_variant:MODIFIER:intron3/29:c.449-582G>A::,OPA1:ENST00000361828.2:missense_variant:MODERATE:exon4/30:c.473G>A:p.Ser158Asn:,OPA1:ENST00000361908.3:missense_variant:MODERATE:exon4/30:c.473G>A:p.Ser158Asn:,OPA1:ENST00000392438.3:missense_variant:MODERATE:exon4/29:c.473G>A:p.Ser158Asn:	OPA1:NM_001354663.2:intron_variant:MODIFIER:intron4/29:c.76+1432G>A::,OPA1:NM_001354664.2:missense_variant:MODERATE:exon5/30:c.101G>A:p.Ser34Asn:,OPA1:NM_015560.2:missense_variant:MODERATE:exon4/29:c.473G>A:p.Ser158Asn:,OPA1:NM_130831.3:intron_variant:MODIFIER:intron3/27:c.448+1432G>A::,OPA1:NM_130832.3:intron_variant:MODIFIER:intron3/28:c.449-582G>A::,OPA1:NM_130833.2:intron_variant:MODIFIER:intron3/28:c.448+1432G>A::,OPA1:NM_130834.3:missense_variant:MODERATE:exon4/30:c.473G>A:p.Ser158Asn:,OPA1:NM_130835.2:intron_variant:MODIFIER:intron3/29:c.449-582G>A::,OPA1:NM_130836.3:missense_variant:MODERATE:exon4/30:c.473G>A:p.Ser158Asn:,OPA1:NM_130837.2:missense_variant:MODERATE:exon4/31:c.473G>A:p.Ser158Asn:		605290 [GENE=OPA1 PHENOS=Glaucoma,normal tension,susceptibility to,606657/Behr syndrome,210000,Autosomal recessive/Optic atrophy 1,165500,Autosomal dominant/Optic atrophy plus syndrome,125250,Autosomal dominant/Mitochondrial DNA depletion syndrome 14 (encephalocardiomyopathic type),616896,Autosomal recessive];	95727 [benign DISEASE=Dominant hereditary optic atrophy,not specified,not provided];			rs7624750	0.4681	0.5101	4117,.	0.5694,0.4203,0.3954,0.4672,0.4352	3.4340	 ,T(0.50), ,T(0.47),T(0.41),T(0.49)	 ,B(0.00), ,B(0.00),B(0.00),B(0.00)	0.08,0.94	16.93	0.21				0.1256	0.1428	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OPA1 (inh=AR+AD oe_syn=0.94 oe_mis=0.76 oe_lof=0.18), OPA1-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr3	193336639	193336639	T	C	het	off-target	QUAL=513;DP=57;AF=0.40;MQM=60;SAP=11;ABP=8	OPA1,OPA1-AS1	intron,non_coding_transcript_exon	OPA1:ENST00000361150.2:intron_variant:MODIFIER:intron3/28:c.449-19T>C::,OPA1:ENST00000361510.2:intron_variant:MODIFIER:intron5/30:c.611-19T>C::,OPA1:ENST00000361715.2:intron_variant:MODIFIER:intron4/29:c.503-19T>C::,OPA1:ENST00000361828.2:intron_variant:MODIFIER:intron5/29:c.611-19T>C::,OPA1:ENST00000361908.3:intron_variant:MODIFIER:intron4/29:c.557-19T>C::,OPA1:ENST00000392438.3:intron_variant:MODIFIER:intron4/28:c.557-19T>C::,OPA1-AS1:ENST00000433105.1:non_coding_transcript_exon_variant:MODIFIER:exon3/3:n.251A>G::,OPA1-AS1:ENST00000444085.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.170A>G::	OPA1:NM_001354663.2:intron_variant:MODIFIER:intron4/29:c.77-19T>C::,OPA1:NM_001354664.2:intron_variant:MODIFIER:intron5/29:c.185-19T>C::,OPA1:NM_015560.2:intron_variant:MODIFIER:intron4/28:c.557-19T>C::,OPA1:NM_130831.3:intron_variant:MODIFIER:intron3/27:c.449-19T>C::,OPA1:NM_130832.3:intron_variant:MODIFIER:intron4/28:c.503-19T>C::,OPA1:NM_130833.2:intron_variant:MODIFIER:intron3/28:c.449-19T>C::,OPA1:NM_130834.3:intron_variant:MODIFIER:intron5/29:c.611-19T>C::,OPA1:NM_130835.2:intron_variant:MODIFIER:intron4/29:c.503-19T>C::,OPA1:NM_130836.3:intron_variant:MODIFIER:intron4/29:c.557-19T>C::,OPA1:NM_130837.2:intron_variant:MODIFIER:intron5/30:c.611-19T>C::,OPA1-AS1:NR_046634.1:non_coding_transcript_exon_variant:MODIFIER:exon3/3:n.251A>G::		605290 [GENE=OPA1 PHENOS=Glaucoma,normal tension,susceptibility to,606657/Behr syndrome,210000,Autosomal recessive/Optic atrophy 1,165500,Autosomal dominant/Optic atrophy plus syndrome,125250,Autosomal dominant/Mitochondrial DNA depletion syndrome 14 (encephalocardiomyopathic type),616896,Autosomal recessive];	95728 [benign DISEASE=not specified];			rs3772393	0.3924	0.4448	3130,.	0.4218,0.4006,0.3321,0.4373,0.3781	-2.0270			0.01,0.09	0.91		7.78>7.75			0.4941	0.9413	0.18	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OPA1 (inh=AR+AD oe_syn=0.94 oe_mis=0.76 oe_lof=0.18), OPA1-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr3	193355074	193355074	T	C	hom		QUAL=1389;DP=48;AF=1.00;MQM=60;SAP=3;ABP=0	OPA1	splice_region&intron	OPA1:ENST00000361150.2:splice_region_variant&intron_variant:LOW:intron8/28:c.873+4T>C::,OPA1:ENST00000361510.2:splice_region_variant&intron_variant:LOW:intron10/30:c.1035+4T>C::,OPA1:ENST00000361715.2:splice_region_variant&intron_variant:LOW:intron9/29:c.927+4T>C::,OPA1:ENST00000361828.2:splice_region_variant&intron_variant:LOW:intron9/29:c.924+4T>C::,OPA1:ENST00000361908.3:splice_region_variant&intron_variant:LOW:intron9/29:c.981+4T>C::,OPA1:ENST00000392438.3:splice_region_variant&intron_variant:LOW:intron8/28:c.870+4T>C::	OPA1:NM_001354663.2:splice_region_variant&intron_variant:LOW:intron9/29:c.501+4T>C::,OPA1:NM_001354664.2:splice_region_variant&intron_variant:LOW:intron9/29:c.498+4T>C::,OPA1:NM_015560.2:splice_region_variant&intron_variant:LOW:intron8/28:c.870+4T>C::,OPA1:NM_130831.3:splice_region_variant&intron_variant:LOW:intron7/27:c.762+4T>C::,OPA1:NM_130832.3:splice_region_variant&intron_variant:LOW:intron8/28:c.816+4T>C::,OPA1:NM_130833.2:splice_region_variant&intron_variant:LOW:intron8/28:c.873+4T>C::,OPA1:NM_130834.3:splice_region_variant&intron_variant:LOW:intron9/29:c.924+4T>C::,OPA1:NM_130835.2:splice_region_variant&intron_variant:LOW:intron9/29:c.927+4T>C::,OPA1:NM_130836.3:splice_region_variant&intron_variant:LOW:intron9/29:c.981+4T>C::,OPA1:NM_130837.2:splice_region_variant&intron_variant:LOW:intron10/30:c.1035+4T>C::		605290 [GENE=OPA1 PHENOS=Glaucoma,normal tension,susceptibility to,606657/Behr syndrome,210000,Autosomal recessive/Optic atrophy 1,165500,Autosomal dominant/Optic atrophy plus syndrome,125250,Autosomal dominant/Mitochondrial DNA depletion syndrome 14 (encephalocardiomyopathic type),616896,Autosomal recessive];	95731 [benign DISEASE=Dominant hereditary optic atrophy,not specified,not provided];			rs166850		0.8873	12376,.	0.9709,0.8938,0.9576,0.8290,0.8961	0.8970			0.58,0.74	1.05		8.79>9.50	0.000/0.002		0.1252	0.2112	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OPA1 (inh=AR+AD oe_syn=0.94 oe_mis=0.76 oe_lof=0.18)
chr3	193365939	193365939	T	G	het	off-target	QUAL=451;DP=34;AF=0.56;MQM=60;SAP=22;ABP=4	OPA1	intron	OPA1:ENST00000361150.2:intron_variant:MODIFIER:intron18/28:c.1773+16T>G::,OPA1:ENST00000361510.2:intron_variant:MODIFIER:intron20/30:c.1935+16T>G::,OPA1:ENST00000361715.2:intron_variant:MODIFIER:intron19/29:c.1827+16T>G::,OPA1:ENST00000361828.2:intron_variant:MODIFIER:intron19/29:c.1824+16T>G::,OPA1:ENST00000361908.3:intron_variant:MODIFIER:intron19/29:c.1881+16T>G::,OPA1:ENST00000392438.3:intron_variant:MODIFIER:intron18/28:c.1770+16T>G::	OPA1:NM_001354663.2:intron_variant:MODIFIER:intron19/29:c.1401+16T>G::,OPA1:NM_001354664.2:intron_variant:MODIFIER:intron19/29:c.1398+16T>G::,OPA1:NM_015560.2:intron_variant:MODIFIER:intron18/28:c.1770+16T>G::,OPA1:NM_130831.3:intron_variant:MODIFIER:intron17/27:c.1662+16T>G::,OPA1:NM_130832.3:intron_variant:MODIFIER:intron18/28:c.1716+16T>G::,OPA1:NM_130833.2:intron_variant:MODIFIER:intron18/28:c.1773+16T>G::,OPA1:NM_130834.3:intron_variant:MODIFIER:intron19/29:c.1824+16T>G::,OPA1:NM_130835.2:intron_variant:MODIFIER:intron19/29:c.1827+16T>G::,OPA1:NM_130836.3:intron_variant:MODIFIER:intron19/29:c.1881+16T>G::,OPA1:NM_130837.2:intron_variant:MODIFIER:intron20/30:c.1935+16T>G::		605290 [GENE=OPA1 PHENOS=Glaucoma,normal tension,susceptibility to,606657/Behr syndrome,210000,Autosomal recessive/Optic atrophy 1,165500,Autosomal dominant/Optic atrophy plus syndrome,125250,Autosomal dominant/Mitochondrial DNA depletion syndrome 14 (encephalocardiomyopathic type),616896,Autosomal recessive];	95714 [benign DISEASE=not specified];			rs9831772	0.0809	0.0891	93,.	0.0466,0.1400,0.0760,0.0778,0.0980	1.1040			0.48,0.30	4.22					-0.0367	0.9529	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OPA1 (inh=AR+AD oe_syn=0.94 oe_mis=0.76 oe_lof=0.18)
chr3	193365974	193365974	T	G	het	off-target	QUAL=512;DP=44;AF=0.50;MQM=60;SAP=13;ABP=3	OPA1	intron	OPA1:ENST00000361150.2:intron_variant:MODIFIER:intron18/28:c.1773+51T>G::,OPA1:ENST00000361510.2:intron_variant:MODIFIER:intron20/30:c.1935+51T>G::,OPA1:ENST00000361715.2:intron_variant:MODIFIER:intron19/29:c.1827+51T>G::,OPA1:ENST00000361828.2:intron_variant:MODIFIER:intron19/29:c.1824+51T>G::,OPA1:ENST00000361908.3:intron_variant:MODIFIER:intron19/29:c.1881+51T>G::,OPA1:ENST00000392438.3:intron_variant:MODIFIER:intron18/28:c.1770+51T>G::	OPA1:NM_001354663.2:intron_variant:MODIFIER:intron19/29:c.1401+51T>G::,OPA1:NM_001354664.2:intron_variant:MODIFIER:intron19/29:c.1398+51T>G::,OPA1:NM_015560.2:intron_variant:MODIFIER:intron18/28:c.1770+51T>G::,OPA1:NM_130831.3:intron_variant:MODIFIER:intron17/27:c.1662+51T>G::,OPA1:NM_130832.3:intron_variant:MODIFIER:intron18/28:c.1716+51T>G::,OPA1:NM_130833.2:intron_variant:MODIFIER:intron18/28:c.1773+51T>G::,OPA1:NM_130834.3:intron_variant:MODIFIER:intron19/29:c.1824+51T>G::,OPA1:NM_130835.2:intron_variant:MODIFIER:intron19/29:c.1827+51T>G::,OPA1:NM_130836.3:intron_variant:MODIFIER:intron19/29:c.1881+51T>G::,OPA1:NM_130837.2:intron_variant:MODIFIER:intron20/30:c.1935+51T>G::		605290 [GENE=OPA1 PHENOS=Glaucoma,normal tension,susceptibility to,606657/Behr syndrome,210000,Autosomal recessive/Optic atrophy 1,165500,Autosomal dominant/Optic atrophy plus syndrome,125250,Autosomal dominant/Mitochondrial DNA depletion syndrome 14 (encephalocardiomyopathic type),616896,Autosomal recessive];				rs9831900	0.4687	0.5108	4137,.	0.5750,0.4213,0.3947,0.4698,0.4376	-1.7070			0.01,0.13	1.82					-0.0628	0.9529	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OPA1 (inh=AR+AD oe_syn=0.94 oe_mis=0.76 oe_lof=0.18)
chr3	193374964	193374964	T	C	het		QUAL=472;DP=43;AF=0.47;MQM=60;SAP=14;ABP=3	OPA1	synonymous	OPA1:ENST00000361150.2:synonymous_variant:LOW:exon21/29:c.2112T>C:p.Ala704=:,OPA1:ENST00000361510.2:synonymous_variant:LOW:exon23/31:c.2274T>C:p.Ala758=:,OPA1:ENST00000361715.2:synonymous_variant:LOW:exon22/30:c.2166T>C:p.Ala722=:,OPA1:ENST00000361828.2:synonymous_variant:LOW:exon22/30:c.2163T>C:p.Ala721=:,OPA1:ENST00000361908.3:synonymous_variant:LOW:exon22/30:c.2220T>C:p.Ala740=:,OPA1:ENST00000392438.3:synonymous_variant:LOW:exon21/29:c.2109T>C:p.Ala703=:	OPA1:NM_001354663.2:synonymous_variant:LOW:exon22/30:c.1740T>C:p.Ala580=:,OPA1:NM_001354664.2:synonymous_variant:LOW:exon22/30:c.1737T>C:p.Ala579=:,OPA1:NM_015560.2:synonymous_variant:LOW:exon21/29:c.2109T>C:p.Ala703=:,OPA1:NM_130831.3:synonymous_variant:LOW:exon20/28:c.2001T>C:p.Ala667=:,OPA1:NM_130832.3:synonymous_variant:LOW:exon21/29:c.2055T>C:p.Ala685=:,OPA1:NM_130833.2:synonymous_variant:LOW:exon21/29:c.2112T>C:p.Ala704=:,OPA1:NM_130834.3:synonymous_variant:LOW:exon22/30:c.2163T>C:p.Ala721=:,OPA1:NM_130835.2:synonymous_variant:LOW:exon22/30:c.2166T>C:p.Ala722=:,OPA1:NM_130836.3:synonymous_variant:LOW:exon22/30:c.2220T>C:p.Ala740=:,OPA1:NM_130837.2:synonymous_variant:LOW:exon23/31:c.2274T>C:p.Ala758=:		605290 [GENE=OPA1 PHENOS=Glaucoma,normal tension,susceptibility to,606657/Behr syndrome,210000,Autosomal recessive/Optic atrophy 1,165500,Autosomal dominant/Optic atrophy plus syndrome,125250,Autosomal dominant/Mitochondrial DNA depletion syndrome 14 (encephalocardiomyopathic type),616896,Autosomal recessive];	95717 [benign DISEASE=Dominant hereditary optic atrophy,not specified,not provided];			rs9851685	0.4665	0.5080	4085,.	0.5694,0.4210,0.3837,0.4670,0.4358	-0.3200			0.44,0.93	10.97					0.1018	0.3399	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OPA1 (inh=AR+AD oe_syn=0.94 oe_mis=0.76 oe_lof=0.18)
chr3	193384203	193384203	T	A	het	off-target	QUAL=54;DP=9;AF=0.44;MQM=60;SAP=12;ABP=3	OPA1	intron	OPA1:ENST00000361150.2:intron_variant:MODIFIER:intron26/28:c.2710+25T>A::,OPA1:ENST00000361510.2:intron_variant:MODIFIER:intron28/30:c.2872+25T>A::,OPA1:ENST00000361715.2:intron_variant:MODIFIER:intron27/29:c.2764+25T>A::,OPA1:ENST00000361828.2:intron_variant:MODIFIER:intron27/29:c.2761+25T>A::,OPA1:ENST00000361908.3:intron_variant:MODIFIER:intron27/29:c.2818+25T>A::,OPA1:ENST00000392438.3:intron_variant:MODIFIER:intron26/28:c.2707+25T>A::	OPA1:NM_001354663.2:intron_variant:MODIFIER:intron27/29:c.2338+25T>A::,OPA1:NM_001354664.2:intron_variant:MODIFIER:intron27/29:c.2335+25T>A::,OPA1:NM_015560.2:intron_variant:MODIFIER:intron26/28:c.2707+25T>A::,OPA1:NM_130831.3:intron_variant:MODIFIER:intron25/27:c.2599+25T>A::,OPA1:NM_130832.3:intron_variant:MODIFIER:intron26/28:c.2653+25T>A::,OPA1:NM_130833.2:intron_variant:MODIFIER:intron26/28:c.2710+25T>A::,OPA1:NM_130834.3:intron_variant:MODIFIER:intron27/29:c.2761+25T>A::,OPA1:NM_130835.2:intron_variant:MODIFIER:intron27/29:c.2764+25T>A::,OPA1:NM_130836.3:intron_variant:MODIFIER:intron27/29:c.2818+25T>A::,OPA1:NM_130837.2:intron_variant:MODIFIER:intron28/30:c.2872+25T>A::		605290 [GENE=OPA1 PHENOS=Glaucoma,normal tension,susceptibility to,606657/Behr syndrome,210000,Autosomal recessive/Optic atrophy 1,165500,Autosomal dominant/Optic atrophy plus syndrome,125250,Autosomal dominant/Mitochondrial DNA depletion syndrome 14 (encephalocardiomyopathic type),616896,Autosomal recessive];				rs10937595	0.3848	0.4382	3062,.	0.4043,0.3994,0.3203,0.4364,0.3774	-0.1570			0.15,0.23	7.48					-0.0298	0.2243	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OPA1 (inh=AR+AD oe_syn=0.94 oe_mis=0.76 oe_lof=0.18)
chr3	193385275	193385275	C	T	het	off-target;low_conf_region	QUAL=38;DP=5;AF=0.60;MQM=60;SAP=10;ABP=3	OPA1	intron	OPA1:ENST00000361150.2:intron_variant:MODIFIER:intron27/28:c.2821+206C>T::,OPA1:ENST00000361510.2:intron_variant:MODIFIER:intron29/30:c.2983+206C>T::,OPA1:ENST00000361715.2:intron_variant:MODIFIER:intron28/29:c.2875+206C>T::,OPA1:ENST00000361828.2:intron_variant:MODIFIER:intron28/29:c.2872+206C>T::,OPA1:ENST00000361908.3:intron_variant:MODIFIER:intron28/29:c.2929+206C>T::,OPA1:ENST00000392438.3:intron_variant:MODIFIER:intron27/28:c.2818+206C>T::	OPA1:NM_001354663.2:intron_variant:MODIFIER:intron28/29:c.2449+206C>T::,OPA1:NM_001354664.2:intron_variant:MODIFIER:intron28/29:c.2446+206C>T::,OPA1:NM_015560.2:intron_variant:MODIFIER:intron27/28:c.2818+206C>T::,OPA1:NM_130831.3:intron_variant:MODIFIER:intron26/27:c.2710+206C>T::,OPA1:NM_130832.3:intron_variant:MODIFIER:intron27/28:c.2764+206C>T::,OPA1:NM_130833.2:intron_variant:MODIFIER:intron27/28:c.2821+206C>T::,OPA1:NM_130834.3:intron_variant:MODIFIER:intron28/29:c.2872+206C>T::,OPA1:NM_130835.2:intron_variant:MODIFIER:intron28/29:c.2875+206C>T::,OPA1:NM_130836.3:intron_variant:MODIFIER:intron28/29:c.2929+206C>T::,OPA1:NM_130837.2:intron_variant:MODIFIER:intron29/30:c.2983+206C>T::		605290 [GENE=OPA1 PHENOS=Glaucoma,normal tension,susceptibility to,606657/Behr syndrome,210000,Autosomal recessive/Optic atrophy 1,165500,Autosomal dominant/Optic atrophy plus syndrome,125250,Autosomal dominant/Mitochondrial DNA depletion syndrome 14 (encephalocardiomyopathic type),616896,Autosomal recessive];	667793 [benign DISEASE=not provided];		AluY (SINE/Alu)	rs13070791	0.3840	0.4290	2861,.	0.4054,0.4085,0.3270,0.4335,0.3834	-0.2570			0.00,0.05	0.51					0.0561	0.6474	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OPA1 (inh=AR+AD oe_syn=0.94 oe_mis=0.76 oe_lof=0.18)
chr3	193385276	193385276	A	G	het	off-target;low_conf_region	QUAL=38;DP=5;AF=0.60;MQM=60;SAP=10;ABP=3	OPA1	intron	OPA1:ENST00000361150.2:intron_variant:MODIFIER:intron27/28:c.2821+207A>G::,OPA1:ENST00000361510.2:intron_variant:MODIFIER:intron29/30:c.2983+207A>G::,OPA1:ENST00000361715.2:intron_variant:MODIFIER:intron28/29:c.2875+207A>G::,OPA1:ENST00000361828.2:intron_variant:MODIFIER:intron28/29:c.2872+207A>G::,OPA1:ENST00000361908.3:intron_variant:MODIFIER:intron28/29:c.2929+207A>G::,OPA1:ENST00000392438.3:intron_variant:MODIFIER:intron27/28:c.2818+207A>G::	OPA1:NM_001354663.2:intron_variant:MODIFIER:intron28/29:c.2449+207A>G::,OPA1:NM_001354664.2:intron_variant:MODIFIER:intron28/29:c.2446+207A>G::,OPA1:NM_015560.2:intron_variant:MODIFIER:intron27/28:c.2818+207A>G::,OPA1:NM_130831.3:intron_variant:MODIFIER:intron26/27:c.2710+207A>G::,OPA1:NM_130832.3:intron_variant:MODIFIER:intron27/28:c.2764+207A>G::,OPA1:NM_130833.2:intron_variant:MODIFIER:intron27/28:c.2821+207A>G::,OPA1:NM_130834.3:intron_variant:MODIFIER:intron28/29:c.2872+207A>G::,OPA1:NM_130835.2:intron_variant:MODIFIER:intron28/29:c.2875+207A>G::,OPA1:NM_130836.3:intron_variant:MODIFIER:intron28/29:c.2929+207A>G::,OPA1:NM_130837.2:intron_variant:MODIFIER:intron29/30:c.2983+207A>G::		605290 [GENE=OPA1 PHENOS=Glaucoma,normal tension,susceptibility to,606657/Behr syndrome,210000,Autosomal recessive/Optic atrophy 1,165500,Autosomal dominant/Optic atrophy plus syndrome,125250,Autosomal dominant/Mitochondrial DNA depletion syndrome 14 (encephalocardiomyopathic type),616896,Autosomal recessive];	667775 [benign DISEASE=not provided];		AluY (SINE/Alu)	rs13070610	0.4653	0.4991	3876,.	0.5651,0.4248,0.3867,0.4613,0.4361	-3.7580			0.00,0.03	0.66					-0.0913	0.6488	0.05	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OPA1 (inh=AR+AD oe_syn=0.94 oe_mis=0.76 oe_lof=0.18)
chr3	193386239	193386239	C	T	het		QUAL=2207;DP=153;AF=0.57;MQM=60;SAP=3;ABP=9	OPA1	intron	OPA1:ENST00000361150.2:intron_variant:MODIFIER:intron27/28:c.2821+1170C>T::,OPA1:ENST00000361510.2:intron_variant:MODIFIER:intron29/30:c.2983+1170C>T::,OPA1:ENST00000361715.2:intron_variant:MODIFIER:intron28/29:c.2875+1170C>T::,OPA1:ENST00000361828.2:intron_variant:MODIFIER:intron28/29:c.2872+1170C>T::,OPA1:ENST00000361908.3:intron_variant:MODIFIER:intron28/29:c.2929+1170C>T::,OPA1:ENST00000392438.3:intron_variant:MODIFIER:intron27/28:c.2818+1170C>T::	OPA1:NM_001354663.2:intron_variant:MODIFIER:intron28/29:c.2449+1170C>T::,OPA1:NM_001354664.2:intron_variant:MODIFIER:intron28/29:c.2446+1170C>T::,OPA1:NM_015560.2:intron_variant:MODIFIER:intron27/28:c.2818+1170C>T::,OPA1:NM_130831.3:intron_variant:MODIFIER:intron26/27:c.2710+1170C>T::,OPA1:NM_130832.3:intron_variant:MODIFIER:intron27/28:c.2764+1170C>T::,OPA1:NM_130833.2:intron_variant:MODIFIER:intron27/28:c.2821+1170C>T::,OPA1:NM_130834.3:intron_variant:MODIFIER:intron28/29:c.2872+1170C>T::,OPA1:NM_130835.2:intron_variant:MODIFIER:intron28/29:c.2875+1170C>T::,OPA1:NM_130836.3:intron_variant:MODIFIER:intron28/29:c.2929+1170C>T::,OPA1:NM_130837.2:intron_variant:MODIFIER:intron29/30:c.2983+1170C>T::		605290 [GENE=OPA1 PHENOS=Glaucoma,normal tension,susceptibility to,606657/Behr syndrome,210000,Autosomal recessive/Optic atrophy 1,165500,Autosomal dominant/Optic atrophy plus syndrome,125250,Autosomal dominant/Mitochondrial DNA depletion syndrome 14 (encephalocardiomyopathic type),616896,Autosomal recessive];				rs12494482	0.4663	0.5079	4084,.	0.5683,0.4234,0.3861,0.4639,0.4331	0.1300			0.00,0.05	5.86					0.0079	0.9465	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OPA1 (inh=AR+AD oe_syn=0.94 oe_mis=0.76 oe_lof=0.18)
chr3	193386462	193386462	C	T	het	off-target	QUAL=330;DP=26;AF=0.65;MQM=60;SAP=40;ABP=8	OPA1	intron	OPA1:ENST00000361150.2:intron_variant:MODIFIER:intron27/28:c.2821+1393C>T::,OPA1:ENST00000361510.2:intron_variant:MODIFIER:intron29/30:c.2983+1393C>T::,OPA1:ENST00000361715.2:intron_variant:MODIFIER:intron28/29:c.2875+1393C>T::,OPA1:ENST00000361828.2:intron_variant:MODIFIER:intron28/29:c.2872+1393C>T::,OPA1:ENST00000361908.3:intron_variant:MODIFIER:intron28/29:c.2929+1393C>T::,OPA1:ENST00000392438.3:intron_variant:MODIFIER:intron27/28:c.2818+1393C>T::	OPA1:NM_001354663.2:intron_variant:MODIFIER:intron28/29:c.2449+1393C>T::,OPA1:NM_001354664.2:intron_variant:MODIFIER:intron28/29:c.2446+1393C>T::,OPA1:NM_015560.2:intron_variant:MODIFIER:intron27/28:c.2818+1393C>T::,OPA1:NM_130831.3:intron_variant:MODIFIER:intron26/27:c.2710+1393C>T::,OPA1:NM_130832.3:intron_variant:MODIFIER:intron27/28:c.2764+1393C>T::,OPA1:NM_130833.2:intron_variant:MODIFIER:intron27/28:c.2821+1393C>T::,OPA1:NM_130834.3:intron_variant:MODIFIER:intron28/29:c.2872+1393C>T::,OPA1:NM_130835.2:intron_variant:MODIFIER:intron28/29:c.2875+1393C>T::,OPA1:NM_130836.3:intron_variant:MODIFIER:intron28/29:c.2929+1393C>T::,OPA1:NM_130837.2:intron_variant:MODIFIER:intron29/30:c.2983+1393C>T::		605290 [GENE=OPA1 PHENOS=Glaucoma,normal tension,susceptibility to,606657/Behr syndrome,210000,Autosomal recessive/Optic atrophy 1,165500,Autosomal dominant/Optic atrophy plus syndrome,125250,Autosomal dominant/Mitochondrial DNA depletion syndrome 14 (encephalocardiomyopathic type),616896,Autosomal recessive];				rs2276722	0.2448	0.2174	739,.		0.7050			0.08,0.13	5.23					0.014	0.9466	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OPA1 (inh=AR+AD oe_syn=0.94 oe_mis=0.76 oe_lof=0.18)
chr4	108868515	108868515	T	C	hom	off-target	QUAL=9515;DP=283;AF=1.00;MQM=60;SAP=3;ABP=0	CYP2U1,RP11-286E11.1	intron,intron&non_coding_transcript	CYP2U1:ENST00000332884.6:intron_variant:MODIFIER:intron2/4:c.1127-17T>C::,CYP2U1:ENST00000508453.1:intron_variant:MODIFIER:intron4/6:c.500-17T>C::,RP11-286E11.1:ENST00000513071.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.80+31361A>G::	CYP2U1:NM_183075.3:intron_variant:MODIFIER:intron2/4:c.1127-17T>C::		610670 [GENE=CYP2U1 PHENOS=Spastic paraplegia 56,autosomal recessive,615030,Autosomal recessive];	377766 [benign DISEASE=not specified];			rs6856745		0.6376	6467,.	0.7527,0.6488,0.7256,0.5626,0.5693	-1.0360			0.02,0.25	11.32		7.51>7.17			-0.3063	0.0939	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CYP2U1 (inh=AR oe_syn=0.92 oe_mis=0.83 oe_lof=0.41)
chr5	10250430	10250430	G	A	hom		QUAL=7082;DP=211;AF=1.00;MQM=60;SAP=3;ABP=0	CCT5	5'UTR,intron	CCT5:ENST00000280326.4:5_prime_UTR_variant:MODIFIER:exon1/11:c.-23G>A::,CCT5:ENST00000503026.1:intron_variant:MODIFIER:intron1/10:c.42+273G>A::,CCT5:ENST00000515390.1:5_prime_UTR_variant:MODIFIER:exon1/10:c.-23G>A::	CCT5:NM_001306153.1:intron_variant:MODIFIER:intron1/10:c.42+273G>A::,CCT5:NM_001306154.1:5_prime_UTR_variant:MODIFIER:exon1/10:c.-23G>A::,CCT5:NM_012073.5:5_prime_UTR_variant:MODIFIER:exon1/11:c.-23G>A::	regulatory_region_variant:promoter,TF_binding_site_variant	610150 [GENE=CCT5 PHENOS=Neuropathy,hereditary sensory,with spastic paraplegia,256840,Autosomal recessive];	350245 [benign DISEASE=Neuropathy, hereditary sensory, with spastic paraplegia, autosomal recessive];			rs2548546		0.7987	9109,.	0.4483,0.8023,0.8629,0.8547,0.6647	-0.6970			0.15,0.38	8.71					0.1435	0.23	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATPSCKMT (inh=n/a oe_syn=0.92 oe_mis=1.12 oe_lof=1.06), CCT5 (inh=AR oe_syn=1.06 oe_mis=0.77 oe_lof=0.04)
chr5	10250443	10250443	T	C	hom		QUAL=8288;DP=252;AF=1.00;MQM=60;SAP=17;ABP=0	CCT5	5'UTR,intron	CCT5:ENST00000280326.4:5_prime_UTR_variant:MODIFIER:exon1/11:c.-10T>C::,CCT5:ENST00000503026.1:intron_variant:MODIFIER:intron1/10:c.42+286T>C::,CCT5:ENST00000515390.1:5_prime_UTR_variant:MODIFIER:exon1/10:c.-10T>C::	CCT5:NM_001306153.1:intron_variant:MODIFIER:intron1/10:c.42+286T>C::,CCT5:NM_001306154.1:5_prime_UTR_variant:MODIFIER:exon1/10:c.-10T>C::,CCT5:NM_012073.5:5_prime_UTR_variant:MODIFIER:exon1/11:c.-10T>C::	regulatory_region_variant:promoter,TF_binding_site_variant	610150 [GENE=CCT5 PHENOS=Neuropathy,hereditary sensory,with spastic paraplegia,256840,Autosomal recessive];	350246 [benign DISEASE=Neuropathy, hereditary sensory, with spastic paraplegia, autosomal recessive];			rs2578618		0.7989	9114,.	0.4490,0.8026,0.8631,0.8549,0.6646	-1.5760			0.02,0.23	11.17					0.2209	0.2316	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATPSCKMT (inh=n/a oe_syn=0.92 oe_mis=1.12 oe_lof=1.06), CCT5 (inh=AR oe_syn=1.06 oe_mis=0.77 oe_lof=0.04)
chr5	10254817	10254817	A	G	hom		QUAL=4954;DP=150;AF=1.00;MQM=60;SAP=5;ABP=0	CCT5	synonymous,intron	CCT5:ENST00000280326.4:synonymous_variant:LOW:exon3/11:c.198A>G:p.Gly66=:PF00118 [TCP-1/cpn60 chaperonin family],CCT5:ENST00000503026.1:synonymous_variant:LOW:exon3/11:c.135A>G:p.Gly45=:PF00118 [TCP-1/cpn60 chaperonin family],CCT5:ENST00000506600.1:intron_variant:MODIFIER:intron2/9:c.52+500A>G::,CCT5:ENST00000515390.1:intron_variant:MODIFIER:intron2/9:c.166+500A>G::,CCT5:ENST00000515676.1:synonymous_variant:LOW:exon3/11:c.84A>G:p.Gly28=:PF00118 [TCP-1/cpn60 chaperonin family]	CCT5:NM_001306153.1:synonymous_variant:LOW:exon3/11:c.135A>G:p.Gly45=:,CCT5:NM_001306154.1:intron_variant:MODIFIER:intron2/9:c.166+500A>G::,CCT5:NM_001306155.1:intron_variant:MODIFIER:intron2/9:c.52+500A>G::,CCT5:NM_001306156.1:synonymous_variant:LOW:exon3/11:c.84A>G:p.Gly28=:,CCT5:NM_012073.5:synonymous_variant:LOW:exon3/11:c.198A>G:p.Gly66=:		610150 [GENE=CCT5 PHENOS=Neuropathy,hereditary sensory,with spastic paraplegia,256840,Autosomal recessive];	350248 [benign DISEASE=Neuropathy, hereditary sensory, with spastic paraplegia, autosomal recessive];			rs2578617		0.7991	9113,.	0.4494,0.8032,0.8633,0.8554,0.6643	-1.3510			0.10,0.14	5.08					-0.4011	0.9093	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATPSCKMT (inh=n/a oe_syn=0.92 oe_mis=1.12 oe_lof=1.06), CCT5 (inh=AR oe_syn=1.06 oe_mis=0.77 oe_lof=0.04)
chr5	10256161	10256161	T	C	hom		QUAL=4806;DP=149;AF=1.00;MQM=60;SAP=8;ABP=0	CCT5	synonymous	CCT5:ENST00000280326.4:synonymous_variant:LOW:exon4/11:c.426T>C:p.Arg142=:PF00118 [TCP-1/cpn60 chaperonin family],CCT5:ENST00000503026.1:synonymous_variant:LOW:exon4/11:c.363T>C:p.Arg121=:PF00118 [TCP-1/cpn60 chaperonin family],CCT5:ENST00000506600.1:synonymous_variant:LOW:exon3/10:c.147T>C:p.Arg49=:PF00118 [TCP-1/cpn60 chaperonin family],CCT5:ENST00000515390.1:synonymous_variant:LOW:exon3/10:c.261T>C:p.Arg87=:PF00118 [TCP-1/cpn60 chaperonin family],CCT5:ENST00000515676.1:synonymous_variant:LOW:exon4/11:c.312T>C:p.Arg104=:PF00118 [TCP-1/cpn60 chaperonin family]	CCT5:NM_001306153.1:synonymous_variant:LOW:exon4/11:c.363T>C:p.Arg121=:,CCT5:NM_001306154.1:synonymous_variant:LOW:exon3/10:c.261T>C:p.Arg87=:,CCT5:NM_001306155.1:synonymous_variant:LOW:exon3/10:c.147T>C:p.Arg49=:,CCT5:NM_001306156.1:synonymous_variant:LOW:exon4/11:c.312T>C:p.Arg104=:,CCT5:NM_012073.5:synonymous_variant:LOW:exon4/11:c.426T>C:p.Arg142=:		610150 [GENE=CCT5 PHENOS=Neuropathy,hereditary sensory,with spastic paraplegia,256840,Autosomal recessive];	350249 [benign DISEASE=Neuropathy, hereditary sensory, with spastic paraplegia, autosomal recessive];			rs1042392		0.8042	9270,.	0.4634,0.8056,0.8723,0.8617,0.6656	0.0210			0.44,0.90	12.96					0.0052	0.5543	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CCT5 (inh=AR oe_syn=1.06 oe_mis=0.77 oe_lof=0.04)
chr5	10262740	10262740	C	A	hom		QUAL=3356;DP=102;AF=1.00;MQM=60;SAP=34;ABP=0	CCT5	intron	CCT5:ENST00000280326.4:intron_variant:MODIFIER:intron9/10:c.1317+10C>A::,CCT5:ENST00000503026.1:intron_variant:MODIFIER:intron9/10:c.1254+10C>A::,CCT5:ENST00000506600.1:intron_variant:MODIFIER:intron8/9:c.1038+10C>A::,CCT5:ENST00000515390.1:intron_variant:MODIFIER:intron8/9:c.1152+10C>A::,CCT5:ENST00000515676.1:intron_variant:MODIFIER:intron9/10:c.1203+10C>A::	CCT5:NM_001306153.1:intron_variant:MODIFIER:intron9/10:c.1254+10C>A::,CCT5:NM_001306154.1:intron_variant:MODIFIER:intron8/9:c.1152+10C>A::,CCT5:NM_001306155.1:intron_variant:MODIFIER:intron8/9:c.1038+10C>A::,CCT5:NM_001306156.1:intron_variant:MODIFIER:intron9/10:c.1203+10C>A::,CCT5:NM_012073.5:intron_variant:MODIFIER:intron9/10:c.1317+10C>A::		610150 [GENE=CCT5 PHENOS=Neuropathy,hereditary sensory,with spastic paraplegia,256840,Autosomal recessive];	350257 [benign DISEASE=Neuropathy, hereditary sensory, with spastic paraplegia, autosomal recessive];			rs2578642	0.6859	0.7990	9119,.	0.4495,0.8031,0.8633,0.8554,0.6641	-0.8030			0.01,0.11	3.29					-0.3929	0.2609	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CCT5 (inh=AR oe_syn=1.06 oe_mis=0.77 oe_lof=0.04)
chr5	10263452	10263454	GGA	-	hom	off-target;low_conf_region	QUAL=3784;DP=124;AF=1.00;MQM=60;SAP=75;ABP=0	CCT5	intron	CCT5:ENST00000280326.4:intron_variant:MODIFIER:intron10/10:c.1498+28_1498+30del::,CCT5:ENST00000503026.1:intron_variant:MODIFIER:intron10/10:c.1435+28_1435+30del::,CCT5:ENST00000506600.1:intron_variant:MODIFIER:intron9/9:c.1219+28_1219+30del::,CCT5:ENST00000515390.1:intron_variant:MODIFIER:intron9/9:c.1333+28_1333+30del::,CCT5:ENST00000515676.1:intron_variant:MODIFIER:intron10/10:c.1384+28_1384+30del::	CCT5:NM_001306153.1:intron_variant:MODIFIER:intron10/10:c.1435+28_1435+30del::,CCT5:NM_001306154.1:intron_variant:MODIFIER:intron9/9:c.1333+28_1333+30del::,CCT5:NM_001306155.1:intron_variant:MODIFIER:intron9/9:c.1219+28_1219+30del::,CCT5:NM_001306156.1:intron_variant:MODIFIER:intron10/10:c.1384+28_1384+30del::,CCT5:NM_012073.5:intron_variant:MODIFIER:intron10/10:c.1498+28_1498+30del::		610150 [GENE=CCT5 PHENOS=Neuropathy,hereditary sensory,with spastic paraplegia,256840,Autosomal recessive];				rs531549616		0.0001		0.0000,0.0000,0.0000,0.0000,0.0004	1.9850				0.97					0.0114	0.2472	0	5542	1989	1139 / 383					CCT5 (inh=AR oe_syn=1.06 oe_mis=0.77 oe_lof=0.04)
chr5	10263459	10263459	G	A	hom	off-target;low_conf_region	QUAL=3784;DP=124;AF=1.00;MQM=60;SAP=75;ABP=0	CCT5	intron	CCT5:ENST00000280326.4:intron_variant:MODIFIER:intron10/10:c.1498+33G>A::,CCT5:ENST00000503026.1:intron_variant:MODIFIER:intron10/10:c.1435+33G>A::,CCT5:ENST00000506600.1:intron_variant:MODIFIER:intron9/9:c.1219+33G>A::,CCT5:ENST00000515390.1:intron_variant:MODIFIER:intron9/9:c.1333+33G>A::,CCT5:ENST00000515676.1:intron_variant:MODIFIER:intron10/10:c.1384+33G>A::	CCT5:NM_001306153.1:intron_variant:MODIFIER:intron10/10:c.1435+33G>A::,CCT5:NM_001306154.1:intron_variant:MODIFIER:intron9/9:c.1333+33G>A::,CCT5:NM_001306155.1:intron_variant:MODIFIER:intron9/9:c.1219+33G>A::,CCT5:NM_001306156.1:intron_variant:MODIFIER:intron10/10:c.1384+33G>A::,CCT5:NM_012073.5:intron_variant:MODIFIER:intron10/10:c.1498+33G>A::		610150 [GENE=CCT5 PHENOS=Neuropathy,hereditary sensory,with spastic paraplegia,256840,Autosomal recessive];				rs56221522		0.0001		0.0001,0.0000,0.0000,0.0001,0.0001	0.0330			0.02,0.14	2.18					0.1259	0.2463	0	5538	1993	1137 / 385					CCT5 (inh=AR oe_syn=1.06 oe_mis=0.77 oe_lof=0.04)
chr5	10263464	10263464	A	-	hom	off-target;low_conf_region	QUAL=3784;DP=124;AF=1.00;MQM=60;SAP=75;ABP=0	CCT5	intron	CCT5:ENST00000280326.4:intron_variant:MODIFIER:intron10/10:c.1498+38del::,CCT5:ENST00000503026.1:intron_variant:MODIFIER:intron10/10:c.1435+38del::,CCT5:ENST00000506600.1:intron_variant:MODIFIER:intron9/9:c.1219+38del::,CCT5:ENST00000515390.1:intron_variant:MODIFIER:intron9/9:c.1333+38del::,CCT5:ENST00000515676.1:intron_variant:MODIFIER:intron10/10:c.1384+38del::	CCT5:NM_001306153.1:intron_variant:MODIFIER:intron10/10:c.1435+38del::,CCT5:NM_001306154.1:intron_variant:MODIFIER:intron9/9:c.1333+38del::,CCT5:NM_001306155.1:intron_variant:MODIFIER:intron9/9:c.1219+38del::,CCT5:NM_001306156.1:intron_variant:MODIFIER:intron10/10:c.1384+38del::,CCT5:NM_012073.5:intron_variant:MODIFIER:intron10/10:c.1498+38del::		610150 [GENE=CCT5 PHENOS=Neuropathy,hereditary sensory,with spastic paraplegia,256840,Autosomal recessive];				rs370363614	0.8814	0.0362	58,.	0.0440,0.0020,0.0006,0.0023,0.0037	0.2160				2.52					-0.0211	0.2474	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CCT5 (inh=AR oe_syn=1.06 oe_mis=0.77 oe_lof=0.04)
chr5	118813240	118813240	T	C	het	off-target	QUAL=227;DP=22;AF=0.45;MQM=60;SAP=4;ABP=3	HSD17B4	intron	HSD17B4:ENST00000256216.6:intron_variant:MODIFIER:intron7/23:c.434+44T>C::,HSD17B4:ENST00000414835.2:intron_variant:MODIFIER:intron7/23:c.14+53T>C::,HSD17B4:ENST00000504811.1:intron_variant:MODIFIER:intron8/24:c.509+44T>C::,HSD17B4:ENST00000509514.1:intron_variant:MODIFIER:intron2/19:c.-451+44T>C::,HSD17B4:ENST00000510025.1:intron_variant:MODIFIER:intron8/24:c.362+44T>C::,HSD17B4:ENST00000513628.1:intron_variant:MODIFIER:intron2/18:c.23+44T>C::,HSD17B4:ENST00000515320.1:intron_variant:MODIFIER:intron6/22:c.380+44T>C::	HSD17B4:NM_000414.4:intron_variant:MODIFIER:intron7/23:c.434+44T>C::,HSD17B4:NM_001199291.3:intron_variant:MODIFIER:intron8/24:c.509+44T>C::,HSD17B4:NM_001199292.2:intron_variant:MODIFIER:intron6/22:c.380+44T>C::,HSD17B4:NM_001292027.2:intron_variant:MODIFIER:intron8/24:c.362+44T>C::,HSD17B4:NM_001292028.2:intron_variant:MODIFIER:intron7/23:c.14+53T>C::		601860 [GENE=HSD17B4 PHENOS=D-bifunctional protein deficiency,261515,Autosomal recessive/Perrault syndrome 1,233400,Autosomal recessive];				rs457106	0.3526	0.4557	2821,.	0.0823,0.5598,0.5581,0.4704,0.3555	-0.0050			0.09,0.22	5.25					-0.1308	0.8369	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSD17B4 (inh=AR oe_syn=1.11 oe_mis=1.04 oe_lof=0.53)
chr5	118837833	118837833	C	T	het	off-target	QUAL=79;DP=22;AF=0.27;MQM=60;SAP=4;ABP=13	HSD17B4	intron	HSD17B4:ENST00000256216.6:intron_variant:MODIFIER:intron14/23:c.1261+46C>T::,HSD17B4:ENST00000414835.2:intron_variant:MODIFIER:intron14/23:c.841+46C>T::,HSD17B4:ENST00000504811.1:intron_variant:MODIFIER:intron15/24:c.1336+46C>T::,HSD17B4:ENST00000509514.1:intron_variant:MODIFIER:intron10/19:c.475+46C>T::,HSD17B4:ENST00000510025.1:intron_variant:MODIFIER:intron15/24:c.1189+46C>T::,HSD17B4:ENST00000513628.1:intron_variant:MODIFIER:intron9/18:c.850+46C>T::,HSD17B4:ENST00000515320.1:intron_variant:MODIFIER:intron13/22:c.1207+46C>T::	HSD17B4:NM_000414.4:intron_variant:MODIFIER:intron14/23:c.1261+46C>T::,HSD17B4:NM_001199291.3:intron_variant:MODIFIER:intron15/24:c.1336+46C>T::,HSD17B4:NM_001199292.2:intron_variant:MODIFIER:intron13/22:c.1207+46C>T::,HSD17B4:NM_001292027.2:intron_variant:MODIFIER:intron15/24:c.1189+46C>T::,HSD17B4:NM_001292028.2:intron_variant:MODIFIER:intron14/23:c.841+46C>T::		601860 [GENE=HSD17B4 PHENOS=D-bifunctional protein deficiency,261515,Autosomal recessive/Perrault syndrome 1,233400,Autosomal recessive];				rs460945	0.2744	0.3328	1474,.	0.1367,0.4251,0.4068,0.3342,0.2086	0.1220			0.05,0.23	6.20					0.1099	0.1843	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSD17B4 (inh=AR oe_syn=1.11 oe_mis=1.04 oe_lof=0.53)
chr5	118837834	118837834	A	G	het	off-target	QUAL=79;DP=22;AF=0.27;MQM=60;SAP=4;ABP=13	HSD17B4	intron	HSD17B4:ENST00000256216.6:intron_variant:MODIFIER:intron14/23:c.1261+47A>G::,HSD17B4:ENST00000414835.2:intron_variant:MODIFIER:intron14/23:c.841+47A>G::,HSD17B4:ENST00000504811.1:intron_variant:MODIFIER:intron15/24:c.1336+47A>G::,HSD17B4:ENST00000509514.1:intron_variant:MODIFIER:intron10/19:c.475+47A>G::,HSD17B4:ENST00000510025.1:intron_variant:MODIFIER:intron15/24:c.1189+47A>G::,HSD17B4:ENST00000513628.1:intron_variant:MODIFIER:intron9/18:c.850+47A>G::,HSD17B4:ENST00000515320.1:intron_variant:MODIFIER:intron13/22:c.1207+47A>G::	HSD17B4:NM_000414.4:intron_variant:MODIFIER:intron14/23:c.1261+47A>G::,HSD17B4:NM_001199291.3:intron_variant:MODIFIER:intron15/24:c.1336+47A>G::,HSD17B4:NM_001199292.2:intron_variant:MODIFIER:intron13/22:c.1207+47A>G::,HSD17B4:NM_001292027.2:intron_variant:MODIFIER:intron15/24:c.1189+47A>G::,HSD17B4:NM_001292028.2:intron_variant:MODIFIER:intron14/23:c.841+47A>G::		601860 [GENE=HSD17B4 PHENOS=D-bifunctional protein deficiency,261515,Autosomal recessive/Perrault syndrome 1,233400,Autosomal recessive];				rs455949	0.4237	0.4827	3289,.	0.3173,0.5783,0.5236,0.4818,0.3998	-0.6300			0.01,0.18	4.14					-0.1214	0.1857	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSD17B4 (inh=AR oe_syn=1.11 oe_mis=1.04 oe_lof=0.53)
chr5	118845089	118845089	G	A	het	off-target	QUAL=983;DP=62;AF=0.61;MQM=60;SAP=11;ABP=10	HSD17B4	intron	HSD17B4:ENST00000256216.6:intron_variant:MODIFIER:intron16/23:c.1437+150G>A::,HSD17B4:ENST00000414835.2:intron_variant:MODIFIER:intron16/23:c.1017+150G>A::,HSD17B4:ENST00000504811.1:intron_variant:MODIFIER:intron17/24:c.1512+150G>A::,HSD17B4:ENST00000509514.1:intron_variant:MODIFIER:intron12/19:c.651+150G>A::,HSD17B4:ENST00000510025.1:intron_variant:MODIFIER:intron17/24:c.1365+150G>A::,HSD17B4:ENST00000513628.1:intron_variant:MODIFIER:intron11/18:c.1026+150G>A::,HSD17B4:ENST00000515320.1:intron_variant:MODIFIER:intron15/22:c.1383+150G>A::	HSD17B4:NM_000414.4:intron_variant:MODIFIER:intron16/23:c.1437+150G>A::,HSD17B4:NM_001199291.3:intron_variant:MODIFIER:intron17/24:c.1512+150G>A::,HSD17B4:NM_001199292.2:intron_variant:MODIFIER:intron15/22:c.1383+150G>A::,HSD17B4:NM_001292027.2:intron_variant:MODIFIER:intron17/24:c.1365+150G>A::,HSD17B4:NM_001292028.2:intron_variant:MODIFIER:intron16/23:c.1017+150G>A::		601860 [GENE=HSD17B4 PHENOS=D-bifunctional protein deficiency,261515,Autosomal recessive/Perrault syndrome 1,233400,Autosomal recessive];			Tigger2a (DNA/TcMar-Tigger)	rs32663	0.4127	0.4773	3330,.	0.3207,0.5709,0.5247,0.4837,0.3598	-0.2910			0.00,0.04	3.38					0.2641	0.3225	0.32	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSD17B4 (inh=AR oe_syn=1.11 oe_mis=1.04 oe_lof=0.53)
chr5	118845139	118845139	G	A	het		QUAL=868;DP=86;AF=0.42;MQM=60;SAP=4;ABP=8	HSD17B4	intron	HSD17B4:ENST00000256216.6:intron_variant:MODIFIER:intron16/23:c.1437+200G>A::,HSD17B4:ENST00000414835.2:intron_variant:MODIFIER:intron16/23:c.1017+200G>A::,HSD17B4:ENST00000504811.1:intron_variant:MODIFIER:intron17/24:c.1512+200G>A::,HSD17B4:ENST00000509514.1:intron_variant:MODIFIER:intron12/19:c.651+200G>A::,HSD17B4:ENST00000510025.1:intron_variant:MODIFIER:intron17/24:c.1365+200G>A::,HSD17B4:ENST00000513628.1:intron_variant:MODIFIER:intron11/18:c.1026+200G>A::,HSD17B4:ENST00000515320.1:intron_variant:MODIFIER:intron15/22:c.1383+200G>A::	HSD17B4:NM_000414.4:intron_variant:MODIFIER:intron16/23:c.1437+200G>A::,HSD17B4:NM_001199291.3:intron_variant:MODIFIER:intron17/24:c.1512+200G>A::,HSD17B4:NM_001199292.2:intron_variant:MODIFIER:intron15/22:c.1383+200G>A::,HSD17B4:NM_001292027.2:intron_variant:MODIFIER:intron17/24:c.1365+200G>A::,HSD17B4:NM_001292028.2:intron_variant:MODIFIER:intron16/23:c.1017+200G>A::		601860 [GENE=HSD17B4 PHENOS=D-bifunctional protein deficiency,261515,Autosomal recessive/Perrault syndrome 1,233400,Autosomal recessive];			Tigger2a (DNA/TcMar-Tigger)	rs32664	0.6759	0.6388	6532,.	0.6959,0.6848,0.9317,0.5620,0.5281	-1.0020			0.00,0.05	6.00					0.5031	0.6764	0.24	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSD17B4 (inh=AR oe_syn=1.11 oe_mis=1.04 oe_lof=0.53)
chr5	118861713	118861713	A	G	het		QUAL=315;DP=25;AF=0.56;MQM=60;SAP=19;ABP=4	HSD17B4	missense	HSD17B4:ENST00000256216.6:missense_variant:MODERATE:exon19/24:c.1675A>G:p.Ile559Val:PF01575 [MaoC like domain],HSD17B4:ENST00000414835.2:missense_variant:MODERATE:exon19/24:c.1255A>G:p.Ile419Val:PF01575 [MaoC like domain],HSD17B4:ENST00000504811.1:missense_variant:MODERATE:exon20/25:c.1750A>G:p.Ile584Val:PF01575 [MaoC like domain],HSD17B4:ENST00000509514.1:missense_variant:MODERATE:exon15/20:c.889A>G:p.Ile297Val:PF01575 [MaoC like domain],HSD17B4:ENST00000510025.1:missense_variant:MODERATE:exon20/25:c.1603A>G:p.Ile535Val:PF01575 [MaoC like domain],HSD17B4:ENST00000513628.1:missense_variant:MODERATE:exon14/19:c.1264A>G:p.Ile422Val:PF01575 [MaoC like domain],HSD17B4:ENST00000515320.1:missense_variant:MODERATE:exon18/23:c.1621A>G:p.Ile541Val:PF01575 [MaoC like domain]	HSD17B4:NM_000414.4:missense_variant:MODERATE:exon19/24:c.1675A>G:p.Ile559Val:,HSD17B4:NM_001199291.3:missense_variant:MODERATE:exon20/25:c.1750A>G:p.Ile584Val:,HSD17B4:NM_001199292.2:missense_variant:MODERATE:exon18/23:c.1621A>G:p.Ile541Val:,HSD17B4:NM_001292027.2:missense_variant:MODERATE:exon20/25:c.1603A>G:p.Ile535Val:,HSD17B4:NM_001292028.2:missense_variant:MODERATE:exon19/24:c.1255A>G:p.Ile419Val:		601860 [GENE=HSD17B4 PHENOS=D-bifunctional protein deficiency,261515,Autosomal recessive/Perrault syndrome 1,233400,Autosomal recessive];	226667 [benign DISEASE=Perrault syndrome 1,Bifunctional peroxisomal enzyme deficiency,not specified,not provided];	CM1616143 [CLASS=DM? MUT=ALT PHEN="Premature ovarian failure" GENE=HSD17B4];		rs11205	0.4002	0.4184	2661,.	0.3872,0.5270,0.4137,0.4070,0.2865	3.8360	T(0.23),T(0.21),T(0.19),T(0.16),T(0.19),T(0.20),T(0.22)	B(0.17),B(0.17),B(0.33),B(0.26),B(0.09),B(0.17),B(0.20)	0.97,0.99	22.20	0.29				-0.0209	0.8122	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSD17B4 (inh=AR oe_syn=1.11 oe_mis=1.04 oe_lof=0.53)
chr5	118862971	118862971	C	T	het	off-target	QUAL=698;DP=64;AF=0.44;MQM=60;SAP=3;ABP=5	HSD17B4	intron	HSD17B4:ENST00000256216.6:intron_variant:MODIFIER:intron20/23:c.1767+57C>T::,HSD17B4:ENST00000414835.2:intron_variant:MODIFIER:intron20/23:c.1347+57C>T::,HSD17B4:ENST00000504811.1:intron_variant:MODIFIER:intron21/24:c.1842+57C>T::,HSD17B4:ENST00000509514.1:intron_variant:MODIFIER:intron16/19:c.981+57C>T::,HSD17B4:ENST00000510025.1:intron_variant:MODIFIER:intron21/24:c.1695+57C>T::,HSD17B4:ENST00000513628.1:intron_variant:MODIFIER:intron15/18:c.1356+57C>T::,HSD17B4:ENST00000515320.1:intron_variant:MODIFIER:intron19/22:c.1713+57C>T::	HSD17B4:NM_000414.4:intron_variant:MODIFIER:intron20/23:c.1767+57C>T::,HSD17B4:NM_001199291.3:intron_variant:MODIFIER:intron21/24:c.1842+57C>T::,HSD17B4:NM_001199292.2:intron_variant:MODIFIER:intron19/22:c.1713+57C>T::,HSD17B4:NM_001292027.2:intron_variant:MODIFIER:intron21/24:c.1695+57C>T::,HSD17B4:NM_001292028.2:intron_variant:MODIFIER:intron20/23:c.1347+57C>T::	regulatory_region_variant:open_chromatin_region,regulatory_region_variant:CTCF_binding_site	601860 [GENE=HSD17B4 PHENOS=D-bifunctional protein deficiency,261515,Autosomal recessive/Perrault syndrome 1,233400,Autosomal recessive];				rs2636961	0.6821	0.6401	6539,.		-0.6100			0.02,0.10	0.42					0.0626	0.2511	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSD17B4 (inh=AR oe_syn=1.11 oe_mis=1.04 oe_lof=0.53)
chr5	138456815	138456815	T	C	het		QUAL=1395;DP=92;AF=0.58;MQM=60;SAP=3;ABP=8	SIL1	synonymous	SIL1:ENST00000265195.5:synonymous_variant:LOW:exon4/11:c.153A>G:p.Thr51=:,SIL1:ENST00000394817.2:synonymous_variant:LOW:exon3/10:c.153A>G:p.Thr51=:,SIL1:ENST00000509534.1:synonymous_variant:LOW:exon4/11:c.174A>G:p.Thr58=:	SIL1:NM_001037633.2:synonymous_variant:LOW:exon4/11:c.153A>G:p.Thr51=:,SIL1:NM_022464.5:synonymous_variant:LOW:exon3/10:c.153A>G:p.Thr51=:		608005 [GENE=SIL1 PHENOS=Marinesco-Sjogren syndrome,248800,Autosomal recessive];	96085 [benign DISEASE=Marinesco-Sjoegren syndrome,not specified,not provided];			rs3088052	0.4269	0.4986	4089,.	0.6717,0.4009,0.1671,0.4419,0.3874	-1.1710			0.03,0.22	6.53					0.3151	0.7684	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SIL1 (inh=AR oe_syn=1.07 oe_mis=0.92 oe_lof=0.34)
chr5	138473077	138473077	-	A	hom	off-target;low_conf_region	QUAL=4113;DP=122;AF=1.00;MQM=60;SAP=9;ABP=0	SIL1	intron,5'UTR	SIL1:ENST00000265195.5:intron_variant:MODIFIER:intron2/10:c.-10-9536dup::,SIL1:ENST00000394817.2:intron_variant:MODIFIER:intron1/9:c.-10-9536dup::,SIL1:ENST00000509534.1:5_prime_UTR_variant:MODIFIER:exon2/11:c.-47dup::	SIL1:NM_001037633.2:intron_variant:MODIFIER:intron2/10:c.-10-9536dup::,SIL1:NM_022464.5:intron_variant:MODIFIER:intron1/9:c.-10-9536dup::	regulatory_region_variant:enhancer	608005 [GENE=SIL1 PHENOS=Marinesco-Sjogren syndrome,248800,Autosomal recessive];			MIR (SINE/MIR)	rs11431215		0.9999	15691,.	0.9995,0.9997,1.0000,1.0000,1.0000					15.87					-0.0485	0.9353	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SIL1 (inh=AR oe_syn=1.07 oe_mis=0.92 oe_lof=0.34)
chr5	146030055	146030055	C	T	hom	off-target	QUAL=2561;DP=82;AF=1.00;MQM=60;SAP=4;ABP=0	PPP2R2B	intron	PPP2R2B:ENST00000336640.6:intron_variant:MODIFIER:intron5/8:c.634+55G>A::,PPP2R2B:ENST00000356826.3:intron_variant:MODIFIER:intron6/9:c.625+55G>A::,PPP2R2B:ENST00000394409.3:intron_variant:MODIFIER:intron6/9:c.799+55G>A::,PPP2R2B:ENST00000394410.2:intron_variant:MODIFIER:intron7/10:c.592+55G>A::,PPP2R2B:ENST00000394411.4:intron_variant:MODIFIER:intron6/9:c.625+55G>A::,PPP2R2B:ENST00000394413.3:intron_variant:MODIFIER:intron5/8:c.625+55G>A::,PPP2R2B:ENST00000394414.1:intron_variant:MODIFIER:intron6/9:c.823+55G>A::,PPP2R2B:ENST00000453001.1:intron_variant:MODIFIER:intron6/9:c.625+55G>A::,PPP2R2B:ENST00000504198.1:intron_variant:MODIFIER:intron6/9:c.643+55G>A::,PPP2R2B:ENST00000508545.2:intron_variant:MODIFIER:intron6/9:c.592+55G>A::	PPP2R2B:NM_001271899.1:intron_variant:MODIFIER:intron6/9:c.643+55G>A::,PPP2R2B:NM_001271900.2:intron_variant:MODIFIER:intron7/10:c.799+55G>A::,PPP2R2B:NM_001271948.1:intron_variant:MODIFIER:intron6/9:c.592+55G>A::,PPP2R2B:NM_181674.2:intron_variant:MODIFIER:intron6/9:c.823+55G>A::,PPP2R2B:NM_181675.3:intron_variant:MODIFIER:intron6/9:c.943+55G>A::,PPP2R2B:NM_181676.2:intron_variant:MODIFIER:intron5/8:c.634+55G>A::,PPP2R2B:NM_181677.2:intron_variant:MODIFIER:intron7/10:c.565+55G>A::,PPP2R2B:NM_181678.2:intron_variant:MODIFIER:intron7/10:c.592+55G>A::,PPP2R2B:NR_073526.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/8:n.1311+55G>A::,PPP2R2B:NR_073527.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/9:n.976+55G>A::		604325 [GENE=PPP2R2B PHENOS=Spinocerebellar ataxia 12,604326,Autosomal dominant];				rs6866598	0.7506	0.7599	9209,.		0.0800			0.00,0.44	13.83					-0.4304	0.6546	0.33	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PPP2R2B (inh=AD oe_syn=0.94 oe_mis=0.62 oe_lof=0.09)
chr5	146420371	146420371	-	A	het	low_conf_region	QUAL=395;DP=56;AF=0.30;MQM=60;SAP=4;ABP=22	PPP2R2B	intron	PPP2R2B:ENST00000336640.6:intron_variant:MODIFIER:intron1/8:c.79+14856dup::,PPP2R2B:ENST00000356826.3:intron_variant:MODIFIER:intron1/9:c.-125+14856dup::,PPP2R2B:ENST00000394409.3:intron_variant:MODIFIER:intron1/9:c.50+40250dup::,PPP2R2B:ENST00000394410.2:intron_variant:MODIFIER:intron2/10:c.-49+40250dup::,PPP2R2B:ENST00000394414.1:intron_variant:MODIFIER:intron1/9:c.74+14856dup::,PPP2R2B:ENST00000504198.1:intron_variant:MODIFIER:intron2/9:c.88+40250dup::	PPP2R2B:NM_001271899.1:intron_variant:MODIFIER:intron2/9:c.88+40250dup::,PPP2R2B:NM_001271900.2:intron_variant:MODIFIER:intron2/10:c.50+40250dup::,PPP2R2B:NM_181674.2:intron_variant:MODIFIER:intron1/9:c.74+14856dup::,PPP2R2B:NM_181676.2:intron_variant:MODIFIER:intron1/8:c.79+14856dup::,PPP2R2B:NM_181677.2:intron_variant:MODIFIER:intron2/10:c.-62-5569dup::,PPP2R2B:NM_181678.2:intron_variant:MODIFIER:intron2/10:c.-49+40250dup::		604325 [GENE=PPP2R2B PHENOS=Spinocerebellar ataxia 12,604326,Autosomal dominant];				rs35011506		0.4002	0,.	0.3329,0.3942,0.4170,0.4000,0.4308					8.22					0.1368	0.1085		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PPP2R2B (inh=AD oe_syn=0.94 oe_mis=0.62 oe_lof=0.09)
chr5	146434146	146434146	C	T	het	off-target	QUAL=1192;DP=113;AF=0.43;MQM=60;SAP=3;ABP=7	PPP2R2B	intron	PPP2R2B:ENST00000336640.6:intron_variant:MODIFIER:intron1/8:c.79+1082G>A::,PPP2R2B:ENST00000356826.3:intron_variant:MODIFIER:intron1/9:c.-125+1082G>A::,PPP2R2B:ENST00000394409.3:intron_variant:MODIFIER:intron1/9:c.50+26476G>A::,PPP2R2B:ENST00000394410.2:intron_variant:MODIFIER:intron2/10:c.-49+26476G>A::,PPP2R2B:ENST00000394414.1:intron_variant:MODIFIER:intron1/9:c.74+1082G>A::,PPP2R2B:ENST00000504198.1:intron_variant:MODIFIER:intron2/9:c.88+26476G>A::	PPP2R2B:NM_001271899.1:intron_variant:MODIFIER:intron2/9:c.88+26476G>A::,PPP2R2B:NM_001271900.2:intron_variant:MODIFIER:intron2/10:c.50+26476G>A::,PPP2R2B:NM_181674.2:intron_variant:MODIFIER:intron1/9:c.74+1082G>A::,PPP2R2B:NM_181676.2:intron_variant:MODIFIER:intron1/8:c.79+1082G>A::,PPP2R2B:NM_181677.2:intron_variant:MODIFIER:intron2/10:c.-62-19343G>A::,PPP2R2B:NM_181678.2:intron_variant:MODIFIER:intron2/10:c.-49+26476G>A::		604325 [GENE=PPP2R2B PHENOS=Spinocerebellar ataxia 12,604326,Autosomal dominant];				rs720305	0.3820	0.3173	1960,.	0.5542,0.2885,0.4996,0.1882,0.1765	-1.1250			0.01,0.14	1.79					-0.0354	0.1812		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PPP2R2B (inh=AD oe_syn=0.94 oe_mis=0.62 oe_lof=0.09)
chr5	146460691	146460691	T	A	het		QUAL=1986;DP=165;AF=0.50;MQM=60;SAP=8;ABP=3	PPP2R2B	5'UTR,missense	PPP2R2B:ENST00000394410.2:5_prime_UTR_variant:MODIFIER:exon2/11:c.-118A>T::,PPP2R2B:ENST00000504198.1:missense_variant:MODERATE:exon2/10:c.19A>T:p.Thr7Ser:	PPP2R2B:NM_001271899.1:missense_variant:MODERATE:exon2/10:c.19A>T:p.Thr7Ser:,PPP2R2B:NM_001271900.2:5_prime_UTR_variant:MODIFIER:exon2/11:c.-20A>T::,PPP2R2B:NM_181677.2:5_prime_UTR_variant:MODIFIER:exon2/11:c.-132A>T::,PPP2R2B:NM_181678.2:5_prime_UTR_variant:MODIFIER:exon2/11:c.-118A>T::		604325 [GENE=PPP2R2B PHENOS=Spinocerebellar ataxia 12,604326,Autosomal dominant];				rs17524553	0.0609	0.1012	207,.	0.0171,0.1178,0.0659,0.1083,0.0226	0.3120	 ,T(0.89)	 ,B(0.00)	0.09,0.28	3.67	0.02			COSV67976049	-0.3406	0.3419		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PPP2R2B (inh=AD oe_syn=0.94 oe_mis=0.62 oe_lof=0.09)
chr5	149433596	149433596	T	G	hom	off-target	QUAL=4377;DP=142;AF=1.00;MQM=60;SAP=19;ABP=0	CSF1R	3'UTR	CSF1R:ENST00000286301.3:3_prime_UTR_variant:MODIFIER:exon22/22:c.*36A>C::	CSF1R:NM_001288705.2:3_prime_UTR_variant:MODIFIER:exon21/21:c.*36A>C::,CSF1R:NM_001349736.1:3_prime_UTR_variant:MODIFIER:exon23/23:c.*36A>C::,CSF1R:NM_005211.3:3_prime_UTR_variant:MODIFIER:exon22/22:c.*36A>C::,CSF1R:NR_109969.1:non_coding_transcript_exon_variant:MODIFIER:exon20/20:n.3005A>C::		164770 [GENE=CSF1R PHENOS=Brain abnormalities,neurodegeneration,and dysosteosclerosis,618476,Autosomal recessive/Leukoencephalopathy,diffuse hereditary,with spheroids,221820,Autosomal dominant];	352120 [benign DISEASE=Hereditary diffuse leukoencephalopathy with spheroids];			rs2066934	0.7967	0.8260	10677,.	0.9495,0.7787,0.7349,0.7624,0.6831	0.8170			0.00,0.11	0.71					-0.0304	0.92	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HMGXB3 (inh=n/a oe_syn=0.76 oe_mis=0.62 oe_lof=0.14), CSF1R (inh=AR+AD oe_syn=1.04 oe_mis=0.81 oe_lof=0.24)
chr5	149433597	149433597	G	A	hom	off-target	QUAL=4377;DP=142;AF=1.00;MQM=60;SAP=19;ABP=0	CSF1R	3'UTR	CSF1R:ENST00000286301.3:3_prime_UTR_variant:MODIFIER:exon22/22:c.*35C>T::	CSF1R:NM_001288705.2:3_prime_UTR_variant:MODIFIER:exon21/21:c.*35C>T::,CSF1R:NM_001349736.1:3_prime_UTR_variant:MODIFIER:exon23/23:c.*35C>T::,CSF1R:NM_005211.3:3_prime_UTR_variant:MODIFIER:exon22/22:c.*35C>T::,CSF1R:NR_109969.1:non_coding_transcript_exon_variant:MODIFIER:exon20/20:n.3004C>T::		164770 [GENE=CSF1R PHENOS=Brain abnormalities,neurodegeneration,and dysosteosclerosis,618476,Autosomal recessive/Leukoencephalopathy,diffuse hereditary,with spheroids,221820,Autosomal dominant];	352121 [benign DISEASE=Hereditary diffuse leukoencephalopathy with spheroids];			rs2066933	0.7959	0.8256	10662,.	0.9496,0.7784,0.7279,0.7623,0.6829	-0.2550			0.00,0.10	3.31					0.0453	0.9205	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HMGXB3 (inh=n/a oe_syn=0.76 oe_mis=0.62 oe_lof=0.14), CSF1R (inh=AR+AD oe_syn=1.04 oe_mis=0.81 oe_lof=0.24)
chr5	149435608	149435608	G	C	het		QUAL=3527;DP=267;AF=0.51;MQM=60;SAP=4;ABP=3	CSF1R	synonymous	CSF1R:ENST00000286301.3:synonymous_variant:LOW:exon19/22:c.2535C>G:p.Leu845=:PF07714 [Protein tyrosine kinase]	CSF1R:NM_001288705.2:synonymous_variant:LOW:exon18/21:c.2535C>G:p.Leu845=:,CSF1R:NM_001349736.1:synonymous_variant:LOW:exon20/23:c.2535C>G:p.Leu845=:,CSF1R:NM_005211.3:synonymous_variant:LOW:exon19/22:c.2535C>G:p.Leu845=:,CSF1R:NR_109969.1:non_coding_transcript_exon_variant:MODIFIER:exon17/20:n.2585C>G::		164770 [GENE=CSF1R PHENOS=Brain abnormalities,neurodegeneration,and dysosteosclerosis,618476,Autosomal recessive/Leukoencephalopathy,diffuse hereditary,with spheroids,221820,Autosomal dominant];	352132 [benign DISEASE=Hereditary diffuse leukoencephalopathy with spheroids];			rs56327604	0.0126	0.0310	24,.	0.0077,0.0220,0.0000,0.0471,0.0074	1.2680			0.83,0.94	10.45					-0.0383	0.9357	0	19	1079	6 / 291					HMGXB3 (inh=n/a oe_syn=0.76 oe_mis=0.62 oe_lof=0.14), CSF1R (inh=AR+AD oe_syn=1.04 oe_mis=0.81 oe_lof=0.24)
chr5	149435759	149435759	G	A	hom	off-target	QUAL=587;DP=25;AF=0.96;MQM=60;SAP=55;ABP=0	CSF1R	intron	CSF1R:ENST00000286301.3:intron_variant:MODIFIER:intron18/21:c.2442+23C>T::	CSF1R:NM_001288705.2:intron_variant:MODIFIER:intron17/20:c.2442+23C>T::,CSF1R:NM_001349736.1:intron_variant:MODIFIER:intron19/22:c.2442+23C>T::,CSF1R:NM_005211.3:intron_variant:MODIFIER:intron18/21:c.2442+23C>T::,CSF1R:NR_109969.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron16/19:n.2492+23C>T::		164770 [GENE=CSF1R PHENOS=Brain abnormalities,neurodegeneration,and dysosteosclerosis,618476,Autosomal recessive/Leukoencephalopathy,diffuse hereditary,with spheroids,221820,Autosomal dominant];				rs216136	0.3942	0.5282	4356,.	0.1632,0.4053,0.4655,0.6025,0.5138	-0.0250			0.10,0.21	6.14					0.076	0.9342	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HMGXB3 (inh=n/a oe_syn=0.76 oe_mis=0.62 oe_lof=0.14), CSF1R (inh=AR+AD oe_syn=1.04 oe_mis=0.81 oe_lof=0.24)
chr5	149437190	149437190	C	G	hom	off-target	QUAL=8131;DP=251;AF=1.00;MQM=60;SAP=8;ABP=0	CSF1R	intron	CSF1R:ENST00000286301.3:intron_variant:MODIFIER:intron15/21:c.2133-35G>C::	CSF1R:NM_001288705.2:intron_variant:MODIFIER:intron14/20:c.2133-35G>C::,CSF1R:NM_001349736.1:intron_variant:MODIFIER:intron16/22:c.2133-35G>C::,CSF1R:NM_005211.3:intron_variant:MODIFIER:intron15/21:c.2133-35G>C::,CSF1R:NR_109969.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron13/19:n.2183-35G>C::	regulatory_region_variant:promoter_flanking_region	164770 [GENE=CSF1R PHENOS=Brain abnormalities,neurodegeneration,and dysosteosclerosis,618476,Autosomal recessive/Leukoencephalopathy,diffuse hereditary,with spheroids,221820,Autosomal dominant];				rs216138	0.7919	0.8222	10668,.	0.9499,0.7764,0.7286,0.7583,0.6777	0.2340			0.00,0.08	6.73					0.3779	0.0236	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HMGXB3 (inh=n/a oe_syn=0.76 oe_mis=0.62 oe_lof=0.14), CSF1R (inh=AR+AD oe_syn=1.04 oe_mis=0.81 oe_lof=0.24)
chr5	149441017	149441017	C	-	hom	off-target;low_conf_region	QUAL=1086;DP=65;AF=0.82;MQM=60;SAP=110;ABP=0	CSF1R	intron	CSF1R:ENST00000286301.3:intron_variant:MODIFIER:intron13/21:c.1858+37del::	CSF1R:NM_001288705.2:intron_variant:MODIFIER:intron12/20:c.1858+37del::,CSF1R:NM_001349736.1:intron_variant:MODIFIER:intron14/22:c.1858+37del::,CSF1R:NM_005211.3:intron_variant:MODIFIER:intron13/21:c.1858+37del::,CSF1R:NR_109969.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron12/19:n.2071+37del::		164770 [GENE=CSF1R PHENOS=Brain abnormalities,neurodegeneration,and dysosteosclerosis,618476,Autosomal recessive/Leukoencephalopathy,diffuse hereditary,with spheroids,221820,Autosomal dominant];				rs11286566		0.5645	3861,.	0.1862,0.4819,0.5179,0.6266,0.5560	-0.2690				0.62					0.0937	0.4258	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CSF1R (inh=AR+AD oe_syn=1.04 oe_mis=0.81 oe_lof=0.24)
chr5	149457678	149457678	G	A	hom		QUAL=5093;DP=152;AF=1.00;MQM=60;SAP=3;ABP=0	CSF1R	synonymous	CSF1R:ENST00000286301.3:synonymous_variant:LOW:exon5/22:c.726C>T:p.Thr242=:PF00047 [Immunoglobulin domain],CSF1R:ENST00000543093.1:synonymous_variant:LOW:exon4/6:c.726C>T:p.Thr242=:PF00047 [Immunoglobulin domain]	CSF1R:NM_001288705.2:synonymous_variant:LOW:exon4/21:c.726C>T:p.Thr242=:,CSF1R:NM_001349736.1:synonymous_variant:LOW:exon6/23:c.726C>T:p.Thr242=:,CSF1R:NM_005211.3:synonymous_variant:LOW:exon5/22:c.726C>T:p.Thr242=:,CSF1R:NR_109969.1:non_coding_transcript_exon_variant:MODIFIER:exon4/20:n.939C>T::		164770 [GENE=CSF1R PHENOS=Brain abnormalities,neurodegeneration,and dysosteosclerosis,618476,Autosomal recessive/Leukoencephalopathy,diffuse hereditary,with spheroids,221820,Autosomal dominant];	352165 [benign DISEASE=Hereditary diffuse leukoencephalopathy with spheroids];	CM153945 [CLASS=FP MUT=ALT PHEN="Loss of enhancer activity" GENE=CSF1R];		rs2228422	0.3874	0.5103	4312,.	0.3201,0.4155,0.2189,0.5676,0.5550	0.0190			0.45,0.93	8.24					-0.5885	0.7343	0.06	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CSF1R (inh=AR+AD oe_syn=1.04 oe_mis=0.81 oe_lof=0.24)
chr5	149460553	149460553	A	G	hom		QUAL=9206;DP=286;AF=0.99;MQM=60;SAP=14;ABP=0	CSF1R	synonymous	CSF1R:ENST00000286301.3:synonymous_variant:LOW:exon3/22:c.84T>C:p.Pro28=:PF13927 [Immunoglobulin domain],CSF1R:ENST00000543093.1:synonymous_variant:LOW:exon2/6:c.84T>C:p.Pro28=:PF13927 [Immunoglobulin domain]	CSF1R:NM_001288705.2:synonymous_variant:LOW:exon2/21:c.84T>C:p.Pro28=:,CSF1R:NM_001349736.1:synonymous_variant:LOW:exon4/23:c.84T>C:p.Pro28=:,CSF1R:NM_005211.3:synonymous_variant:LOW:exon3/22:c.84T>C:p.Pro28=:,CSF1R:NR_109969.1:non_coding_transcript_exon_variant:MODIFIER:exon2/20:n.297T>C::		164770 [GENE=CSF1R PHENOS=Brain abnormalities,neurodegeneration,and dysosteosclerosis,618476,Autosomal recessive/Leukoencephalopathy,diffuse hereditary,with spheroids,221820,Autosomal dominant];	352179 [benign DISEASE=Hereditary diffuse leukoencephalopathy with spheroids];			rs216123	0.3353	0.4823	4117,.	0.2921,0.3591,0.0952,0.5669,0.4657	-0.8850			0.04,0.36	4.83					0.0109	0.0919	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CSF1R (inh=AR+AD oe_syn=1.04 oe_mis=0.81 oe_lof=0.24)
chr6	110012714	110012714	C	T	het		QUAL=2116;DP=186;AF=0.45;MQM=60;SAP=7;ABP=7	FIG4	intron	FIG4:ENST00000230124.3:intron_variant:MODIFIER:intron1/22:c.66+10C>T::,FIG4:ENST00000441478.2:intron_variant:MODIFIER:intron1/16:c.-92+10C>T::	FIG4:NM_014845.5:intron_variant:MODIFIER:intron1/22:c.66+10C>T::	regulatory_region_variant:promoter	609390 [GENE=FIG4 PHENOS=Yunis-Varon syndrome,216340,Autosomal recessive/Polymicrogyria,bilateral temporooccipital,612691,Autosomal recessive/Charcot-Marie-Tooth disease,type 4J,611228,Autosomal recessive/Amyotrophic lateral sclerosis 11,612577,Autosomal dominant];	220332 [benign/likely benign DISEASE=Charcot-Marie-Tooth disease, type 4J,Amyotrophic lateral sclerosis type 11,Charcot-Marie-Tooth disease,Charcot-Marie-Tooth disease type 4,not specified,not provided];			rs200063827	0.0016	0.0059	0,.	0.0005,0.0018,0.0000,0.0052,0.0005	1.4430			0.01,0.20	9.57					-0.6794	0.1836	0.01	1	137	0 / 38	1	"VUS1, MR, 30.08.2016%0A[1] ahrautm1 30.08.2016"			AK9 (inh=n/a oe_syn=0.83 oe_mis=0.80 oe_lof=0.59), FIG4 (inh=AR+AD oe_syn=1.04 oe_mis=0.76 oe_lof=0.98)
chr6	110048489	110048489	-	T	het	off-target;low_conf_region	QUAL=1451;DP=103;AF=0.59;MQM=60;SAP=3;ABP=11	FIG4	intron	FIG4:ENST00000230124.3:intron_variant:MODIFIER:intron4/22:c.446+32dup::,FIG4:ENST00000368941.1:intron_variant:MODIFIER:intron2/4:c.215+32dup::,FIG4:ENST00000441478.2:intron_variant:MODIFIER:intron2/16:c.9-5340dup::	FIG4:NM_014845.5:intron_variant:MODIFIER:intron4/22:c.446+32dup::		609390 [GENE=FIG4 PHENOS=Yunis-Varon syndrome,216340,Autosomal recessive/Polymicrogyria,bilateral temporooccipital,612691,Autosomal recessive/Charcot-Marie-Tooth disease,type 4J,611228,Autosomal recessive/Amyotrophic lateral sclerosis 11,612577,Autosomal dominant];	917314 [benign DISEASE=Charcot-Marie-Tooth disease];		AluJb (SINE/Alu)	rs11459279		0.7770	8382,.	0.5322,0.4981,0.4992,0.5141,0.4969					2.24					0.1477	0.2707	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FIG4 (inh=AR+AD oe_syn=1.04 oe_mis=0.76 oe_lof=0.98)
chr6	110053824	110053824	-	T	het	off-target;low_conf_region	QUAL=178;DP=39;AF=0.31;MQM=60;SAP=4;ABP=16	FIG4	intron	FIG4:ENST00000230124.3:intron_variant:MODIFIER:intron4/22:c.447-3dup::,FIG4:ENST00000368941.1:intron_variant:MODIFIER:intron2/4:c.216-3dup::,FIG4:ENST00000441478.2:intron_variant:MODIFIER:intron2/16:c.9-3dup::	FIG4:NM_014845.5:intron_variant:MODIFIER:intron4/22:c.447-3dup::		609390 [GENE=FIG4 PHENOS=Yunis-Varon syndrome,216340,Autosomal recessive/Polymicrogyria,bilateral temporooccipital,612691,Autosomal recessive/Charcot-Marie-Tooth disease,type 4J,611228,Autosomal recessive/Amyotrophic lateral sclerosis 11,612577,Autosomal dominant];	694980 [benign DISEASE=Charcot-Marie-Tooth disease];			rs11377100		0.7859	8319,.	0.6430,0.5234,0.5407,0.5673,0.5270					0.35					-0.0878	0.078	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FIG4 (inh=AR+AD oe_syn=1.04 oe_mis=0.76 oe_lof=0.98)
chr6	110064256	110064260	ATTTC	-	het	off-target	QUAL=134;DP=12;AF=0.67;MQM=60;SAP=20;ABP=6	FIG4	intron	FIG4:ENST00000230124.3:intron_variant:MODIFIER:intron8/22:c.877-54_877-50del::,FIG4:ENST00000368941.1:intron_variant:MODIFIER:intron4/4:c.416-54_416-50del::,FIG4:ENST00000441478.2:intron_variant:MODIFIER:intron4/16:c.209-619_209-615del::	FIG4:NM_014845.5:intron_variant:MODIFIER:intron8/22:c.877-54_877-50del::		609390 [GENE=FIG4 PHENOS=Yunis-Varon syndrome,216340,Autosomal recessive/Polymicrogyria,bilateral temporooccipital,612691,Autosomal recessive/Charcot-Marie-Tooth disease,type 4J,611228,Autosomal recessive/Amyotrophic lateral sclerosis 11,612577,Autosomal dominant];				rs57291908		0.3007	1505,.		0.7000				5.69					0.0072	0.8993	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FIG4 (inh=AR+AD oe_syn=1.04 oe_mis=0.76 oe_lof=0.98)
chr6	110106234	110106234	A	G	hom		QUAL=708;DP=23;AF=1.00;MQM=60;SAP=45;ABP=0	FIG4	splice_region&intron	FIG4:ENST00000230124.3:splice_region_variant&intron_variant:LOW:intron17/22:c.1948+3A>G::,FIG4:ENST00000441478.2:splice_region_variant&intron_variant:LOW:intron12/16:c.1117+3A>G::	FIG4:NM_014845.5:splice_region_variant&intron_variant:LOW:intron17/22:c.1948+3A>G::		609390 [GENE=FIG4 PHENOS=Yunis-Varon syndrome,216340,Autosomal recessive/Polymicrogyria,bilateral temporooccipital,612691,Autosomal recessive/Charcot-Marie-Tooth disease,type 4J,611228,Autosomal recessive/Amyotrophic lateral sclerosis 11,612577,Autosomal dominant];	260447 [benign DISEASE=Charcot-Marie-Tooth disease, type 4J,Amyotrophic lateral sclerosis type 11,Charcot-Marie-Tooth disease,Charcot-Marie-Tooth disease type 4,not specified];			rs10499054	0.3588	0.5281	4428,.	0.1884,0.4384,0.3316,0.6719,0.3569	4.8680			0.64,0.98	14.66		10.29>8.23	0.048/0.136		-0.6347	0.689	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FIG4 (inh=AR+AD oe_syn=1.04 oe_mis=0.76 oe_lof=0.98)
chr6	110146303	110146303	G	A	het		QUAL=2561;DP=202;AF=0.50;MQM=60;SAP=3;ABP=3	FIG4	synonymous	FIG4:ENST00000230124.3:synonymous_variant:LOW:exon23/23:c.2559G>A:p.Ser853=:,FIG4:ENST00000441478.2:synonymous_variant:LOW:exon17/17:c.1641G>A:p.Ser547=:	FIG4:NM_014845.5:synonymous_variant:LOW:exon23/23:c.2559G>A:p.Ser853=:	regulatory_region_variant:promoter_flanking_region	609390 [GENE=FIG4 PHENOS=Yunis-Varon syndrome,216340,Autosomal recessive/Polymicrogyria,bilateral temporooccipital,612691,Autosomal recessive/Charcot-Marie-Tooth disease,type 4J,611228,Autosomal recessive/Amyotrophic lateral sclerosis 11,612577,Autosomal dominant];	260449 [benign DISEASE=Charcot-Marie-Tooth disease, type 4J,Amyotrophic lateral sclerosis type 11,Charcot-Marie-Tooth disease,Charcot-Marie-Tooth disease type 4,not specified];			rs1127771	0.3958	0.4388	2277,.	0.1390,0.4955,0.5753,0.4109,0.5493	-2.6820			0.01,0.35	0.85					-0.0683	0.9317	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FIG4 (inh=AR+AD oe_syn=1.04 oe_mis=0.76 oe_lof=0.98)
chr6	167360389	167360389	T	C	hom	off-target	QUAL=4632;DP=150;AF=1.00;MQM=60;SAP=3;ABP=0	RNASET2,RP11-514O12.4	intron	RNASET2:ENST00000366855.6:intron_variant:MODIFIER:intron4/9:c.90-162A>G::,RNASET2:ENST00000476238.2:intron_variant:MODIFIER:intron4/9:c.204-162A>G::,RP11-514O12.4:ENST00000507747.1:intron_variant:MODIFIER:intron3/7:c.146-162A>G::,RNASET2:ENST00000508775.1:intron_variant:MODIFIER:intron3/8:c.204-162A>G::	RNASET2:NM_003730.6:intron_variant:MODIFIER:intron3/8:c.204-162A>G::		612944 [GENE=RNASET2 PHENOS=Leukoencephalopathy,cystic,without megalencephaly,612951,Autosomal recessive];				rs2236313	0.5942	0.5283	3910,.	0.5978,0.6432,0.6311,0.4146,0.6616	-0.4010			0.00,0.05	3.28							0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RNASET2 (inh=AR oe_syn=1.07 oe_mis=0.94 oe_lof=0.53)
chr7	881668	881668	C	T	het		QUAL=978;DP=78;AF=0.53;MQM=60;SAP=15;ABP=3	SUN1	missense	SUN1:ENST00000389574.3:missense_variant:MODERATE:exon3/18:c.202C>T:p.His68Tyr:PF09387 [Mitochondrial RNA binding protein MRP],SUN1:ENST00000401592.1:missense_variant:MODERATE:exon3/19:c.352C>T:p.His118Tyr:PF09387 [Mitochondrial RNA binding protein MRP],SUN1:ENST00000403868.1:missense_variant:MODERATE:exon3/5:c.352C>T:p.His118Tyr:PF09387 [Mitochondrial RNA binding protein MRP],SUN1:ENST00000405266.1:missense_variant:MODERATE:exon3/20:c.352C>T:p.His118Tyr:PF09387 [Mitochondrial RNA binding protein MRP],SUN1:ENST00000425407.2:missense_variant:MODERATE:exon3/18:c.202C>T:p.His68Tyr:PF09387 [Mitochondrial RNA binding protein MRP],SUN1:ENST00000452783.2:missense_variant:MODERATE:exon4/17:c.352C>T:p.His118Tyr:PF09387 [Mitochondrial RNA binding protein MRP],SUN1:ENST00000456758.2:missense_variant:MODERATE:exon6/25:c.526C>T:p.His176Tyr:PF09387 [Mitochondrial RNA binding protein MRP],SUN1:ENST00000457378.2:missense_variant:MODERATE:exon5/7:c.415C>T:p.His139Tyr:PF09387 [Mitochondrial RNA binding protein MRP]	SUN1:NM_001130965.3:missense_variant:MODERATE:exon3/19:c.352C>T:p.His118Tyr:,SUN1:NM_001171944.2:missense_variant:MODERATE:exon4/17:c.352C>T:p.His118Tyr:,SUN1:NM_001171945.2:missense_variant:MODERATE:exon5/7:c.415C>T:p.His139Tyr:,SUN1:NM_001171946.2:missense_variant:MODERATE:exon4/6:c.352C>T:p.His118Tyr:,SUN1:NM_001367633.1:missense_variant:MODERATE:exon4/20:c.352C>T:p.His118Tyr:,SUN1:NM_001367634.1:missense_variant:MODERATE:exon5/21:c.352C>T:p.His118Tyr:,SUN1:NM_001367635.1:5_prime_UTR_variant:MODIFIER:exon4/21:c.-106C>T::,SUN1:NM_001367636.1:missense_variant:MODERATE:exon3/21:c.202C>T:p.His68Tyr:,SUN1:NM_001367637.1:missense_variant:MODERATE:exon3/4:c.202C>T:p.His68Tyr:,SUN1:NM_001367638.1:missense_variant:MODERATE:exon4/21:c.352C>T:p.His118Tyr:,SUN1:NM_001367639.1:5_prime_UTR_variant:MODIFIER:exon2/19:c.-216C>T::,SUN1:NM_001367640.1:missense_variant:MODERATE:exon4/21:c.352C>T:p.His118Tyr:,SUN1:NM_001367641.1:missense_variant:MODERATE:exon4/22:c.352C>T:p.His118Tyr:,SUN1:NM_001367642.1:missense_variant:MODERATE:exon4/20:c.352C>T:p.His118Tyr:,SUN1:NM_001367643.1:missense_variant:MODERATE:exon4/22:c.352C>T:p.His118Tyr:,SUN1:NM_001367644.1:missense_variant:MODERATE:exon3/20:c.202C>T:p.His68Tyr:,SUN1:NM_001367645.1:missense_variant:MODERATE:exon3/21:c.202C>T:p.His68Tyr:,SUN1:NM_001367646.1:missense_variant:MODERATE:exon3/21:c.202C>T:p.His68Tyr:,SUN1:NM_001367647.1:missense_variant:MODERATE:exon3/20:c.202C>T:p.His68Tyr:,SUN1:NM_001367648.1:missense_variant:MODERATE:exon3/19:c.202C>T:p.His68Tyr:,SUN1:NM_001367649.1:missense_variant:MODERATE:exon3/21:c.202C>T:p.His68Tyr:,SUN1:NM_001367651.1:missense_variant:MODERATE:exon4/22:c.571C>T:p.His191Tyr:,SUN1:NM_001367653.1:missense_variant:MODERATE:exon4/19:c.352C>T:p.His118Tyr:,SUN1:NM_001367655.1:missense_variant:MODERATE:exon3/22:c.202C>T:p.His68Tyr:,SUN1:NM_001367658.1:5_prime_UTR_variant:MODIFIER:exon3/20:c.-410C>T::,SUN1:NM_001367660.1:missense_variant:MODERATE:exon3/19:c.202C>T:p.His68Tyr:,SUN1:NM_001367662.1:missense_variant:MODERATE:exon3/18:c.202C>T:p.His68Tyr:,SUN1:NM_001367664.1:missense_variant:MODERATE:exon4/21:c.352C>T:p.His118Tyr:,SUN1:NM_001367665.1:missense_variant:MODERATE:exon4/19:c.352C>T:p.His118Tyr:,SUN1:NM_001367666.1:missense_variant:MODERATE:exon3/22:c.202C>T:p.His68Tyr:,SUN1:NM_001367667.1:missense_variant:MODERATE:exon3/19:c.202C>T:p.His68Tyr:,SUN1:NM_001367668.1:missense_variant:MODERATE:exon3/21:c.202C>T:p.His68Tyr:,SUN1:NM_001367669.1:missense_variant:MODERATE:exon4/20:c.352C>T:p.His118Tyr:,SUN1:NM_001367670.1:missense_variant:MODERATE:exon3/19:c.202C>T:p.His68Tyr:,SUN1:NM_001367671.1:missense_variant:MODERATE:exon3/19:c.202C>T:p.His68Tyr:,SUN1:NM_001367672.1:missense_variant:MODERATE:exon4/20:c.352C>T:p.His118Tyr:,SUN1:NM_001367673.1:missense_variant:MODERATE:exon3/21:c.202C>T:p.His68Tyr:,SUN1:NM_001367674.1:missense_variant:MODERATE:exon4/21:c.352C>T:p.His118Tyr:,SUN1:NM_001367675.1:missense_variant:MODERATE:exon4/21:c.352C>T:p.His118Tyr:,SUN1:NM_001367676.1:missense_variant:MODERATE:exon4/21:c.352C>T:p.His118Tyr:,SUN1:NM_001367677.1:missense_variant:MODERATE:exon4/22:c.352C>T:p.His118Tyr:,SUN1:NM_001367678.1:missense_variant:MODERATE:exon4/23:c.352C>T:p.His118Tyr:,SUN1:NM_001367679.1:missense_variant:MODERATE:exon3/20:c.202C>T:p.His68Tyr:,SUN1:NM_001367680.1:missense_variant:MODERATE:exon3/20:c.202C>T:p.His68Tyr:,SUN1:NM_001367681.1:missense_variant:MODERATE:exon3/20:c.202C>T:p.His68Tyr:,SUN1:NM_001367682.1:missense_variant:MODERATE:exon4/21:c.352C>T:p.His118Tyr:,SUN1:NM_001367683.1:missense_variant:MODERATE:exon4/21:c.352C>T:p.His118Tyr:,SUN1:NM_001367684.1:missense_variant:MODERATE:exon3/21:c.202C>T:p.His68Tyr:,SUN1:NM_001367685.1:missense_variant:MODERATE:exon4/20:c.352C>T:p.His118Tyr:,SUN1:NM_001367686.1:missense_variant:MODERATE:exon3/19:c.202C>T:p.His68Tyr:,SUN1:NM_001367687.1:missense_variant:MODERATE:exon4/17:c.352C>T:p.His118Tyr:,SUN1:NM_001367688.1:missense_variant:MODERATE:exon4/21:c.352C>T:p.His118Tyr:,SUN1:NM_001367689.1:missense_variant:MODERATE:exon3/20:c.202C>T:p.His68Tyr:,SUN1:NM_001367690.1:missense_variant:MODERATE:exon4/22:c.352C>T:p.His118Tyr:,SUN1:NM_001367691.1:missense_variant:MODERATE:exon3/22:c.202C>T:p.His68Tyr:,SUN1:NM_001367692.1:missense_variant:MODERATE:exon4/22:c.352C>T:p.His118Tyr:,SUN1:NM_001367693.1:missense_variant:MODERATE:exon4/21:c.352C>T:p.His118Tyr:,SUN1:NM_001367694.1:missense_variant:MODERATE:exon4/20:c.352C>T:p.His118Tyr:,SUN1:NM_001367695.1:missense_variant:MODERATE:exon3/20:c.163C>T:p.His55Tyr:,SUN1:NM_001367696.1:missense_variant:MODERATE:exon4/21:c.352C>T:p.His118Tyr:,SUN1:NM_001367697.1:missense_variant:MODERATE:exon4/22:c.352C>T:p.His118Tyr:,SUN1:NM_001367698.1:missense_variant:MODERATE:exon4/22:c.352C>T:p.His118Tyr:,SUN1:NM_001367699.1:missense_variant:MODERATE:exon4/22:c.352C>T:p.His118Tyr:,SUN1:NM_001367700.1:missense_variant:MODERATE:exon4/21:c.352C>T:p.His118Tyr:,SUN1:NM_001367701.1:missense_variant:MODERATE:exon3/20:c.202C>T:p.His68Tyr:,SUN1:NM_001367702.1:missense_variant:MODERATE:exon4/20:c.352C>T:p.His118Tyr:,SUN1:NM_001367703.1:missense_variant:MODERATE:exon4/22:c.352C>T:p.His118Tyr:,SUN1:NM_001367704.1:missense_variant:MODERATE:exon4/20:c.352C>T:p.His118Tyr:,SUN1:NM_001367705.1:missense_variant:MODERATE:exon4/23:c.352C>T:p.His118Tyr:,SUN1:NM_001367706.1:missense_variant:MODERATE:exon3/20:c.202C>T:p.His68Tyr:,SUN1:NM_001367708.1:5_prime_UTR_variant:MODIFIER:exon2/18:c.-216C>T::,SUN1:NM_025154.6:missense_variant:MODERATE:exon3/18:c.202C>T:p.His68Tyr:,SUN1:NR_160281.1:non_coding_transcript_exon_variant:MODIFIER:exon4/20:n.403C>T::,SUN1:NR_160282.1:non_coding_transcript_exon_variant:MODIFIER:exon4/23:n.403C>T::,SUN1:NR_160283.1:non_coding_transcript_exon_variant:MODIFIER:exon4/21:n.403C>T::						rs6461378	0.5329	0.5018	4011,.	0.5902,0.4223,0.6462,0.4393,0.4473	5.3770	T(0.37),T(0.59),T(0.80),T(0.72),T(0.37),T(1.00),T(0.62),T(0.45)	B(0.31),P(0.56),B(0.18),P(0.52),B(0.31),B(0.21),B(0.08),B(0.18)	0.99,0.99	21.00	0.20				-0.2062	0.9261	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SUN1 (inh=n/a oe_syn=1.10 oe_mis=0.96 oe_lof=0.37)
chr7	882895	882895	C	G	het	off-target	QUAL=1250;DP=98;AF=0.48;MQM=60;SAP=7;ABP=3	SUN1	intron	SUN1:ENST00000389574.3:intron_variant:MODIFIER:intron4/17:c.328+26C>G::,SUN1:ENST00000401592.1:intron_variant:MODIFIER:intron4/18:c.478+26C>G::,SUN1:ENST00000403868.1:intron_variant:MODIFIER:intron4/4:c.478+26C>G::,SUN1:ENST00000405266.1:intron_variant:MODIFIER:intron4/19:c.478+26C>G::,SUN1:ENST00000425407.2:intron_variant:MODIFIER:intron4/17:c.328+26C>G::,SUN1:ENST00000452783.2:intron_variant:MODIFIER:intron4/16:c.451+1128C>G::,SUN1:ENST00000456758.2:intron_variant:MODIFIER:intron7/24:c.652+26C>G::,SUN1:ENST00000457378.2:intron_variant:MODIFIER:intron6/6:c.541+26C>G::	SUN1:NM_001130965.3:intron_variant:MODIFIER:intron4/18:c.478+26C>G::,SUN1:NM_001171944.2:intron_variant:MODIFIER:intron4/16:c.451+1128C>G::,SUN1:NM_001171945.2:intron_variant:MODIFIER:intron6/6:c.541+26C>G::,SUN1:NM_001171946.2:intron_variant:MODIFIER:intron5/5:c.478+26C>G::,SUN1:NM_001367633.1:intron_variant:MODIFIER:intron5/19:c.478+26C>G::,SUN1:NM_001367634.1:intron_variant:MODIFIER:intron6/20:c.478+26C>G::,SUN1:NM_001367635.1:intron_variant:MODIFIER:intron5/20:c.21+26C>G::,SUN1:NM_001367636.1:intron_variant:MODIFIER:intron4/20:c.328+26C>G::,SUN1:NM_001367638.1:intron_variant:MODIFIER:intron5/20:c.478+26C>G::,SUN1:NM_001367639.1:intron_variant:MODIFIER:intron3/18:c.-90+26C>G::,SUN1:NM_001367640.1:intron_variant:MODIFIER:intron5/20:c.478+26C>G::,SUN1:NM_001367641.1:intron_variant:MODIFIER:intron5/21:c.478+26C>G::,SUN1:NM_001367642.1:intron_variant:MODIFIER:intron5/19:c.478+26C>G::,SUN1:NM_001367643.1:intron_variant:MODIFIER:intron5/21:c.478+26C>G::,SUN1:NM_001367644.1:intron_variant:MODIFIER:intron4/19:c.328+26C>G::,SUN1:NM_001367645.1:intron_variant:MODIFIER:intron4/20:c.328+26C>G::,SUN1:NM_001367646.1:intron_variant:MODIFIER:intron4/20:c.328+26C>G::,SUN1:NM_001367647.1:intron_variant:MODIFIER:intron4/19:c.328+26C>G::,SUN1:NM_001367648.1:intron_variant:MODIFIER:intron4/18:c.328+26C>G::,SUN1:NM_001367649.1:intron_variant:MODIFIER:intron4/20:c.328+26C>G::,SUN1:NM_001367651.1:intron_variant:MODIFIER:intron5/21:c.697+26C>G::,SUN1:NM_001367653.1:intron_variant:MODIFIER:intron5/18:c.478+26C>G::,SUN1:NM_001367655.1:intron_variant:MODIFIER:intron4/21:c.328+26C>G::,SUN1:NM_001367658.1:intron_variant:MODIFIER:intron4/19:c.-284+26C>G::,SUN1:NM_001367660.1:intron_variant:MODIFIER:intron4/18:c.328+26C>G::,SUN1:NM_001367662.1:intron_variant:MODIFIER:intron4/17:c.328+26C>G::,SUN1:NM_001367664.1:intron_variant:MODIFIER:intron5/20:c.478+26C>G::,SUN1:NM_001367665.1:intron_variant:MODIFIER:intron5/18:c.478+26C>G::,SUN1:NM_001367666.1:intron_variant:MODIFIER:intron4/21:c.328+26C>G::,SUN1:NM_001367667.1:intron_variant:MODIFIER:intron4/18:c.328+26C>G::,SUN1:NM_001367668.1:intron_variant:MODIFIER:intron4/20:c.328+26C>G::,SUN1:NM_001367669.1:intron_variant:MODIFIER:intron5/19:c.478+26C>G::,SUN1:NM_001367670.1:intron_variant:MODIFIER:intron4/18:c.328+26C>G::,SUN1:NM_001367671.1:intron_variant:MODIFIER:intron4/18:c.328+26C>G::,SUN1:NM_001367672.1:intron_variant:MODIFIER:intron5/19:c.478+26C>G::,SUN1:NM_001367673.1:intron_variant:MODIFIER:intron4/20:c.328+26C>G::,SUN1:NM_001367674.1:intron_variant:MODIFIER:intron5/20:c.478+26C>G::,SUN1:NM_001367675.1:intron_variant:MODIFIER:intron5/20:c.478+26C>G::,SUN1:NM_001367676.1:intron_variant:MODIFIER:intron5/20:c.478+26C>G::,SUN1:NM_001367677.1:intron_variant:MODIFIER:intron5/21:c.478+26C>G::,SUN1:NM_001367678.1:intron_variant:MODIFIER:intron5/22:c.478+26C>G::,SUN1:NM_001367679.1:intron_variant:MODIFIER:intron4/19:c.328+26C>G::,SUN1:NM_001367680.1:intron_variant:MODIFIER:intron4/19:c.328+26C>G::,SUN1:NM_001367681.1:intron_variant:MODIFIER:intron4/19:c.328+26C>G::,SUN1:NM_001367682.1:intron_variant:MODIFIER:intron5/20:c.478+26C>G::,SUN1:NM_001367683.1:intron_variant:MODIFIER:intron5/20:c.478+26C>G::,SUN1:NM_001367684.1:intron_variant:MODIFIER:intron4/20:c.328+26C>G::,SUN1:NM_001367685.1:intron_variant:MODIFIER:intron5/19:c.478+26C>G::,SUN1:NM_001367686.1:intron_variant:MODIFIER:intron4/18:c.328+26C>G::,SUN1:NM_001367687.1:intron_variant:MODIFIER:intron5/16:c.478+26C>G::,SUN1:NM_001367688.1:intron_variant:MODIFIER:intron5/20:c.478+26C>G::,SUN1:NM_001367689.1:intron_variant:MODIFIER:intron4/19:c.328+26C>G::,SUN1:NM_001367690.1:intron_variant:MODIFIER:intron5/21:c.478+26C>G::,SUN1:NM_001367691.1:intron_variant:MODIFIER:intron4/21:c.328+26C>G::,SUN1:NM_001367692.1:intron_variant:MODIFIER:intron5/21:c.478+26C>G::,SUN1:NM_001367693.1:intron_variant:MODIFIER:intron5/20:c.478+26C>G::,SUN1:NM_001367694.1:intron_variant:MODIFIER:intron5/19:c.478+26C>G::,SUN1:NM_001367695.1:intron_variant:MODIFIER:intron4/19:c.289+26C>G::,SUN1:NM_001367696.1:intron_variant:MODIFIER:intron5/20:c.478+26C>G::,SUN1:NM_001367697.1:intron_variant:MODIFIER:intron5/21:c.478+26C>G::,SUN1:NM_001367698.1:intron_variant:MODIFIER:intron5/21:c.478+26C>G::,SUN1:NM_001367699.1:intron_variant:MODIFIER:intron5/21:c.478+26C>G::,SUN1:NM_001367700.1:intron_variant:MODIFIER:intron5/20:c.478+26C>G::,SUN1:NM_001367701.1:intron_variant:MODIFIER:intron4/19:c.328+26C>G::,SUN1:NM_001367702.1:intron_variant:MODIFIER:intron5/19:c.478+26C>G::,SUN1:NM_001367703.1:intron_variant:MODIFIER:intron5/21:c.478+26C>G::,SUN1:NM_001367704.1:intron_variant:MODIFIER:intron5/19:c.478+26C>G::,SUN1:NM_001367705.1:intron_variant:MODIFIER:intron5/22:c.478+26C>G::,SUN1:NM_001367706.1:intron_variant:MODIFIER:intron4/19:c.328+26C>G::,SUN1:NM_001367708.1:intron_variant:MODIFIER:intron3/17:c.-90+26C>G::,SUN1:NM_025154.6:intron_variant:MODIFIER:intron4/17:c.328+26C>G::,SUN1:NR_160281.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/19:n.529+26C>G::,SUN1:NR_160282.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/22:n.529+26C>G::,SUN1:NR_160283.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/20:n.529+26C>G::						rs6970511	0.4952	0.4675	3413,.	0.4632,0.4169,0.6556,0.4381,0.4464	-1.6060			0.13,0.19	2.48					-0.0329	0.9761	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SUN1 (inh=n/a oe_syn=1.10 oe_mis=0.96 oe_lof=0.37)
chr7	890978	890978	T	C	het	off-target	QUAL=759;DP=62;AF=0.52;MQM=60;SAP=3;ABP=3	SUN1	intron	SUN1:ENST00000389574.3:intron_variant:MODIFIER:intron5/17:c.509-609T>C::,SUN1:ENST00000401592.1:intron_variant:MODIFIER:intron5/18:c.659-43T>C::,SUN1:ENST00000405266.1:intron_variant:MODIFIER:intron6/19:c.770-43T>C::,SUN1:ENST00000413514.2:intron_variant:MODIFIER:intron2/14:c.185-609T>C::,SUN1:ENST00000425407.2:intron_variant:MODIFIER:intron5/17:c.509-609T>C::,SUN1:ENST00000452783.2:intron_variant:MODIFIER:intron4/16:c.452-609T>C::,SUN1:ENST00000456758.2:intron_variant:MODIFIER:intron11/24:c.1226-43T>C::	SUN1:NM_001130965.3:intron_variant:MODIFIER:intron5/18:c.659-43T>C::,SUN1:NM_001171944.2:intron_variant:MODIFIER:intron4/16:c.452-609T>C::,SUN1:NM_001367633.1:intron_variant:MODIFIER:intron6/19:c.659-43T>C::,SUN1:NM_001367634.1:intron_variant:MODIFIER:intron7/20:c.659-43T>C::,SUN1:NM_001367635.1:intron_variant:MODIFIER:intron7/20:c.313-43T>C::,SUN1:NM_001367636.1:intron_variant:MODIFIER:intron8/20:c.902-43T>C::,SUN1:NM_001367638.1:intron_variant:MODIFIER:intron7/20:c.770-43T>C::,SUN1:NM_001367639.1:intron_variant:MODIFIER:intron5/18:c.203-43T>C::,SUN1:NM_001367640.1:intron_variant:MODIFIER:intron8/20:c.941-609T>C::,SUN1:NM_001367641.1:intron_variant:MODIFIER:intron8/21:c.941-43T>C::,SUN1:NM_001367642.1:intron_variant:MODIFIER:intron7/19:c.743-609T>C::,SUN1:NM_001367643.1:intron_variant:MODIFIER:intron8/21:c.854-43T>C::,SUN1:NM_001367644.1:intron_variant:MODIFIER:intron6/19:c.593-43T>C::,SUN1:NM_001367645.1:intron_variant:MODIFIER:intron6/20:c.620-43T>C::,SUN1:NM_001367646.1:intron_variant:MODIFIER:intron7/20:c.791-43T>C::,SUN1:NM_001367647.1:intron_variant:MODIFIER:intron7/19:c.704-43T>C::,SUN1:NM_001367648.1:intron_variant:MODIFIER:intron6/18:c.620-609T>C::,SUN1:NM_001367649.1:intron_variant:MODIFIER:intron7/20:c.704-43T>C::,SUN1:NM_001367651.1:intron_variant:MODIFIER:intron8/21:c.1073-43T>C::,SUN1:NM_001367653.1:intron_variant:MODIFIER:intron6/18:c.659-43T>C::,SUN1:NM_001367655.1:intron_variant:MODIFIER:intron8/21:c.902-43T>C::,SUN1:NM_001367658.1:intron_variant:MODIFIER:intron6/19:c.9-43T>C::,SUN1:NM_001367660.1:intron_variant:MODIFIER:intron5/18:c.509-43T>C::,SUN1:NM_001367662.1:intron_variant:MODIFIER:intron5/17:c.509-43T>C::,SUN1:NM_001367664.1:intron_variant:MODIFIER:intron7/20:c.770-43T>C::,SUN1:NM_001367665.1:intron_variant:MODIFIER:intron6/18:c.659-43T>C::,SUN1:NM_001367666.1:intron_variant:MODIFIER:intron8/21:c.902-43T>C::,SUN1:NM_001367667.1:intron_variant:MODIFIER:intron6/18:c.620-43T>C::,SUN1:NM_001367668.1:intron_variant:MODIFIER:intron7/20:c.704-43T>C::,SUN1:NM_001367669.1:intron_variant:MODIFIER:intron6/19:c.686-43T>C::,SUN1:NM_001367670.1:intron_variant:MODIFIER:intron5/18:c.509-43T>C::,SUN1:NM_001367671.1:intron_variant:MODIFIER:intron5/18:c.509-43T>C::,SUN1:NM_001367672.1:intron_variant:MODIFIER:intron6/19:c.659-43T>C::,SUN1:NM_001367673.1:intron_variant:MODIFIER:intron7/20:c.791-43T>C::,SUN1:NM_001367674.1:intron_variant:MODIFIER:intron7/20:c.857-43T>C::,SUN1:NM_001367675.1:intron_variant:MODIFIER:intron8/20:c.941-609T>C::,SUN1:NM_001367676.1:intron_variant:MODIFIER:intron8/20:c.941-609T>C::,SUN1:NM_001367677.1:intron_variant:MODIFIER:intron8/21:c.968-43T>C::,SUN1:NM_001367678.1:intron_variant:MODIFIER:intron9/22:c.1052-43T>C::,SUN1:NM_001367679.1:intron_variant:MODIFIER:intron6/19:c.620-43T>C::,SUN1:NM_001367680.1:intron_variant:MODIFIER:intron6/19:c.593-43T>C::,SUN1:NM_001367681.1:intron_variant:MODIFIER:intron6/19:c.707-43T>C::,SUN1:NM_001367682.1:intron_variant:MODIFIER:intron8/20:c.941-43T>C::,SUN1:NM_001367683.1:intron_variant:MODIFIER:intron7/20:c.743-43T>C::,SUN1:NM_001367684.1:intron_variant:MODIFIER:intron7/20:c.818-43T>C::,SUN1:NM_001367685.1:intron_variant:MODIFIER:intron7/19:c.770-43T>C::,SUN1:NM_001367686.1:intron_variant:MODIFIER:intron6/18:c.593-609T>C::,SUN1:NM_001367687.1:intron_variant:MODIFIER:intron9/16:c.1052-43T>C::,SUN1:NM_001367688.1:intron_variant:MODIFIER:intron7/20:c.743-43T>C::,SUN1:NM_001367689.1:intron_variant:MODIFIER:intron6/19:c.620-43T>C::,SUN1:NM_001367690.1:intron_variant:MODIFIER:intron9/21:c.1052-609T>C::,SUN1:NM_001367691.1:intron_variant:MODIFIER:intron8/21:c.902-43T>C::,SUN1:NM_001367692.1:intron_variant:MODIFIER:intron8/21:c.968-43T>C::,SUN1:NM_001367693.1:intron_variant:MODIFIER:intron8/20:c.854-43T>C::,SUN1:NM_001367694.1:intron_variant:MODIFIER:intron6/19:c.659-43T>C::,SUN1:NM_001367695.1:intron_variant:MODIFIER:intron6/19:c.581-43T>C::,SUN1:NM_001367696.1:intron_variant:MODIFIER:intron7/20:c.770-43T>C::,SUN1:NM_001367697.1:intron_variant:MODIFIER:intron8/21:c.854-43T>C::,SUN1:NM_001367698.1:intron_variant:MODIFIER:intron8/21:c.941-43T>C::,SUN1:NM_001367699.1:intron_variant:MODIFIER:intron9/21:c.1052-43T>C::,SUN1:NM_001367700.1:intron_variant:MODIFIER:intron8/20:c.968-609T>C::,SUN1:NM_001367701.1:intron_variant:MODIFIER:intron6/19:c.593-43T>C::,SUN1:NM_001367702.1:intron_variant:MODIFIER:intron7/19:c.770-609T>C::,SUN1:NM_001367703.1:intron_variant:MODIFIER:intron9/21:c.1052-43T>C::,SUN1:NM_001367704.1:intron_variant:MODIFIER:intron7/19:c.770-609T>C::,SUN1:NM_001367705.1:intron_variant:MODIFIER:intron9/22:c.1052-43T>C::,SUN1:NM_001367706.1:intron_variant:MODIFIER:intron7/19:c.791-43T>C::,SUN1:NM_001367708.1:intron_variant:MODIFIER:intron4/17:c.92-43T>C::,SUN1:NM_025154.6:intron_variant:MODIFIER:intron5/17:c.509-609T>C::,SUN1:NR_160281.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/19:n.710-43T>C::,SUN1:NR_160282.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron9/22:n.1103-43T>C::,SUN1:NR_160283.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/20:n.811-43T>C::						rs7792674	0.4936	0.4632	3385,.	0.4709,0.4246,0.6542,0.4367,0.4459	0.2150			0.01,0.13	3.46					0.2408	0.6333	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SUN1 (inh=n/a oe_syn=1.10 oe_mis=0.96 oe_lof=0.37)
chr7	892432	892432	G	A	het	off-target	QUAL=1684;DP=106;AF=0.58;MQM=60;SAP=3;ABP=8	SUN1	intron	SUN1:ENST00000389574.3:intron_variant:MODIFIER:intron7/17:c.662-15G>A::,SUN1:ENST00000401592.1:intron_variant:MODIFIER:intron8/18:c.911-15G>A::,SUN1:ENST00000405266.1:intron_variant:MODIFIER:intron9/19:c.1022-15G>A::,SUN1:ENST00000413514.2:intron_variant:MODIFIER:intron4/14:c.338-15G>A::,SUN1:ENST00000425407.2:intron_variant:MODIFIER:intron7/17:c.662-15G>A::,SUN1:ENST00000452783.2:intron_variant:MODIFIER:intron6/16:c.605-18G>A::,SUN1:ENST00000456758.2:intron_variant:MODIFIER:intron14/24:c.1478-15G>A::	SUN1:NM_001130965.3:intron_variant:MODIFIER:intron8/18:c.911-15G>A::,SUN1:NM_001171944.2:intron_variant:MODIFIER:intron6/16:c.605-18G>A::,SUN1:NM_001367633.1:intron_variant:MODIFIER:intron9/19:c.911-15G>A::,SUN1:NM_001367634.1:intron_variant:MODIFIER:intron10/20:c.911-15G>A::,SUN1:NM_001367635.1:intron_variant:MODIFIER:intron10/20:c.560-15G>A::,SUN1:NM_001367636.1:intron_variant:MODIFIER:intron11/20:c.1154-18G>A::,SUN1:NM_001367638.1:intron_variant:MODIFIER:intron10/20:c.1022-18G>A::,SUN1:NM_001367639.1:intron_variant:MODIFIER:intron8/18:c.455-18G>A::,SUN1:NM_001367640.1:intron_variant:MODIFIER:intron10/20:c.1094-18G>A::,SUN1:NM_001367641.1:intron_variant:MODIFIER:intron11/21:c.1193-15G>A::,SUN1:NM_001367642.1:intron_variant:MODIFIER:intron9/19:c.896-15G>A::,SUN1:NM_001367643.1:intron_variant:MODIFIER:intron11/21:c.1106-18G>A::,SUN1:NM_001367644.1:intron_variant:MODIFIER:intron9/19:c.845-18G>A::,SUN1:NM_001367645.1:intron_variant:MODIFIER:intron9/20:c.872-15G>A::,SUN1:NM_001367646.1:intron_variant:MODIFIER:intron10/20:c.1043-18G>A::,SUN1:NM_001367647.1:intron_variant:MODIFIER:intron10/19:c.956-18G>A::,SUN1:NM_001367648.1:intron_variant:MODIFIER:intron8/18:c.773-15G>A::,SUN1:NM_001367649.1:intron_variant:MODIFIER:intron10/20:c.956-15G>A::,SUN1:NM_001367651.1:intron_variant:MODIFIER:intron11/21:c.1325-15G>A::,SUN1:NM_001367653.1:intron_variant:MODIFIER:intron9/18:c.911-15G>A::,SUN1:NM_001367655.1:intron_variant:MODIFIER:intron11/21:c.1154-15G>A::,SUN1:NM_001367658.1:intron_variant:MODIFIER:intron9/19:c.261-79G>A::,SUN1:NM_001367660.1:intron_variant:MODIFIER:intron8/18:c.761-15G>A::,SUN1:NM_001367662.1:intron_variant:MODIFIER:intron8/17:c.761-18G>A::,SUN1:NM_001367664.1:intron_variant:MODIFIER:intron10/20:c.1022-15G>A::,SUN1:NM_001367665.1:intron_variant:MODIFIER:intron9/18:c.911-18G>A::,SUN1:NM_001367666.1:intron_variant:MODIFIER:intron11/21:c.1154-15G>A::,SUN1:NM_001367667.1:intron_variant:MODIFIER:intron9/18:c.872-15G>A::,SUN1:NM_001367668.1:intron_variant:MODIFIER:intron10/20:c.956-18G>A::,SUN1:NM_001367669.1:intron_variant:MODIFIER:intron9/19:c.938-15G>A::,SUN1:NM_001367670.1:intron_variant:MODIFIER:intron8/18:c.761-15G>A::,SUN1:NM_001367671.1:intron_variant:MODIFIER:intron8/18:c.761-18G>A::,SUN1:NM_001367672.1:intron_variant:MODIFIER:intron9/19:c.911-15G>A::,SUN1:NM_001367673.1:intron_variant:MODIFIER:intron10/20:c.1043-15G>A::,SUN1:NM_001367674.1:intron_variant:MODIFIER:intron10/20:c.1109-15G>A::,SUN1:NM_001367675.1:intron_variant:MODIFIER:intron10/20:c.1094-15G>A::,SUN1:NM_001367676.1:intron_variant:MODIFIER:intron10/20:c.1094-15G>A::,SUN1:NM_001367677.1:intron_variant:MODIFIER:intron11/21:c.1220-18G>A::,SUN1:NM_001367678.1:intron_variant:MODIFIER:intron12/22:c.1304-18G>A::,SUN1:NM_001367679.1:intron_variant:MODIFIER:intron9/19:c.872-18G>A::,SUN1:NM_001367680.1:intron_variant:MODIFIER:intron9/19:c.845-15G>A::,SUN1:NM_001367681.1:intron_variant:MODIFIER:intron9/19:c.959-15G>A::,SUN1:NM_001367682.1:intron_variant:MODIFIER:intron11/20:c.1193-15G>A::,SUN1:NM_001367683.1:intron_variant:MODIFIER:intron10/20:c.995-15G>A::,SUN1:NM_001367684.1:intron_variant:MODIFIER:intron10/20:c.1070-15G>A::,SUN1:NM_001367685.1:intron_variant:MODIFIER:intron10/19:c.1022-15G>A::,SUN1:NM_001367686.1:intron_variant:MODIFIER:intron8/18:c.746-18G>A::,SUN1:NM_001367687.1:intron_variant:MODIFIER:intron12/16:c.1304-18G>A::,SUN1:NM_001367688.1:intron_variant:MODIFIER:intron10/20:c.995-18G>A::,SUN1:NM_001367689.1:intron_variant:MODIFIER:intron9/19:c.872-15G>A::,SUN1:NM_001367690.1:intron_variant:MODIFIER:intron11/21:c.1205-18G>A::,SUN1:NM_001367691.1:intron_variant:MODIFIER:intron11/21:c.1154-18G>A::,SUN1:NM_001367692.1:intron_variant:MODIFIER:intron11/21:c.1220-15G>A::,SUN1:NM_001367693.1:intron_variant:MODIFIER:intron11/20:c.1106-15G>A::,SUN1:NM_001367694.1:intron_variant:MODIFIER:intron9/19:c.911-18G>A::,SUN1:NM_001367695.1:intron_variant:MODIFIER:intron9/19:c.833-15G>A::,SUN1:NM_001367696.1:intron_variant:MODIFIER:intron10/20:c.1022-15G>A::,SUN1:NM_001367697.1:intron_variant:MODIFIER:intron11/21:c.1106-15G>A::,SUN1:NM_001367698.1:intron_variant:MODIFIER:intron11/21:c.1193-18G>A::,SUN1:NM_001367699.1:intron_variant:MODIFIER:intron12/21:c.1304-18G>A::,SUN1:NM_001367700.1:intron_variant:MODIFIER:intron10/20:c.1121-15G>A::,SUN1:NM_001367701.1:intron_variant:MODIFIER:intron9/19:c.845-15G>A::,SUN1:NM_001367702.1:intron_variant:MODIFIER:intron9/19:c.923-15G>A::,SUN1:NM_001367703.1:intron_variant:MODIFIER:intron12/21:c.1304-15G>A::,SUN1:NM_001367704.1:intron_variant:MODIFIER:intron9/19:c.923-15G>A::,SUN1:NM_001367705.1:intron_variant:MODIFIER:intron12/22:c.1304-15G>A::,SUN1:NM_001367706.1:intron_variant:MODIFIER:intron10/19:c.1043-15G>A::,SUN1:NM_001367708.1:intron_variant:MODIFIER:intron7/17:c.344-15G>A::,SUN1:NM_025154.6:intron_variant:MODIFIER:intron7/17:c.662-15G>A::,SUN1:NR_160281.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron9/19:n.962-15G>A::,SUN1:NR_160282.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron12/22:n.1355-15G>A::,SUN1:NR_160283.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron10/20:n.1063-15G>A::						rs117993725	0.0042	0.0099	1,.	0.0019,0.0045,0.0000,0.0140,0.0006	-0.1340			0.05,0.16	0.54		7.64>6.93,7.60>8.43			0.7385	0.9581	0.12	3	425	1 / 132					SUN1 (inh=n/a oe_syn=1.10 oe_mis=0.96 oe_lof=0.37)
chr7	893297	893297	G	C	het	off-target	QUAL=300;DP=36;AF=0.50;MQM=60;SAP=42;ABP=3	SUN1	intron	SUN1:ENST00000389574.3:intron_variant:MODIFIER:intron9/17:c.1014+42G>C::,SUN1:ENST00000401592.1:intron_variant:MODIFIER:intron10/18:c.1263+42G>C::,SUN1:ENST00000405266.1:intron_variant:MODIFIER:intron11/19:c.1374+42G>C::,SUN1:ENST00000413514.2:intron_variant:MODIFIER:intron6/14:c.657+75G>C::,SUN1:ENST00000425407.2:intron_variant:MODIFIER:intron9/17:c.1014+42G>C::,SUN1:ENST00000452783.2:intron_variant:MODIFIER:intron8/16:c.954+42G>C::,SUN1:ENST00000456758.2:intron_variant:MODIFIER:intron16/24:c.1830+42G>C::	SUN1:NM_001130965.3:intron_variant:MODIFIER:intron10/18:c.1263+42G>C::,SUN1:NM_001171944.2:intron_variant:MODIFIER:intron8/16:c.954+42G>C::,SUN1:NM_001367633.1:intron_variant:MODIFIER:intron11/19:c.1263+42G>C::,SUN1:NM_001367634.1:intron_variant:MODIFIER:intron12/20:c.1263+42G>C::,SUN1:NM_001367635.1:intron_variant:MODIFIER:intron12/20:c.912+42G>C::,SUN1:NM_001367636.1:intron_variant:MODIFIER:intron13/20:c.1503+42G>C::,SUN1:NM_001367638.1:intron_variant:MODIFIER:intron12/20:c.1371+42G>C::,SUN1:NM_001367639.1:intron_variant:MODIFIER:intron10/18:c.804+42G>C::,SUN1:NM_001367640.1:intron_variant:MODIFIER:intron12/20:c.1443+42G>C::,SUN1:NM_001367641.1:intron_variant:MODIFIER:intron13/21:c.1545+42G>C::,SUN1:NM_001367642.1:intron_variant:MODIFIER:intron11/19:c.1248+42G>C::,SUN1:NM_001367643.1:intron_variant:MODIFIER:intron13/21:c.1455+42G>C::,SUN1:NM_001367644.1:intron_variant:MODIFIER:intron11/19:c.1194+42G>C::,SUN1:NM_001367645.1:intron_variant:MODIFIER:intron11/20:c.1224+42G>C::,SUN1:NM_001367646.1:intron_variant:MODIFIER:intron12/20:c.1392+42G>C::,SUN1:NM_001367647.1:intron_variant:MODIFIER:intron12/19:c.1305+42G>C::,SUN1:NM_001367648.1:intron_variant:MODIFIER:intron10/18:c.1125+42G>C::,SUN1:NM_001367649.1:intron_variant:MODIFIER:intron12/20:c.1308+42G>C::,SUN1:NM_001367651.1:intron_variant:MODIFIER:intron13/21:c.1677+42G>C::,SUN1:NM_001367653.1:intron_variant:MODIFIER:intron11/18:c.1263+42G>C::,SUN1:NM_001367655.1:intron_variant:MODIFIER:intron13/21:c.1473+75G>C::,SUN1:NM_001367658.1:intron_variant:MODIFIER:intron11/19:c.549+42G>C::,SUN1:NM_001367660.1:intron_variant:MODIFIER:intron10/18:c.1080+75G>C::,SUN1:NM_001367662.1:intron_variant:MODIFIER:intron10/17:c.1110+42G>C::,SUN1:NM_001367664.1:intron_variant:MODIFIER:intron12/20:c.1374+42G>C::,SUN1:NM_001367665.1:intron_variant:MODIFIER:intron11/18:c.1260+42G>C::,SUN1:NM_001367666.1:intron_variant:MODIFIER:intron13/21:c.1506+42G>C::,SUN1:NM_001367667.1:intron_variant:MODIFIER:intron11/18:c.1224+42G>C::,SUN1:NM_001367668.1:intron_variant:MODIFIER:intron12/20:c.1305+42G>C::,SUN1:NM_001367669.1:intron_variant:MODIFIER:intron11/19:c.1290+42G>C::,SUN1:NM_001367670.1:intron_variant:MODIFIER:intron10/18:c.1113+42G>C::,SUN1:NM_001367671.1:intron_variant:MODIFIER:intron10/18:c.1110+42G>C::,SUN1:NM_001367672.1:intron_variant:MODIFIER:intron11/19:c.1230+75G>C::,SUN1:NM_001367673.1:intron_variant:MODIFIER:intron12/20:c.1395+42G>C::,SUN1:NM_001367674.1:intron_variant:MODIFIER:intron12/20:c.1461+42G>C::,SUN1:NM_001367675.1:intron_variant:MODIFIER:intron12/20:c.1413+75G>C::,SUN1:NM_001367676.1:intron_variant:MODIFIER:intron12/20:c.1446+42G>C::,SUN1:NM_001367677.1:intron_variant:MODIFIER:intron13/21:c.1569+42G>C::,SUN1:NM_001367678.1:intron_variant:MODIFIER:intron14/22:c.1653+42G>C::,SUN1:NM_001367679.1:intron_variant:MODIFIER:intron11/19:c.1221+42G>C::,SUN1:NM_001367680.1:intron_variant:MODIFIER:intron11/19:c.1197+42G>C::,SUN1:NM_001367681.1:intron_variant:MODIFIER:intron11/19:c.1311+42G>C::,SUN1:NM_001367682.1:intron_variant:MODIFIER:intron13/20:c.1545+42G>C::,SUN1:NM_001367683.1:intron_variant:MODIFIER:intron12/20:c.1347+42G>C::,SUN1:NM_001367684.1:intron_variant:MODIFIER:intron12/20:c.1422+42G>C::,SUN1:NM_001367685.1:intron_variant:MODIFIER:intron12/19:c.1374+42G>C::,SUN1:NM_001367686.1:intron_variant:MODIFIER:intron10/18:c.1095+42G>C::,SUN1:NM_001367687.1:intron_variant:MODIFIER:intron14/16:c.1653+42G>C::,SUN1:NM_001367688.1:intron_variant:MODIFIER:intron12/20:c.1344+42G>C::,SUN1:NM_001367689.1:intron_variant:MODIFIER:intron11/19:c.1224+42G>C::,SUN1:NM_001367690.1:intron_variant:MODIFIER:intron13/21:c.1554+42G>C::,SUN1:NM_001367691.1:intron_variant:MODIFIER:intron13/21:c.1503+42G>C::,SUN1:NM_001367692.1:intron_variant:MODIFIER:intron13/21:c.1572+42G>C::,SUN1:NM_001367693.1:intron_variant:MODIFIER:intron13/20:c.1458+42G>C::,SUN1:NM_001367694.1:intron_variant:MODIFIER:intron11/19:c.1260+42G>C::,SUN1:NM_001367695.1:intron_variant:MODIFIER:intron11/19:c.1185+42G>C::,SUN1:NM_001367696.1:intron_variant:MODIFIER:intron12/20:c.1341+75G>C::,SUN1:NM_001367697.1:intron_variant:MODIFIER:intron13/21:c.1458+42G>C::,SUN1:NM_001367698.1:intron_variant:MODIFIER:intron13/21:c.1542+42G>C::,SUN1:NM_001367699.1:intron_variant:MODIFIER:intron14/21:c.1653+42G>C::,SUN1:NM_001367700.1:intron_variant:MODIFIER:intron12/20:c.1473+42G>C::,SUN1:NM_001367701.1:intron_variant:MODIFIER:intron11/19:c.1164+75G>C::,SUN1:NM_001367702.1:intron_variant:MODIFIER:intron11/19:c.1275+42G>C::,SUN1:NM_001367703.1:intron_variant:MODIFIER:intron14/21:c.1656+42G>C::,SUN1:NM_001367704.1:intron_variant:MODIFIER:intron11/19:c.1275+42G>C::,SUN1:NM_001367705.1:intron_variant:MODIFIER:intron14/22:c.1656+42G>C::,SUN1:NM_001367706.1:intron_variant:MODIFIER:intron12/19:c.1395+42G>C::,SUN1:NM_001367708.1:intron_variant:MODIFIER:intron9/17:c.696+42G>C::,SUN1:NM_025154.6:intron_variant:MODIFIER:intron9/17:c.1014+42G>C::,SUN1:NR_160281.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron11/19:n.1281+75G>C::,SUN1:NR_160282.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron14/22:n.1674+75G>C::,SUN1:NR_160283.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron12/20:n.1415+42G>C::						rs4605959	0.4890	0.4595	3348,.	0.4549,0.4199,0.6527,0.4390,0.4458	-0.9850			0.02,0.09	0.09					0.1148	0.4628	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SUN1 (inh=n/a oe_syn=1.10 oe_mis=0.96 oe_lof=0.37)
chr7	899710	899710	A	C	het	off-target	QUAL=1984;DP=169;AF=0.46;MQM=60;SAP=3;ABP=6	SUN1	intron	SUN1:ENST00000389574.3:intron_variant:MODIFIER:intron12/17:c.1276-55A>C::,SUN1:ENST00000401592.1:intron_variant:MODIFIER:intron13/18:c.1525-55A>C::,SUN1:ENST00000405266.1:intron_variant:MODIFIER:intron14/19:c.1636-55A>C::,SUN1:ENST00000413514.2:intron_variant:MODIFIER:intron9/14:c.919-55A>C::,SUN1:ENST00000425407.2:intron_variant:MODIFIER:intron12/17:c.1276-55A>C::,SUN1:ENST00000452783.2:intron_variant:MODIFIER:intron11/16:c.1216-55A>C::,SUN1:ENST00000456758.2:intron_variant:MODIFIER:intron19/24:c.2092-55A>C::	SUN1:NM_001130965.3:intron_variant:MODIFIER:intron13/18:c.1525-55A>C::,SUN1:NM_001171944.2:intron_variant:MODIFIER:intron11/16:c.1216-55A>C::,SUN1:NM_001367633.1:intron_variant:MODIFIER:intron14/19:c.1525-55A>C::,SUN1:NM_001367634.1:intron_variant:MODIFIER:intron15/20:c.1525-55A>C::,SUN1:NM_001367635.1:intron_variant:MODIFIER:intron15/20:c.1174-55A>C::,SUN1:NM_001367636.1:intron_variant:MODIFIER:intron16/20:c.1765-55A>C::,SUN1:NM_001367638.1:intron_variant:MODIFIER:intron15/20:c.1633-55A>C::,SUN1:NM_001367639.1:intron_variant:MODIFIER:intron13/18:c.1066-55A>C::,SUN1:NM_001367640.1:intron_variant:MODIFIER:intron15/20:c.1705-55A>C::,SUN1:NM_001367641.1:intron_variant:MODIFIER:intron16/21:c.1807-55A>C::,SUN1:NM_001367642.1:intron_variant:MODIFIER:intron14/19:c.1510-55A>C::,SUN1:NM_001367643.1:intron_variant:MODIFIER:intron16/21:c.1717-55A>C::,SUN1:NM_001367644.1:intron_variant:MODIFIER:intron14/19:c.1456-55A>C::,SUN1:NM_001367645.1:intron_variant:MODIFIER:intron15/20:c.1573-55A>C::,SUN1:NM_001367646.1:intron_variant:MODIFIER:intron15/20:c.1654-55A>C::,SUN1:NM_001367647.1:intron_variant:MODIFIER:intron15/19:c.1567-55A>C::,SUN1:NM_001367648.1:intron_variant:MODIFIER:intron13/18:c.1387-55A>C::,SUN1:NM_001367649.1:intron_variant:MODIFIER:intron15/20:c.1570-55A>C::,SUN1:NM_001367651.1:intron_variant:MODIFIER:intron16/21:c.1939-55A>C::,SUN1:NM_001367653.1:intron_variant:MODIFIER:intron14/18:c.1525-55A>C::,SUN1:NM_001367655.1:intron_variant:MODIFIER:intron16/21:c.1735-55A>C::,SUN1:NM_001367658.1:intron_variant:MODIFIER:intron14/19:c.811-55A>C::,SUN1:NM_001367660.1:intron_variant:MODIFIER:intron13/18:c.1342-55A>C::,SUN1:NM_001367662.1:intron_variant:MODIFIER:intron13/17:c.1372-55A>C::,SUN1:NM_001367664.1:intron_variant:MODIFIER:intron15/20:c.1636-55A>C::,SUN1:NM_001367665.1:intron_variant:MODIFIER:intron14/18:c.1522-55A>C::,SUN1:NM_001367666.1:intron_variant:MODIFIER:intron16/21:c.1768-55A>C::,SUN1:NM_001367667.1:intron_variant:MODIFIER:intron14/18:c.1486-55A>C::,SUN1:NM_001367668.1:intron_variant:MODIFIER:intron15/20:c.1567-55A>C::,SUN1:NM_001367669.1:intron_variant:MODIFIER:intron14/19:c.1552-55A>C::,SUN1:NM_001367670.1:intron_variant:MODIFIER:intron13/18:c.1375-55A>C::,SUN1:NM_001367671.1:intron_variant:MODIFIER:intron13/18:c.1372-55A>C::,SUN1:NM_001367672.1:intron_variant:MODIFIER:intron14/19:c.1492-55A>C::,SUN1:NM_001367673.1:intron_variant:MODIFIER:intron15/20:c.1657-55A>C::,SUN1:NM_001367674.1:intron_variant:MODIFIER:intron15/20:c.1723-55A>C::,SUN1:NM_001367675.1:intron_variant:MODIFIER:intron15/20:c.1675-55A>C::,SUN1:NM_001367676.1:intron_variant:MODIFIER:intron15/20:c.1708-55A>C::,SUN1:NM_001367677.1:intron_variant:MODIFIER:intron16/21:c.1831-55A>C::,SUN1:NM_001367678.1:intron_variant:MODIFIER:intron17/22:c.1915-55A>C::,SUN1:NM_001367679.1:intron_variant:MODIFIER:intron14/19:c.1483-55A>C::,SUN1:NM_001367680.1:intron_variant:MODIFIER:intron14/19:c.1459-55A>C::,SUN1:NM_001367681.1:intron_variant:MODIFIER:intron14/19:c.1573-55A>C::,SUN1:NM_001367682.1:intron_variant:MODIFIER:intron16/20:c.1807-55A>C::,SUN1:NM_001367683.1:intron_variant:MODIFIER:intron15/20:c.1609-55A>C::,SUN1:NM_001367684.1:intron_variant:MODIFIER:intron15/20:c.1684-55A>C::,SUN1:NM_001367685.1:intron_variant:MODIFIER:intron15/19:c.1636-55A>C::,SUN1:NM_001367686.1:intron_variant:MODIFIER:intron13/18:c.1357-55A>C::,SUN1:NM_001367688.1:intron_variant:MODIFIER:intron15/20:c.1606-55A>C::,SUN1:NM_001367689.1:intron_variant:MODIFIER:intron14/19:c.1486-55A>C::,SUN1:NM_001367690.1:intron_variant:MODIFIER:intron16/21:c.1816-55A>C::,SUN1:NM_001367691.1:intron_variant:MODIFIER:intron16/21:c.1765-55A>C::,SUN1:NM_001367692.1:intron_variant:MODIFIER:intron16/21:c.1834-55A>C::,SUN1:NM_001367693.1:intron_variant:MODIFIER:intron16/20:c.1720-55A>C::,SUN1:NM_001367694.1:intron_variant:MODIFIER:intron14/19:c.1522-55A>C::,SUN1:NM_001367695.1:intron_variant:MODIFIER:intron14/19:c.1447-55A>C::,SUN1:NM_001367696.1:intron_variant:MODIFIER:intron15/20:c.1603-55A>C::,SUN1:NM_001367697.1:intron_variant:MODIFIER:intron16/21:c.1720-55A>C::,SUN1:NM_001367698.1:intron_variant:MODIFIER:intron16/21:c.1804-55A>C::,SUN1:NM_001367699.1:intron_variant:MODIFIER:intron17/21:c.1915-55A>C::,SUN1:NM_001367700.1:intron_variant:MODIFIER:intron15/20:c.1735-55A>C::,SUN1:NM_001367701.1:intron_variant:MODIFIER:intron14/19:c.1426-55A>C::,SUN1:NM_001367702.1:intron_variant:MODIFIER:intron14/19:c.1537-55A>C::,SUN1:NM_001367703.1:intron_variant:MODIFIER:intron17/21:c.1918-55A>C::,SUN1:NM_001367704.1:intron_variant:MODIFIER:intron14/19:c.1537-55A>C::,SUN1:NM_001367705.1:intron_variant:MODIFIER:intron17/22:c.1918-55A>C::,SUN1:NM_001367706.1:intron_variant:MODIFIER:intron15/19:c.1657-55A>C::,SUN1:NM_001367708.1:intron_variant:MODIFIER:intron12/17:c.958-55A>C::,SUN1:NM_025154.6:intron_variant:MODIFIER:intron12/17:c.1276-55A>C::,SUN1:NR_160281.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron14/19:n.1543-25A>C::,SUN1:NR_160282.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron17/22:n.1936-55A>C::,SUN1:NR_160283.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron15/20:n.1677-55A>C::						rs12700166		0.4955	3883,.		-1.1930			0.03,0.10	0.66					0.0019	0.1107	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SUN1 (inh=n/a oe_syn=1.10 oe_mis=0.96 oe_lof=0.37)
chr7	4830463	4830463	G	A	het		QUAL=3727;DP=244;AF=0.56;MQM=60;SAP=24;ABP=10	AP5Z1	missense	AP5Z1:ENST00000348624.4:missense_variant:MODERATE:exon16/17:c.2098G>A:p.Val700Met:PF14764 [AP-5 complex subunit vesicle trafficking]	AP5Z1:NM_001364858.1:missense_variant:MODERATE:exon15/16:c.1630G>A:p.Val544Met:,AP5Z1:NM_014855.3:missense_variant:MODERATE:exon16/17:c.2098G>A:p.Val700Met:,AP5Z1:NR_157345.1:non_coding_transcript_exon_variant:MODIFIER:exon16/17:n.2229G>A::		613653 [GENE=AP5Z1 PHENOS=Spastic paraplegia 48,autosomal recessive,613647,Autosomal recessive];	128411 [benign/likely benign DISEASE=Spastic paraplegia 48, autosomal recessive,not specified];			rs11766611	0.0112	0.0180	6,.	0.0038,0.0114,0.0001,0.0254,0.0027	3.5370	T(0.12)	B(0.14)	0.75,0.27	13.58	0.14				-0.0843	0.4404	0.05	13	650	4 / 159					AP5Z1 (inh=AR oe_syn=1.61 oe_mis=1.37 oe_lof=1.14), MIR4656 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr7	22983702	22983702	A	T	het	off-target	QUAL=1974;DP=145;AF=0.54;MQM=60;SAP=4;ABP=5	FAM126A	3'UTR	FAM126A:ENST00000432176.2:3_prime_UTR_variant:MODIFIER:exon11/11:c.*1506T>A::	FAM126A:NM_001363466.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2108T>A::,FAM126A:NM_001363467.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2066T>A::,FAM126A:NM_032581.4:3_prime_UTR_variant:MODIFIER:exon11/11:c.*1506T>A::	regulatory_region_variant:enhancer	610531 [GENE=FAM126A PHENOS=Leukodystrophy,hypomyelinating,5,610532,Autosomal recessive];	359745 [benign DISEASE=Hypomyelination and Congenital Cataract];			rs4607514	0.6671	0.6822	7330,.		-1.4660			0.00,0.12	3.66					-0.0006	0.8991	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FAM126A (inh=AR oe_syn=1.18 oe_mis=0.83 oe_lof=0.26)
chr7	23015831	23015831	T	C	het		QUAL=693;DP=38;AF=0.66;MQM=60;SAP=3;ABP=11	FAM126A	splice_region&synonymous	FAM126A:ENST00000409923.1:splice_region_variant&synonymous_variant:LOW:exon7/12:c.624A>G:p.Ser208=:PF09790 [Hyccin],FAM126A:ENST00000432176.2:splice_region_variant&synonymous_variant:LOW:exon7/11:c.624A>G:p.Ser208=:PF09790 [Hyccin]	FAM126A:NM_001363466.2:splice_region_variant&synonymous_variant:LOW:exon7/12:c.624A>G:p.Ser208=:,FAM126A:NM_001363467.2:splice_region_variant&synonymous_variant:LOW:exon7/12:c.624A>G:p.Ser208=:,FAM126A:NM_032581.4:splice_region_variant&synonymous_variant:LOW:exon7/11:c.624A>G:p.Ser208=:		610531 [GENE=FAM126A PHENOS=Leukodystrophy,hypomyelinating,5,610532,Autosomal recessive];	21726 [benign DISEASE=Hypomyelination and Congenital Cataract,not specified,not provided];			rs3735231	0.3748	0.3697	1989,.	0.3534,0.3859,0.4851,0.3476,0.3719	1.6450			0.92,0.98	15.20		9.06>8.27	0.008/0.118		-0.2141	0.4034	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FAM126A (inh=AR oe_syn=1.18 oe_mis=0.83 oe_lof=0.26)
chr7	30634661	30634661	C	G	hom		QUAL=3695;DP=129;AF=1.00;MQM=60;SAP=4;ABP=0	GARS1	missense	GARS1:ENST00000389266.3:missense_variant:MODERATE:exon1/17:c.124C>G:p.Pro42Ala:	GARS:NM_001316772.1:5_prime_UTR_variant:MODIFIER:exon1/17:c.-39C>G::,GARS:NM_002047.4:missense_variant:MODERATE:exon1/17:c.124C>G:p.Pro42Ala:	regulatory_region_variant:promoter,TF_binding_site_variant	600287 [GENE=GARS1 PHENOS=Charcot-Marie-Tooth disease,type 2D,601472,Autosomal dominant/Spinal muscular atrophy,infantile,James type,619042,Autosomal dominant/Neuronopathy,distal hereditary motor,type VA,600794,Autosomal dominant];	258532 [benign DISEASE=Charcot-Marie-Tooth disease type 2D,Distal hereditary motor neuronopathy type 5,Charcot-Marie-Tooth disease,Charcot-Marie-Tooth disease, type 2,Distal spinal muscular atrophy,not specified,not provided];			rs1049402		0.7059	7814,.	0.5462,0.6627,0.6393,0.7698,0.6171	-0.6700	T(0.87)	B(0.00)	0.01,0.15	0.00	0.09				0.0738	0.3615	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GARS1-DT (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), GARS1 (inh=AD oe_syn=1.02 oe_mis=0.83 oe_lof=0.23)
chr7	30643069	30643069	C	A	hom	off-target	QUAL=3308;DP=109;AF=1.00;MQM=60;SAP=22;ABP=0	GARS1	intron	GARS1:ENST00000389266.3:intron_variant:MODIFIER:intron5/16:c.659-43C>A::	GARS:NM_001316772.1:intron_variant:MODIFIER:intron5/16:c.497-43C>A::,GARS:NM_002047.4:intron_variant:MODIFIER:intron5/16:c.659-43C>A::		600287 [GENE=GARS1 PHENOS=Charcot-Marie-Tooth disease,type 2D,601472,Autosomal dominant/Spinal muscular atrophy,infantile,James type,619042,Autosomal dominant/Neuronopathy,distal hereditary motor,type VA,600794,Autosomal dominant];	258537 [benign DISEASE=not specified];			rs1558064	0.3992	0.5591	4609,.	0.1290,0.5572,0.4884,0.6427,0.4158	-0.0730			0.21,0.19	3.00					-0.091	0.0524	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GARS1 (inh=AD oe_syn=1.02 oe_mis=0.83 oe_lof=0.23)
chr7	30673345	30673345	C	T	hom		QUAL=2599;DP=78;AF=1.00;MQM=60;SAP=52;ABP=0	GARS1	splice_region&intron	GARS1:ENST00000389266.3:splice_region_variant&intron_variant:LOW:intron16/16:c.2095-6C>T::	GARS:NM_001316772.1:splice_region_variant&intron_variant:LOW:intron16/16:c.1933-6C>T::,GARS:NM_002047.4:splice_region_variant&intron_variant:LOW:intron16/16:c.2095-6C>T::		600287 [GENE=GARS1 PHENOS=Charcot-Marie-Tooth disease,type 2D,601472,Autosomal dominant/Spinal muscular atrophy,infantile,James type,619042,Autosomal dominant/Neuronopathy,distal hereditary motor,type VA,600794,Autosomal dominant];	258536 [benign DISEASE=Charcot-Marie-Tooth disease type 2D,Distal hereditary motor neuronopathy type 5,Charcot-Marie-Tooth disease,Charcot-Marie-Tooth disease, type 2,Distal spinal muscular atrophy,not specified,not provided];			rs2240401	0.4042	0.5604	4616,.	0.1411,0.5586,0.4881,0.6428,0.4157	-1.9980			0.17,0.17	0.83		12.03>11.62	0.000/0.002		0.0613	0.8564	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GARS1 (inh=AD oe_syn=1.02 oe_mis=0.83 oe_lof=0.23)
chr7	30673513	30673513	A	-	het	off-target;low_conf_region	QUAL=1227;DP=77;AF=0.57;MQM=60;SAP=8;ABP=6	GARS1	3'UTR	GARS1:ENST00000389266.3:3_prime_UTR_variant:MODIFIER:exon17/17:c.*51del::	GARS:NM_001316772.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*51del::,GARS:NM_002047.4:3_prime_UTR_variant:MODIFIER:exon17/17:c.*51del::		600287 [GENE=GARS1 PHENOS=Charcot-Marie-Tooth disease,type 2D,601472,Autosomal dominant/Spinal muscular atrophy,infantile,James type,619042,Autosomal dominant/Neuronopathy,distal hereditary motor,type VA,600794,Autosomal dominant];	360021 [uncertain significance DISEASE=Peripheral axonal neuropathy,Charcot-Marie-Tooth disease, type 2,Distal spinal muscular atrophy];			rs70983380		0.5743	4252,.	0.3468,0.4382,0.3988,0.4660,0.3639	0.8020				1.51					0.0217	0.8892	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GARS1 (inh=AD oe_syn=1.02 oe_mis=0.83 oe_lof=0.23)
chr7	30673513	30673514	AA	-	het	off-target;low_conf_region	QUAL=1227;DP=77;AF=0.18;MQM=60;SAP=4;ABP=71	GARS1	3'UTR	GARS1:ENST00000389266.3:3_prime_UTR_variant:MODIFIER:exon17/17:c.*50_*51del::	GARS:NM_001316772.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*50_*51del::,GARS:NM_002047.4:3_prime_UTR_variant:MODIFIER:exon17/17:c.*50_*51del::		600287 [GENE=GARS1 PHENOS=Charcot-Marie-Tooth disease,type 2D,601472,Autosomal dominant/Spinal muscular atrophy,infantile,James type,619042,Autosomal dominant/Neuronopathy,distal hereditary motor,type VA,600794,Autosomal dominant];	360022 [uncertain significance DISEASE=Peripheral axonal neuropathy,Charcot-Marie-Tooth disease, type 2,Distal spinal muscular atrophy];			rs70983380		0.1277	139,.	0.1401,0.0962,0.1716,0.1178,0.1901	1.1240				1.92					0.043	0.8895	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GARS1 (inh=AD oe_syn=1.02 oe_mis=0.83 oe_lof=0.23)
chr7	99699849	99699849	-	A	het	off-target;low_conf_region	QUAL=26;DP=45;AF=0.16;MQM=58;SAP=3;ABP=49	AP4M1	intron,5'UTR	AP4M1:ENST00000359593.4:intron_variant:MODIFIER:intron2/14:c.147+272dup::,AP4M1:ENST00000421755.1:intron_variant:MODIFIER:intron2/15:c.147+272dup::,AP4M1:ENST00000422582.1:5_prime_UTR_variant:MODIFIER:exon1/14:c.-391dup::,AP4M1:ENST00000429084.1:intron_variant:MODIFIER:intron2/14:c.168+251dup::	AP4M1:NM_001363671.1:intron_variant:MODIFIER:intron2/14:c.168+251dup::,AP4M1:NM_004722.4:intron_variant:MODIFIER:intron2/14:c.147+272dup::	regulatory_region_variant:promoter,TF_binding_site_variant	602296 [GENE=AP4M1 PHENOS=Spastic paraplegia 50,autosomal recessive,612936,Autosomal recessive];			AluSx1 (SINE/Alu)	rs750730419		0.4132	1,.	0.4443,0.4108,0.4276,0.4137,0.4102					5.48					-0.0476	0.516	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MCM7 (inh=n/a oe_syn=1.34 oe_mis=1.10 oe_lof=0.97), AP4M1 (inh=AR oe_syn=1.39 oe_mis=1.21 oe_lof=0.95), TAF6 (inh=AR oe_syn=1.15 oe_mis=0.74 oe_lof=0.53)
chr7	99701176	99701176	G	A	het	off-target	QUAL=3457;DP=266;AF=0.49;MQM=60;SAP=13;ABP=3	AP4M1	intron	AP4M1:ENST00000359593.4:intron_variant:MODIFIER:intron5/14:c.462+34G>A::,AP4M1:ENST00000421755.1:intron_variant:MODIFIER:intron5/15:c.462+34G>A::,AP4M1:ENST00000422582.1:intron_variant:MODIFIER:intron4/13:c.78+34G>A::,AP4M1:ENST00000429084.1:intron_variant:MODIFIER:intron5/14:c.483+34G>A::	AP4M1:NM_001363671.1:intron_variant:MODIFIER:intron5/14:c.483+34G>A::,AP4M1:NM_004722.4:intron_variant:MODIFIER:intron5/14:c.462+34G>A::		602296 [GENE=AP4M1 PHENOS=Spastic paraplegia 50,autosomal recessive,612936,Autosomal recessive];	678005 [benign DISEASE=not provided];			rs999885	0.5371	0.5576	3570,.	0.2750,0.6136,0.8351,0.5146,0.6393	0.5510			0.12,0.18	4.66					0.0695	0.9422	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MCM7 (inh=n/a oe_syn=1.34 oe_mis=1.10 oe_lof=0.97), AP4M1 (inh=AR oe_syn=1.39 oe_mis=1.21 oe_lof=0.95), TAF6 (inh=AR oe_syn=1.15 oe_mis=0.74 oe_lof=0.53)
chr7	99703958	99703958	T	C	het	off-target	QUAL=1524;DP=82;AF=0.71;MQM=60;SAP=7;ABP=34	AP4M1	intron	AP4M1:ENST00000359593.4:intron_variant:MODIFIER:intron13/14:c.1025+44T>C::,AP4M1:ENST00000421755.1:intron_variant:MODIFIER:intron13/15:c.1025+44T>C::,AP4M1:ENST00000422582.1:intron_variant:MODIFIER:intron12/13:c.641+44T>C::,AP4M1:ENST00000429084.1:intron_variant:MODIFIER:intron13/14:c.1046+44T>C::	AP4M1:NM_001363671.1:intron_variant:MODIFIER:intron13/14:c.1046+44T>C::,AP4M1:NM_004722.4:intron_variant:MODIFIER:intron13/14:c.1025+44T>C::		602296 [GENE=AP4M1 PHENOS=Spastic paraplegia 50,autosomal recessive,612936,Autosomal recessive];	680070 [benign DISEASE=not provided];			rs2293479	0.3031	0.2909	1234,.	0.1955,0.2212,0.4415,0.2947,0.2995	1.5390			0.38,0.26	7.78					-0.0908	0.85	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MCM7 (inh=n/a oe_syn=1.34 oe_mis=1.10 oe_lof=0.97), AP4M1 (inh=AR oe_syn=1.39 oe_mis=1.21 oe_lof=0.95), TAF6 (inh=AR oe_syn=1.15 oe_mis=0.74 oe_lof=0.53)
chr7	99704196	99704196	A	C	het	off-target	QUAL=285;DP=256;AF=0.30;MQM=60;SAP=170;ABP=91	AP4M1	intron	AP4M1:ENST00000359593.4:intron_variant:MODIFIER:intron14/14:c.1137+59A>C::,AP4M1:ENST00000421755.1:intron_variant:MODIFIER:intron14/15:c.1137+59A>C::,AP4M1:ENST00000422582.1:intron_variant:MODIFIER:intron13/13:c.753+59A>C::,AP4M1:ENST00000429084.1:intron_variant:MODIFIER:intron14/14:c.1158+59A>C::	AP4M1:NM_001363671.1:intron_variant:MODIFIER:intron14/14:c.1158+59A>C::,AP4M1:NM_004722.4:intron_variant:MODIFIER:intron14/14:c.1137+59A>C::		602296 [GENE=AP4M1 PHENOS=Spastic paraplegia 50,autosomal recessive,612936,Autosomal recessive];				rs1051835720		0.3205	0,.		-1.7510			0.01,0.11	0.07				COSV57996366	0.2435	0.898	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MCM7 (inh=n/a oe_syn=1.34 oe_mis=1.10 oe_lof=0.97), AP4M1 (inh=AR oe_syn=1.39 oe_mis=1.21 oe_lof=0.95), TAF6 (inh=AR oe_syn=1.15 oe_mis=0.74 oe_lof=0.53)
chr7	99704200	99704200	T	C	het	off-target	QUAL=285;DP=256;AF=0.30;MQM=60;SAP=170;ABP=91	AP4M1	intron	AP4M1:ENST00000359593.4:intron_variant:MODIFIER:intron14/14:c.1137+63T>C::,AP4M1:ENST00000421755.1:intron_variant:MODIFIER:intron14/15:c.1137+63T>C::,AP4M1:ENST00000422582.1:intron_variant:MODIFIER:intron13/13:c.753+63T>C::,AP4M1:ENST00000429084.1:intron_variant:MODIFIER:intron14/14:c.1158+63T>C::	AP4M1:NM_001363671.1:intron_variant:MODIFIER:intron14/14:c.1158+63T>C::,AP4M1:NM_004722.4:intron_variant:MODIFIER:intron14/14:c.1137+63T>C::		602296 [GENE=AP4M1 PHENOS=Spastic paraplegia 50,autosomal recessive,612936,Autosomal recessive];				rs890132567		0.2425	0,.		-0.0430			0.06,0.16	0.95					0.1982	0.9021	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MCM7 (inh=n/a oe_syn=1.34 oe_mis=1.10 oe_lof=0.97), AP4M1 (inh=AR oe_syn=1.39 oe_mis=1.21 oe_lof=0.95), TAF6 (inh=AR oe_syn=1.15 oe_mis=0.74 oe_lof=0.53)
chr7	99707950	99707950	C	T	het	off-target	QUAL=1526;DP=108;AF=0.56;MQM=60;SAP=3;ABP=6	TAF6	intron	TAF6:ENST00000344095.4:intron_variant:MODIFIER:intron10/14:c.1084-53G>A::,TAF6:ENST00000418432.2:intron_variant:MODIFIER:intron9/13:c.856-53G>A::,TAF6:ENST00000437822.2:intron_variant:MODIFIER:intron10/14:c.1195-53G>A::,TAF6:ENST00000452041.1:intron_variant:MODIFIER:intron10/14:c.1084-53G>A::,TAF6:ENST00000453269.2:intron_variant:MODIFIER:intron10/14:c.1084-53G>A::,TAF6:ENST00000472509.1:intron_variant:MODIFIER:intron9/13:c.1255-53G>A::	TAF6:NM_001190415.2:intron_variant:MODIFIER:intron10/14:c.1195-53G>A::,TAF6:NM_001364998.1:intron_variant:MODIFIER:intron11/15:c.1084-53G>A::,TAF6:NM_001364999.1:intron_variant:MODIFIER:intron11/15:c.1084-53G>A::,TAF6:NM_001365000.1:intron_variant:MODIFIER:intron10/14:c.1054-53G>A::,TAF6:NM_001365001.1:intron_variant:MODIFIER:intron10/14:c.1054-53G>A::,TAF6:NM_001365002.1:intron_variant:MODIFIER:intron10/14:c.1054-53G>A::,TAF6:NM_001365003.1:intron_variant:MODIFIER:intron11/15:c.1054-53G>A::,TAF6:NM_001365004.1:intron_variant:MODIFIER:intron11/15:c.1222-53G>A::,TAF6:NM_005641.4:intron_variant:MODIFIER:intron10/14:c.1084-53G>A::,TAF6:NM_139315.3:intron_variant:MODIFIER:intron10/14:c.1084-53G>A::,TAF6:NR_033792.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron10/14:n.1173-53G>A::		602296 [GENE=AP4M1 PHENOS=Spastic paraplegia 50,autosomal recessive,612936,Autosomal recessive],602955 [GENE=TAF6 PHENOS=Alazami-Yuan syndrome,617126,Autosomal recessive];				rs4134917	0.6550	0.6172	5120,.	0.5580,0.6549,0.8758,0.5621,0.6832	0.3460			0.00,0.04	8.85					-0.2205	0.935	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AP4M1 (inh=AR oe_syn=1.39 oe_mis=1.21 oe_lof=0.95), TAF6 (inh=AR oe_syn=1.15 oe_mis=0.74 oe_lof=0.53)
chr8	17105771	17105771	T	-	het	off-target;low_conf_region	QUAL=137;DP=45;AF=0.16;MQM=60;SAP=18;ABP=49	VPS37A	intron	VPS37A:ENST00000324815.3:intron_variant:MODIFIER:intron1/5:c.125+911del::,VPS37A:ENST00000324849.4:intron_variant:MODIFIER:intron1/11:c.125+911del::,VPS37A:ENST00000521829.1:intron_variant:MODIFIER:intron1/10:c.125+911del::	VPS37A:NM_001145152.1:intron_variant:MODIFIER:intron1/10:c.125+911del::,VPS37A:NM_001363167.1:intron_variant:MODIFIER:intron1/11:c.125+911del::,VPS37A:NM_001363168.1:intron_variant:MODIFIER:intron1/12:c.-191+911del::,VPS37A:NM_001363169.1:intron_variant:MODIFIER:intron1/11:c.-141+911del::,VPS37A:NM_001363170.1:intron_variant:MODIFIER:intron1/12:c.-191+911del::,VPS37A:NM_001363171.1:intron_variant:MODIFIER:intron1/11:c.-141+911del::,VPS37A:NM_001363172.2:intron_variant:MODIFIER:intron1/12:c.-191+911del::,VPS37A:NM_001363173.2:intron_variant:MODIFIER:intron1/11:c.125+911del::,VPS37A:NM_152415.3:intron_variant:MODIFIER:intron1/11:c.125+911del::	regulatory_region_variant:promoter	609927 [GENE=VPS37A PHENOS=Spastic paraplegia 53,autosomal recessive,614898,Autosomal recessive];			AluSx (SINE/Alu)	rs77478205		0.0147	25,.		0.2180				3.03					-0.0824	0.1889	0.03	30	5555	6 / 1473					CNOT7 (inh=n/a oe_syn=1.24 oe_mis=0.40 oe_lof=0.00), VPS37A (inh=AR oe_syn=1.27 oe_mis=1.18 oe_lof=0.41)
chr8	17105772	17105772	T	C	het	off-target;low_conf_region	QUAL=137;DP=45;AF=0.16;MQM=60;SAP=18;ABP=49	VPS37A	intron	VPS37A:ENST00000324815.3:intron_variant:MODIFIER:intron1/5:c.125+894T>C::,VPS37A:ENST00000324849.4:intron_variant:MODIFIER:intron1/11:c.125+894T>C::,VPS37A:ENST00000521829.1:intron_variant:MODIFIER:intron1/10:c.125+894T>C::	VPS37A:NM_001145152.1:intron_variant:MODIFIER:intron1/10:c.125+894T>C::,VPS37A:NM_001363167.1:intron_variant:MODIFIER:intron1/11:c.125+894T>C::,VPS37A:NM_001363168.1:intron_variant:MODIFIER:intron1/12:c.-191+894T>C::,VPS37A:NM_001363169.1:intron_variant:MODIFIER:intron1/11:c.-141+894T>C::,VPS37A:NM_001363170.1:intron_variant:MODIFIER:intron1/12:c.-191+894T>C::,VPS37A:NM_001363171.1:intron_variant:MODIFIER:intron1/11:c.-141+894T>C::,VPS37A:NM_001363172.2:intron_variant:MODIFIER:intron1/12:c.-191+894T>C::,VPS37A:NM_001363173.2:intron_variant:MODIFIER:intron1/11:c.125+894T>C::,VPS37A:NM_152415.3:intron_variant:MODIFIER:intron1/11:c.125+894T>C::	regulatory_region_variant:promoter	609927 [GENE=VPS37A PHENOS=Spastic paraplegia 53,autosomal recessive,614898,Autosomal recessive];			AluSx (SINE/Alu)	rs763008815		0.2532	23,.	0.1498,0.2046,0.1421,0.3108,0.2244	-0.2480			0.00,0.06	1.04					-0.1187	0.2541	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNOT7 (inh=n/a oe_syn=1.24 oe_mis=0.40 oe_lof=0.00), VPS37A (inh=AR oe_syn=1.27 oe_mis=1.18 oe_lof=0.41)
chr8	17126348	17126348	T	C	het	off-target	QUAL=1181;DP=120;AF=0.41;MQM=60;SAP=5;ABP=12	VPS37A	intron	VPS37A:ENST00000324815.3:intron_variant:MODIFIER:intron3/5:c.316-17T>C::,VPS37A:ENST00000324849.4:intron_variant:MODIFIER:intron3/11:c.316-17T>C::,VPS37A:ENST00000521829.1:intron_variant:MODIFIER:intron2/10:c.241-17T>C::	VPS37A:NM_001145152.1:intron_variant:MODIFIER:intron2/10:c.241-17T>C::,VPS37A:NM_001363167.1:intron_variant:MODIFIER:intron3/11:c.316-17T>C::,VPS37A:NM_001363168.1:intron_variant:MODIFIER:intron4/12:c.46-17T>C::,VPS37A:NM_001363169.1:intron_variant:MODIFIER:intron3/11:c.46-17T>C::,VPS37A:NM_001363170.1:intron_variant:MODIFIER:intron4/12:c.46-17T>C::,VPS37A:NM_001363171.1:intron_variant:MODIFIER:intron3/11:c.46-17T>C::,VPS37A:NM_001363172.2:intron_variant:MODIFIER:intron4/12:c.46-17T>C::,VPS37A:NM_001363173.2:intron_variant:MODIFIER:intron3/11:c.316-17T>C::,VPS37A:NM_152415.3:intron_variant:MODIFIER:intron3/11:c.316-17T>C::		609927 [GENE=VPS37A PHENOS=Spastic paraplegia 53,autosomal recessive,614898,Autosomal recessive];	380929 [benign DISEASE=not specified];			rs117165264	0.0046	0.0121	3,.	0.0030,0.0040,0.0001,0.0201,0.0043	1.4470			0.14,0.27	10.39		7.59>7.36			-0.4043	0.595	0.03	8	480	4 / 132					VPS37A (inh=AR oe_syn=1.27 oe_mis=1.18 oe_lof=0.41)
chr8	17137413	17137413	G	A	het		QUAL=411;DP=36;AF=0.50;MQM=60;SAP=3;ABP=3	VPS37A	intron	VPS37A:ENST00000324849.4:intron_variant:MODIFIER:intron6/11:c.714-124G>A::,VPS37A:ENST00000521829.1:intron_variant:MODIFIER:intron5/10:c.639-124G>A::	VPS37A:NM_001145152.1:intron_variant:MODIFIER:intron5/10:c.639-124G>A::,VPS37A:NM_001363167.1:intron_variant:MODIFIER:intron6/11:c.714-124G>A::,VPS37A:NM_001363168.1:intron_variant:MODIFIER:intron7/12:c.444-124G>A::,VPS37A:NM_001363169.1:intron_variant:MODIFIER:intron6/11:c.444-124G>A::,VPS37A:NM_001363170.1:intron_variant:MODIFIER:intron7/12:c.444-124G>A::,VPS37A:NM_001363171.1:intron_variant:MODIFIER:intron6/11:c.444-124G>A::,VPS37A:NM_001363172.2:intron_variant:MODIFIER:intron7/12:c.444-124G>A::,VPS37A:NM_001363173.2:intron_variant:MODIFIER:intron6/11:c.714-124G>A::,VPS37A:NM_152415.3:intron_variant:MODIFIER:intron6/11:c.714-124G>A::		609927 [GENE=VPS37A PHENOS=Spastic paraplegia 53,autosomal recessive,614898,Autosomal recessive];	670266 [benign DISEASE=not provided];			rs17587086	0.0659	0.1352	353,.	0.0331,0.0775,0.0017,0.1710,0.0882	-0.1600			0.01,0.11	0.68				COSV61365036	-0.0011	0.2992	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS37A (inh=AR oe_syn=1.27 oe_mis=1.18 oe_lof=0.41)
chr8	17137687	17137687	G	A	het	off-target	QUAL=919;DP=77;AF=0.48;MQM=60;SAP=16;ABP=3	VPS37A	intron	VPS37A:ENST00000324849.4:intron_variant:MODIFIER:intron7/11:c.841+23G>A::,VPS37A:ENST00000521829.1:intron_variant:MODIFIER:intron6/10:c.766+23G>A::	VPS37A:NM_001145152.1:intron_variant:MODIFIER:intron6/10:c.766+23G>A::,VPS37A:NM_001363167.1:intron_variant:MODIFIER:intron7/11:c.841+23G>A::,VPS37A:NM_001363168.1:intron_variant:MODIFIER:intron8/12:c.571+23G>A::,VPS37A:NM_001363169.1:intron_variant:MODIFIER:intron7/11:c.571+23G>A::,VPS37A:NM_001363170.1:intron_variant:MODIFIER:intron8/12:c.571+23G>A::,VPS37A:NM_001363171.1:intron_variant:MODIFIER:intron7/11:c.571+23G>A::,VPS37A:NM_001363172.2:intron_variant:MODIFIER:intron8/12:c.571+23G>A::,VPS37A:NM_001363173.2:intron_variant:MODIFIER:intron7/11:c.841+23G>A::,VPS37A:NM_152415.3:intron_variant:MODIFIER:intron7/11:c.841+23G>A::		609927 [GENE=VPS37A PHENOS=Spastic paraplegia 53,autosomal recessive,614898,Autosomal recessive];	670833 [benign DISEASE=not provided];			rs3213601	0.2682	0.4227	2705,.	0.0866,0.3604,0.2402,0.5184,0.3598	0.3200			0.13,0.30	4.27					-0.03	0.3248	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VPS37A (inh=AR oe_syn=1.27 oe_mis=1.18 oe_lof=0.41)
chr8	37611415	37611415	T	-	het	off-target	QUAL=604;DP=187;AF=0.20;MQM=60;SAP=3;ABP=146	ERLIN2	intron	ERLIN2:ENST00000276461.5:intron_variant:MODIFIER:intron11/11:c.820-6del::,ERLIN2:ENST00000519638.1:intron_variant:MODIFIER:intron10/10:c.820-6del::	ERLIN2:NM_001362878.2:intron_variant:MODIFIER:intron11/11:c.820-6del::,ERLIN2:NM_007175.8:intron_variant:MODIFIER:intron11/11:c.820-6del::		611605 [GENE=ERLIN2 PHENOS=Spastic paraplegia 18,autosomal recessive,611225,Autosomal recessive];				rs748383831		0.3274	0,.	0.2243,0.3839,0.3172,0.3111,0.3940	0.1440				1.32					-0.3127	0.8965	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ERLIN2 (inh=AR oe_syn=0.95 oe_mis=0.60 oe_lof=0.46)
chr8	65537105	65537105	A	-	het		QUAL=29;DP=20;AF=0.20;MQM=60;SAP=12;ABP=19	CYP7B1	intron	CYP7B1:ENST00000310193.3:intron_variant:MODIFIER:intron1/5:c.123-9del::	CYP7B1:NM_001324112.2:intron_variant:MODIFIER:intron1/6:c.123-9del::,CYP7B1:NM_004820.5:intron_variant:MODIFIER:intron1/5:c.123-9del::		603711 [GENE=CYP7B1 PHENOS=Spastic paraplegia 5A,autosomal recessive,270800,Autosomal recessive/Bile acid synthesis defect,congenital,3,613812,Autosomal recessive];	195232 [benign DISEASE=Spastic paraplegia,not specified,not provided];		A-rich (Low_complexity)	rs8192895		0.1090	0,.	0.0819,0.1266,0.0987,0.1027,0.1071	-0.3620				1.38								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CYP7B1 (inh=AR oe_syn=1.22 oe_mis=1.07 oe_lof=0.57)
chr8	126051035	126051035	A	C	het	off-target	QUAL=32;DP=71;AF=0.23;MQM=60;SAP=38;ABP=50	WASHC5	intron	WASHC5:ENST00000318410.7:intron_variant:MODIFIER:intron25/28:c.3084+37T>G::,WASHC5:ENST00000517845.1:intron_variant:MODIFIER:intron23/26:c.2640+37T>G::	WASHC5:NM_001330609.1:intron_variant:MODIFIER:intron24/27:c.2640+37T>G::,WASHC5:NM_014846.4:intron_variant:MODIFIER:intron25/28:c.3084+37T>G::		610657 [GENE=WASHC5 PHENOS=Ritscher-Schinzel syndrome 1,220210,Autosomal recessive/Spastic paraplegia 8,autosomal dominant,603563,Autosomal dominant];				rs746350762		0.0004	0,.	0.0000,0.0000,0.0000,0.0001,0.0000	-2.6840			0.03,0.13	0.94					-0.004	0.1458	0	7	446	7 / 445					WASHC5 (inh=AR+AD oe_syn=1.04 oe_mis=0.85 oe_lof=0.57), WASHC5-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr8	126056215	126056215	-	C	hom	off-target	QUAL=1429;DP=49;AF=1.00;MQM=60;SAP=3;ABP=0	WASHC5,WASHC5-AS1	intron,intron&non_coding_transcript	WASHC5:ENST00000318410.7:intron_variant:MODIFIER:intron22/28:c.2770+18_2770+19insG::,WASHC5:ENST00000517845.1:intron_variant:MODIFIER:intron20/26:c.2326+18_2326+19insG::,WASHC5-AS1:ENST00000519140.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.97-526_97-525insC::	WASHC5:NM_001330609.1:intron_variant:MODIFIER:intron21/27:c.2326+18_2326+19insG::,WASHC5:NM_014846.4:intron_variant:MODIFIER:intron22/28:c.2770+18_2770+19insG::		610657 [GENE=WASHC5 PHENOS=Ritscher-Schinzel syndrome 1,220210,Autosomal recessive/Spastic paraplegia 8,autosomal dominant,603563,Autosomal dominant];	516650 [benign DISEASE=not specified];			rs11370883	1.0000	0.9999	15702,.	0.9999,1.0000,1.0000,0.9999,1.0000					6.82					0.1916	0.2742	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					WASHC5 (inh=AR+AD oe_syn=1.04 oe_mis=0.85 oe_lof=0.57), WASHC5-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr8	126068873	126068873	T	G	het	off-target	QUAL=1666;DP=140;AF=0.51;MQM=60;SAP=47;ABP=3	WASHC5	intron	WASHC5:ENST00000318410.7:intron_variant:MODIFIER:intron16/28:c.2016+46A>C::,WASHC5:ENST00000517845.1:intron_variant:MODIFIER:intron14/26:c.1572+46A>C::	WASHC5:NM_001330609.1:intron_variant:MODIFIER:intron15/27:c.1572+46A>C::,WASHC5:NM_014846.4:intron_variant:MODIFIER:intron16/28:c.2016+46A>C::		610657 [GENE=WASHC5 PHENOS=Ritscher-Schinzel syndrome 1,220210,Autosomal recessive/Spastic paraplegia 8,autosomal dominant,603563,Autosomal dominant];	682821 [benign DISEASE=not provided];			rs2303523	0.0701	0.0851	66,.	0.0183,0.0907,0.0615,0.0931,0.1135	-0.5950			0.05,0.15	4.78					-0.0813	0.5092	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					WASHC5 (inh=AR+AD oe_syn=1.04 oe_mis=0.85 oe_lof=0.57)
chr8	126068886	126068886	T	C	het	off-target	QUAL=1821;DP=144;AF=0.52;MQM=60;SAP=38;ABP=4	WASHC5	intron	WASHC5:ENST00000318410.7:intron_variant:MODIFIER:intron16/28:c.2016+33A>G::,WASHC5:ENST00000517845.1:intron_variant:MODIFIER:intron14/26:c.1572+33A>G::	WASHC5:NM_001330609.1:intron_variant:MODIFIER:intron15/27:c.1572+33A>G::,WASHC5:NM_014846.4:intron_variant:MODIFIER:intron16/28:c.2016+33A>G::		610657 [GENE=WASHC5 PHENOS=Ritscher-Schinzel syndrome 1,220210,Autosomal recessive/Spastic paraplegia 8,autosomal dominant,603563,Autosomal dominant];				rs2303522	0.2432	0.2480	659,.	0.1757,0.4621,0.3155,0.1912,0.2672	-1.5830			0.03,0.13	5.05					-0.1474	0.5099	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					WASHC5 (inh=AR+AD oe_syn=1.04 oe_mis=0.85 oe_lof=0.57)
chr8	126085363	126085363	T	C	het	off-target	QUAL=775;DP=78;AF=0.41;MQM=60;SAP=3;ABP=8	WASHC5	intron	WASHC5:ENST00000318410.7:intron_variant:MODIFIER:intron9/28:c.1150+32A>G::,WASHC5:ENST00000517845.1:intron_variant:MODIFIER:intron7/26:c.706+32A>G::	WASHC5:NM_001330609.1:intron_variant:MODIFIER:intron8/27:c.706+32A>G::,WASHC5:NM_014846.4:intron_variant:MODIFIER:intron9/28:c.1150+32A>G::		610657 [GENE=WASHC5 PHENOS=Ritscher-Schinzel syndrome 1,220210,Autosomal recessive/Spastic paraplegia 8,autosomal dominant,603563,Autosomal dominant];				rs10102230	0.4936	0.4198	3289,.	0.6949,0.5503,0.3928,0.3086,0.4500	-0.5220			0.01,0.16	5.64					-0.0921	0.3886	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					WASHC5 (inh=AR+AD oe_syn=1.04 oe_mis=0.85 oe_lof=0.57)
chr8	126085586	126085586	G	A	het	off-target	QUAL=492;DP=30;AF=0.60;MQM=60;SAP=3;ABP=6	WASHC5	intron	WASHC5:ENST00000318410.7:intron_variant:MODIFIER:intron8/28:c.979-20C>T::,WASHC5:ENST00000517845.1:intron_variant:MODIFIER:intron6/26:c.535-20C>T::	WASHC5:NM_001330609.1:intron_variant:MODIFIER:intron7/27:c.535-20C>T::,WASHC5:NM_014846.4:intron_variant:MODIFIER:intron8/28:c.979-20C>T::		610657 [GENE=WASHC5 PHENOS=Ritscher-Schinzel syndrome 1,220210,Autosomal recessive/Spastic paraplegia 8,autosomal dominant,603563,Autosomal dominant];	380826 [benign DISEASE=not specified];			rs12546285	0.2254	0.2421	592,.	0.1172,0.4583,0.3153,0.1903,0.2658	-0.0870			0.17,0.26	1.74		2.33>2.44			0.1072	0.1043	0.05	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					WASHC5 (inh=AR+AD oe_syn=1.04 oe_mis=0.85 oe_lof=0.57)
chr9	35739115	35739115	-	C	het		QUAL=1572;DP=114;AF=0.53;MQM=60;SAP=3;ABP=4	GBA2	intron	GBA2:ENST00000378094.4:intron_variant:MODIFIER:intron10/16:c.1688-10_1688-9insG::,GBA2:ENST00000378103.3:intron_variant:MODIFIER:intron10/16:c.1688-10_1688-9insG::,GBA2:ENST00000545786.1:intron_variant:MODIFIER:intron11/17:c.1706-10_1706-9insG::	GBA2:NM_001330660.2:intron_variant:MODIFIER:intron10/16:c.1688-10_1688-9insG::,GBA2:NM_020944.3:intron_variant:MODIFIER:intron10/16:c.1688-10_1688-9insG::		609471 [GENE=GBA2 PHENOS=Spastic paraplegia 46,autosomal recessive,614409,Autosomal recessive];	516643 [benign DISEASE=not specified];			rs3833700	0.7105	0.6865	7400,.	0.7454,0.6487,0.8357,0.6646,0.6345					12.30					-1.0441	0.4413	0.22	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CREB3 (inh=n/a oe_syn=1.04 oe_mis=0.99 oe_lof=0.60), GBA2 (inh=AR oe_syn=0.92 oe_mis=0.80 oe_lof=0.72)
chr9	71650752	71650752	A	G	hom		QUAL=404;DP=14;AF=1.00;MQM=60;SAP=33;ABP=0	FXN	synonymous	FXN:ENST00000377270.3:synonymous_variant:LOW:exon1/5:c.54A>G:p.Pro18=:,FXN:ENST00000396364.3:synonymous_variant:LOW:exon1/5:c.54A>G:p.Pro18=:,FXN:ENST00000396366.2:synonymous_variant:LOW:exon1/5:c.54A>G:p.Pro18=:	FXN:NM_000144.5:synonymous_variant:LOW:exon1/5:c.54A>G:p.Pro18=:,FXN:NM_181425.3:synonymous_variant:LOW:exon1/5:c.54A>G:p.Pro18=:	regulatory_region_variant:promoter,TF_binding_site_variant	606829 [GENE=FXN PHENOS=Friedreich ataxia with retained reflexes,229300,Autosomal recessive/Friedreich ataxia,229300,Autosomal recessive];	129120 [benign DISEASE=Friedreich ataxia 1,not specified,Cardiovascular phenotype,not provided];		(ACCCAG)n (Simple_repeat)	rs2481598		0.9979	15194,.	0.9409,0.9971,1.0000,0.9998,0.9998	-0.4710			0.00,0.51	5.19					0.0553	0.1002	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FXN (inh=AR oe_syn=1.06 oe_mis=0.92 oe_lof=0.23)
chr9	71668197	71668197	T	C	het	off-target	QUAL=3622;DP=225;AF=0.56;MQM=60;SAP=12;ABP=11	FXN	intron	FXN:ENST00000377270.3:intron_variant:MODIFIER:intron3/4:c.384+21T>C::,FXN:ENST00000396364.3:intron_variant:MODIFIER:intron3/4:c.384+21T>C::,FXN:ENST00000396366.2:intron_variant:MODIFIER:intron3/4:c.384+21T>C::,FXN:ENST00000498653.1:intron_variant:MODIFIER:intron3/4:c.159+21T>C::	FXN:NM_000144.5:intron_variant:MODIFIER:intron3/4:c.384+21T>C::,FXN:NM_181425.3:intron_variant:MODIFIER:intron3/4:c.384+21T>C::		606829 [GENE=FXN PHENOS=Friedreich ataxia with retained reflexes,229300,Autosomal recessive/Friedreich ataxia,229300,Autosomal recessive];				rs3829062	0.5016	0.5183	3566,.	0.3930,0.5590,0.5768,0.5291,0.5249	0.4850			0.08,0.28	9.07					-0.0861	0.7246	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FXN (inh=AR oe_syn=1.06 oe_mis=0.92 oe_lof=0.23)
chr9	135139901	135139901	T	C	hom		QUAL=813;DP=30;AF=0.93;MQM=60;SAP=3;ABP=0	SETX	missense	SETX:ENST00000224140.5:missense_variant:MODERATE:exon26/26:c.7759A>G:p.Ile2587Val:,SETX:ENST00000372169.2:missense_variant:MODERATE:exon27/27:c.7846A>G:p.Ile2616Val:,SETX:ENST00000393220.1:missense_variant:MODERATE:exon25/25:c.7660A>G:p.Ile2554Val:	SETX:NM_001351527.1:missense_variant:MODERATE:exon26/26:c.7759A>G:p.Ile2587Val:,SETX:NM_001351528.2:missense_variant:MODERATE:exon27/27:c.7846A>G:p.Ile2616Val:,SETX:NM_015046.7:missense_variant:MODERATE:exon26/26:c.7759A>G:p.Ile2587Val:		608465 [GENE=SETX PHENOS=Spinocerebellar ataxia,autosomal recessive,with axonal neuropathy 2,606002,Autosomal recessive/Amyotrophic lateral sclerosis 4,juvenile,602433,Autosomal dominant];	95669 [benign DISEASE=Amyotrophic lateral sclerosis type 4,Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2,not specified,not provided];	CM1417740 [CLASS=DP MUT=ALT PHEN="Alzheimer disease increased risk association with" GENE=SETX];		rs1056899	0.5387	0.4449	3790,.	0.7561,0.3160,0.7274,0.2953,0.4408	-1.1110	T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00)	0.02,0.13	0.01	0.19				0.0027	0.9386	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SETX (inh=AR+AD oe_syn=1.11 oe_mis=1.01 oe_lof=0.21)
chr9	135152544	135152544	A	-	het	low_conf_region	QUAL=63;DP=25;AF=0.20;MQM=60;SAP=7;ABP=23	SETX	splice_region&intron	SETX:ENST00000224140.5:splice_region_variant&intron_variant:LOW:intron21/25:c.6843-5del::,SETX:ENST00000372169.2:splice_region_variant&intron_variant:LOW:intron21/26:c.6843-5del::,SETX:ENST00000393220.1:splice_region_variant&intron_variant:LOW:intron21/24:c.6843-5del::	SETX:NM_001351527.1:splice_region_variant&intron_variant:LOW:intron21/25:c.6843-5del::,SETX:NM_001351528.2:splice_region_variant&intron_variant:LOW:intron21/26:c.6843-5del::,SETX:NM_015046.7:splice_region_variant&intron_variant:LOW:intron21/25:c.6843-5del::		608465 [GENE=SETX PHENOS=Spinocerebellar ataxia,autosomal recessive,with axonal neuropathy 2,606002,Autosomal recessive/Amyotrophic lateral sclerosis 4,juvenile,602433,Autosomal dominant];	810897 [benign DISEASE=not specified];			rs34769225		0.2322	0,.	0.1604,0.2865,0.0979,0.2683,0.1764	0.0720				1.09					-0.1655	0.365	0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SETX (inh=AR+AD oe_syn=1.11 oe_mis=1.01 oe_lof=0.21)
chr9	135153668	135153668	C	T	het	off-target	QUAL=1793;DP=95;AF=0.67;MQM=60;SAP=3;ABP=28	SETX	intron	SETX:ENST00000224140.5:intron_variant:MODIFIER:intron20/25:c.6655-24G>A::,SETX:ENST00000372169.2:intron_variant:MODIFIER:intron20/26:c.6655-24G>A::,SETX:ENST00000393220.1:intron_variant:MODIFIER:intron20/24:c.6655-24G>A::	SETX:NM_001351527.1:intron_variant:MODIFIER:intron20/25:c.6655-24G>A::,SETX:NM_001351528.2:intron_variant:MODIFIER:intron20/26:c.6655-24G>A::,SETX:NM_015046.7:intron_variant:MODIFIER:intron20/25:c.6655-24G>A::		608465 [GENE=SETX PHENOS=Spinocerebellar ataxia,autosomal recessive,with axonal neuropathy 2,606002,Autosomal recessive/Amyotrophic lateral sclerosis 4,juvenile,602433,Autosomal dominant];	260513 [benign DISEASE=not specified];			rs11243704	0.5339	0.4423	3730,.	0.7549,0.2890,0.7152,0.2944,0.4399	-1.0590			0.01,0.08	1.48					-0.1323	0.077	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SETX (inh=AR+AD oe_syn=1.11 oe_mis=1.01 oe_lof=0.21)
chr9	135153673	135153673	T	C	het	off-target	QUAL=1735;DP=94;AF=0.66;MQM=60;SAP=3;ABP=24	SETX	intron	SETX:ENST00000224140.5:intron_variant:MODIFIER:intron20/25:c.6655-29A>G::,SETX:ENST00000372169.2:intron_variant:MODIFIER:intron20/26:c.6655-29A>G::,SETX:ENST00000393220.1:intron_variant:MODIFIER:intron20/24:c.6655-29A>G::	SETX:NM_001351527.1:intron_variant:MODIFIER:intron20/25:c.6655-29A>G::,SETX:NM_001351528.2:intron_variant:MODIFIER:intron20/26:c.6655-29A>G::,SETX:NM_015046.7:intron_variant:MODIFIER:intron20/25:c.6655-29A>G::		608465 [GENE=SETX PHENOS=Spinocerebellar ataxia,autosomal recessive,with axonal neuropathy 2,606002,Autosomal recessive/Amyotrophic lateral sclerosis 4,juvenile,602433,Autosomal dominant];				rs11243705	0.1587	0.1649	334,.	0.0976,0.1440,0.2905,0.1651,0.1575	0.4200			0.03,0.13	8.19					-0.3891	0.1318	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SETX (inh=AR+AD oe_syn=1.11 oe_mis=1.01 oe_lof=0.21)
chr9	135202829	135202829	T	C	hom		QUAL=2942;DP=90;AF=1.00;MQM=60;SAP=3;ABP=0	SETX	missense	SETX:ENST00000224140.5:missense_variant:MODERATE:exon10/26:c.4156A>G:p.Ile1386Val:,SETX:ENST00000372169.2:missense_variant:MODERATE:exon10/27:c.4156A>G:p.Ile1386Val:,SETX:ENST00000393220.1:missense_variant:MODERATE:exon10/25:c.4156A>G:p.Ile1386Val:	SETX:NM_001351527.1:missense_variant:MODERATE:exon10/26:c.4156A>G:p.Ile1386Val:,SETX:NM_001351528.2:missense_variant:MODERATE:exon10/27:c.4156A>G:p.Ile1386Val:,SETX:NM_015046.7:missense_variant:MODERATE:exon10/26:c.4156A>G:p.Ile1386Val:		608465 [GENE=SETX PHENOS=Spinocerebellar ataxia,autosomal recessive,with axonal neuropathy 2,606002,Autosomal recessive/Amyotrophic lateral sclerosis 4,juvenile,602433,Autosomal dominant];	95663 [benign DISEASE=Amyotrophic lateral sclerosis type 4,Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2,not specified,not provided];			rs543573		0.7345	8039,.	0.3739,0.7950,0.3052,0.8417,0.6352	-0.6580	T(0.55),T(0.56),T(0.55)	B(0.00),B(0.00),B(0.00)	0.06,0.18	0.00	0.25				0.0067	0.1634	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SETX (inh=AR+AD oe_syn=1.11 oe_mis=1.01 oe_lof=0.21)
chr9	135203231	135203231	C	T	hom		QUAL=3179;DP=95;AF=1.00;MQM=60;SAP=15;ABP=0	SETX	missense	SETX:ENST00000224140.5:missense_variant:MODERATE:exon10/26:c.3754G>A:p.Gly1252Arg:,SETX:ENST00000372169.2:missense_variant:MODERATE:exon10/27:c.3754G>A:p.Gly1252Arg:,SETX:ENST00000393220.1:missense_variant:MODERATE:exon10/25:c.3754G>A:p.Gly1252Arg:	SETX:NM_001351527.1:missense_variant:MODERATE:exon10/26:c.3754G>A:p.Gly1252Arg:,SETX:NM_001351528.2:missense_variant:MODERATE:exon10/27:c.3754G>A:p.Gly1252Arg:,SETX:NM_015046.7:missense_variant:MODERATE:exon10/26:c.3754G>A:p.Gly1252Arg:		608465 [GENE=SETX PHENOS=Spinocerebellar ataxia,autosomal recessive,with axonal neuropathy 2,606002,Autosomal recessive/Amyotrophic lateral sclerosis 4,juvenile,602433,Autosomal dominant];	95662 [benign DISEASE=Amyotrophic lateral sclerosis type 4,Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2,not specified,not provided];			rs1183768	0.5561	0.7344	8030,.	0.3738,0.7949,0.3050,0.8417,0.6352	0.4900	T(0.43),T(0.43),T(0.43)	B(0.11),B(0.22),B(0.22)	0.22,0.86	18.79	0.24			COSV56383300	-0.002	0.1631	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SETX (inh=AR+AD oe_syn=1.11 oe_mis=1.01 oe_lof=0.21)
chr9	135203409	135203409	A	C	hom		QUAL=3432;DP=105;AF=1.00;MQM=60;SAP=5;ABP=0	SETX	missense	SETX:ENST00000224140.5:missense_variant:MODERATE:exon10/26:c.3576T>G:p.Asp1192Glu:,SETX:ENST00000372169.2:missense_variant:MODERATE:exon10/27:c.3576T>G:p.Asp1192Glu:,SETX:ENST00000393220.1:missense_variant:MODERATE:exon10/25:c.3576T>G:p.Asp1192Glu:	SETX:NM_001351527.1:missense_variant:MODERATE:exon10/26:c.3576T>G:p.Asp1192Glu:,SETX:NM_001351528.2:missense_variant:MODERATE:exon10/27:c.3576T>G:p.Asp1192Glu:,SETX:NM_015046.7:missense_variant:MODERATE:exon10/26:c.3576T>G:p.Asp1192Glu:		608465 [GENE=SETX PHENOS=Spinocerebellar ataxia,autosomal recessive,with axonal neuropathy 2,606002,Autosomal recessive/Amyotrophic lateral sclerosis 4,juvenile,602433,Autosomal dominant];	95661 [benign DISEASE=Amyotrophic lateral sclerosis type 4,Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2,not specified,not provided];			rs1185193		0.7679	9525,.	0.6419,0.8121,0.3127,0.8566,0.6539	-0.9940	T(0.42),T(0.41),T(0.41)	B(0.00),B(0.01),B(0.01)	0.09,0.19	0.00	0.27				-0.0007	0.1632	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SETX (inh=AR+AD oe_syn=1.11 oe_mis=1.01 oe_lof=0.21)
chr9	135206460	135206460	A	G	hom		QUAL=2725;DP=84;AF=1.00;MQM=60;SAP=16;ABP=0	SETX	synonymous	SETX:ENST00000224140.5:synonymous_variant:LOW:exon9/26:c.1077T>C:p.Tyr359=:,SETX:ENST00000372169.2:synonymous_variant:LOW:exon9/27:c.1077T>C:p.Tyr359=:,SETX:ENST00000393220.1:synonymous_variant:LOW:exon9/25:c.1077T>C:p.Tyr359=:	SETX:NM_001351527.1:synonymous_variant:LOW:exon9/26:c.1077T>C:p.Tyr359=:,SETX:NM_001351528.2:synonymous_variant:LOW:exon9/27:c.1077T>C:p.Tyr359=:,SETX:NM_015046.7:synonymous_variant:LOW:exon9/26:c.1077T>C:p.Tyr359=:		608465 [GENE=SETX PHENOS=Spinocerebellar ataxia,autosomal recessive,with axonal neuropathy 2,606002,Autosomal recessive/Amyotrophic lateral sclerosis 4,juvenile,602433,Autosomal dominant];	95658 [benign DISEASE=Amyotrophic lateral sclerosis type 4,Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2,not specified,not provided];			rs9411449	0.6266	0.7524	9101,.	0.6171,0.8059,0.3075,0.8422,0.6361	0.1510			0.20,0.41	6.05					0.2383	0.3184	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SETX (inh=AR+AD oe_syn=1.11 oe_mis=1.01 oe_lof=0.21)
chr9	135221597	135221597	G	A	hom	off-target	QUAL=1482;DP=48;AF=1.00;MQM=60;SAP=3;ABP=0	SETX	intron	SETX:ENST00000224140.5:intron_variant:MODIFIER:intron4/25:c.388+51C>T::,SETX:ENST00000372169.2:intron_variant:MODIFIER:intron4/26:c.388+51C>T::,SETX:ENST00000393220.1:intron_variant:MODIFIER:intron4/24:c.388+51C>T::	SETX:NM_001351527.1:intron_variant:MODIFIER:intron4/25:c.388+51C>T::,SETX:NM_001351528.2:intron_variant:MODIFIER:intron4/26:c.388+51C>T::,SETX:NM_015046.7:intron_variant:MODIFIER:intron4/25:c.388+51C>T::		608465 [GENE=SETX PHENOS=Spinocerebellar ataxia,autosomal recessive,with axonal neuropathy 2,606002,Autosomal recessive/Amyotrophic lateral sclerosis 4,juvenile,602433,Autosomal dominant];				rs497650	0.9956	0.9991	15570,.	0.9867,0.9994,1.0000,1.0000,1.0000	0.3960			0.00,0.07	1.82					0.0481	0.5058	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SETX (inh=AR+AD oe_syn=1.11 oe_mis=1.01 oe_lof=0.21)
chr10	13151224	13151224	G	A	het		QUAL=342;DP=40;AF=0.40;MQM=60;SAP=3;ABP=6	OPTN	synonymous	OPTN:ENST00000263036.5:synonymous_variant:LOW:exon3/15:c.102G>A:p.Thr34=:,OPTN:ENST00000378747.3:synonymous_variant:LOW:exon3/15:c.102G>A:p.Thr34=:,OPTN:ENST00000378748.3:synonymous_variant:LOW:exon4/16:c.102G>A:p.Thr34=:,OPTN:ENST00000378752.3:synonymous_variant:LOW:exon4/16:c.102G>A:p.Thr34=:,OPTN:ENST00000378757.2:synonymous_variant:LOW:exon2/14:c.102G>A:p.Thr34=:,OPTN:ENST00000378764.2:synonymous_variant:LOW:exon3/15:c.102G>A:p.Thr34=:	OPTN:NM_001008211.1:synonymous_variant:LOW:exon4/16:c.102G>A:p.Thr34=:,OPTN:NM_001008212.2:synonymous_variant:LOW:exon3/15:c.102G>A:p.Thr34=:,OPTN:NM_001008213.1:synonymous_variant:LOW:exon4/16:c.102G>A:p.Thr34=:,OPTN:NM_021980.4:synonymous_variant:LOW:exon2/14:c.102G>A:p.Thr34=:		602432 [GENE=OPTN PHENOS=Glaucoma,normal tension,susceptibility to,606657/Glaucoma 1,open angle,E,137760,Autosomal dominant/Amyotrophic lateral sclerosis 12 with or without frontotemporal dementia,613435];	96022 [benign DISEASE=Primary open angle glaucoma,Amyotrophic lateral sclerosis type 12,not specified];	CM066944 [CLASS=DP MUT=ALT PHEN="Glaucoma open angle association with" GENE=OPTN];		rs2234968	0.1783	0.2423	695,.	0.0479,0.2831,0.2017,0.2734,0.2213	-3.2780			0.02,0.10	1.03					-0.0897	0.0877	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OPTN (inh=AR+AD oe_syn=1.07 oe_mis=0.90 oe_lof=0.92), SNRPGP5 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr10	13152505	13152505	T	-	hom	off-target;low_conf_region	QUAL=2143;DP=89;AF=0.58;MQM=60;SAP=22;ABP=24	OPTN	intron	OPTN:ENST00000263036.5:intron_variant:MODIFIER:intron4/14:c.369+40del::,OPTN:ENST00000378747.3:intron_variant:MODIFIER:intron4/14:c.369+40del::,OPTN:ENST00000378748.3:intron_variant:MODIFIER:intron5/15:c.369+40del::,OPTN:ENST00000378752.3:intron_variant:MODIFIER:intron5/15:c.369+40del::,OPTN:ENST00000378757.2:intron_variant:MODIFIER:intron3/13:c.369+40del::,OPTN:ENST00000378764.2:intron_variant:MODIFIER:intron4/14:c.369+40del::	OPTN:NM_001008211.1:intron_variant:MODIFIER:intron5/15:c.369+40del::,OPTN:NM_001008212.2:intron_variant:MODIFIER:intron4/14:c.369+40del::,OPTN:NM_001008213.1:intron_variant:MODIFIER:intron5/15:c.369+40del::,OPTN:NM_021980.4:intron_variant:MODIFIER:intron3/13:c.369+40del::		602432 [GENE=OPTN PHENOS=Glaucoma,normal tension,susceptibility to,606657/Glaucoma 1,open angle,E,137760,Autosomal dominant/Amyotrophic lateral sclerosis 12 with or without frontotemporal dementia,613435];				rs34617995		0.7803	8863,.	0.5953,0.6603,0.6791,0.7816,0.7316	0.3640				0.72					-0.3016	0.342	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OPTN (inh=AR+AD oe_syn=1.07 oe_mis=0.90 oe_lof=0.92)
chr10	13152515	13152515	T	G	het	off-target;low_conf_region	QUAL=2143;DP=89;AF=0.58;MQM=60;SAP=41;ABP=8	OPTN	intron	OPTN:ENST00000263036.5:intron_variant:MODIFIER:intron4/14:c.369+39T>G::,OPTN:ENST00000378747.3:intron_variant:MODIFIER:intron4/14:c.369+39T>G::,OPTN:ENST00000378748.3:intron_variant:MODIFIER:intron5/15:c.369+39T>G::,OPTN:ENST00000378752.3:intron_variant:MODIFIER:intron5/15:c.369+39T>G::,OPTN:ENST00000378757.2:intron_variant:MODIFIER:intron3/13:c.369+39T>G::,OPTN:ENST00000378764.2:intron_variant:MODIFIER:intron4/14:c.369+39T>G::	OPTN:NM_001008211.1:intron_variant:MODIFIER:intron5/15:c.369+39T>G::,OPTN:NM_001008212.2:intron_variant:MODIFIER:intron4/14:c.369+39T>G::,OPTN:NM_001008213.1:intron_variant:MODIFIER:intron5/15:c.369+39T>G::,OPTN:NM_021980.4:intron_variant:MODIFIER:intron3/13:c.369+39T>G::		602432 [GENE=OPTN PHENOS=Glaucoma,normal tension,susceptibility to,606657/Glaucoma 1,open angle,E,137760,Autosomal dominant/Amyotrophic lateral sclerosis 12 with or without frontotemporal dementia,613435];		CS180380 [CLASS=FP MUT=ALT PHEN="Altered splicing" GENE=OPTN];		rs79529484	0.2318	0.2859	893,.	0.0596,0.3261,0.2986,0.3113,0.2945	0.4020			0.03,0.13	0.16					-0.0348	0.3395	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OPTN (inh=AR+AD oe_syn=1.07 oe_mis=0.90 oe_lof=0.92)
chr10	13158262	13158262	C	T	hom		QUAL=9540;DP=283;AF=1.00;MQM=60;SAP=8;ABP=0	OPTN	splice_region&intron	OPTN:ENST00000263036.5:splice_region_variant&intron_variant:LOW:intron5/14:c.553-5C>T::,OPTN:ENST00000378747.3:splice_region_variant&intron_variant:LOW:intron5/14:c.553-5C>T::,OPTN:ENST00000378748.3:splice_region_variant&intron_variant:LOW:intron6/15:c.553-5C>T::,OPTN:ENST00000378752.3:splice_region_variant&intron_variant:LOW:intron6/15:c.553-5C>T::,OPTN:ENST00000378757.2:splice_region_variant&intron_variant:LOW:intron4/13:c.553-5C>T::,OPTN:ENST00000378764.2:splice_region_variant&intron_variant:LOW:intron5/14:c.553-5C>T::	OPTN:NM_001008211.1:splice_region_variant&intron_variant:LOW:intron6/15:c.553-5C>T::,OPTN:NM_001008212.2:splice_region_variant&intron_variant:LOW:intron5/14:c.553-5C>T::,OPTN:NM_001008213.1:splice_region_variant&intron_variant:LOW:intron6/15:c.553-5C>T::,OPTN:NM_021980.4:splice_region_variant&intron_variant:LOW:intron4/13:c.553-5C>T::	regulatory_region_variant:promoter_flanking_region	602432 [GENE=OPTN PHENOS=Glaucoma,normal tension,susceptibility to,606657/Glaucoma 1,open angle,E,137760,Autosomal dominant/Amyotrophic lateral sclerosis 12 with or without frontotemporal dementia,613435];	197846 [benign DISEASE=Primary open angle glaucoma,Amyotrophic lateral sclerosis type 12,not specified];	CS045331 [CLASS=DP MUT=ALT PHEN="Glaucoma 1 open angle association with" GENE=OPTN];		rs2244380	0.8039	0.8168	9851,.	0.8054,0.8802,0.7416,0.8176,0.8261	-0.1270			0.00,0.11	5.26		8.92>9.75	0.000/0.000	COSV53810619	0.3443	0.6551	0.07	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OPTN (inh=AR+AD oe_syn=1.07 oe_mis=0.90 oe_lof=0.92)
chr10	13164332	13164332	T	C	het	off-target	QUAL=1950;DP=129;AF=0.57;MQM=60;SAP=3;ABP=8	OPTN	intron	OPTN:ENST00000263036.5:intron_variant:MODIFIER:intron7/14:c.780-53T>C::,OPTN:ENST00000378747.3:intron_variant:MODIFIER:intron7/14:c.780-53T>C::,OPTN:ENST00000378748.3:intron_variant:MODIFIER:intron8/15:c.780-53T>C::,OPTN:ENST00000378752.3:intron_variant:MODIFIER:intron8/15:c.762-53T>C::,OPTN:ENST00000378757.2:intron_variant:MODIFIER:intron6/13:c.780-53T>C::,OPTN:ENST00000378764.2:intron_variant:MODIFIER:intron7/14:c.762-53T>C::	OPTN:NM_001008211.1:intron_variant:MODIFIER:intron8/15:c.780-53T>C::,OPTN:NM_001008212.2:intron_variant:MODIFIER:intron7/14:c.780-53T>C::,OPTN:NM_001008213.1:intron_variant:MODIFIER:intron8/15:c.780-53T>C::,OPTN:NM_021980.4:intron_variant:MODIFIER:intron6/13:c.780-53T>C::		602432 [GENE=OPTN PHENOS=Glaucoma,normal tension,susceptibility to,606657/Glaucoma 1,open angle,E,137760,Autosomal dominant/Amyotrophic lateral sclerosis 12 with or without frontotemporal dementia,613435];				rs765884	0.1891	0.2274	916,.		-0.1440			0.07,0.14	4.99					-0.036	0.317	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OPTN (inh=AR+AD oe_syn=1.07 oe_mis=0.90 oe_lof=0.92)
chr10	13166076	13166076	A	G	hom		QUAL=2092;DP=68;AF=1.00;MQM=60;SAP=3;ABP=0	OPTN	missense	OPTN:ENST00000263036.5:missense_variant:MODERATE:exon9/15:c.964A>G:p.Lys322Glu:,OPTN:ENST00000378747.3:missense_variant:MODERATE:exon9/15:c.964A>G:p.Lys322Glu:,OPTN:ENST00000378748.3:missense_variant:MODERATE:exon10/16:c.964A>G:p.Lys322Glu:,OPTN:ENST00000378752.3:missense_variant:MODERATE:exon10/16:c.946A>G:p.Lys316Glu:,OPTN:ENST00000378757.2:missense_variant:MODERATE:exon8/14:c.964A>G:p.Lys322Glu:,OPTN:ENST00000378764.2:missense_variant:MODERATE:exon9/15:c.946A>G:p.Lys316Glu:	OPTN:NM_001008211.1:synonymous_variant:LOW:exon10/16:c.964A>G:p.Glu322=:,OPTN:NM_001008212.2:synonymous_variant:LOW:exon9/15:c.964A>G:p.Glu322=:,OPTN:NM_001008213.1:synonymous_variant:LOW:exon10/16:c.964A>G:p.Glu322=:,OPTN:NM_021980.4:synonymous_variant:LOW:exon8/14:c.964A>G:p.Glu322=:		602432 [GENE=OPTN PHENOS=Glaucoma,normal tension,susceptibility to,606657/Glaucoma 1,open angle,E,137760,Autosomal dominant/Amyotrophic lateral sclerosis 12 with or without frontotemporal dementia,613435];	802562 [benign DISEASE=Primary open angle glaucoma];			rs523747		0.9975	15497,.	0.9781,0.9988,1.0000,0.9994,0.9994	6.0470	T(1.00),T(1.00),T(1.00),T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00)	0.07,0.95	18.73	0.30				0.1688	0.6797	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OPTN (inh=AR+AD oe_syn=1.07 oe_mis=0.90 oe_lof=0.92)
chr10	30629136	30629136	G	A	het		QUAL=646;DP=50;AF=0.52;MQM=60;SAP=3;ABP=3	MTPAP	intron	MTPAP:ENST00000263063.4:intron_variant:MODIFIER:intron3/8:c.555+19C>T::,MTPAP:ENST00000358107.4:intron_variant:MODIFIER:intron4/9:c.945+19C>T::	MTPAP:NM_018109.3:intron_variant:MODIFIER:intron3/8:c.555+19C>T::		613669 [GENE=MTPAP PHENOS=Spastic ataxia 4,autosomal recessive,613672,Autosomal recessive];	138281 [benign DISEASE=Ataxia, spastic, 4, autosomal recessive,not specified];			rs1047988	0.2256	0.2472	941,.	0.2342,0.1281,0.2298,0.2805,0.2717	0.6950			0.00,0.10	1.53					-0.0475	0.9278	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTPAP (inh=AR oe_syn=1.07 oe_mis=0.85 oe_lof=0.04)
chr10	30629226	30629226	G	A	het		QUAL=1215;DP=117;AF=0.41;MQM=60;SAP=3;ABP=11	MTPAP	missense	MTPAP:ENST00000263063.4:missense_variant:MODERATE:exon3/9:c.484C>T:p.Arg162Cys:,MTPAP:ENST00000358107.4:missense_variant:MODERATE:exon4/10:c.874C>T:p.Arg292Cys:	MTPAP:NM_018109.3:missense_variant:MODERATE:exon3/9:c.484C>T:p.Arg162Cys:		613669 [GENE=MTPAP PHENOS=Spastic ataxia 4,autosomal recessive,613672,Autosomal recessive];	129624 [benign DISEASE=Ataxia, spastic, 4, autosomal recessive,not specified,not provided];			rs1047991	0.2184	0.2461	902,.	0.2153,0.1274,0.2274,0.2813,0.2710	-3.2700	T(0.08),T(0.08)	B(0.00),B(0.00)	0.02,0.08	0.00	0.03				-0.0358	0.9276	0.06	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTPAP (inh=AR oe_syn=1.07 oe_mis=0.85 oe_lof=0.04)
chr10	30629435	30629439	TATTT	-	het	off-target	QUAL=137;DP=22;AF=0.41;MQM=60;SAP=23;ABP=5	MTPAP	intron	MTPAP:ENST00000263063.4:intron_variant:MODIFIER:intron2/8:c.331-60_331-56del::,MTPAP:ENST00000358107.4:intron_variant:MODIFIER:intron3/9:c.721-60_721-56del::	MTPAP:NM_018109.3:intron_variant:MODIFIER:intron2/8:c.331-60_331-56del::		613669 [GENE=MTPAP PHENOS=Spastic ataxia 4,autosomal recessive,613672,Autosomal recessive];				rs36002941		0.2115	711,.		1.1240				3.16					0.0083	0.9268	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTPAP (inh=AR oe_syn=1.07 oe_mis=0.85 oe_lof=0.04)
chr10	30638231	30638231	C	A	het	off-target;low_conf_region	QUAL=549;DP=35;AF=0.89;MQM=60;SAP=70;ABP=48	MTPAP	5'UTR,intron	MTPAP:ENST00000263063.4:5_prime_UTR_variant:MODIFIER:exon1/9:c.-27G>T::,MTPAP:ENST00000358107.4:intron_variant:MODIFIER:intron2/9:c.548-7662G>T::	MTPAP:NM_018109.3:5_prime_UTR_variant:MODIFIER:exon1/9:c.-27G>T::	regulatory_region_variant:promoter,TF_binding_site_variant	613669 [GENE=MTPAP PHENOS=Spastic ataxia 4,autosomal recessive,613672,Autosomal recessive];	669910 [likely benign DISEASE=not provided];			rs773131360		0.0096	0,.	0.0011,0.0051,0.0033,0.0118,0.0122	-5.0580			0.00,0.38	0.64					-0.1624	0.2444	0	778	424	775 / 408	2	"[2] auto-classification 09.11.2017%0A%0A"			MTPAP (inh=AR oe_syn=1.07 oe_mis=0.85 oe_lof=0.04), DNM1P17 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr10	79742617	79742617	G	T	het	off-target	QUAL=1290;DP=112;AF=0.45;MQM=60;SAP=7;ABP=6	POLR3A	intron	POLR3A:ENST00000372371.3:intron_variant:MODIFIER:intron26/30:c.3430-42C>A::	POLR3A:NM_007055.4:intron_variant:MODIFIER:intron26/30:c.3430-42C>A::		614258 [GENE=POLR3A PHENOS=Leukodystrophy,hypomyelinating,7,with or without oligodontia and/or hypogonadotropic hypogonadism,607694,Autosomal recessive/Wiedemann-Rautenstrauch syndrome,264090,Autosomal recessive];			MER106B (DNA/hAT-Charlie)	rs3781180	0.2005	0.1555	627,.	0.3632,0.0867,0.1555,0.0928,0.1168	-0.5850			0.00,0.06	2.46					-0.0059	0.3551	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					POLR3A (inh=AR oe_syn=0.96 oe_mis=0.76 oe_lof=0.69)
chr10	99498234	99498234	G	A	hom		QUAL=2748;DP=95;AF=1.00;MQM=60;SAP=100;ABP=0	ZFYVE27	splice_region&5'UTR,5'UTR,intron	ZFYVE27:ENST00000337540.7:splice_region_variant&5_prime_UTR_variant:LOW:exon2/11:c.-1G>A::,ZFYVE27:ENST00000356257.4:5_prime_UTR_variant:MODIFIER:exon1/12:c.-1G>A::,ZFYVE27:ENST00000357540.4:splice_region_variant&5_prime_UTR_variant:LOW:exon2/10:c.-1G>A::,ZFYVE27:ENST00000359980.3:splice_region_variant&5_prime_UTR_variant:LOW:exon2/12:c.-1G>A::,ZFYVE27:ENST00000370610.3:intron_variant:MODIFIER:intron1/9:c.-27+1156G>A::,ZFYVE27:ENST00000370613.3:splice_region_variant&5_prime_UTR_variant:LOW:exon2/9:c.-1G>A::,ZFYVE27:ENST00000393677.4:splice_region_variant&5_prime_UTR_variant:LOW:exon2/13:c.-1G>A::,ZFYVE27:ENST00000453958.2:splice_region_variant&5_prime_UTR_variant:LOW:exon2/12:c.-1G>A::	ZFYVE27:NM_001002261.3:5_prime_UTR_variant:MODIFIER:exon1/12:c.-1G>A::,ZFYVE27:NM_001002262.4:splice_region_variant&5_prime_UTR_variant:LOW:exon2/12:c.-1G>A::,ZFYVE27:NM_001174119.1:splice_region_variant&5_prime_UTR_variant:LOW:exon2/11:c.-1G>A::,ZFYVE27:NM_001174120.1:splice_region_variant&5_prime_UTR_variant:LOW:exon2/10:c.-1G>A::,ZFYVE27:NM_001174121.1:intron_variant:MODIFIER:intron1/9:c.-27+1156G>A::,ZFYVE27:NM_001174122.1:splice_region_variant&5_prime_UTR_variant:LOW:exon2/9:c.-1G>A::,ZFYVE27:NM_144588.7:splice_region_variant&5_prime_UTR_variant:LOW:exon2/13:c.-1G>A::	regulatory_region_variant:promoter	610243 [GENE=ZFYVE27 PHENOS=Spastic paraplegia 33,autosomal dominant,610244,Autosomal dominant];	301827 [benign DISEASE=Spastic paraplegia,Spastic paraplegia 33, autosomal dominant];			rs3818876	0.4369	0.5318	4767,.	0.3389,0.4228,0.3078,0.6060,0.4748	0.9700			0.63,0.86	18.71		2.93>1.97	0.000/0.002		-0.8204	0.9993	0.1	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZFYVE27 (inh=AD oe_syn=1.04 oe_mis=0.85 oe_lof=0.74)
chr10	99504630	99504630	G	T	hom		QUAL=4306;DP=137;AF=1.00;MQM=60;SAP=92;ABP=0	ZFYVE27	missense,intron	ZFYVE27:ENST00000337540.7:missense_variant:MODERATE:exon3/11:c.317G>T:p.Gly106Val:,ZFYVE27:ENST00000356257.4:missense_variant:MODERATE:exon3/12:c.413G>T:p.Gly138Val:,ZFYVE27:ENST00000357540.4:intron_variant:MODIFIER:intron2/9:c.198-3396G>T::,ZFYVE27:ENST00000359980.3:missense_variant:MODERATE:exon4/12:c.413G>T:p.Gly138Val:,ZFYVE27:ENST00000370610.3:missense_variant:MODERATE:exon2/10:c.119G>T:p.Gly40Val:,ZFYVE27:ENST00000370613.3:intron_variant:MODIFIER:intron2/8:c.198-4601G>T::,ZFYVE27:ENST00000393677.4:missense_variant:MODERATE:exon4/13:c.413G>T:p.Gly138Val:,ZFYVE27:ENST00000453958.2:missense_variant:MODERATE:exon4/12:c.413G>T:p.Gly138Val:	ZFYVE27:NM_001002261.3:missense_variant:MODERATE:exon3/12:c.413G>T:p.Gly138Val:,ZFYVE27:NM_001002262.4:missense_variant:MODERATE:exon4/12:c.413G>T:p.Gly138Val:,ZFYVE27:NM_001174119.1:missense_variant:MODERATE:exon3/11:c.317G>T:p.Gly106Val:,ZFYVE27:NM_001174120.1:intron_variant:MODIFIER:intron2/9:c.198-3396G>T::,ZFYVE27:NM_001174121.1:missense_variant:MODERATE:exon2/10:c.119G>T:p.Gly40Val:,ZFYVE27:NM_001174122.1:intron_variant:MODIFIER:intron2/8:c.198-4601G>T::,ZFYVE27:NM_144588.7:missense_variant:MODERATE:exon4/13:c.413G>T:p.Gly138Val:		610243 [GENE=ZFYVE27 PHENOS=Spastic paraplegia 33,autosomal dominant,610244,Autosomal dominant];	130787 [benign DISEASE=Spastic paraplegia,Spastic paraplegia 33, autosomal dominant,not specified];			rs10882993	0.6965	0.7496	8887,.	0.7552,0.5588,0.5036,0.7588,0.6944	3.3300	T(1.00),T(1.00), ,T(1.00),T(1.00), ,T(1.00),T(1.00)	B(0.00),B(0.00), ,B(0.00),B(0.00), ,B(0.00),B(0.00)	0.07,0.69	9.79	0.10				0.0077	0.2411	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZFYVE27 (inh=AD oe_syn=1.04 oe_mis=0.85 oe_lof=0.74)
chr10	99504725	99504725	A	G	hom	off-target	QUAL=778;DP=31;AF=1.00;MQM=60;SAP=70;ABP=0	ZFYVE27	intron	ZFYVE27:ENST00000337540.7:intron_variant:MODIFIER:intron3/10:c.359+53A>G::,ZFYVE27:ENST00000356257.4:intron_variant:MODIFIER:intron3/11:c.455+53A>G::,ZFYVE27:ENST00000357540.4:intron_variant:MODIFIER:intron2/9:c.198-3301A>G::,ZFYVE27:ENST00000359980.3:intron_variant:MODIFIER:intron4/11:c.455+53A>G::,ZFYVE27:ENST00000370610.3:intron_variant:MODIFIER:intron2/9:c.161+53A>G::,ZFYVE27:ENST00000370613.3:intron_variant:MODIFIER:intron2/8:c.198-4506A>G::,ZFYVE27:ENST00000393677.4:intron_variant:MODIFIER:intron4/12:c.455+53A>G::,ZFYVE27:ENST00000453958.2:intron_variant:MODIFIER:intron4/11:c.455+53A>G::	ZFYVE27:NM_001002261.3:intron_variant:MODIFIER:intron3/11:c.455+53A>G::,ZFYVE27:NM_001002262.4:intron_variant:MODIFIER:intron4/11:c.455+53A>G::,ZFYVE27:NM_001174119.1:intron_variant:MODIFIER:intron3/10:c.359+53A>G::,ZFYVE27:NM_001174120.1:intron_variant:MODIFIER:intron2/9:c.198-3301A>G::,ZFYVE27:NM_001174121.1:intron_variant:MODIFIER:intron2/9:c.161+53A>G::,ZFYVE27:NM_001174122.1:intron_variant:MODIFIER:intron2/8:c.198-4506A>G::,ZFYVE27:NM_144588.7:intron_variant:MODIFIER:intron4/12:c.455+53A>G::		610243 [GENE=ZFYVE27 PHENOS=Spastic paraplegia 33,autosomal dominant,610244,Autosomal dominant];			MIRb (SINE/MIR)	rs10882994	0.6408	0.7046	7918,.		-1.3330			0.03,0.15	3.71					-0.027	0.2411	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZFYVE27 (inh=AD oe_syn=1.04 oe_mis=0.85 oe_lof=0.74)
chr10	99508142	99508142	C	T	het	off-target	QUAL=2514;DP=157;AF=0.61;MQM=60;SAP=4;ABP=18	ZFYVE27	intron	ZFYVE27:ENST00000337540.7:intron_variant:MODIFIER:intron4/10:c.455+21C>T::,ZFYVE27:ENST00000356257.4:intron_variant:MODIFIER:intron4/11:c.551+21C>T::,ZFYVE27:ENST00000357540.4:intron_variant:MODIFIER:intron3/9:c.293+21C>T::,ZFYVE27:ENST00000359980.3:intron_variant:MODIFIER:intron5/11:c.551+21C>T::,ZFYVE27:ENST00000370610.3:intron_variant:MODIFIER:intron3/9:c.257+21C>T::,ZFYVE27:ENST00000370613.3:intron_variant:MODIFIER:intron2/8:c.198-1089C>T::,ZFYVE27:ENST00000393677.4:intron_variant:MODIFIER:intron5/12:c.551+21C>T::,ZFYVE27:ENST00000453958.2:intron_variant:MODIFIER:intron5/11:c.551+21C>T::	ZFYVE27:NM_001002261.3:intron_variant:MODIFIER:intron4/11:c.551+21C>T::,ZFYVE27:NM_001002262.4:intron_variant:MODIFIER:intron5/11:c.551+21C>T::,ZFYVE27:NM_001174119.1:intron_variant:MODIFIER:intron4/10:c.455+21C>T::,ZFYVE27:NM_001174120.1:intron_variant:MODIFIER:intron3/9:c.293+21C>T::,ZFYVE27:NM_001174121.1:intron_variant:MODIFIER:intron3/9:c.257+21C>T::,ZFYVE27:NM_001174122.1:intron_variant:MODIFIER:intron2/8:c.198-1089C>T::,ZFYVE27:NM_144588.7:intron_variant:MODIFIER:intron5/12:c.551+21C>T::		610243 [GENE=ZFYVE27 PHENOS=Spastic paraplegia 33,autosomal dominant,610244,Autosomal dominant];				rs41317028	0.0276	0.0442	40,.	0.0134,0.0451,0.0001,0.0656,0.0142	-0.3590			0.06,0.21	6.63					-0.1996	0.3138	0	73	1655	22 / 458					ZFYVE27 (inh=AD oe_syn=1.04 oe_mis=0.85 oe_lof=0.74)
chr10	99510068	99510068	G	T	hom	off-target	QUAL=6515;DP=194;AF=1.00;MQM=60;SAP=64;ABP=0	ZFYVE27	intron	ZFYVE27:ENST00000337540.7:intron_variant:MODIFIER:intron5/10:c.569-20G>T::,ZFYVE27:ENST00000356257.4:intron_variant:MODIFIER:intron5/11:c.665-20G>T::,ZFYVE27:ENST00000357540.4:intron_variant:MODIFIER:intron4/9:c.407-20G>T::,ZFYVE27:ENST00000359980.3:intron_variant:MODIFIER:intron6/11:c.665-20G>T::,ZFYVE27:ENST00000370610.3:intron_variant:MODIFIER:intron4/9:c.371-20G>T::,ZFYVE27:ENST00000370613.3:intron_variant:MODIFIER:intron3/8:c.311-20G>T::,ZFYVE27:ENST00000393677.4:intron_variant:MODIFIER:intron6/12:c.665-20G>T::,ZFYVE27:ENST00000453958.2:intron_variant:MODIFIER:intron6/11:c.665-20G>T::	ZFYVE27:NM_001002261.3:intron_variant:MODIFIER:intron5/11:c.665-20G>T::,ZFYVE27:NM_001002262.4:intron_variant:MODIFIER:intron6/11:c.665-20G>T::,ZFYVE27:NM_001174119.1:intron_variant:MODIFIER:intron5/10:c.569-20G>T::,ZFYVE27:NM_001174120.1:intron_variant:MODIFIER:intron4/9:c.407-20G>T::,ZFYVE27:NM_001174121.1:intron_variant:MODIFIER:intron4/9:c.371-20G>T::,ZFYVE27:NM_001174122.1:intron_variant:MODIFIER:intron3/8:c.311-20G>T::,ZFYVE27:NM_144588.7:intron_variant:MODIFIER:intron6/12:c.665-20G>T::		610243 [GENE=ZFYVE27 PHENOS=Spastic paraplegia 33,autosomal dominant,610244,Autosomal dominant];				rs3750614	0.5527	0.6460	6629,.	0.4087,0.5188,0.4486,0.7237,0.6232	-2.2290			0.04,0.11	0.06		7.18>8.32			0.4739	0.0711	0.06	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZFYVE27 (inh=AD oe_syn=1.04 oe_mis=0.85 oe_lof=0.74)
chr10	99510284	99510284	T	C	hom	off-target	QUAL=2676;DP=84;AF=1.00;MQM=60;SAP=23;ABP=0	ZFYVE27	intron	ZFYVE27:ENST00000337540.7:intron_variant:MODIFIER:intron6/10:c.708+57T>C::,ZFYVE27:ENST00000356257.4:intron_variant:MODIFIER:intron6/11:c.804+57T>C::,ZFYVE27:ENST00000357540.4:intron_variant:MODIFIER:intron5/9:c.546+57T>C::,ZFYVE27:ENST00000359980.3:intron_variant:MODIFIER:intron7/11:c.804+57T>C::,ZFYVE27:ENST00000370610.3:intron_variant:MODIFIER:intron5/9:c.510+57T>C::,ZFYVE27:ENST00000370613.3:intron_variant:MODIFIER:intron4/8:c.450+57T>C::,ZFYVE27:ENST00000393677.4:intron_variant:MODIFIER:intron7/12:c.804+57T>C::,ZFYVE27:ENST00000453958.2:intron_variant:MODIFIER:intron7/11:c.804+57T>C::	ZFYVE27:NM_001002261.3:intron_variant:MODIFIER:intron6/11:c.804+57T>C::,ZFYVE27:NM_001002262.4:intron_variant:MODIFIER:intron7/11:c.804+57T>C::,ZFYVE27:NM_001174119.1:intron_variant:MODIFIER:intron6/10:c.708+57T>C::,ZFYVE27:NM_001174120.1:intron_variant:MODIFIER:intron5/9:c.546+57T>C::,ZFYVE27:NM_001174121.1:intron_variant:MODIFIER:intron5/9:c.510+57T>C::,ZFYVE27:NM_001174122.1:intron_variant:MODIFIER:intron4/8:c.450+57T>C::,ZFYVE27:NM_144588.7:intron_variant:MODIFIER:intron7/12:c.804+57T>C::		610243 [GENE=ZFYVE27 PHENOS=Spastic paraplegia 33,autosomal dominant,610244,Autosomal dominant];				rs3829137	0.3437	0.4390	3713,.		-0.6400			0.00,0.11	6.40					-0.0649	0.0884	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZFYVE27 (inh=AD oe_syn=1.04 oe_mis=0.85 oe_lof=0.74)
chr10	99517355	99517355	A	G	hom	off-target	QUAL=6392;DP=190;AF=1.00;MQM=60;SAP=9;ABP=0	ZFYVE27	intron	ZFYVE27:ENST00000337540.7:intron_variant:MODIFIER:intron9/10:c.973-44A>G::,ZFYVE27:ENST00000356257.4:intron_variant:MODIFIER:intron10/11:c.1105-44A>G::,ZFYVE27:ENST00000357540.4:intron_variant:MODIFIER:intron8/9:c.811-44A>G::,ZFYVE27:ENST00000359980.3:intron_variant:MODIFIER:intron10/11:c.1069-44A>G::,ZFYVE27:ENST00000370610.3:intron_variant:MODIFIER:intron8/9:c.790-44A>G::,ZFYVE27:ENST00000370613.3:intron_variant:MODIFIER:intron7/8:c.715-44A>G::,ZFYVE27:ENST00000393677.4:intron_variant:MODIFIER:intron11/12:c.1090-44A>G::,ZFYVE27:ENST00000453958.2:intron_variant:MODIFIER:intron10/11:c.*107-44A>G::	ZFYVE27:NM_001002261.3:intron_variant:MODIFIER:intron10/11:c.1105-44A>G::,ZFYVE27:NM_001002262.4:intron_variant:MODIFIER:intron10/11:c.1069-44A>G::,ZFYVE27:NM_001174119.1:intron_variant:MODIFIER:intron9/10:c.973-44A>G::,ZFYVE27:NM_001174120.1:intron_variant:MODIFIER:intron8/9:c.811-44A>G::,ZFYVE27:NM_001174121.1:intron_variant:MODIFIER:intron8/9:c.790-44A>G::,ZFYVE27:NM_001174122.1:intron_variant:MODIFIER:intron7/8:c.715-44A>G::,ZFYVE27:NM_144588.7:intron_variant:MODIFIER:intron11/12:c.1090-44A>G::		610243 [GENE=ZFYVE27 PHENOS=Spastic paraplegia 33,autosomal dominant,610244,Autosomal dominant];				rs3750612	0.6254	0.7064	8039,.	0.5458,0.5616,0.4897,0.7873,0.6899	-0.7660			0.01,0.16	7.57					0.3932	0.0042	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZFYVE27 (inh=AD oe_syn=1.04 oe_mis=0.85 oe_lof=0.74)
chr10	99519097	99519097	A	G	hom	off-target	QUAL=4573;DP=140;AF=1.00;MQM=60;SAP=5;ABP=0	ZFYVE27	3'UTR	ZFYVE27:ENST00000337540.7:3_prime_UTR_variant:MODIFIER:exon11/11:c.*40A>G::,ZFYVE27:ENST00000356257.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*40A>G::,ZFYVE27:ENST00000357540.4:3_prime_UTR_variant:MODIFIER:exon10/10:c.*40A>G::,ZFYVE27:ENST00000359980.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*40A>G::,ZFYVE27:ENST00000370610.3:3_prime_UTR_variant:MODIFIER:exon10/10:c.*40A>G::,ZFYVE27:ENST00000370613.3:3_prime_UTR_variant:MODIFIER:exon9/9:c.*40A>G::,ZFYVE27:ENST00000393677.4:3_prime_UTR_variant:MODIFIER:exon13/13:c.*40A>G::	ZFYVE27:NM_001002261.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*40A>G::,ZFYVE27:NM_001002262.4:3_prime_UTR_variant:MODIFIER:exon12/12:c.*40A>G::,ZFYVE27:NM_001174119.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*40A>G::,ZFYVE27:NM_001174120.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*40A>G::,ZFYVE27:NM_001174121.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*40A>G::,ZFYVE27:NM_001174122.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*40A>G::,ZFYVE27:NM_144588.7:3_prime_UTR_variant:MODIFIER:exon13/13:c.*40A>G::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	610243 [GENE=ZFYVE27 PHENOS=Spastic paraplegia 33,autosomal dominant,610244,Autosomal dominant];	301841 [benign DISEASE=Spastic paraplegia 33, autosomal dominant];			rs1981237		0.7441	8782,.	0.6768,0.5741,0.4838,0.7886,0.7232	0.0340			0.16,0.78	14.39					-0.0401	0.9534	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZFYVE27 (inh=AD oe_syn=1.04 oe_mis=0.85 oe_lof=0.74)
chr11	2189185	2189185	G	A	hom	off-target	QUAL=8530;DP=273;AF=1.00;MQM=60;SAP=8;ABP=0	TH	intron	TH:ENST00000333684.5:intron_variant:MODIFIER:intron4/10:c.589-22C>T::,TH:ENST00000352909.3:intron_variant:MODIFIER:intron4/12:c.577-22C>T::,TH:ENST00000381175.1:intron_variant:MODIFIER:intron5/13:c.658-22C>T::,TH:ENST00000381178.1:intron_variant:MODIFIER:intron5/13:c.670-22C>T::	TH:NM_000360.4:intron_variant:MODIFIER:intron4/12:c.577-22C>T::,TH:NM_199292.3:intron_variant:MODIFIER:intron5/13:c.670-22C>T::,TH:NM_199293.3:intron_variant:MODIFIER:intron5/13:c.658-22C>T::	regulatory_region_variant:CTCF_binding_site	191290 [GENE=TH PHENOS=Segawa syndrome,recessive,605407,Autosomal recessive];	263257 [benign DISEASE=not specified];			rs4074905	0.7057	0.7209	6518,.	0.4500,0.7767,0.9625,0.6692,0.8508	-0.0730			0.00,0.10	1.38					0.0968	0.3984	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TH (inh=AR oe_syn=1.02 oe_mis=0.92 oe_lof=0.50)
chr11	2190951	2190951	C	T	het		QUAL=744;DP=78;AF=0.41;MQM=60;SAP=13;ABP=8	TH	missense	TH:ENST00000333684.5:missense_variant:MODERATE:exon2/11:c.253G>A:p.Val85Met:,TH:ENST00000352909.3:missense_variant:MODERATE:exon2/13:c.241G>A:p.Val81Met:,TH:ENST00000381175.1:missense_variant:MODERATE:exon3/14:c.322G>A:p.Val108Met:,TH:ENST00000381178.1:missense_variant:MODERATE:exon3/14:c.334G>A:p.Val112Met:	TH:NM_000360.4:missense_variant:MODERATE:exon2/13:c.241G>A:p.Val81Met:,TH:NM_199292.3:missense_variant:MODERATE:exon3/14:c.334G>A:p.Val112Met:,TH:NM_199293.3:missense_variant:MODERATE:exon3/14:c.322G>A:p.Val108Met:	regulatory_region_variant:CTCF_binding_site	191290 [GENE=TH PHENOS=Segawa syndrome,recessive,605407,Autosomal recessive];	21866 [benign DISEASE=Autosomal recessive DOPA responsive dystonia,not specified,not provided];			rs6356	0.4305	0.4286	2153,.	0.1322,0.4351,0.7989,0.3724,0.5581	-0.3270	T(0.26),T(0.22),T(0.25),T(0.23)	B(0.01),B(0.02),B(0.03),B(0.01)	0.08,0.19	12.34	0.18				-0.1052	0.3093	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahharmf1 07.05.2020; gnomAD: >10%"			TH (inh=AR oe_syn=1.02 oe_mis=0.92 oe_lof=0.50), MIR4686 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr11	2191155	2191155	T	C	het	off-target	QUAL=252;DP=44;AF=0.32;MQM=60;SAP=5;ABP=16	TH	intron	TH:ENST00000333684.5:intron_variant:MODIFIER:intron1/10:c.103-54A>G::,TH:ENST00000352909.3:intron_variant:MODIFIER:intron1/12:c.91-54A>G::,TH:ENST00000381175.1:intron_variant:MODIFIER:intron2/13:c.172-54A>G::,TH:ENST00000381178.1:intron_variant:MODIFIER:intron2/13:c.184-54A>G::	TH:NM_000360.4:intron_variant:MODIFIER:intron1/12:c.91-54A>G::,TH:NM_199292.3:intron_variant:MODIFIER:intron2/13:c.184-54A>G::,TH:NM_199293.3:intron_variant:MODIFIER:intron2/13:c.172-54A>G::		191290 [GENE=TH PHENOS=Segawa syndrome,recessive,605407,Autosomal recessive];				rs7925375		0.7035	7931,.		0.4370			0.00,0.06	5.48					-0.0482	0.2493	0.28	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TH (inh=AR oe_syn=1.02 oe_mis=0.92 oe_lof=0.50), MIR4686 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr11	62459994	62459994	A	G	hom	off-target	QUAL=3774;DP=122;AF=1.00;MQM=60;SAP=44;ABP=0	BSCL2,HNRNPUL2-BSCL2	intron,intron&NMD_transcript	BSCL2:ENST00000278893.7:intron_variant:MODIFIER:intron5/9:c.574-49T>C::,BSCL2:ENST00000360796.5:intron_variant:MODIFIER:intron5/10:c.766-49T>C::,BSCL2:ENST00000403550.1:intron_variant:MODIFIER:intron5/10:c.574-49T>C::,HNRNPUL2-BSCL2:ENST00000403734.2:intron_variant&NMD_transcript_variant:MODIFIER:intron18/23:c.*817-49T>C::,BSCL2:ENST00000405837.1:intron_variant:MODIFIER:intron6/11:c.766-49T>C::,BSCL2:ENST00000407022.3:intron_variant:MODIFIER:intron5/10:c.574-49T>C::,BSCL2:ENST00000421906.1:intron_variant:MODIFIER:intron5/10:c.574-49T>C::,BSCL2:ENST00000433053.1:intron_variant:MODIFIER:intron6/11:c.766-49T>C::	BSCL2:NM_001122955.3:intron_variant:MODIFIER:intron5/10:c.766-49T>C::,BSCL2:NM_001130702.2:intron_variant:MODIFIER:intron5/9:c.574-49T>C::,BSCL2:NM_032667.6:intron_variant:MODIFIER:intron5/10:c.574-49T>C::,HNRNPUL2-BSCL2:NR_037946.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron18/23:n.3286-49T>C::,BSCL2:NR_037948.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/11:n.1368-49T>C::,BSCL2:NR_037949.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron6/11:n.1368-49T>C::		606158 [GENE=BSCL2 PHENOS=Neuropathy,distal hereditary motor,type VC,619112,Autosomal dominant/Lipodystrophy,congenital generalized,type 2,269700,Autosomal recessive/Silver spastic paraplegia syndrome,270685,Autosomal dominant/Encephalopathy,progressive,with or without lipodystrophy,615924,Autosomal recessive];	257500 [benign DISEASE=not specified,not provided];			rs2850597	0.7494	0.7812	8981,.	0.6721,0.8474,0.7687,0.7607,0.8026	0.1820			0.00,0.07	6.57					0.1082	0.7378	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LRRN4CL (inh=n/a oe_syn=0.84 oe_mis=0.98 oe_lof=1.50), BSCL2 (inh=AR+AD oe_syn=1.06 oe_mis=0.95 oe_lof=0.68), HNRNPUL2-BSCL2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr11	124793682	124793682	T	C	het		QUAL=2660;DP=201;AF=0.51;MQM=60;SAP=22;ABP=3	HEPACAM	missense	HEPACAM:ENST00000298251.4:missense_variant:MODERATE:exon3/7:c.652A>G:p.Met218Val:PF13895 [Immunoglobulin domain]	HEPACAM:NM_152722.5:missense_variant:MODERATE:exon3/7:c.652A>G:p.Met218Val:	regulatory_region_variant:enhancer	611642 [GENE=HEPACAM PHENOS=Megalencephalic leukoencephalopathy with subcortical cysts 2A,613925,Autosomal recessive/Megalencephalic leukoencephalopathy with subcortical cysts 2B,remitting,with or without mental retardation,613926,Autosomal dominant];	262681 [benign DISEASE=Megalencephalic leukoencephalopathy with subcortical cysts,not specified];			rs10790715	0.7939	0.7646	9227,.	0.8806,0.6069,0.8919,0.7001,0.7464	0.2100	T(0.49)	B(0.00)	0.38,0.97	15.95	0.05				-0.0135	0.948	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HEPACAM (inh=AR+AD oe_syn=0.97 oe_mis=0.69 oe_lof=0.13), HEPN1 (inh=n/a oe_syn=1.14 oe_mis=0.94 oe_lof=n/a)
chr12	57958313	57958313	A	G	het	off-target	QUAL=1393;DP=104;AF=0.50;MQM=60;SAP=4;ABP=3	KIF5A	intron	KIF5A:ENST00000286452.5:intron_variant:MODIFIER:intron2/25:c.178+22A>G::,KIF5A:ENST00000455537.2:intron_variant:MODIFIER:intron5/28:c.445+22A>G::	KIF5A:NM_001354705.2:intron_variant:MODIFIER:intron2/25:c.178+22A>G::,KIF5A:NM_004984.4:intron_variant:MODIFIER:intron5/28:c.445+22A>G::		602821 [GENE=KIF5A PHENOS=Myoclonus,intractable,neonatal,617235,Autosomal dominant/Spastic paraplegia 10,autosomal dominant,604187,Autosomal dominant/Amyotrophic lateral sclerosis,susceptibility to,25,617921,Autosomal dominant];	682854 [benign DISEASE=not provided];			rs775322	0.5333	0.4690	3106,.	0.4260,0.5181,0.7867,0.3747,0.5923	-0.2310			0.01,0.09	0.86					0.0928	0.2386	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF5A (inh=AD oe_syn=0.93 oe_mis=0.58 oe_lof=0.13)
chr12	57961445	57961445	T	-	het	off-target;low_conf_region	QUAL=112;DP=22;AF=0.32;MQM=60;SAP=18;ABP=9	KIF5A	intron	KIF5A:ENST00000286452.5:intron_variant:MODIFIER:intron5/25:c.447+60del::,KIF5A:ENST00000455537.2:intron_variant:MODIFIER:intron8/28:c.714+60del::	KIF5A:NM_001354705.2:intron_variant:MODIFIER:intron5/25:c.447+60del::,KIF5A:NM_004984.4:intron_variant:MODIFIER:intron8/28:c.714+60del::		602821 [GENE=KIF5A PHENOS=Myoclonus,intractable,neonatal,617235,Autosomal dominant/Spastic paraplegia 10,autosomal dominant,604187,Autosomal dominant/Amyotrophic lateral sclerosis,susceptibility to,25,617921,Autosomal dominant];			AluSx3 (SINE/Alu)	rs371727146		0.3430	1,.	0.3684,0.3620,0.3249,0.3450,0.3517	0.1640				2.49								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF5A (inh=AD oe_syn=0.93 oe_mis=0.58 oe_lof=0.13)
chr12	106763013	106763013	C	T	het	off-target	QUAL=492;DP=36;AF=0.56;MQM=60;SAP=3;ABP=4	POLR3B	intron	POLR3B:ENST00000228347.4:intron_variant:MODIFIER:intron4/27:c.228-40C>T::,POLR3B:ENST00000539066.1:intron_variant:MODIFIER:intron4/27:c.54-40C>T::	POLR3B:NM_001160708.1:intron_variant:MODIFIER:intron4/27:c.54-40C>T::,POLR3B:NM_018082.6:intron_variant:MODIFIER:intron4/27:c.228-40C>T::		614366 [GENE=POLR3B PHENOS=Leukodystrophy,hypomyelinating,8,with or without oligodontia and/or hypogonadotropic hypogonadism,614381,Autosomal recessive];				rs7134881	0.3325	0.3819	2686,.	0.6185,0.3100,0.0369,0.3234,0.2757	-0.0410			0.00,0.09	4.63					0.2542	0.0557	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					POLR3B (inh=AR oe_syn=0.93 oe_mis=0.64 oe_lof=0.68)
chr12	106838340	106838340	T	C	het		QUAL=1080;DP=79;AF=0.53;MQM=60;SAP=6;ABP=4	POLR3B	synonymous	POLR3B:ENST00000228347.4:synonymous_variant:LOW:exon19/28:c.2055T>C:p.Tyr685=:PF00562 [RNA polymerase Rpb2 domain 6],POLR3B:ENST00000539066.1:synonymous_variant:LOW:exon19/28:c.1881T>C:p.Tyr627=:PF00562 [RNA polymerase Rpb2 domain 6]	POLR3B:NM_001160708.1:synonymous_variant:LOW:exon19/28:c.1881T>C:p.Tyr627=:,POLR3B:NM_018082.6:synonymous_variant:LOW:exon19/28:c.2055T>C:p.Tyr685=:		614366 [GENE=POLR3B PHENOS=Leukodystrophy,hypomyelinating,8,with or without oligodontia and/or hypogonadotropic hypogonadism,614381,Autosomal recessive];	130001 [benign DISEASE=Hypomyelinating leukodystrophy 8, with or without oligodontia and/or hypogonadotropic hypogonadism,not specified];			rs10861607	0.3179	0.3211	1296,.	0.0501,0.3811,0.7029,0.2616,0.3541	-0.0830			0.26,0.96	1.93					0.1388	0.3007	0.16	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					POLR3B (inh=AR oe_syn=0.93 oe_mis=0.64 oe_lof=0.68)
chr12	106903321	106903321	T	C	het		QUAL=451;DP=31;AF=0.58;MQM=60;SAP=5;ABP=5	POLR3B,RP11-144F15.1	synonymous,intron	POLR3B:ENST00000228347.4:synonymous_variant:LOW:exon28/28:c.3396T>C:p.Asn1132=:,POLR3B:ENST00000539066.1:synonymous_variant:LOW:exon28/28:c.3222T>C:p.Asn1074=:,RP11-144F15.1:ENST00000551505.1:intron_variant:MODIFIER:intron1/2:c.210-9361A>G::	POLR3B:NM_001160708.1:synonymous_variant:LOW:exon28/28:c.3222T>C:p.Asn1074=:,POLR3B:NM_018082.6:synonymous_variant:LOW:exon28/28:c.3396T>C:p.Asn1132=:,LOC100287944:NR_040246.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/3:n.143-1733A>G::		614366 [GENE=POLR3B PHENOS=Leukodystrophy,hypomyelinating,8,with or without oligodontia and/or hypogonadotropic hypogonadism,614381,Autosomal recessive];	130003 [benign DISEASE=Hypomyelinating leukodystrophy 8, with or without oligodontia and/or hypogonadotropic hypogonadism,not specified];			rs13561	0.3249	0.3305	1331,.	0.0754,0.3877,0.6696,0.2768,0.3585	-0.0550			0.58,0.97	9.06					0.0381	0.9106	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					POLR3B (inh=AR oe_syn=0.93 oe_mis=0.64 oe_lof=0.68)
chr12	110221604	110221604	A	G	het	off-target	QUAL=23;DP=37;AF=0.30;MQM=60;SAP=27;ABP=16	TRPV4	intron	TRPV4:ENST00000261740.2:intron_variant:MODIFIER:intron15/15:c.2459-21T>C::,TRPV4:ENST00000346520.2:intron_variant:MODIFIER:intron14/14:c.2279-21T>C::,TRPV4:ENST00000392719.2:intron_variant:MODIFIER:intron14/14:c.2318-21T>C::,TRPV4:ENST00000418703.2:intron_variant:MODIFIER:intron14/14:c.2459-21T>C::,TRPV4:ENST00000536838.1:intron_variant:MODIFIER:intron15/15:c.2357-21T>C::,TRPV4:ENST00000537083.1:intron_variant:MODIFIER:intron13/13:c.2279-21T>C::,TRPV4:ENST00000541794.1:intron_variant:MODIFIER:intron13/13:c.2318-21T>C::,TRPV4:ENST00000544971.1:intron_variant:MODIFIER:intron12/12:c.2138-21T>C::	TRPV4:NM_001177428.1:intron_variant:MODIFIER:intron13/13:c.2318-21T>C::,TRPV4:NM_001177431.1:intron_variant:MODIFIER:intron15/15:c.2357-21T>C::,TRPV4:NM_001177433.1:intron_variant:MODIFIER:intron12/12:c.2138-21T>C::,TRPV4:NM_021625.5:intron_variant:MODIFIER:intron15/15:c.2459-21T>C::,TRPV4:NM_147204.2:intron_variant:MODIFIER:intron13/13:c.2279-21T>C::		605427 [GENE=TRPV4 PHENOS=Spondylometaphyseal dysplasia,Kozlowski type,184252,Autosomal dominant/Parastremmatic dwarfism,168400,Autosomal dominant/SED,Maroteaux type,184095,Autosomal dominant/Neuronopathy,distal hereditary motor,type VIII,600175,Autosomal dominant/Sodium serum level QTL 1,613508/Scapuloperoneal spinal muscular atrophy,181405,Autosomal dominant/Metatropic dysplasia,156530,Autosomal dominant/Digital arthropathy-brachydactyly,familial,606835,Autosomal dominant/Hereditary motor and sensory neuropathy,type IIc,606071,Autosomal dominant/Brachyolmia type 3,113500,Autosomal dominant/Avascular necrosis of femoral head,primary,2,617383,Autosomal dominant];									0.0800			0.03,0.17	0.83					-0.3554	0.9342	0	0	44	0 / 43					TRPV4 (inh=AD oe_syn=1.00 oe_mis=0.77 oe_lof=0.77)
chr12	110221608	110221608	A	G	het	off-target	QUAL=16;DP=36;AF=0.36;MQM=60;SAP=31;ABP=9	TRPV4	intron	TRPV4:ENST00000261740.2:intron_variant:MODIFIER:intron15/15:c.2459-25T>C::,TRPV4:ENST00000346520.2:intron_variant:MODIFIER:intron14/14:c.2279-25T>C::,TRPV4:ENST00000392719.2:intron_variant:MODIFIER:intron14/14:c.2318-25T>C::,TRPV4:ENST00000418703.2:intron_variant:MODIFIER:intron14/14:c.2459-25T>C::,TRPV4:ENST00000536838.1:intron_variant:MODIFIER:intron15/15:c.2357-25T>C::,TRPV4:ENST00000537083.1:intron_variant:MODIFIER:intron13/13:c.2279-25T>C::,TRPV4:ENST00000541794.1:intron_variant:MODIFIER:intron13/13:c.2318-25T>C::,TRPV4:ENST00000544971.1:intron_variant:MODIFIER:intron12/12:c.2138-25T>C::	TRPV4:NM_001177428.1:intron_variant:MODIFIER:intron13/13:c.2318-25T>C::,TRPV4:NM_001177431.1:intron_variant:MODIFIER:intron15/15:c.2357-25T>C::,TRPV4:NM_001177433.1:intron_variant:MODIFIER:intron12/12:c.2138-25T>C::,TRPV4:NM_021625.5:intron_variant:MODIFIER:intron15/15:c.2459-25T>C::,TRPV4:NM_147204.2:intron_variant:MODIFIER:intron13/13:c.2279-25T>C::		605427 [GENE=TRPV4 PHENOS=Spondylometaphyseal dysplasia,Kozlowski type,184252,Autosomal dominant/Parastremmatic dwarfism,168400,Autosomal dominant/SED,Maroteaux type,184095,Autosomal dominant/Neuronopathy,distal hereditary motor,type VIII,600175,Autosomal dominant/Sodium serum level QTL 1,613508/Scapuloperoneal spinal muscular atrophy,181405,Autosomal dominant/Metatropic dysplasia,156530,Autosomal dominant/Digital arthropathy-brachydactyly,familial,606835,Autosomal dominant/Hereditary motor and sensory neuropathy,type IIc,606071,Autosomal dominant/Brachyolmia type 3,113500,Autosomal dominant/Avascular necrosis of femoral head,primary,2,617383,Autosomal dominant];				rs758097427		0.0001		0.0000,0.0000,0.0000,0.0000,0.0001	-0.4930			0.02,0.12	3.15					-0.3144	0.9541	0	0	196	0 / 166					TRPV4 (inh=AD oe_syn=1.00 oe_mis=0.77 oe_lof=0.77)
chr12	110232308	110232308	T	G	het	off-target	QUAL=25;DP=91;AF=0.23;MQM=60;SAP=49;ABP=60	TRPV4	intron	TRPV4:ENST00000261740.2:intron_variant:MODIFIER:intron7/15:c.1333-16A>C::,TRPV4:ENST00000346520.2:intron_variant:MODIFIER:intron6/14:c.1153-16A>C::,TRPV4:ENST00000392719.2:intron_variant:MODIFIER:intron6/14:c.1192-16A>C::,TRPV4:ENST00000418703.2:intron_variant:MODIFIER:intron6/14:c.1333-16A>C::,TRPV4:ENST00000536838.1:intron_variant:MODIFIER:intron7/15:c.1231-16A>C::,TRPV4:ENST00000537083.1:intron_variant:MODIFIER:intron5/13:c.1153-16A>C::,TRPV4:ENST00000541794.1:intron_variant:MODIFIER:intron5/13:c.1192-16A>C::,TRPV4:ENST00000544971.1:intron_variant:MODIFIER:intron4/12:c.1012-16A>C::	TRPV4:NM_001177428.1:intron_variant:MODIFIER:intron5/13:c.1192-16A>C::,TRPV4:NM_001177431.1:intron_variant:MODIFIER:intron7/15:c.1231-16A>C::,TRPV4:NM_001177433.1:intron_variant:MODIFIER:intron4/12:c.1012-16A>C::,TRPV4:NM_021625.5:intron_variant:MODIFIER:intron7/15:c.1333-16A>C::,TRPV4:NM_147204.2:intron_variant:MODIFIER:intron5/13:c.1153-16A>C::		605427 [GENE=TRPV4 PHENOS=Spondylometaphyseal dysplasia,Kozlowski type,184252,Autosomal dominant/Parastremmatic dwarfism,168400,Autosomal dominant/SED,Maroteaux type,184095,Autosomal dominant/Neuronopathy,distal hereditary motor,type VIII,600175,Autosomal dominant/Sodium serum level QTL 1,613508/Scapuloperoneal spinal muscular atrophy,181405,Autosomal dominant/Metatropic dysplasia,156530,Autosomal dominant/Digital arthropathy-brachydactyly,familial,606835,Autosomal dominant/Hereditary motor and sensory neuropathy,type IIc,606071,Autosomal dominant/Brachyolmia type 3,113500,Autosomal dominant/Avascular necrosis of femoral head,primary,2,617383,Autosomal dominant];	916866 [benign DISEASE=Charcot-Marie-Tooth disease];			rs199994834		0.0003	0,.	0.0000,0.0000,0.0000,0.0001,0.0000	-0.3930			0.02,0.23	3.25		7.18>7.93			0.0679	0.0236	0.05	0	109	0 / 109	2	"VUS2, MR, 28.03.2017%0A[2] ahrautm1 28.03.2017"			TRPV4 (inh=AD oe_syn=1.00 oe_mis=0.77 oe_lof=0.77)
chr12	110232311	110232311	T	G	het	off-target	QUAL=25;DP=91;AF=0.23;MQM=60;SAP=49;ABP=60	TRPV4	intron	TRPV4:ENST00000261740.2:intron_variant:MODIFIER:intron7/15:c.1333-19A>C::,TRPV4:ENST00000346520.2:intron_variant:MODIFIER:intron6/14:c.1153-19A>C::,TRPV4:ENST00000392719.2:intron_variant:MODIFIER:intron6/14:c.1192-19A>C::,TRPV4:ENST00000418703.2:intron_variant:MODIFIER:intron6/14:c.1333-19A>C::,TRPV4:ENST00000536838.1:intron_variant:MODIFIER:intron7/15:c.1231-19A>C::,TRPV4:ENST00000537083.1:intron_variant:MODIFIER:intron5/13:c.1153-19A>C::,TRPV4:ENST00000541794.1:intron_variant:MODIFIER:intron5/13:c.1192-19A>C::,TRPV4:ENST00000544971.1:intron_variant:MODIFIER:intron4/12:c.1012-19A>C::	TRPV4:NM_001177428.1:intron_variant:MODIFIER:intron5/13:c.1192-19A>C::,TRPV4:NM_001177431.1:intron_variant:MODIFIER:intron7/15:c.1231-19A>C::,TRPV4:NM_001177433.1:intron_variant:MODIFIER:intron4/12:c.1012-19A>C::,TRPV4:NM_021625.5:intron_variant:MODIFIER:intron7/15:c.1333-19A>C::,TRPV4:NM_147204.2:intron_variant:MODIFIER:intron5/13:c.1153-19A>C::		605427 [GENE=TRPV4 PHENOS=Spondylometaphyseal dysplasia,Kozlowski type,184252,Autosomal dominant/Parastremmatic dwarfism,168400,Autosomal dominant/SED,Maroteaux type,184095,Autosomal dominant/Neuronopathy,distal hereditary motor,type VIII,600175,Autosomal dominant/Sodium serum level QTL 1,613508/Scapuloperoneal spinal muscular atrophy,181405,Autosomal dominant/Metatropic dysplasia,156530,Autosomal dominant/Digital arthropathy-brachydactyly,familial,606835,Autosomal dominant/Hereditary motor and sensory neuropathy,type IIc,606071,Autosomal dominant/Brachyolmia type 3,113500,Autosomal dominant/Avascular necrosis of femoral head,primary,2,617383,Autosomal dominant];									-0.1070			0.03,0.18	3.29		7.18>7.48			0.009	0.0709	0.05	0	13	0 / 11					TRPV4 (inh=AD oe_syn=1.00 oe_mis=0.77 oe_lof=0.77)
chr12	110240838	110240838	T	G	het		QUAL=1291;DP=92;AF=0.54;MQM=60;SAP=3;ABP=5	TRPV4	synonymous	TRPV4:ENST00000261740.2:synonymous_variant:LOW:exon4/16:c.670A>C:p.Arg224=:,TRPV4:ENST00000346520.2:synonymous_variant:LOW:exon4/15:c.670A>C:p.Arg224=:,TRPV4:ENST00000392719.2:synonymous_variant:LOW:exon4/15:c.670A>C:p.Arg224=:,TRPV4:ENST00000418703.2:synonymous_variant:LOW:exon3/15:c.670A>C:p.Arg224=:,TRPV4:ENST00000536838.1:synonymous_variant:LOW:exon4/16:c.568A>C:p.Arg190=:,TRPV4:ENST00000537083.1:synonymous_variant:LOW:exon3/14:c.670A>C:p.Arg224=:,TRPV4:ENST00000541794.1:synonymous_variant:LOW:exon3/14:c.670A>C:p.Arg224=:,TRPV4:ENST00000544971.1:synonymous_variant:LOW:exon3/13:c.670A>C:p.Arg224=:	TRPV4:NM_001177428.1:synonymous_variant:LOW:exon3/14:c.670A>C:p.Arg224=:,TRPV4:NM_001177431.1:synonymous_variant:LOW:exon4/16:c.568A>C:p.Arg190=:,TRPV4:NM_001177433.1:synonymous_variant:LOW:exon3/13:c.670A>C:p.Arg224=:,TRPV4:NM_021625.5:synonymous_variant:LOW:exon4/16:c.670A>C:p.Arg224=:,TRPV4:NM_147204.2:synonymous_variant:LOW:exon3/14:c.670A>C:p.Arg224=:		605427 [GENE=TRPV4 PHENOS=Spondylometaphyseal dysplasia,Kozlowski type,184252,Autosomal dominant/Parastremmatic dwarfism,168400,Autosomal dominant/SED,Maroteaux type,184095,Autosomal dominant/Neuronopathy,distal hereditary motor,type VIII,600175,Autosomal dominant/Sodium serum level QTL 1,613508/Scapuloperoneal spinal muscular atrophy,181405,Autosomal dominant/Metatropic dysplasia,156530,Autosomal dominant/Digital arthropathy-brachydactyly,familial,606835,Autosomal dominant/Hereditary motor and sensory neuropathy,type IIc,606071,Autosomal dominant/Brachyolmia type 3,113500,Autosomal dominant/Avascular necrosis of femoral head,primary,2,617383,Autosomal dominant];	261420 [benign DISEASE=Brachyrachia (short spine dysplasia),Metatrophic dysplasia,Spondylometaphyseal dysplasia, Kozlowski type,Distal spinal muscular atrophy, congenital nonprogressive,Charcot-Marie-Tooth disease axonal type 2C,Charcot-Marie-Tooth disease,Scapuloperoneal spinal muscular atrophy,not specified];			rs3825394		0.6342	5879,.	0.7028,0.7371,0.9530,0.5256,0.8096	0.1490			0.05,0.97	12.87					0.0891	0.1697	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TRPV4 (inh=AD oe_syn=1.00 oe_mis=0.77 oe_lof=0.77)
chr13	23907677	23907677	C	T	hom		QUAL=5224;DP=155;AF=1.00;MQM=60;SAP=15;ABP=0	SACS	synonymous	SACS:ENST00000382292.3:synonymous_variant:LOW:exon9/9:c.10338G>A:p.Gln3446=:,SACS:ENST00000382298.3:synonymous_variant:LOW:exon10/10:c.10338G>A:p.Gln3446=:,SACS:ENST00000402364.1:synonymous_variant:LOW:exon8/8:c.8088G>A:p.Gln2696=:	SACS:NM_001278055.2:synonymous_variant:LOW:exon8/8:c.9897G>A:p.Gln3299=:,SACS:NM_014363.6:synonymous_variant:LOW:exon10/10:c.10338G>A:p.Gln3446=:		604490 [GENE=SACS PHENOS=Spastic ataxia,Charlevoix-Saguenay type,270550,Autosomal recessive];	130200 [benign DISEASE=Charlevoix-Saguenay spastic ataxia,not specified,not provided];			rs2737701	0.9854	0.9964	15316,.	0.9531,0.9976,0.9999,0.9998,0.9998	-1.1670			0.04,0.20	0.57					-0.0001	0.9241	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SACS (inh=AR oe_syn=1.06 oe_mis=0.94 oe_lof=0.44)
chr13	23908034	23908034	A	G	het		QUAL=1321;DP=87;AF=0.55;MQM=60;SAP=3;ABP=5	SACS	synonymous	SACS:ENST00000382292.3:synonymous_variant:LOW:exon9/9:c.9981T>C:p.Ala3327=:,SACS:ENST00000382298.3:synonymous_variant:LOW:exon10/10:c.9981T>C:p.Ala3327=:,SACS:ENST00000402364.1:synonymous_variant:LOW:exon8/8:c.7731T>C:p.Ala2577=:	SACS:NM_001278055.2:synonymous_variant:LOW:exon8/8:c.9540T>C:p.Ala3180=:,SACS:NM_014363.6:synonymous_variant:LOW:exon10/10:c.9981T>C:p.Ala3327=:		604490 [GENE=SACS PHENOS=Spastic ataxia,Charlevoix-Saguenay type,270550,Autosomal recessive];	130206 [benign/likely benign DISEASE=Charlevoix-Saguenay spastic ataxia,not specified,not provided];			rs2737700	0.3387	0.4109	2357,.	0.1672,0.4266,0.3969,0.4422,0.3955	0.4890			0.82,0.97	9.57					0.0023	0.9241	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SACS (inh=AR oe_syn=1.06 oe_mis=0.94 oe_lof=0.44)
chr13	23929095	23929095	T	C	het		QUAL=786;DP=83;AF=0.41;MQM=60;SAP=3;ABP=9	SACS	synonymous,5'UTR	SACS:ENST00000382292.3:synonymous_variant:LOW:exon7/9:c.1656A>G:p.Leu552=:,SACS:ENST00000382298.3:synonymous_variant:LOW:exon8/10:c.1656A>G:p.Leu552=:,SACS:ENST00000402364.1:5_prime_UTR_variant:MODIFIER:exon6/8:c.-595A>G::	SACS:NM_001278055.2:synonymous_variant:LOW:exon6/8:c.1215A>G:p.Leu405=:,SACS:NM_014363.6:synonymous_variant:LOW:exon8/10:c.1656A>G:p.Leu552=:		604490 [GENE=SACS PHENOS=Spastic ataxia,Charlevoix-Saguenay type,270550,Autosomal recessive];	130202 [benign/likely benign DISEASE=Charlevoix-Saguenay spastic ataxia,not specified,not provided];			rs1536365	0.0867	0.1119	190,.	0.0177,0.0826,0.1154,0.1222,0.1324	-0.2330			0.14,0.89	9.02					0.0039	0.1006	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SACS (inh=AR oe_syn=1.06 oe_mis=0.94 oe_lof=0.44)
chr13	23930055	23930055	A	T	het		QUAL=1935;DP=184;AF=0.42;MQM=60;SAP=10;ABP=12	SACS	missense,5'UTR	SACS:ENST00000382292.3:missense_variant:MODERATE:exon7/9:c.696T>A:p.Asn232Lys:,SACS:ENST00000382298.3:missense_variant:MODERATE:exon8/10:c.696T>A:p.Asn232Lys:,SACS:ENST00000402364.1:5_prime_UTR_variant:MODIFIER:exon6/8:c.-1555T>A::	SACS:NM_001278055.2:missense_variant:MODERATE:exon6/8:c.255T>A:p.Asn85Lys:,SACS:NM_014363.6:missense_variant:MODERATE:exon8/10:c.696T>A:p.Asn232Lys:		604490 [GENE=SACS PHENOS=Spastic ataxia,Charlevoix-Saguenay type,270550,Autosomal recessive];	130204 [benign/likely benign DISEASE=Charlevoix-Saguenay spastic ataxia,not specified,not provided];			rs2031640	0.0865	0.1118	192,.	0.0175,0.0823,0.1146,0.1221,0.1324	0.5370	D(0.04),D(0.04), 	B(0.35),B(0.35), 	0.81,0.92	22.20	0.31				-0.0037	0.0538	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SACS (inh=AR oe_syn=1.06 oe_mis=0.94 oe_lof=0.44)
chr13	23949252	23949252	G	A	het		QUAL=719;DP=71;AF=0.48;MQM=60;SAP=9;ABP=3	SACS	splice_region&intron	SACS:ENST00000382292.3:splice_region_variant&intron_variant:LOW:intron2/8:c.171+6C>T::,SACS:ENST00000382298.3:splice_region_variant&intron_variant:LOW:intron3/9:c.171+6C>T::,SACS:ENST00000402364.1:splice_region_variant&intron_variant:LOW:intron2/7:c.-1992+6C>T::	SACS:NM_001278055.2:splice_region_variant&intron_variant:LOW:intron2/7:c.-183+6C>T::,SACS:NM_014363.6:splice_region_variant&intron_variant:LOW:intron3/9:c.171+6C>T::	regulatory_region_variant:promoter	604490 [GENE=SACS PHENOS=Spastic ataxia,Charlevoix-Saguenay type,270550,Autosomal recessive];	260393 [benign/likely benign DISEASE=Charlevoix-Saguenay spastic ataxia,not specified,not provided];			rs3751368	0.0895	0.1620	344,.	0.0336,0.2448,0.0546,0.1830,0.0862	-0.7050			0.01,0.26	0.93		8.99>9.65	0.000/0.002		0.374	0.0151	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SACS (inh=AR oe_syn=1.06 oe_mis=0.94 oe_lof=0.44), RPLP1P13 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr13	41367370	41367370	C	G	het		QUAL=3510;DP=268;AF=0.48;MQM=60;SAP=10;ABP=4	SLC25A15	missense	SLC25A15:ENST00000338625.4:missense_variant:MODERATE:exon2/7:c.8C>G:p.Ser3Cys:	SLC25A15:NM_014252.4:missense_variant:MODERATE:exon2/7:c.8C>G:p.Ser3Cys:		603861 [GENE=SLC25A15 PHENOS=Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome,238970,Autosomal recessive];									2.6320	T(0.22)	B(0.00)	0.93,0.95	15.89	0.22				0.0941	0.3291	0	0	2	0 / 1	3	"[3] old entry - no details available"			SLC25A15 (inh=AR oe_syn=1.09 oe_mis=0.98 oe_lof=0.83)
chr13	41382711	41382711	A	T	het		QUAL=289;DP=32;AF=0.47;MQM=60;SAP=36;ABP=3	SLC25A15	missense	SLC25A15:ENST00000338625.4:missense_variant:MODERATE:exon6/7:c.760A>T:p.Ile254Leu:PF00153 [Mitochondrial carrier protein]	SLC25A15:NM_014252.4:missense_variant:MODERATE:exon6/7:c.760A>T:p.Ile254Leu:,TPTE2P5:NR_038258.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron7/7:n.623-7851T>A::,TPTE2P5:NR_038259.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/5:n.452-7851T>A::		603861 [GENE=SLC25A15 PHENOS=Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome,238970,Autosomal recessive];	139127 [benign DISEASE=Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome,not specified];			rs17849654	0.3227	0.3761	1918,.	0.1909,0.3607,0.3685,0.4166,0.2783	1.3490	T(1.00)	B(0.00)	0.11,0.26	1.55	0.10				-0.0194	0.0872	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC25A15 (inh=AR oe_syn=1.09 oe_mis=0.98 oe_lof=0.83), MIR621 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr14	31549745	31549745	T	G	hom	off-target	QUAL=2505;DP=75;AF=1.00;MQM=60;SAP=43;ABP=0	AP4S1	intron	AP4S1:ENST00000216366.4:intron_variant:MODIFIER:intron4/5:c.295-34T>G::,AP4S1:ENST00000313566.6:intron_variant:MODIFIER:intron4/5:c.299-2924T>G::,AP4S1:ENST00000334725.4:intron_variant:MODIFIER:intron4/6:c.295-34T>G::,AP4S1:ENST00000542754.2:intron_variant:MODIFIER:intron4/5:c.295-34T>G::,AP4S1:ENST00000554345.1:intron_variant:MODIFIER:intron4/4:c.295-4230T>G::,AP4S1:ENST00000554609.1:intron_variant:MODIFIER:intron4/4:c.298+7562T>G::	AP4S1:NM_001128126.3:intron_variant:MODIFIER:intron4/5:c.295-34T>G::,AP4S1:NM_001254726.1:intron_variant:MODIFIER:intron4/4:c.295-4230T>G::,AP4S1:NM_001254727.1:intron_variant:MODIFIER:intron4/6:c.295-34T>G::,AP4S1:NM_001254728.1:intron_variant:MODIFIER:intron4/5:c.295-34T>G::,AP4S1:NM_001254729.1:intron_variant:MODIFIER:intron4/5:c.295-34T>G::,AP4S1:NM_007077.4:intron_variant:MODIFIER:intron4/5:c.295-34T>G::	regulatory_region_variant:open_chromatin_region	607243 [GENE=AP4S1 PHENOS=Spastic paraplegia 52,autosomal recessive,614067,Autosomal recessive];				rs11621299		0.8738	12048,.	0.9651,0.9122,0.6704,0.8514,0.8637	-2.4560			0.00,0.11	1.21					-0.0659	0.3988	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AP4S1 (inh=AR oe_syn=1.09 oe_mis=1.00 oe_lof=0.96)
chr14	51057727	51057727	G	A	hom		QUAL=931;DP=35;AF=1.00;MQM=60;SAP=79;ABP=0	ATL1	synonymous	ATL1:ENST00000354525.4:synonymous_variant:LOW:exon3/13:c.351G>A:p.Glu117=:PF02263 [Guanylate-binding protein N-terminal domain],ATL1:ENST00000357032.3:synonymous_variant:LOW:exon3/14:c.351G>A:p.Glu117=:PF02263 [Guanylate-binding protein N-terminal domain],ATL1:ENST00000358385.6:synonymous_variant:LOW:exon3/14:c.351G>A:p.Glu117=:PF02263 [Guanylate-binding protein N-terminal domain],ATL1:ENST00000441560.2:synonymous_variant:LOW:exon4/14:c.351G>A:p.Glu117=:PF02263 [Guanylate-binding protein N-terminal domain]	ATL1:NM_001127713.1:synonymous_variant:LOW:exon4/14:c.351G>A:p.Glu117=:,ATL1:NM_015915.4:synonymous_variant:LOW:exon3/14:c.351G>A:p.Glu117=:,ATL1:NM_181598.3:synonymous_variant:LOW:exon3/13:c.351G>A:p.Glu117=:		606439 [GENE=ATL1 PHENOS=Spastic paraplegia 3A,autosomal dominant,182600,Autosomal dominant/Neuropathy,hereditary sensory,type ID,613708,Autosomal dominant];	21530 [benign DISEASE=Hereditary spastic paraplegia 3A,not specified,not provided];			rs1060197	0.8215	0.8013	10202,.	0.9319,0.8282,0.8275,0.7186,0.7428	2.3240			0.59,0.97	11.37					0.1319	0.956	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATL1 (inh=AD oe_syn=0.99 oe_mis=0.57 oe_lof=0.15)
chr14	51058234	51058234	G	T	hom	off-target	QUAL=2389;DP=72;AF=0.99;MQM=60;SAP=14;ABP=0	ATL1	intron	ATL1:ENST00000354525.4:intron_variant:MODIFIER:intron3/12:c.418-19G>T::,ATL1:ENST00000357032.3:intron_variant:MODIFIER:intron3/13:c.418-19G>T::,ATL1:ENST00000358385.6:intron_variant:MODIFIER:intron3/13:c.418-19G>T::,ATL1:ENST00000441560.2:intron_variant:MODIFIER:intron4/13:c.418-19G>T::	ATL1:NM_001127713.1:intron_variant:MODIFIER:intron4/13:c.418-19G>T::,ATL1:NM_015915.4:intron_variant:MODIFIER:intron3/13:c.418-19G>T::,ATL1:NM_181598.3:intron_variant:MODIFIER:intron3/12:c.418-19G>T::		606439 [GENE=ATL1 PHENOS=Spastic paraplegia 3A,autosomal dominant,182600,Autosomal dominant/Neuropathy,hereditary sensory,type ID,613708,Autosomal dominant];				rs2934684		0.8013	10198,.	0.9317,0.8282,0.8276,0.7181,0.7428	0.9260			0.52,0.27	5.49		10.31>10.80			-0.0126	0.7648	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATL1 (inh=AD oe_syn=0.99 oe_mis=0.57 oe_lof=0.15)
chr14	51062237	51062238	TC	-	het	off-target;low_conf_region	QUAL=2845;DP=123;AF=0.80;MQM=60;SAP=9;ABP=102	ATL1	intron	ATL1:ENST00000354525.4:intron_variant:MODIFIER:intron5/12:c.574-34_574-33del::,ATL1:ENST00000357032.3:intron_variant:MODIFIER:intron5/13:c.574-34_574-33del::,ATL1:ENST00000358385.6:intron_variant:MODIFIER:intron5/13:c.574-34_574-33del::,ATL1:ENST00000441560.2:intron_variant:MODIFIER:intron6/13:c.574-34_574-33del::	ATL1:NM_001127713.1:intron_variant:MODIFIER:intron6/13:c.574-34_574-33del::,ATL1:NM_015915.4:intron_variant:MODIFIER:intron5/13:c.574-34_574-33del::,ATL1:NM_181598.3:intron_variant:MODIFIER:intron5/12:c.574-34_574-33del::		606439 [GENE=ATL1 PHENOS=Spastic paraplegia 3A,autosomal dominant,182600,Autosomal dominant/Neuropathy,hereditary sensory,type ID,613708,Autosomal dominant];			(TC)n (Simple_repeat)	rs3834518		0.7688	8340,.		-0.7390				1.98					-0.033	0.1862	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATL1 (inh=AD oe_syn=0.99 oe_mis=0.57 oe_lof=0.15)
chr14	51062237	51062240	TCTC	-	het	off-target;low_conf_region	QUAL=2845;DP=123;AF=0.15;MQM=60;SAP=4;ABP=131	ATL1	intron	ATL1:ENST00000354525.4:intron_variant:MODIFIER:intron5/12:c.574-36_574-33del::,ATL1:ENST00000357032.3:intron_variant:MODIFIER:intron5/13:c.574-36_574-33del::,ATL1:ENST00000358385.6:intron_variant:MODIFIER:intron5/13:c.574-36_574-33del::,ATL1:ENST00000441560.2:intron_variant:MODIFIER:intron6/13:c.574-36_574-33del::	ATL1:NM_001127713.1:intron_variant:MODIFIER:intron6/13:c.574-36_574-33del::,ATL1:NM_015915.4:intron_variant:MODIFIER:intron5/13:c.574-36_574-33del::,ATL1:NM_181598.3:intron_variant:MODIFIER:intron5/12:c.574-36_574-33del::		606439 [GENE=ATL1 PHENOS=Spastic paraplegia 3A,autosomal dominant,182600,Autosomal dominant/Neuropathy,hereditary sensory,type ID,613708,Autosomal dominant];			(TC)n (Simple_repeat)	rs3834518		0.0084	0,.		3.0430				6.48					-0.047	0.1909	0	0	48	0 / 17					ATL1 (inh=AD oe_syn=0.99 oe_mis=0.57 oe_lof=0.15)
chr14	51087263	51087263	A	G	hom	off-target	QUAL=2983;DP=92;AF=1.00;MQM=60;SAP=12;ABP=0	ATL1	intron	ATL1:ENST00000354525.4:intron_variant:MODIFIER:intron8/12:c.863-54A>G::,ATL1:ENST00000357032.3:intron_variant:MODIFIER:intron8/13:c.863-54A>G::,ATL1:ENST00000358385.6:intron_variant:MODIFIER:intron8/13:c.863-54A>G::,ATL1:ENST00000441560.2:intron_variant:MODIFIER:intron9/13:c.863-54A>G::	ATL1:NM_001127713.1:intron_variant:MODIFIER:intron9/13:c.863-54A>G::,ATL1:NM_015915.4:intron_variant:MODIFIER:intron8/13:c.863-54A>G::,ATL1:NM_181598.3:intron_variant:MODIFIER:intron8/12:c.863-54A>G::		606439 [GENE=ATL1 PHENOS=Spastic paraplegia 3A,autosomal dominant,182600,Autosomal dominant/Neuropathy,hereditary sensory,type ID,613708,Autosomal dominant];	670500 [benign DISEASE=not provided];			rs11157759	0.5040	0.4797	4076,.		-0.3270			0.06,0.17	0.59					-0.0141	0.3235	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATL1 (inh=AD oe_syn=0.99 oe_mis=0.57 oe_lof=0.15)
chr14	53513479	53513480	AG	-	het		QUAL=97;DP=64;AF=0.22;MQM=60;SAP=33;ABP=47	DDHD1	3'UTR	DDHD1:ENST00000323669.5:3_prime_UTR_variant:MODIFIER:exon13/13:c.*6_*7del::,DDHD1:ENST00000357758.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*6_*7del::,DDHD1:ENST00000395606.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*6_*7del::	DDHD1:NM_001160147.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*6_*7del::,DDHD1:NM_001160148.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*6_*7del::,DDHD1:NM_030637.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*6_*7del::		614603 [GENE=DDHD1 PHENOS=Spastic paraplegia 28,autosomal recessive,609340,Autosomal recessive];				rs3037072		0.8600	10872,.	0.7764,0.9037,0.9772,0.8366,0.8800	0.7970				6.72					0.0106	0.9294	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DDHD1 (inh=AR oe_syn=1.02 oe_mis=0.85 oe_lof=0.19)
chr14	53522324	53522324	-	A	het	off-target	QUAL=1438;DP=91;AF=0.59;MQM=60;SAP=3;ABP=10	DDHD1	intron	DDHD1:ENST00000323669.5:intron_variant:MODIFIER:intron10/12:c.2245+53dup::,DDHD1:ENST00000357758.3:intron_variant:MODIFIER:intron10/11:c.2245+53dup::,DDHD1:ENST00000395606.1:intron_variant:MODIFIER:intron11/12:c.2266+53dup::	DDHD1:NM_001160147.2:intron_variant:MODIFIER:intron11/12:c.2266+53dup::,DDHD1:NM_001160148.2:intron_variant:MODIFIER:intron10/12:c.2245+53dup::,DDHD1:NM_030637.3:intron_variant:MODIFIER:intron10/11:c.2245+53dup::	regulatory_region_variant:promoter_flanking_region	614603 [GENE=DDHD1 PHENOS=Spastic paraplegia 28,autosomal recessive,609340,Autosomal recessive];				rs5808701		0.8849	12297,.						2.55					0.0213	0.5117	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DDHD1 (inh=AR oe_syn=1.02 oe_mis=0.85 oe_lof=0.19)
chr14	53529669	53529669	A	T	het		QUAL=627;DP=56;AF=0.45;MQM=60;SAP=10;ABP=4	DDHD1	synonymous	DDHD1:ENST00000323669.5:synonymous_variant:LOW:exon7/13:c.1758T>A:p.Thr586=:,DDHD1:ENST00000357758.3:synonymous_variant:LOW:exon7/12:c.1758T>A:p.Thr586=:,DDHD1:ENST00000395606.1:synonymous_variant:LOW:exon8/13:c.1779T>A:p.Thr593=:	DDHD1:NM_001160147.2:synonymous_variant:LOW:exon8/13:c.1779T>A:p.Thr593=:,DDHD1:NM_001160148.2:synonymous_variant:LOW:exon7/13:c.1758T>A:p.Thr586=:,DDHD1:NM_030637.3:synonymous_variant:LOW:exon7/12:c.1758T>A:p.Thr586=:		614603 [GENE=DDHD1 PHENOS=Spastic paraplegia 28,autosomal recessive,609340,Autosomal recessive];	379963 [benign DISEASE=not specified];			rs4898778		0.8510	10314,.	0.6246,0.8904,0.9755,0.8424,0.8751	-3.7420			0.01,0.12	0.12					0.0482	0.2661	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DDHD1 (inh=AR oe_syn=1.02 oe_mis=0.85 oe_lof=0.19)
chr14	53539471	53539471	A	G	het	off-target	QUAL=198;DP=20;AF=0.45;MQM=60;SAP=15;ABP=3	DDHD1	intron	DDHD1:ENST00000323669.5:intron_variant:MODIFIER:intron5/12:c.1397-50T>C::,DDHD1:ENST00000357758.3:intron_variant:MODIFIER:intron5/11:c.1397-50T>C::,DDHD1:ENST00000395606.1:intron_variant:MODIFIER:intron6/12:c.1418-50T>C::	DDHD1:NM_001160147.2:intron_variant:MODIFIER:intron6/12:c.1418-50T>C::,DDHD1:NM_001160148.2:intron_variant:MODIFIER:intron5/12:c.1397-50T>C::,DDHD1:NM_030637.3:intron_variant:MODIFIER:intron5/11:c.1397-50T>C::		614603 [GENE=DDHD1 PHENOS=Spastic paraplegia 28,autosomal recessive,609340,Autosomal recessive];				rs875663	0.7554	0.8379	9452,.	0.4446,0.8784,0.9731,0.8427,0.8772	-0.4370			0.02,0.16	2.32					-0.297	0.1297	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DDHD1 (inh=AR oe_syn=1.02 oe_mis=0.85 oe_lof=0.19)
chr14	53619463	53619463	G	A	het		QUAL=453;DP=55;AF=0.42;MQM=60;SAP=8;ABP=6	DDHD1	synonymous	DDHD1:ENST00000323669.5:synonymous_variant:LOW:exon1/13:c.354C>T:p.His118=:,DDHD1:ENST00000357758.3:synonymous_variant:LOW:exon1/12:c.354C>T:p.His118=:,DDHD1:ENST00000395606.1:synonymous_variant:LOW:exon1/13:c.354C>T:p.His118=:	DDHD1:NM_001160147.2:synonymous_variant:LOW:exon1/13:c.354C>T:p.His118=:,DDHD1:NM_001160148.2:synonymous_variant:LOW:exon1/13:c.354C>T:p.His118=:,DDHD1:NM_030637.3:synonymous_variant:LOW:exon1/12:c.354C>T:p.His118=:	regulatory_region_variant:promoter	614603 [GENE=DDHD1 PHENOS=Spastic paraplegia 28,autosomal recessive,609340,Autosomal recessive];	379962 [benign DISEASE=not specified];			rs2358188	0.7522	0.8435	9333,.	0.4447,0.8803,0.9728,0.8438,0.8805	0.1440			0.42,0.27	8.93					0.0128	0.0891	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DDHD1 (inh=AR oe_syn=1.02 oe_mis=0.85 oe_lof=0.19)
chr14	53619480	53619480	-	GCCGCC	het		QUAL=349;DP=79;AF=0.29;MQM=60;SAP=11;ABP=33	DDHD1	inframe_insertion	DDHD1:ENST00000323669.5:inframe_insertion:MODERATE:exon1/13:c.331_336dup:p.Gly111_Gly112dup:,DDHD1:ENST00000357758.3:inframe_insertion:MODERATE:exon1/12:c.331_336dup:p.Gly111_Gly112dup:,DDHD1:ENST00000395606.1:inframe_insertion:MODERATE:exon1/13:c.331_336dup:p.Gly111_Gly112dup:	DDHD1:NM_001160147.2:inframe_insertion:MODERATE:exon1/13:c.331_336dup:p.Gly111_Gly112dup:,DDHD1:NM_001160148.2:inframe_insertion:MODERATE:exon1/13:c.331_336dup:p.Gly111_Gly112dup:,DDHD1:NM_030637.3:inframe_insertion:MODERATE:exon1/12:c.331_336dup:p.Gly111_Gly112dup:	regulatory_region_variant:promoter	614603 [GENE=DDHD1 PHENOS=Spastic paraplegia 28,autosomal recessive,609340,Autosomal recessive];	221131 [benign DISEASE=Spastic paraplegia 28, autosomal recessive,not specified];			rs55671452		0.8336	9130,.	0.5033,0.8767,0.9610,0.8358,0.8733					18.23				COSV60356941	0.0172	0.0892	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DDHD1 (inh=AR oe_syn=1.02 oe_mis=0.85 oe_lof=0.19)
chr14	53619544	53619544	G	A	het		QUAL=751;DP=80;AF=0.41;MQM=60;SAP=3;ABP=8	DDHD1	synonymous	DDHD1:ENST00000323669.5:synonymous_variant:LOW:exon1/13:c.273C>T:p.Phe91=:,DDHD1:ENST00000357758.3:synonymous_variant:LOW:exon1/12:c.273C>T:p.Phe91=:,DDHD1:ENST00000395606.1:synonymous_variant:LOW:exon1/13:c.273C>T:p.Phe91=:	DDHD1:NM_001160147.2:synonymous_variant:LOW:exon1/13:c.273C>T:p.Phe91=:,DDHD1:NM_001160148.2:synonymous_variant:LOW:exon1/13:c.273C>T:p.Phe91=:,DDHD1:NM_030637.3:synonymous_variant:LOW:exon1/12:c.273C>T:p.Phe91=:	regulatory_region_variant:promoter,TF_binding_site_variant	614603 [GENE=DDHD1 PHENOS=Spastic paraplegia 28,autosomal recessive,609340,Autosomal recessive];	379960 [benign DISEASE=not specified];			rs2358189		0.8361	9305,.	0.4251,0.8799,0.9725,0.8412,0.8797	2.8840			0.76,0.92	14.09					-0.061	0.0881	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DDHD1 (inh=AR oe_syn=1.02 oe_mis=0.85 oe_lof=0.19)
chr14	68234539	68234539	T	C	hom		QUAL=4401;DP=134;AF=1.00;MQM=60;SAP=11;ABP=0	ZFYVE26	missense	ZFYVE26:ENST00000347230.4:missense_variant:MODERATE:exon31/42:c.5672A>G:p.Asn1891Ser:,ZFYVE26:ENST00000555452.1:missense_variant:MODERATE:exon31/35:c.5672A>G:p.Asn1891Ser:	ZFYVE26:NM_015346.4:missense_variant:MODERATE:exon31/42:c.5672A>G:p.Asn1891Ser:		612012 [GENE=ZFYVE26 PHENOS=Spastic paraplegia 15,autosomal recessive,270700,Autosomal recessive];	130783 [benign DISEASE=Spastic paraplegia,Hereditary spastic paraplegia 15,not specified];			rs3742883	0.9032	0.9542	13909,.	0.8457,0.8937,0.8571,0.9863,0.9744	-0.3940	T(1.00),T(1.00)	B(0.00),B(0.00)	0.02,0.14	0.04	0.02				-0.0749	0.2487	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZFYVE26 (inh=AR oe_syn=0.97 oe_mis=0.96 oe_lof=0.48)
chr14	68236522	68236522	G	A	hom	off-target	QUAL=5577;DP=165;AF=1.00;MQM=60;SAP=3;ABP=0	ZFYVE26	intron	ZFYVE26:ENST00000347230.4:intron_variant:MODIFIER:intron28/41:c.5485-75C>T::,ZFYVE26:ENST00000555452.1:intron_variant:MODIFIER:intron28/34:c.5485-75C>T::	ZFYVE26:NM_015346.4:intron_variant:MODIFIER:intron28/41:c.5485-75C>T::		612012 [GENE=ZFYVE26 PHENOS=Spastic paraplegia 15,autosomal recessive,270700,Autosomal recessive];	670343 [benign DISEASE=not provided];			rs2295111	0.3101	0.4516	3812,.		0.9330			0.45,0.56	8.23					-0.0142	0.3336	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZFYVE26 (inh=AR oe_syn=0.97 oe_mis=0.96 oe_lof=0.48)
chr14	68244906	68244906	G	A	het		QUAL=163;DP=37;AF=0.38;MQM=60;SAP=33;ABP=8	ZFYVE26	synonymous	ZFYVE26:ENST00000347230.4:synonymous_variant:LOW:exon24/42:c.4734C>T:p.Ile1578=:,ZFYVE26:ENST00000555452.1:synonymous_variant:LOW:exon24/35:c.4734C>T:p.Ile1578=:	ZFYVE26:NM_015346.4:synonymous_variant:LOW:exon24/42:c.4734C>T:p.Ile1578=:		612012 [GENE=ZFYVE26 PHENOS=Spastic paraplegia 15,autosomal recessive,270700,Autosomal recessive];	215519 [likely benign(replaced by megSAP based on classifications:1x1,1x2,1x3) DISEASE=Spastic paraplegia,Hereditary spastic paraplegia 15,not specified];			rs200243306		0.0012	0,.	0.0001,0.0002,0.0000,0.0011,0.0010	1.9970			0.92,0.98	13.25					-0.4703	0.245	0.01	0	29	0 / 8	2	"VUS2, best., MR, 14.03.2017%0A[2] ahrautm1 02.03.2016, VUS2, MR, 02.03.16"			ZFYVE26 (inh=AR oe_syn=0.97 oe_mis=0.96 oe_lof=0.48)
chr14	68249499	68249499	C	T	hom		QUAL=7948;DP=240;AF=0.98;MQM=60;SAP=5;ABP=0	ZFYVE26	missense&splice_region	ZFYVE26:ENST00000347230.4:missense_variant&splice_region_variant:MODERATE:exon21/42:c.4370G>A:p.Cys1457Tyr:,ZFYVE26:ENST00000555452.1:missense_variant&splice_region_variant:MODERATE:exon21/35:c.4370G>A:p.Cys1457Tyr:	ZFYVE26:NM_015346.4:missense_variant&splice_region_variant:MODERATE:exon21/42:c.4370G>A:p.Cys1457Tyr:		612012 [GENE=ZFYVE26 PHENOS=Spastic paraplegia 15,autosomal recessive,270700,Autosomal recessive];	130782 [benign DISEASE=Spastic paraplegia,Hereditary spastic paraplegia 15,not specified];			rs2235967	0.1601	0.2616	1160,.	0.0719,0.1738,0.0225,0.3468,0.2167	2.5290	T(0.10),T(0.09)	B(0.00),B(0.00)	0.29,0.44	16.53	0.05	6.64>8.27	0.000/0.042		0.3686	0.1432	0.09	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZFYVE26 (inh=AR oe_syn=0.97 oe_mis=0.96 oe_lof=0.48)
chr14	68252980	68252980	A	-	het	off-target;low_conf_region	QUAL=13;DP=19;AF=0.21;MQM=60;SAP=12;ABP=17	ZFYVE26	intron	ZFYVE26:ENST00000347230.4:intron_variant:MODIFIER:intron16/41:c.3020-30del::,ZFYVE26:ENST00000555452.1:intron_variant:MODIFIER:intron16/34:c.3020-30del::	ZFYVE26:NM_015346.4:intron_variant:MODIFIER:intron16/41:c.3020-30del::		612012 [GENE=ZFYVE26 PHENOS=Spastic paraplegia 15,autosomal recessive,270700,Autosomal recessive];				rs10525614					1.3410				0.45					-0.0337	0.0198	0	0	40	0 / 20					ZFYVE26 (inh=AR oe_syn=0.97 oe_mis=0.96 oe_lof=0.48)
chr14	68257485	68257485	C	T	hom		QUAL=7299;DP=229;AF=0.99;MQM=60;SAP=7;ABP=0	ZFYVE26	synonymous	ZFYVE26:ENST00000347230.4:synonymous_variant:LOW:exon15/42:c.2559G>A:p.Leu853=:,ZFYVE26:ENST00000555452.1:synonymous_variant:LOW:exon15/35:c.2559G>A:p.Leu853=:	ZFYVE26:NM_015346.4:synonymous_variant:LOW:exon15/42:c.2559G>A:p.Leu853=:		612012 [GENE=ZFYVE26 PHENOS=Spastic paraplegia 15,autosomal recessive,270700,Autosomal recessive];	130777 [benign DISEASE=Spastic paraplegia,Hereditary spastic paraplegia 15,not specified];			rs7143196	0.0747	0.1516	479,.	0.0363,0.0960,0.0176,0.2035,0.0716	-0.0760			0.66,0.88	9.03					-0.08	0.2581	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZFYVE26 (inh=AR oe_syn=0.97 oe_mis=0.96 oe_lof=0.48)
chr14	88387230	88387230	A	G	het	off-target	QUAL=542;DP=51;AF=0.55;MQM=60;SAP=64;ABP=4		intergenic	::intergenic_variant:MODIFIER::::	::intergenic_variant:MODIFIER::::						rs425198	0.1877	0.2809	1426,.		-0.5900			0.00,0.05	3.40								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					
chr14	88401213	88401213	T	C	hom		QUAL=3322;DP=103;AF=1.00;MQM=60;SAP=5;ABP=0	GALC	missense,intron	GALC:ENST00000261304.2:missense_variant:MODERATE:exon17/17:c.1921A>G:p.Thr641Ala:PF02057 [Glycosyl hydrolase family 59],GALC:ENST00000393568.4:missense_variant:MODERATE:exon16/16:c.1852A>G:p.Thr618Ala:PF02057 [Glycosyl hydrolase family 59],GALC:ENST00000393569.2:missense_variant:MODERATE:exon17/17:c.1843A>G:p.Thr615Ala:PF02057 [Glycosyl hydrolase family 59],GALC:ENST00000544807.2:intron_variant:MODIFIER:intron16/16:c.1744-870A>G::	GALC:NM_000153.4:missense_variant:MODERATE:exon17/17:c.1921A>G:p.Thr641Ala:,GALC:NM_001201401.1:missense_variant:MODERATE:exon16/16:c.1852A>G:p.Thr618Ala:,GALC:NM_001201402.1:missense_variant:MODERATE:exon17/17:c.1843A>G:p.Thr615Ala:		606890 [GENE=GALC PHENOS=Krabbe disease,245200,Autosomal recessive];	92500 [benign DISEASE=Galactosylceramide beta-galactosidase deficiency,not specified,not provided];			rs421262		0.9847	14449,.	0.8581,0.9920,0.9388,0.9995,0.9970	0.5190	T(1.00),T(1.00),T(1.00), 	B(0.00),B(0.00),B(0.00), 	0.01,0.17	0.03	0.26				0.1124	0.9569	0.07	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GALC (inh=AR oe_syn=1.01 oe_mis=0.97 oe_lof=0.69)
chr14	88407716	88407716	-	A	het	off-target;low_conf_region	QUAL=1868;DP=94;AF=0.60;MQM=60;SAP=13;ABP=10	GALC	intron	GALC:ENST00000261304.2:intron_variant:MODIFIER:intron15/16:c.1834+22dup::,GALC:ENST00000393568.4:intron_variant:MODIFIER:intron14/15:c.1765+22dup::,GALC:ENST00000393569.2:intron_variant:MODIFIER:intron15/16:c.1756+22dup::,GALC:ENST00000544807.2:intron_variant:MODIFIER:intron15/16:c.1666+22dup::	GALC:NM_000153.4:intron_variant:MODIFIER:intron15/16:c.1834+22dup::,GALC:NM_001201401.1:intron_variant:MODIFIER:intron14/15:c.1765+22dup::,GALC:NM_001201402.1:intron_variant:MODIFIER:intron15/16:c.1756+22dup::		606890 [GENE=GALC PHENOS=Krabbe disease,245200,Autosomal recessive];	445792 [likely benign DISEASE=not provided];			rs34752717		0.4721	3079,.	0.3264,0.4906,0.4991,0.4595,0.4705					1.57					0.0477	0.3554	0.08	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GALC (inh=AR oe_syn=1.01 oe_mis=0.97 oe_lof=0.69)
chr14	88407734	88407734	G	C	hom	low_conf_region	QUAL=1868;DP=94;AF=0.60;MQM=60;SAP=4;ABP=98	GALC	splice_region&intron	GALC:ENST00000261304.2:splice_region_variant&intron_variant:LOW:intron15/16:c.1834+5C>G::,GALC:ENST00000393568.4:splice_region_variant&intron_variant:LOW:intron14/15:c.1765+5C>G::,GALC:ENST00000393569.2:splice_region_variant&intron_variant:LOW:intron15/16:c.1756+5C>G::,GALC:ENST00000544807.2:splice_region_variant&intron_variant:LOW:intron15/16:c.1666+5C>G::	GALC:NM_000153.4:splice_region_variant&intron_variant:LOW:intron15/16:c.1834+5C>G::,GALC:NM_001201401.1:splice_region_variant&intron_variant:LOW:intron14/15:c.1765+5C>G::,GALC:NM_001201402.1:splice_region_variant&intron_variant:LOW:intron15/16:c.1756+5C>G::		606890 [GENE=GALC PHENOS=Krabbe disease,245200,Autosomal recessive];	92499 [benign DISEASE=Galactosylceramide beta-galactosidase deficiency,not specified,not provided];			rs448805	0.9409	0.9841	14051,.	0.8576,0.9916,0.9379,0.9994,0.9966	2.9180			0.40,0.88	12.83		6.43>9.66	0.000/0.136				0.55	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GALC (inh=AR oe_syn=1.01 oe_mis=0.97 oe_lof=0.69)
chr14	88407875	88407875	T	A	hom		QUAL=806;DP=26;AF=1.00;MQM=60;SAP=3;ABP=0	GALC	synonymous	GALC:ENST00000261304.2:synonymous_variant:LOW:exon15/17:c.1698A>T:p.Val566=:PF02057 [Glycosyl hydrolase family 59],GALC:ENST00000393568.4:synonymous_variant:LOW:exon14/16:c.1629A>T:p.Val543=:PF02057 [Glycosyl hydrolase family 59],GALC:ENST00000393569.2:synonymous_variant:LOW:exon15/17:c.1620A>T:p.Val540=:PF02057 [Glycosyl hydrolase family 59],GALC:ENST00000544807.2:synonymous_variant:LOW:exon15/17:c.1530A>T:p.Val510=:PF02057 [Glycosyl hydrolase family 59]	GALC:NM_000153.4:synonymous_variant:LOW:exon15/17:c.1698A>T:p.Val566=:,GALC:NM_001201401.1:synonymous_variant:LOW:exon14/16:c.1629A>T:p.Val543=:,GALC:NM_001201402.1:synonymous_variant:LOW:exon15/17:c.1620A>T:p.Val540=:		606890 [GENE=GALC PHENOS=Krabbe disease,245200,Autosomal recessive];	92498 [benign DISEASE=Galactosylceramide beta-galactosidase deficiency,not specified,not provided];			rs421466		0.9847	14439,.	0.8580,0.9920,0.9387,0.9995,0.9970	-0.0280			0.40,0.96	8.60					-0.004	0.8701	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GALC (inh=AR oe_syn=1.01 oe_mis=0.97 oe_lof=0.69)
chr14	88407917	88407917	G	A	hom	off-target	QUAL=814;DP=26;AF=1.00;MQM=60;SAP=3;ABP=0	GALC	intron	GALC:ENST00000261304.2:intron_variant:MODIFIER:intron14/16:c.1671-15C>T::,GALC:ENST00000393568.4:intron_variant:MODIFIER:intron13/15:c.1602-15C>T::,GALC:ENST00000393569.2:intron_variant:MODIFIER:intron14/16:c.1593-15C>T::,GALC:ENST00000544807.2:intron_variant:MODIFIER:intron14/16:c.1503-15C>T::	GALC:NM_000153.4:intron_variant:MODIFIER:intron14/16:c.1671-15C>T::,GALC:NM_001201401.1:intron_variant:MODIFIER:intron13/15:c.1602-15C>T::,GALC:NM_001201402.1:intron_variant:MODIFIER:intron14/16:c.1593-15C>T::		606890 [GENE=GALC PHENOS=Krabbe disease,245200,Autosomal recessive];	92496 [benign DISEASE=Galactosylceramide beta-galactosidase deficiency,not specified,not provided];			rs12432149	0.4888	0.5507	3767,.	0.2317,0.6750,0.7639,0.5247,0.5767	-1.9910			0.01,0.14	0.02		11.23>11.12			0.3507	0.478	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GALC (inh=AR oe_syn=1.01 oe_mis=0.97 oe_lof=0.69)
chr14	88411947	88411947	T	C	hom		QUAL=1678;DP=52;AF=1.00;MQM=60;SAP=4;ABP=0	GALC	synonymous	GALC:ENST00000261304.2:synonymous_variant:LOW:exon14/17:c.1620A>G:p.Thr540=:PF02057 [Glycosyl hydrolase family 59],GALC:ENST00000393568.4:synonymous_variant:LOW:exon13/16:c.1551A>G:p.Thr517=:PF02057 [Glycosyl hydrolase family 59],GALC:ENST00000393569.2:synonymous_variant:LOW:exon14/17:c.1542A>G:p.Thr514=:PF02057 [Glycosyl hydrolase family 59],GALC:ENST00000544807.2:synonymous_variant:LOW:exon14/17:c.1452A>G:p.Thr484=:PF02057 [Glycosyl hydrolase family 59]	GALC:NM_000153.4:synonymous_variant:LOW:exon14/17:c.1620A>G:p.Thr540=:,GALC:NM_001201401.1:synonymous_variant:LOW:exon13/16:c.1551A>G:p.Thr517=:,GALC:NM_001201402.1:synonymous_variant:LOW:exon14/17:c.1542A>G:p.Thr514=:	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	606890 [GENE=GALC PHENOS=Krabbe disease,245200,Autosomal recessive];	167118 [benign DISEASE=not specified];			rs367327	0.9427	0.9851	14482,.	0.8626,0.9923,0.9387,0.9995,0.9970	-2.8100			0.03,0.09	0.03					0.0521	0.3401	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GALC (inh=AR oe_syn=1.01 oe_mis=0.97 oe_lof=0.69)
chr14	88417096	88417096	A	-	hom		QUAL=914;DP=32;AF=0.94;MQM=60;SAP=3;ABP=0	GALC	splice_region&intron	GALC:ENST00000261304.2:splice_region_variant&intron_variant:LOW:intron10/16:c.1162-4del::,GALC:ENST00000393568.4:splice_region_variant&intron_variant:LOW:intron9/15:c.1093-4del::,GALC:ENST00000393569.2:splice_region_variant&intron_variant:LOW:intron10/16:c.1084-4del::,GALC:ENST00000544807.2:splice_region_variant&intron_variant:LOW:intron10/16:c.994-4del::	GALC:NM_000153.4:splice_region_variant&intron_variant:LOW:intron10/16:c.1162-4del::,GALC:NM_001201401.1:splice_region_variant&intron_variant:LOW:intron9/15:c.1093-4del::,GALC:NM_001201402.1:splice_region_variant&intron_variant:LOW:intron10/16:c.1084-4del::	regulatory_region_variant:promoter_flanking_region	606890 [GENE=GALC PHENOS=Krabbe disease,245200,Autosomal recessive];	92493 [conflicting interpretations of pathogenicity DISEASE=Abnormality of brain morphology,Galactosylceramide beta-galactosidase deficiency,not specified,not provided];			rs11300320		0.9743	13912,.	0.8409,0.9721,0.9832,0.9844,0.9839	-0.1400				8.20					-0.0199	0.2103	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GALC (inh=AR oe_syn=1.01 oe_mis=0.97 oe_lof=0.69), SHLD2P2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr14	88429690	88429690	A	G	het		QUAL=957;DP=89;AF=0.46;MQM=60;SAP=12;ABP=4	GALC	intron	GALC:ENST00000261304.2:intron_variant:MODIFIER:intron10/16:c.1161+38T>C::,GALC:ENST00000393568.4:intron_variant:MODIFIER:intron9/15:c.1092+38T>C::,GALC:ENST00000393569.2:intron_variant:MODIFIER:intron10/16:c.1083+38T>C::,GALC:ENST00000544807.2:intron_variant:MODIFIER:intron10/16:c.993+38T>C::	GALC:NM_000153.4:intron_variant:MODIFIER:intron10/16:c.1161+38T>C::,GALC:NM_001201401.1:intron_variant:MODIFIER:intron9/15:c.1092+38T>C::,GALC:NM_001201402.1:intron_variant:MODIFIER:intron10/16:c.1083+38T>C::		606890 [GENE=GALC PHENOS=Krabbe disease,245200,Autosomal recessive];	255369 [benign DISEASE=not specified];			rs17687109	0.0795	0.1264	275,.	0.0369,0.1438,0.0020,0.1551,0.0988	-0.0390			0.02,0.14	2.66					0.0608	0.9134	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GALC (inh=AR oe_syn=1.01 oe_mis=0.97 oe_lof=0.69)
chr14	88431898	88431898	C	T	het		QUAL=1216;DP=83;AF=0.63;MQM=60;SAP=17;ABP=15	GALC	synonymous	GALC:ENST00000261304.2:synonymous_variant:LOW:exon9/17:c.984G>A:p.Gln328=:PF02057 [Glycosyl hydrolase family 59],GALC:ENST00000393568.4:synonymous_variant:LOW:exon8/16:c.915G>A:p.Gln305=:PF02057 [Glycosyl hydrolase family 59],GALC:ENST00000393569.2:synonymous_variant:LOW:exon9/17:c.906G>A:p.Gln302=:PF02057 [Glycosyl hydrolase family 59],GALC:ENST00000544807.2:synonymous_variant:LOW:exon9/17:c.816G>A:p.Gln272=:PF02057 [Glycosyl hydrolase family 59]	GALC:NM_000153.4:synonymous_variant:LOW:exon9/17:c.984G>A:p.Gln328=:,GALC:NM_001201401.1:synonymous_variant:LOW:exon8/16:c.915G>A:p.Gln305=:,GALC:NM_001201402.1:synonymous_variant:LOW:exon9/17:c.906G>A:p.Gln302=:		606890 [GENE=GALC PHENOS=Krabbe disease,245200,Autosomal recessive];	92513 [benign DISEASE=Galactosylceramide beta-galactosidase deficiency,not specified,not provided];			rs12888666	0.3311	0.3897	1714,.	0.1160,0.5194,0.5961,0.3561,0.4256	1.4440			0.87,0.99	11.01					-0.1169	0.2065	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GALC (inh=AR oe_syn=1.01 oe_mis=0.97 oe_lof=0.69)
chr14	88434893	88434893	G	A	het	off-target	QUAL=1120;DP=81;AF=0.53;MQM=60;SAP=5;ABP=4	GALC	intron	GALC:ENST00000261304.2:intron_variant:MODIFIER:intron7/16:c.753-59C>T::,GALC:ENST00000393568.4:intron_variant:MODIFIER:intron6/15:c.684-59C>T::,GALC:ENST00000393569.2:intron_variant:MODIFIER:intron7/16:c.675-59C>T::,GALC:ENST00000544807.2:intron_variant:MODIFIER:intron7/16:c.585-59C>T::	GALC:NM_000153.4:intron_variant:MODIFIER:intron7/16:c.753-59C>T::,GALC:NM_001201401.1:intron_variant:MODIFIER:intron6/15:c.684-59C>T::,GALC:NM_001201402.1:intron_variant:MODIFIER:intron7/16:c.675-59C>T::		606890 [GENE=GALC PHENOS=Krabbe disease,245200,Autosomal recessive];				rs17687364	0.0795	0.1203	279,.		-0.1260			0.00,0.05	1.60				COSV54331512	0.0281	0.8511	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GALC (inh=AR oe_syn=1.01 oe_mis=0.97 oe_lof=0.69)
chr14	88442646	88442646	A	G	het	off-target	QUAL=1201;DP=68;AF=0.65;MQM=60;SAP=8;ABP=16	GALC	intron	GALC:ENST00000261304.2:intron_variant:MODIFIER:intron7/16:c.752+56T>C::,GALC:ENST00000393568.4:intron_variant:MODIFIER:intron6/15:c.683+56T>C::,GALC:ENST00000393569.2:intron_variant:MODIFIER:intron7/16:c.674+56T>C::,GALC:ENST00000544807.2:intron_variant:MODIFIER:intron7/16:c.584+56T>C::	GALC:NM_000153.4:intron_variant:MODIFIER:intron7/16:c.752+56T>C::,GALC:NM_001201401.1:intron_variant:MODIFIER:intron6/15:c.683+56T>C::,GALC:NM_001201402.1:intron_variant:MODIFIER:intron7/16:c.674+56T>C::		606890 [GENE=GALC PHENOS=Krabbe disease,245200,Autosomal recessive];				rs76521220	0.0795	0.1200	277,.		-0.4330			0.01,0.15	4.12					-0.0947	0.3533	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GALC (inh=AR oe_syn=1.01 oe_mis=0.97 oe_lof=0.69)
chr14	88442712	88442712	C	T	het		QUAL=1116;DP=68;AF=0.65;MQM=60;SAP=8;ABP=16	GALC	missense	GALC:ENST00000261304.2:missense_variant:MODERATE:exon7/17:c.742G>A:p.Asp248Asn:PF02057 [Glycosyl hydrolase family 59],GALC:ENST00000393568.4:missense_variant:MODERATE:exon6/16:c.673G>A:p.Asp225Asn:PF02057 [Glycosyl hydrolase family 59],GALC:ENST00000393569.2:missense_variant:MODERATE:exon7/17:c.664G>A:p.Asp222Asn:PF02057 [Glycosyl hydrolase family 59],GALC:ENST00000544807.2:missense_variant:MODERATE:exon7/17:c.574G>A:p.Asp192Asn:PF02057 [Glycosyl hydrolase family 59]	GALC:NM_000153.4:missense_variant:MODERATE:exon7/17:c.742G>A:p.Asp248Asn:,GALC:NM_001201401.1:missense_variant:MODERATE:exon6/16:c.673G>A:p.Asp225Asn:,GALC:NM_001201402.1:missense_variant:MODERATE:exon7/17:c.664G>A:p.Asp222Asn:		606890 [GENE=GALC PHENOS=Krabbe disease,245200,Autosomal recessive];	92509 [benign, other DISEASE=Galactosylceramide beta-galactosidase deficiency,not specified,not provided];			rs34362748	0.0795	0.1263	273,.	0.0369,0.1438,0.0019,0.1549,0.0987	5.2950	D(0.04),D(0.03),T(0.05),D(0.03)	B(0.03),P(0.53),B(0.04),B(0.08)	0.96,0.99	24.20	0.62				-0.263	0.9249	0.12	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GALC (inh=AR oe_syn=1.01 oe_mis=0.97 oe_lof=0.69)
chr14	88448643	88448643	C	T	het	off-target	QUAL=163;DP=16;AF=0.50;MQM=60;SAP=3;ABP=3	GALC	intron	GALC:ENST00000261304.2:intron_variant:MODIFIER:intron5/16:c.583-56G>A::,GALC:ENST00000393568.4:intron_variant:MODIFIER:intron4/15:c.514-56G>A::,GALC:ENST00000393569.2:intron_variant:MODIFIER:intron5/16:c.505-56G>A::,GALC:ENST00000544807.2:intron_variant:MODIFIER:intron5/16:c.415-56G>A::	GALC:NM_000153.4:intron_variant:MODIFIER:intron5/16:c.583-56G>A::,GALC:NM_001201401.1:intron_variant:MODIFIER:intron4/15:c.514-56G>A::,GALC:NM_001201402.1:intron_variant:MODIFIER:intron5/16:c.505-56G>A::		606890 [GENE=GALC PHENOS=Krabbe disease,245200,Autosomal recessive];				rs79515863	0.0795	0.1201	276,.		-0.9120			0.00,0.07	5.01					-0.0081	0.7834	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GALC (inh=AR oe_syn=1.01 oe_mis=0.97 oe_lof=0.69)
chr14	88450928	88450928	C	T	het	off-target	QUAL=399;DP=53;AF=0.38;MQM=60;SAP=5;ABP=10	GALC	intron	GALC:ENST00000261304.2:intron_variant:MODIFIER:intron4/16:c.443-51G>A::,GALC:ENST00000393568.4:intron_variant:MODIFIER:intron3/15:c.374-51G>A::,GALC:ENST00000393569.2:intron_variant:MODIFIER:intron4/16:c.365-51G>A::,GALC:ENST00000544807.2:intron_variant:MODIFIER:intron4/16:c.275-51G>A::	GALC:NM_000153.4:intron_variant:MODIFIER:intron4/16:c.443-51G>A::,GALC:NM_001201401.1:intron_variant:MODIFIER:intron3/15:c.374-51G>A::,GALC:NM_001201402.1:intron_variant:MODIFIER:intron4/16:c.365-51G>A::		606890 [GENE=GALC PHENOS=Krabbe disease,245200,Autosomal recessive];				rs77468347	0.0795	0.1276	278,.	0.0375,0.1449,0.0011,0.1571,0.0995	-0.5970			0.04,0.15	4.01					-0.0137	0.8666	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GALC (inh=AR oe_syn=1.01 oe_mis=0.97 oe_lof=0.69)
chr14	88452981	88452981	C	T	het	off-target	QUAL=1155;DP=98;AF=0.49;MQM=60;SAP=3;ABP=3	GALC	intron	GALC:ENST00000261304.2:intron_variant:MODIFIER:intron3/16:c.329-35G>A::,GALC:ENST00000393568.4:intron_variant:MODIFIER:intron2/15:c.260-35G>A::,GALC:ENST00000393569.2:intron_variant:MODIFIER:intron3/16:c.251-35G>A::,GALC:ENST00000544807.2:intron_variant:MODIFIER:intron3/16:c.161-35G>A::	GALC:NM_000153.4:intron_variant:MODIFIER:intron3/16:c.329-35G>A::,GALC:NM_001201401.1:intron_variant:MODIFIER:intron2/15:c.260-35G>A::,GALC:NM_001201402.1:intron_variant:MODIFIER:intron3/16:c.251-35G>A::		606890 [GENE=GALC PHENOS=Krabbe disease,245200,Autosomal recessive];	255375 [benign DISEASE=not specified];			rs77466023	0.0797	0.1270	277,.	0.0377,0.1447,0.0025,0.1564,0.0998	-0.0540			0.03,0.20	6.41					0.1596	0.1222	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GALC (inh=AR oe_syn=1.01 oe_mis=0.97 oe_lof=0.69)
chr14	88453424	88453424	G	A	hom	off-target;low_conf_region	QUAL=7407;DP=233;AF=0.97;MQM=60;SAP=26;ABP=0	GALC	intron	GALC:ENST00000261304.2:intron_variant:MODIFIER:intron3/16:c.329-478C>T::,GALC:ENST00000393568.4:intron_variant:MODIFIER:intron2/15:c.260-478C>T::,GALC:ENST00000393569.2:intron_variant:MODIFIER:intron3/16:c.251-478C>T::,GALC:ENST00000544807.2:intron_variant:MODIFIER:intron3/16:c.161-478C>T::	GALC:NM_000153.4:intron_variant:MODIFIER:intron3/16:c.329-478C>T::,GALC:NM_001201401.1:intron_variant:MODIFIER:intron2/15:c.260-478C>T::,GALC:NM_001201402.1:intron_variant:MODIFIER:intron3/16:c.251-478C>T::		606890 [GENE=GALC PHENOS=Krabbe disease,245200,Autosomal recessive];				rs2119703	0.8163	0.7392	8318,.	0.8089,0.8243,0.9654,0.6514,0.7904	-0.2010			0.00,0.06	3.53					0.0	0.3977	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GALC (inh=AR oe_syn=1.01 oe_mis=0.97 oe_lof=0.69)
chr14	88454469	88454469	A	T	het	off-target	QUAL=681;DP=75;AF=0.40;MQM=60;SAP=3;ABP=10	GALC	intron	GALC:ENST00000261304.2:intron_variant:MODIFIER:intron3/16:c.328+19T>A::,GALC:ENST00000393568.4:intron_variant:MODIFIER:intron2/15:c.259+19T>A::,GALC:ENST00000393569.2:intron_variant:MODIFIER:intron3/16:c.250+19T>A::,GALC:ENST00000544807.2:intron_variant:MODIFIER:intron3/16:c.160+19T>A::	GALC:NM_000153.4:intron_variant:MODIFIER:intron3/16:c.328+19T>A::,GALC:NM_001201401.1:intron_variant:MODIFIER:intron2/15:c.259+19T>A::,GALC:NM_001201402.1:intron_variant:MODIFIER:intron3/16:c.250+19T>A::		606890 [GENE=GALC PHENOS=Krabbe disease,245200,Autosomal recessive];	92501 [benign DISEASE=not specified,not provided];			rs74337989	0.0795	0.1263	277,.	0.0370,0.1439,0.0021,0.1548,0.0987	0.9010			0.07,0.19	6.30					-0.105	0.9302	0.09	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GALC (inh=AR oe_syn=1.01 oe_mis=0.97 oe_lof=0.69)
chr14	88454910	88454910	G	A	hom	off-target	QUAL=7506;DP=227;AF=0.99;MQM=60;SAP=5;ABP=0	GALC	intron	GALC:ENST00000261304.2:intron_variant:MODIFIER:intron1/16:c.196-43C>T::,GALC:ENST00000393568.4:intron_variant:MODIFIER:intron1/15:c.196-359C>T::,GALC:ENST00000393569.2:intron_variant:MODIFIER:intron1/16:c.118-43C>T::,GALC:ENST00000544807.2:intron_variant:MODIFIER:intron1/16:c.28-43C>T::	GALC:NM_000153.4:intron_variant:MODIFIER:intron1/16:c.196-43C>T::,GALC:NM_001201401.1:intron_variant:MODIFIER:intron1/15:c.196-359C>T::,GALC:NM_001201402.1:intron_variant:MODIFIER:intron1/16:c.118-43C>T::		606890 [GENE=GALC PHENOS=Krabbe disease,245200,Autosomal recessive];	255374 [benign DISEASE=not specified];			rs2289511	0.6192	0.6219	5585,.	0.5636,0.7241,0.8251,0.5876,0.5933	0.1300			0.00,0.07	4.63					-0.0556	0.1551	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GALC (inh=AR oe_syn=1.01 oe_mis=0.97 oe_lof=0.69)
chr14	88458745	88458745	C	T	het		QUAL=4063;DP=264;AF=0.55;MQM=60;SAP=3;ABP=8	GALC	intron,5'UTR	GALC:ENST00000261304.2:intron_variant:MODIFIER:intron1/16:c.195+569G>A::,GALC:ENST00000393568.4:intron_variant:MODIFIER:intron1/15:c.195+569G>A::,GALC:ENST00000393569.2:intron_variant:MODIFIER:intron1/16:c.117+982G>A::,GALC:ENST00000544807.2:5_prime_UTR_variant:MODIFIER:exon1/17:c.-71G>A::	GALC:NM_000153.4:intron_variant:MODIFIER:intron1/16:c.195+569G>A::,GALC:NM_001201401.1:intron_variant:MODIFIER:intron1/15:c.195+569G>A::,GALC:NM_001201402.1:intron_variant:MODIFIER:intron1/16:c.117+982G>A::	regulatory_region_variant:promoter	606890 [GENE=GALC PHENOS=Krabbe disease,245200,Autosomal recessive];				rs78187751	0.0791	0.1208	261,.	0.0368,0.1431,0.0007,0.1536,0.0999	0.3660			0.02,0.08	6.03					-0.2337	0.6682	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GALC (inh=AR oe_syn=1.01 oe_mis=0.97 oe_lof=0.69), RNU6-835P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr14	88459280	88459280	C	A	het	off-target	QUAL=1328;DP=99;AF=0.59;MQM=60;SAP=4;ABP=9	GALC	intron	GALC:ENST00000261304.2:intron_variant:MODIFIER:intron1/16:c.195+34G>T::,GALC:ENST00000393568.4:intron_variant:MODIFIER:intron1/15:c.195+34G>T::,GALC:ENST00000393569.2:intron_variant:MODIFIER:intron1/16:c.117+447G>T::	GALC:NM_000153.4:intron_variant:MODIFIER:intron1/16:c.195+34G>T::,GALC:NM_001201401.1:intron_variant:MODIFIER:intron1/15:c.195+34G>T::,GALC:NM_001201402.1:intron_variant:MODIFIER:intron1/16:c.117+447G>T::	regulatory_region_variant:promoter,TF_binding_site_variant	606890 [GENE=GALC PHENOS=Krabbe disease,245200,Autosomal recessive];				rs143228205	0.0783	0.1349	260,.	0.0593,0.1534,0.0008,0.1642,0.1055	-3.0440			0.01,0.08	0.94					-0.0522	0.2651	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GALC (inh=AR oe_syn=1.01 oe_mis=0.97 oe_lof=0.69), RNU6-835P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr14	88459434	88459434	G	T	het		QUAL=245;DP=23;AF=0.57;MQM=60;SAP=31;ABP=4	GALC	synonymous,intron	GALC:ENST00000261304.2:synonymous_variant:LOW:exon1/17:c.75C>A:p.Gly25=:PF02057 [Glycosyl hydrolase family 59],GALC:ENST00000393568.4:synonymous_variant:LOW:exon1/16:c.75C>A:p.Gly25=:PF02057 [Glycosyl hydrolase family 59],GALC:ENST00000393569.2:intron_variant:MODIFIER:intron1/16:c.117+293C>A::	GALC:NM_000153.4:synonymous_variant:LOW:exon1/17:c.75C>A:p.Gly25=:,GALC:NM_001201401.1:synonymous_variant:LOW:exon1/16:c.75C>A:p.Gly25=:,GALC:NM_001201402.1:intron_variant:MODIFIER:intron1/16:c.117+293C>A::	regulatory_region_variant:promoter	606890 [GENE=GALC PHENOS=Krabbe disease,245200,Autosomal recessive];	92510 [benign DISEASE=Galactosylceramide beta-galactosidase deficiency,not specified,not provided];			rs111976362	0.0785	0.1180	261,.	0.0327,0.1332,0.0007,0.1342,0.0926	3.0370			0.49,0.83	13.60					0.0932	0.2685	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GALC (inh=AR oe_syn=1.01 oe_mis=0.97 oe_lof=0.69), RNU6-835P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr14	88459448	88459448	C	G	het		QUAL=190;DP=24;AF=0.50;MQM=60;SAP=29;ABP=3	GALC	missense,intron	GALC:ENST00000261304.2:missense_variant:MODERATE:exon1/17:c.61G>C:p.Ala21Pro:PF02057 [Glycosyl hydrolase family 59],GALC:ENST00000393568.4:missense_variant:MODERATE:exon1/16:c.61G>C:p.Ala21Pro:PF02057 [Glycosyl hydrolase family 59],GALC:ENST00000393569.2:intron_variant:MODIFIER:intron1/16:c.117+279G>C::	GALC:NM_000153.4:missense_variant:MODERATE:exon1/17:c.61G>C:p.Ala21Pro:,GALC:NM_001201401.1:missense_variant:MODERATE:exon1/16:c.61G>C:p.Ala21Pro:,GALC:NM_001201402.1:intron_variant:MODIFIER:intron1/16:c.117+279G>C::	regulatory_region_variant:promoter	606890 [GENE=GALC PHENOS=Krabbe disease,245200,Autosomal recessive];	92508 [benign DISEASE=Galactosylceramide beta-galactosidase deficiency,not specified,not provided];			rs111887056	0.0789	0.1183	265,.	0.0329,0.1355,0.0007,0.1393,0.0948	0.6500	T(0.10),T(0.09), 	D(0.96),D(1.00), 	0.61,0.89	23.60	0.51				-0.0712	0.2618	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GALC (inh=AR oe_syn=1.01 oe_mis=0.97 oe_lof=0.69), RNU6-835P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr14	88459467	88459467	C	G	het		QUAL=3117;DP=253;AF=0.53;MQM=60;SAP=16;ABP=5	GALC	synonymous,intron	GALC:ENST00000261304.2:synonymous_variant:LOW:exon1/17:c.42G>C:p.Ala14=:,GALC:ENST00000393568.4:synonymous_variant:LOW:exon1/16:c.42G>C:p.Ala14=:,GALC:ENST00000393569.2:intron_variant:MODIFIER:intron1/16:c.117+260G>C::	GALC:NM_000153.4:synonymous_variant:LOW:exon1/17:c.42G>C:p.Ala14=:,GALC:NM_001201401.1:synonymous_variant:LOW:exon1/16:c.42G>C:p.Ala14=:,GALC:NM_001201402.1:intron_variant:MODIFIER:intron1/16:c.117+260G>C::	regulatory_region_variant:promoter	606890 [GENE=GALC PHENOS=Krabbe disease,245200,Autosomal recessive];	92505 [benign DISEASE=Galactosylceramide beta-galactosidase deficiency,not specified,not provided];			rs112992946	0.0787	0.1184	266,.	0.0342,0.1362,0.0008,0.1429,0.0956	0.1290			0.05,0.08	7.43					-0.0416	0.255	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GALC (inh=AR oe_syn=1.01 oe_mis=0.97 oe_lof=0.69), RNU6-835P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr14	102891646	102891646	A	G	het	off-target	QUAL=1732;DP=102;AF=0.64;MQM=60;SAP=5;ABP=20	TECPR2	intron	TECPR2:ENST00000359520.7:intron_variant:MODIFIER:intron6/19:c.951+18A>G::,TECPR2:ENST00000558678.1:intron_variant:MODIFIER:intron6/16:c.951+18A>G::	TECPR2:NM_001172631.3:intron_variant:MODIFIER:intron6/16:c.951+18A>G::,TECPR2:NM_014844.5:intron_variant:MODIFIER:intron6/19:c.951+18A>G::		615000 [GENE=TECPR2 PHENOS=Spastic paraplegia 49,autosomal recessive,615031,Autosomal recessive];	380890 [benign DISEASE=not specified];			rs4906197	0.3055	0.3571	2027,.	0.3199,0.2957,0.1587,0.4158,0.3638	-2.3850			0.00,0.07	0.31				COSV63974182	-0.1447	0.0567	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TECPR2 (inh=AR oe_syn=1.00 oe_mis=0.83 oe_lof=0.22)
chr14	102894593	102894593	G	A	hom		QUAL=4052;DP=139;AF=1.00;MQM=60;SAP=3;ABP=0	TECPR2	missense	TECPR2:ENST00000359520.7:missense_variant:MODERATE:exon7/20:c.958G>A:p.Val320Ile:,TECPR2:ENST00000558678.1:missense_variant:MODERATE:exon7/17:c.958G>A:p.Val320Ile:	TECPR2:NM_001172631.3:missense_variant:MODERATE:exon7/17:c.958G>A:p.Val320Ile:,TECPR2:NM_014844.5:missense_variant:MODERATE:exon7/20:c.958G>A:p.Val320Ile:		615000 [GENE=TECPR2 PHENOS=Spastic paraplegia 49,autosomal recessive,615031,Autosomal recessive];	380873 [benign DISEASE=Autosomal recessive spastic paraplegia type 49,not specified];			rs1309353		0.9324	10031,.	0.9870,0.6065,0.6127,0.9525,0.9357	1.3170	T(1.00),T(1.00)	B(0.00),B(0.00)	0.20,0.92	14.14	0.14				-0.0394	0.165	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TECPR2 (inh=AR oe_syn=1.00 oe_mis=0.83 oe_lof=0.22)
chr14	102901201	102901201	A	G	het		QUAL=964;DP=80;AF=0.50;MQM=60;SAP=6;ABP=3	TECPR2	missense	TECPR2:ENST00000359520.7:missense_variant:MODERATE:exon9/20:c.2047A>G:p.Ile683Val:,TECPR2:ENST00000558678.1:missense_variant:MODERATE:exon9/17:c.2047A>G:p.Ile683Val:	TECPR2:NM_001172631.3:missense_variant:MODERATE:exon9/17:c.2047A>G:p.Ile683Val:,TECPR2:NM_014844.5:missense_variant:MODERATE:exon9/20:c.2047A>G:p.Ile683Val:		615000 [GENE=TECPR2 PHENOS=Spastic paraplegia 49,autosomal recessive,615031,Autosomal recessive];	380891 [benign DISEASE=Autosomal recessive spastic paraplegia type 49,not specified];	CM197978 [CLASS=DM? MUT=ALT PHEN="Alzheimer disease protection against" GENE=TECPR2];		rs10149146	0.2149	0.2829	1063,.	0.1425,0.2488,0.1163,0.3307,0.3251	-0.8360	T(1.00),T(1.00)	B(0.00),B(0.00)	0.03,0.14	0.00	0.01				0.129	0.4195	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TECPR2 (inh=AR oe_syn=1.00 oe_mis=0.83 oe_lof=0.22)
chr14	102904552	102904564	CCCGCTCCCTGCT	-	het		QUAL=548;DP=48;AF=0.50;MQM=60;SAP=3;ABP=3	TECPR2	intron	TECPR2:ENST00000359520.7:intron_variant:MODIFIER:intron10/19:c.2578+30_2578+42del::,TECPR2:ENST00000558678.1:intron_variant:MODIFIER:intron10/16:c.2578+30_2578+42del::	TECPR2:NM_001172631.3:intron_variant:MODIFIER:intron10/16:c.2578+30_2578+42del::,TECPR2:NM_014844.5:intron_variant:MODIFIER:intron10/19:c.2578+30_2578+42del::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region,TF_binding_site_variant	615000 [GENE=TECPR2 PHENOS=Spastic paraplegia 49,autosomal recessive,615031,Autosomal recessive];	516666 [benign DISEASE=not specified];		(CCCGCT)n (Simple_repeat)	rs3831019		0.2181	631,.	0.0749,0.1736,0.1095,0.2615,0.2657	2.9770				10.56					-0.3267	0.3127	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TECPR2 (inh=AR oe_syn=1.00 oe_mis=0.83 oe_lof=0.22)
chr14	102918686	102918686	T	C	het	off-target	QUAL=1290;DP=123;AF=0.46;MQM=60;SAP=3;ABP=5	TECPR2	intron	TECPR2:ENST00000359520.7:intron_variant:MODIFIER:intron15/19:c.3407-45T>C::,TECPR2:ENST00000558678.1:intron_variant:MODIFIER:intron15/16:c.3407-45T>C::	TECPR2:NM_001172631.3:intron_variant:MODIFIER:intron15/16:c.3407-45T>C::,TECPR2:NM_014844.5:intron_variant:MODIFIER:intron15/19:c.3407-45T>C::		615000 [GENE=TECPR2 PHENOS=Spastic paraplegia 49,autosomal recessive,615031,Autosomal recessive];				rs1190554	0.7302	0.6833	7296,.	0.7859,0.7667,0.6728,0.6452,0.7642	-1.2300			0.00,0.08	0.60					0.0327	0.045	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TECPR2 (inh=AR oe_syn=1.00 oe_mis=0.83 oe_lof=0.22)
chr14	102964654	102964654	A	G	het	off-target	QUAL=585;DP=45;AF=0.64;MQM=60;SAP=66;ABP=11	TECPR2	3'UTR	TECPR2:ENST00000359520.7:3_prime_UTR_variant:MODIFIER:exon20/20:c.*60A>G::	TECPR2:NM_014844.5:3_prime_UTR_variant:MODIFIER:exon20/20:c.*60A>G::	regulatory_region_variant:promoter_flanking_region,regulatory_region_variant:CTCF_binding_site	615000 [GENE=TECPR2 PHENOS=Spastic paraplegia 49,autosomal recessive,615031,Autosomal recessive];				rs2403058		0.7015	7865,.		-3.7270			0.03,0.05	0.21					0.0689	0.9365	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TECPR2 (inh=AR oe_syn=1.00 oe_mis=0.83 oe_lof=0.22), RNU6-244P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr15	23052632	23052632	T	C	het		QUAL=738;DP=103;AF=0.34;MQM=60;SAP=11;ABP=26	NIPA1	synonymous,5'UTR	NIPA1:ENST00000337435.4:synonymous_variant:LOW:exon4/5:c.441A>G:p.Thr147=:PF05653 [Magnesium transporter NIPA],NIPA1:ENST00000437912.2:synonymous_variant:LOW:exon4/5:c.216A>G:p.Thr72=:PF05653 [Magnesium transporter NIPA],NIPA1:ENST00000538684.1:5_prime_UTR_variant:MODIFIER:exon5/6:c.-70A>G::,NIPA1:ENST00000561183.1:synonymous_variant:LOW:exon4/5:c.216A>G:p.Thr72=:PF05653 [Magnesium transporter NIPA]	NIPA1:NM_001142275.1:synonymous_variant:LOW:exon4/5:c.216A>G:p.Thr72=:,NIPA1:NM_144599.5:synonymous_variant:LOW:exon4/5:c.441A>G:p.Thr147=:		608145 [GENE=NIPA1 PHENOS=Spastic paraplegia 6,autosomal dominant,600363,Autosomal dominant];	129804 [benign DISEASE=Hereditary spastic paraplegia 6,not specified];			rs11263683	0.7041	0.7449	6748,.	0.4867,0.8660,0.8189,0.7213,0.8446	-4.6810			0.02,0.13	2.33					0.113	0.193	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NIPA1 (inh=AD oe_syn=1.18 oe_mis=0.60 oe_lof=0.49)
chr15	23059394	23059394	C	T	hom		QUAL=1042;DP=36;AF=1.00;MQM=60;SAP=18;ABP=0	NIPA1	intron,5'UTR	NIPA1:ENST00000337435.4:intron_variant:MODIFIER:intron3/4:c.317+1421G>A::,NIPA1:ENST00000437912.2:intron_variant:MODIFIER:intron3/4:c.92+1421G>A::,NIPA1:ENST00000538684.1:5_prime_UTR_variant:MODIFIER:exon4/6:c.-234G>A::,NIPA1:ENST00000561183.1:intron_variant:MODIFIER:intron3/4:c.92+1421G>A::	NIPA1:NM_001142275.1:intron_variant:MODIFIER:intron3/4:c.92+1421G>A::,NIPA1:NM_144599.5:intron_variant:MODIFIER:intron3/4:c.317+1421G>A::		608145 [GENE=NIPA1 PHENOS=Spastic paraplegia 6,autosomal dominant,600363,Autosomal dominant];				rs1991922		0.9300	13501,.	0.9599,0.9605,0.9993,0.9103,0.9173	0.2010			0.00,0.04	9.01					0.7653	0.8709	0.2	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NIPA1 (inh=AD oe_syn=1.18 oe_mis=0.60 oe_lof=0.49)
chr15	43170690	43170690	-	AC	het	off-target;low_conf_region	QUAL=33;DP=18;AF=0.33;MQM=60;SAP=9;ABP=7	TTBK2	intron	TTBK2:ENST00000267890.6:intron_variant:MODIFIER:intron2/14:c.69+55_69+56dup::,TTBK2:ENST00000567274.1:intron_variant:MODIFIER:intron2/10:c.69+55_69+56dup::,TTBK2:ENST00000567840.1:intron_variant:MODIFIER:intron2/11:c.69+55_69+56dup::	TTBK2:NM_173500.4:intron_variant:MODIFIER:intron2/14:c.69+55_69+56dup::		611695 [GENE=TTBK2 PHENOS=Spinocerebellar ataxia 11,604432,Autosomal dominant];			(AC)n (Simple_repeat)	rs10650948		0.6133	5076,.						2.53					0.0441	0.1897	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TTBK2 (inh=AD oe_syn=0.99 oe_mis=0.85 oe_lof=0.14)
chr15	44877801	44877801	A	-	het	off-target;low_conf_region	QUAL=137;DP=44;AF=0.20;MQM=60;SAP=5;ABP=36	SPG11	intron	SPG11:ENST00000261866.7:intron_variant:MODIFIER:intron29/39:c.5121+33del::,SPG11:ENST00000427534.2:intron_variant:MODIFIER:intron29/36:c.5121+33del::,SPG11:ENST00000535302.2:intron_variant:MODIFIER:intron29/37:c.5121+33del::,SPG11:ENST00000558319.1:intron_variant:MODIFIER:intron29/31:c.5121+33del::	SPG11:NM_001160227.2:intron_variant:MODIFIER:intron29/37:c.5121+33del::,SPG11:NM_025137.4:intron_variant:MODIFIER:intron29/39:c.5121+33del::		610844 [GENE=SPG11 PHENOS=Charcot-Marie-Tooth disease,axonal,type 2X,616668,Autosomal recessive/Spastic paraplegia 11,autosomal recessive,604360,Autosomal recessive/Amyotrophic lateral sclerosis 5,juvenile,602099,Autosomal recessive];			AluY (SINE/Alu)	rs34800368		0.1115	0,.	0.1279,0.1682,0.1544,0.0901,0.0884	0.1170				1.18					-0.0053	0.2154	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SPG11 (inh=AR oe_syn=1.13 oe_mis=1.11 oe_lof=0.67)
chr15	44880783	44880783	C	T	het	off-target	QUAL=460;DP=47;AF=0.40;MQM=60;SAP=3;ABP=7	SPG11	intron	SPG11:ENST00000261866.7:intron_variant:MODIFIER:intron28/39:c.4906+667G>A::,SPG11:ENST00000427534.2:intron_variant:MODIFIER:intron28/36:c.4906+667G>A::,SPG11:ENST00000535302.2:intron_variant:MODIFIER:intron28/37:c.4906+667G>A::,SPG11:ENST00000558319.1:intron_variant:MODIFIER:intron28/31:c.4906+667G>A::	SPG11:NM_001160227.2:intron_variant:MODIFIER:intron28/37:c.4906+667G>A::,SPG11:NM_025137.4:intron_variant:MODIFIER:intron28/39:c.4906+667G>A::		610844 [GENE=SPG11 PHENOS=Charcot-Marie-Tooth disease,axonal,type 2X,616668,Autosomal recessive/Spastic paraplegia 11,autosomal recessive,604360,Autosomal recessive/Amyotrophic lateral sclerosis 5,juvenile,602099,Autosomal recessive];			LTR22B1 (LTR/ERVK)	rs148770227	0.0092	0.0189	7,.	0.0037,0.0172,0.0000,0.0277,0.0070	-0.8740			0.00,0.07	0.30					-0.2118	0.3372	0.19	19	645	8 / 148					SPG11 (inh=AR oe_syn=1.13 oe_mis=1.11 oe_lof=0.67)
chr15	44896398	44896398	A	-	het	low_conf_region	QUAL=178;DP=56;AF=0.23;MQM=60;SAP=7;ABP=38	SPG11	intron	SPG11:ENST00000261866.7:intron_variant:MODIFIER:intron20/39:c.3520+1825del::,SPG11:ENST00000427534.2:intron_variant:MODIFIER:intron20/36:c.3520+1825del::,SPG11:ENST00000535302.2:intron_variant:MODIFIER:intron20/37:c.3520+1825del::,SPG11:ENST00000558319.1:intron_variant:MODIFIER:intron20/31:c.3520+1825del::	SPG11:NM_001160227.2:intron_variant:MODIFIER:intron20/37:c.3520+1825del::,SPG11:NM_025137.4:intron_variant:MODIFIER:intron20/39:c.3520+1825del::		610844 [GENE=SPG11 PHENOS=Charcot-Marie-Tooth disease,axonal,type 2X,616668,Autosomal recessive/Spastic paraplegia 11,autosomal recessive,604360,Autosomal recessive/Amyotrophic lateral sclerosis 5,juvenile,602099,Autosomal recessive];			Charlie30b (DNA/hAT-Charlie)	rs748979322		0.4089	1,.	0.3496,0.3934,0.3899,0.4124,0.4278	-0.0560				1.84					-0.771	0.8913	0.16	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SPG11 (inh=AR oe_syn=1.13 oe_mis=1.11 oe_lof=0.67)
chr15	51201158	51201158	A	G	het	off-target	QUAL=140;DP=11;AF=0.73;MQM=60;SAP=20;ABP=8	AP4E1	intron	AP4E1:ENST00000261842.5:intron_variant:MODIFIER:intron1/20:c.150+33A>G::,AP4E1:ENST00000560508.1:intron_variant:MODIFIER:intron1/20:c.-99+33A>G::	AP4E1:NM_001252127.2:intron_variant:MODIFIER:intron1/20:c.-99+33A>G::,AP4E1:NM_007347.5:intron_variant:MODIFIER:intron1/20:c.150+33A>G::	regulatory_region_variant:promoter	607244 [GENE=AP4E1 PHENOS=Stuttering,familial persistent,1,184450,Autosomal dominant/Spastic paraplegia 51,autosomal recessive,613744,Autosomal recessive];	677999 [benign DISEASE=not provided];			rs76674534	0.1566	0.1745	389,.	0.1590,0.2989,0.0157,0.1619,0.1958	0.0660			0.00,0.31	9.99					-0.1192	0.1569	0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AP4E1 (inh=AR+AD oe_syn=1.04 oe_mis=0.94 oe_lof=0.28)
chr15	51204364	51204364	G	A	hom	off-target	QUAL=8064;DP=236;AF=1.00;MQM=60;SAP=3;ABP=0	AP4E1	intron	AP4E1:ENST00000261842.5:intron_variant:MODIFIER:intron2/20:c.222+18G>A::,AP4E1:ENST00000560508.1:intron_variant:MODIFIER:intron2/20:c.-27+18G>A::	AP4E1:NM_001252127.2:intron_variant:MODIFIER:intron2/20:c.-27+18G>A::,AP4E1:NM_007347.5:intron_variant:MODIFIER:intron2/20:c.222+18G>A::		607244 [GENE=AP4E1 PHENOS=Stuttering,familial persistent,1,184450,Autosomal dominant/Spastic paraplegia 51,autosomal recessive,613744,Autosomal recessive];	380768 [benign DISEASE=Spastic paraplegia 51, autosomal recessive,not specified];			rs1147129	0.5591	0.5704	4797,.	0.6022,0.6718,0.4278,0.5404,0.6088	0.0570			0.02,0.16	12.49					0.1179	0.2643	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AP4E1 (inh=AR+AD oe_syn=1.04 oe_mis=0.94 oe_lof=0.28)
chr15	51204394	51204394	-	T	hom	off-target	QUAL=3801;DP=124;AF=1.00;MQM=60;SAP=3;ABP=0	AP4E1	intron	AP4E1:ENST00000261842.5:intron_variant:MODIFIER:intron2/20:c.222+48_222+49insT::,AP4E1:ENST00000560508.1:intron_variant:MODIFIER:intron2/20:c.-27+48_-27+49insT::	AP4E1:NM_001252127.2:intron_variant:MODIFIER:intron2/20:c.-27+48_-27+49insT::,AP4E1:NM_007347.5:intron_variant:MODIFIER:intron2/20:c.222+48_222+49insT::		607244 [GENE=AP4E1 PHENOS=Stuttering,familial persistent,1,184450,Autosomal dominant/Spastic paraplegia 51,autosomal recessive,613744,Autosomal recessive];				rs3214932	0.5637	0.5713	4883,.	0.6217,0.6717,0.4273,0.5397,0.6086					1.39					0.127	0.2642	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AP4E1 (inh=AR+AD oe_syn=1.04 oe_mis=0.94 oe_lof=0.28)
chr15	65273399	65273399	T	C	hom	off-target	QUAL=4317;DP=133;AF=1.00;MQM=60;SAP=7;ABP=0	SPG21	intron,5'UTR	SPG21:ENST00000204566.2:intron_variant:MODIFIER:intron2/8:c.64-36A>G::,SPG21:ENST00000416889.2:intron_variant:MODIFIER:intron2/7:c.64-36A>G::,SPG21:ENST00000433215.2:intron_variant:MODIFIER:intron2/8:c.64-36A>G::,SPG21:ENST00000559199.1:5_prime_UTR_variant:MODIFIER:exon1/7:c.-435A>G::	SPG21:NM_001127889.5:intron_variant:MODIFIER:intron2/8:c.64-36A>G::,SPG21:NM_001127890.5:intron_variant:MODIFIER:intron2/7:c.64-36A>G::,SPG21:NM_016630.7:intron_variant:MODIFIER:intron2/8:c.64-36A>G::		608181 [GENE=SPG21 PHENOS=Mast syndrome,248900,Autosomal recessive];	670117 [benign DISEASE=not provided];			rs4776659		0.5661	4729,.	0.3932,0.6912,0.8651,0.5562,0.3634	0.5070			0.13,0.23	7.94					-0.5747	0.9667	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SPG21 (inh=AR oe_syn=1.08 oe_mis=0.75 oe_lof=0.46)
chr15	72637795	72637795	T	C	hom		QUAL=7177;DP=226;AF=1.00;MQM=60;SAP=31;ABP=0	HEXA,RP11-106M3.2,RP11-106M3.3	synonymous,non_coding_transcript_exon,3'UTR	HEXA:ENST00000268097.5:synonymous_variant:LOW:exon13/14:c.1518A>G:p.Glu506=:,RP11-106M3.2:ENST00000379915.4:non_coding_transcript_exon_variant:MODIFIER:exon5/16:n.609A>G::,HEXA:ENST00000457859.2:3_prime_UTR_variant:MODIFIER:exon11/11:c.*178A>G::,HEXA:ENST00000566304.1:synonymous_variant:LOW:exon13/14:c.1551A>G:p.Glu517=:,HEXA:ENST00000567159.1:synonymous_variant:LOW:exon13/13:c.1518A>G:p.Glu506=:,RP11-106M3.3:ENST00000570175.1:non_coding_transcript_exon_variant:MODIFIER:exon2/3:n.234T>C::	HEXA:NM_000520.6:synonymous_variant:LOW:exon13/14:c.1518A>G:p.Glu506=:,HEXA:NM_001318825.2:synonymous_variant:LOW:exon13/14:c.1551A>G:p.Glu517=:,HEXA:NR_134869.2:non_coding_transcript_exon_variant:MODIFIER:exon11/11:n.1303A>G::		606869 [GENE=HEXA PHENOS=GM2-gangliosidosis,several forms,272800,Autosomal recessive/Tay-Sachs disease,272800,Autosomal recessive/Hex A pseudodeficiency,272800,Autosomal recessive];	93191 [benign DISEASE=Tay-Sachs disease,not specified,not provided];			rs4777502		0.9705	12841,.	0.6046,0.9815,1.0000,0.9983,0.9991	-0.3750			0.01,0.82	19.27					-0.1684	0.9301	0.14	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HEXA (inh=AR oe_syn=0.96 oe_mis=1.07 oe_lof=0.68)
chr15	72638892	72638892	T	C	hom		QUAL=14222;DP=420;AF=1.00;MQM=60;SAP=4;ABP=0	HEXA,RP11-106M3.2,RP11-106M3.3	missense,intron&non_coding_transcript,intron,non_coding_transcript_exon	HEXA:ENST00000268097.5:missense_variant:MODERATE:exon11/14:c.1306A>G:p.Ile436Val:PF00728 [Glycosyl hydrolase family 20 catalytic domain],RP11-106M3.2:ENST00000379915.4:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/15:n.422-226A>G::,HEXA:ENST00000429918.2:missense_variant:MODERATE:exon9/10:c.787A>G:p.Ile263Val:PF00728 [Glycosyl hydrolase family 20 catalytic domain],HEXA:ENST00000457859.2:intron_variant:MODIFIER:intron9/10:c.498-226A>G::,HEXA:ENST00000566304.1:missense_variant:MODERATE:exon11/14:c.1339A>G:p.Ile447Val:PF00728 [Glycosyl hydrolase family 20 catalytic domain],HEXA:ENST00000567159.1:missense_variant:MODERATE:exon11/13:c.1306A>G:p.Ile436Val:PF00728 [Glycosyl hydrolase family 20 catalytic domain],RP11-106M3.3:ENST00000570175.1:non_coding_transcript_exon_variant:MODIFIER:exon2/3:n.1331T>C::	HEXA:NM_000520.6:missense_variant:MODERATE:exon11/14:c.1306A>G:p.Ile436Val:,HEXA:NM_001318825.2:missense_variant:MODERATE:exon11/14:c.1339A>G:p.Ile447Val:,HEXA:NR_134869.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron9/10:n.1116-226A>G::		606869 [GENE=HEXA PHENOS=GM2-gangliosidosis,several forms,272800,Autosomal recessive/Tay-Sachs disease,272800,Autosomal recessive/Hex A pseudodeficiency,272800,Autosomal recessive];	93189 [benign DISEASE=Tay-Sachs disease,not specified,not provided];			rs1800431	0.8764	0.9703	12846,.	0.6041,0.9812,0.9997,0.9982,0.9984	-0.2010	T(0.29), ,T(0.29), ,T(0.31),T(0.30), 	B(0.00), ,B(0.00), ,B(0.00),B(0.00), 	0.14,0.23	9.88	0.23				0.084	0.5362	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HEXA (inh=AR oe_syn=0.96 oe_mis=1.07 oe_lof=0.68)
chr16	31191482	31191482	A	G	hom	off-target	QUAL=1559;DP=48;AF=1.00;MQM=60;SAP=25;ABP=0	FUS	5'UTR	FUS:ENST00000254108.7:5_prime_UTR_variant:MODIFIER:exon1/15:c.-54A>G::,FUS:ENST00000380244.3:5_prime_UTR_variant:MODIFIER:exon1/15:c.-54A>G::,FUS:ENST00000568685.1:5_prime_UTR_variant:MODIFIER:exon1/15:c.-54A>G::	FUS:NM_001170634.1:5_prime_UTR_variant:MODIFIER:exon1/15:c.-54A>G::,FUS:NM_001170937.1:5_prime_UTR_variant:MODIFIER:exon1/15:c.-54A>G::,FUS:NM_004960.3:5_prime_UTR_variant:MODIFIER:exon1/15:c.-54A>G::,FUS:NR_028388.2:non_coding_transcript_exon_variant:MODIFIER:exon1/14:n.52A>G::	regulatory_region_variant:promoter	137070 [GENE=FUS PHENOS=Amyotrophic lateral sclerosis 6,with or without frontotemporal dementia,608030/Essential tremor,hereditary,4,614782,Autosomal dominant];	318979 [benign DISEASE=Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia];			rs929867		0.9868	14273,.	0.8141,0.9904,1.0000,0.9995,0.9996	0.6950			0.04,0.44	13.64					-0.001	0.1173	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FUS (inh=AR+AD oe_syn=1.25 oe_mis=0.66 oe_lof=0.10)
chr16	31195760	31195760	T	-	het	off-target;low_conf_region	QUAL=19;DP=30;AF=0.17;MQM=59;SAP=3;ABP=32	FUS	intron	FUS:ENST00000254108.7:intron_variant:MODIFIER:intron5/14:c.523+59del::,FUS:ENST00000380244.3:intron_variant:MODIFIER:intron5/14:c.520+59del::,FUS:ENST00000568685.1:intron_variant:MODIFIER:intron5/14:c.523+59del::	FUS:NM_001170634.1:intron_variant:MODIFIER:intron5/14:c.520+59del::,FUS:NM_001170937.1:intron_variant:MODIFIER:intron5/14:c.511+71del::,FUS:NM_004960.3:intron_variant:MODIFIER:intron5/14:c.523+59del::,FUS:NR_028388.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/13:n.628+59del::		137070 [GENE=FUS PHENOS=Amyotrophic lateral sclerosis 6,with or without frontotemporal dementia,608030/Essential tremor,hereditary,4,614782,Autosomal dominant];			AluY (SINE/Alu)	rs370126678		0.3162	31,.	0.2865,0.3362,0.3179,0.3197,0.3122	-1.1110				1.17					-0.0459	0.2242	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FUS (inh=AR+AD oe_syn=1.25 oe_mis=0.66 oe_lof=0.10)
chr16	31202699	31202699	T	-	het	off-target;low_conf_region	QUAL=251;DP=94;AF=0.19;MQM=60;SAP=5;ABP=81	FUS	intron	FUS:ENST00000254108.7:intron_variant:MODIFIER:intron14/14:c.1542-5del::,FUS:ENST00000380244.3:intron_variant:MODIFIER:intron14/14:c.1539-5del::,FUS:ENST00000568685.1:intron_variant:MODIFIER:intron14/14:c.1545-5del::	FUS:NM_001170634.1:intron_variant:MODIFIER:intron14/14:c.1539-5del::,FUS:NM_001170937.1:intron_variant:MODIFIER:intron14/14:c.1530-5del::,FUS:NM_004960.3:intron_variant:MODIFIER:intron14/14:c.1542-5del::,FUS:NR_028388.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron13/13:n.1612-5del::		137070 [GENE=FUS PHENOS=Amyotrophic lateral sclerosis 6,with or without frontotemporal dementia,608030/Essential tremor,hereditary,4,614782,Autosomal dominant];			(T)n (Simple_repeat)	rs371057360		0.3518	0,.	0.3551,0.3722,0.3835,0.3581,0.3345	-0.0400				7.62					-0.4293	0.9727	0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FUS (inh=AR+AD oe_syn=1.25 oe_mis=0.66 oe_lof=0.10)
chr16	74750405	74750405	G	A	het		QUAL=4570;DP=368;AF=0.48;MQM=60;SAP=9;ABP=4	FA2H	synonymous	FA2H:ENST00000219368.3:synonymous_variant:LOW:exon6/7:c.879C>T:p.Pro293=:PF04116 [Fatty acid hydroxylase superfamily],FA2H:ENST00000544337.1:synonymous_variant:LOW:exon4/5:c.240C>T:p.Pro80=:PF04116 [Fatty acid hydroxylase superfamily]	FA2H:NM_024306.5:synonymous_variant:LOW:exon6/7:c.879C>T:p.Pro293=:	regulatory_region_variant:promoter_flanking_region	611026 [GENE=FA2H PHENOS=Spastic paraplegia 35,autosomal recessive,612319,Autosomal recessive];	129031 [benign DISEASE=Spastic paraplegia 35,not specified];			rs2301865		0.7785	9519,.	0.7113,0.7539,0.6557,0.8125,0.6910	-2.6200			0.07,0.24	1.18					0.0288	0.1538	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FA2H (inh=AR oe_syn=1.07 oe_mis=0.91 oe_lof=0.26)
chr16	74753079	74753079	C	T	het	off-target	QUAL=847;DP=65;AF=0.55;MQM=60;SAP=50;ABP=5	FA2H	intron	FA2H:ENST00000219368.3:intron_variant:MODIFIER:intron4/6:c.614-21G>A::,FA2H:ENST00000544337.1:intron_variant:MODIFIER:intron2/4:c.-26-21G>A::	FA2H:NM_024306.5:intron_variant:MODIFIER:intron4/6:c.614-21G>A::	regulatory_region_variant:promoter_flanking_region	611026 [GENE=FA2H PHENOS=Spastic paraplegia 35,autosomal recessive,612319,Autosomal recessive];	680134 [benign DISEASE=not provided];			rs2074629	0.2574	0.2714	1232,.	0.4000,0.1184,0.2486,0.2518,0.1553	0.1880			0.11,0.23	2.70					0.1549	0.7824	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FA2H (inh=AR oe_syn=1.07 oe_mis=0.91 oe_lof=0.26)
chr16	74808425	74808425	G	A	het		QUAL=2452;DP=178;AF=0.57;MQM=60;SAP=4;ABP=10	FA2H	synonymous,5'UTR	FA2H:ENST00000219368.3:synonymous_variant:LOW:exon1/7:c.229C>T:p.Leu77=:PF00173 [Cytochrome b5-like Heme/Steroid binding domain],FA2H:ENST00000544337.1:5_prime_UTR_variant:MODIFIER:exon1/5:c.-161C>T::	FA2H:NM_024306.5:synonymous_variant:LOW:exon1/7:c.229C>T:p.Leu77=:	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site	611026 [GENE=FA2H PHENOS=Spastic paraplegia 35,autosomal recessive,612319,Autosomal recessive];	129028 [benign DISEASE=Spastic paraplegia 35,not specified];			rs929881	0.2490	0.3217	1748,.	0.4666,0.2073,0.0417,0.3303,0.1846	3.0900			0.49,0.95	11.68					-0.0571	0.122	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FA2H (inh=AR oe_syn=1.07 oe_mis=0.91 oe_lof=0.26)
chr16	81398520	81398520	G	A	het	off-target	QUAL=520;DP=85;AF=0.31;MQM=60;SAP=19;ABP=31	GAN	intron	GAN:ENST00000568107.2:intron_variant:MODIFIER:intron7/10:c.1237-59G>A::	GAN:NM_022041.3:intron_variant:MODIFIER:intron7/10:c.1237-59G>A::		605379 [GENE=GAN PHENOS=Giant axonal neuropathy-1,256850,Autosomal recessive];	680741 [benign DISEASE=not provided];			rs4889313	0.7396	0.6401	6570,.		-1.6590			0.00,0.09	0.56					0.044	0.069	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GAN (inh=AR oe_syn=1.55 oe_mis=1.11 oe_lof=0.29)
chr16	81398635	81398635	C	T	het		QUAL=1496;DP=85;AF=0.65;MQM=60;SAP=14;ABP=19	GAN	synonymous	GAN:ENST00000568107.2:synonymous_variant:LOW:exon8/11:c.1293C>T:p.Tyr431=:PF01344 [Kelch motif]	GAN:NM_022041.3:synonymous_variant:LOW:exon8/11:c.1293C>T:p.Tyr431=:		605379 [GENE=GAN PHENOS=Giant axonal neuropathy-1,256850,Autosomal recessive];	129131 [benign DISEASE=Giant axonal neuropathy 1,not specified];			rs2608555	0.1512	0.2118	769,.	0.1881,0.1231,0.0287,0.2497,0.1447	0.1940			0.34,0.94	1.26					-0.1119	0.0737	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GAN (inh=AR oe_syn=1.55 oe_mis=1.11 oe_lof=0.29)
chr16	89574166	89574166	C	G	het	off-target	QUAL=3447;DP=228;AF=0.55;MQM=60;SAP=3;ABP=8	SPG7,RP11-104N10.1	upstream_gene	SPG7:ENST00000268704.2:upstream_gene_variant:MODIFIER::::,SPG7:ENST00000341316.2:upstream_gene_variant:MODIFIER::::,RP11-104N10.1:ENST00000565623.1:upstream_gene_variant:MODIFIER::::		regulatory_region_variant:promoter					rs3809641		0.4793	3017,.	0.3743,0.3910,0.6776,0.4495,0.5627	-2.0510			0.00,0.14	4.38					0.3374	0.1277		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SPG7 (inh=AR+AD oe_syn=1.38 oe_mis=1.11 oe_lof=1.30)
chr16	89576880	89576880	T	-	het	off-target;low_conf_region	QUAL=859;DP=97;AF=0.42;MQM=60;SAP=68;ABP=8	SPG7	intron	SPG7:ENST00000268704.2:intron_variant:MODIFIER:intron1/16:c.184-4del::,SPG7:ENST00000341316.2:intron_variant:MODIFIER:intron1/9:c.184-4del::	SPG7:NM_001363850.1:intron_variant:MODIFIER:intron1/17:c.184-4del::,SPG7:NM_003119.4:intron_variant:MODIFIER:intron1/16:c.184-4del::,SPG7:NM_199367.3:intron_variant:MODIFIER:intron1/9:c.184-4del::		602783 [GENE=SPG7 PHENOS=Spastic paraplegia 7,autosomal recessive,607259,Autosomal recessive,Autosomal dominant];	516996 [benign DISEASE=not specified];			rs5818722		0.4014	1481,.	0.3307,0.3599,0.4600,0.3816,0.4345	1.0150				0.59					-0.0679	0.7848	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SPG7 (inh=AR+AD oe_syn=1.38 oe_mis=1.11 oe_lof=1.30)
chr16	89577046	89577046	C	T	het	off-target	QUAL=995;DP=67;AF=0.60;MQM=60;SAP=3;ABP=8	SPG7	intron	SPG7:ENST00000268704.2:intron_variant:MODIFIER:intron2/16:c.286+46C>T::,SPG7:ENST00000341316.2:intron_variant:MODIFIER:intron2/9:c.286+46C>T::	SPG7:NM_001363850.1:intron_variant:MODIFIER:intron2/17:c.286+46C>T::,SPG7:NM_003119.4:intron_variant:MODIFIER:intron2/16:c.286+46C>T::,SPG7:NM_199367.3:intron_variant:MODIFIER:intron2/9:c.286+46C>T::		602783 [GENE=SPG7 PHENOS=Spastic paraplegia 7,autosomal recessive,607259,Autosomal recessive,Autosomal dominant];				rs3922633		0.4719	3041,.	0.3820,0.3834,0.6743,0.4525,0.5672	-2.1620			0.00,0.02	2.00					0.027	0.2833	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SPG7 (inh=AR+AD oe_syn=1.38 oe_mis=1.11 oe_lof=1.30)
chr16	89590168	89590168	-	ATCTC	het		QUAL=3474;DP=218;AF=0.60;MQM=60;SAP=3;ABP=21	SPG7	intron	SPG7:ENST00000268704.2:intron_variant:MODIFIER:intron3/16:c.377-245_377-244insTCTCA::,SPG7:ENST00000341316.2:intron_variant:MODIFIER:intron3/9:c.377-245_377-244insTCTCA::	SPG7:NM_001363850.1:intron_variant:MODIFIER:intron3/17:c.377-245_377-244insTCTCA::,SPG7:NM_003119.4:intron_variant:MODIFIER:intron3/16:c.377-245_377-244insTCTCA::,SPG7:NM_199367.3:intron_variant:MODIFIER:intron3/9:c.377-245_377-244insTCTCA::		602783 [GENE=SPG7 PHENOS=Spastic paraplegia 7,autosomal recessive,607259,Autosomal recessive,Autosomal dominant];				rs59761318		0.4825	3125,.	0.4076,0.3977,0.6804,0.4543,0.5630					6.71					0.0089	0.3328	0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SPG7 (inh=AR+AD oe_syn=1.38 oe_mis=1.11 oe_lof=1.30)
chr16	89590243	89590243	G	A	het		QUAL=4411;DP=252;AF=0.61;MQM=60;SAP=3;ABP=28	SPG7	intron	SPG7:ENST00000268704.2:intron_variant:MODIFIER:intron3/16:c.377-171G>A::,SPG7:ENST00000341316.2:intron_variant:MODIFIER:intron3/9:c.377-171G>A::	SPG7:NM_001363850.1:intron_variant:MODIFIER:intron3/17:c.377-171G>A::,SPG7:NM_003119.4:intron_variant:MODIFIER:intron3/16:c.377-171G>A::,SPG7:NM_199367.3:intron_variant:MODIFIER:intron3/9:c.377-171G>A::		602783 [GENE=SPG7 PHENOS=Spastic paraplegia 7,autosomal recessive,607259,Autosomal recessive,Autosomal dominant];	670124 [benign DISEASE=not provided];			rs3803680	0.4990	0.4769	2889,.	0.3233,0.3917,0.6814,0.4548,0.5626	-0.1410			0.01,0.14	0.84					-0.0035	0.3322	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SPG7 (inh=AR+AD oe_syn=1.38 oe_mis=1.11 oe_lof=1.30)
chr16	89590667	89590667	T	C	het	off-target	QUAL=1570;DP=115;AF=0.54;MQM=60;SAP=4;ABP=5	SPG7	intron	SPG7:ENST00000268704.2:intron_variant:MODIFIER:intron4/16:c.618+12T>C::,SPG7:ENST00000341316.2:intron_variant:MODIFIER:intron4/9:c.618+12T>C::	SPG7:NM_001363850.1:intron_variant:MODIFIER:intron4/17:c.618+12T>C::,SPG7:NM_003119.4:intron_variant:MODIFIER:intron4/16:c.618+12T>C::,SPG7:NM_199367.3:intron_variant:MODIFIER:intron4/9:c.618+12T>C::		602783 [GENE=SPG7 PHENOS=Spastic paraplegia 7,autosomal recessive,607259,Autosomal recessive,Autosomal dominant];	258910 [benign DISEASE=Hereditary spastic paraplegia 7,not specified];			rs3803679	0.5294	0.4752	3248,.	0.4237,0.3819,0.6772,0.4523,0.5684	-0.4130			0.00,0.08	1.42					0.656	0.0163	0.18	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SPG7 (inh=AR+AD oe_syn=1.38 oe_mis=1.11 oe_lof=1.30)
chr16	89597057	89597057	G	T	het	off-target	QUAL=901;DP=79;AF=0.49;MQM=60;SAP=16;ABP=3	SPG7	intron	SPG7:ENST00000268704.2:intron_variant:MODIFIER:intron6/16:c.862-34G>T::,SPG7:ENST00000341316.2:intron_variant:MODIFIER:intron6/9:c.862-34G>T::	SPG7:NM_001363850.1:intron_variant:MODIFIER:intron6/17:c.862-34G>T::,SPG7:NM_003119.4:intron_variant:MODIFIER:intron6/16:c.862-34G>T::,SPG7:NM_199367.3:intron_variant:MODIFIER:intron6/9:c.862-34G>T::		602783 [GENE=SPG7 PHENOS=Spastic paraplegia 7,autosomal recessive,607259,Autosomal recessive,Autosomal dominant];				rs4785690	0.4976	0.4656	2842,.	0.3263,0.3762,0.6760,0.4497,0.5667	0.2430			0.01,0.13	0.27					0.0851	0.1753	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SPG7 (inh=AR+AD oe_syn=1.38 oe_mis=1.11 oe_lof=1.30)
chr16	89597221	89597221	A	G	het		QUAL=1481;DP=146;AF=0.42;MQM=60;SAP=5;ABP=10	SPG7	splice_region&intron	SPG7:ENST00000268704.2:splice_region_variant&intron_variant:LOW:intron7/16:c.987+5A>G::,SPG7:ENST00000341316.2:splice_region_variant&intron_variant:LOW:intron7/9:c.987+5A>G::	SPG7:NM_001363850.1:splice_region_variant&intron_variant:LOW:intron7/17:c.987+5A>G::,SPG7:NM_003119.4:splice_region_variant&intron_variant:LOW:intron7/16:c.987+5A>G::,SPG7:NM_199367.3:splice_region_variant&intron_variant:LOW:intron7/9:c.987+5A>G::		602783 [GENE=SPG7 PHENOS=Spastic paraplegia 7,autosomal recessive,607259,Autosomal recessive,Autosomal dominant];	258911 [benign DISEASE=Hereditary spastic paraplegia 7,not specified];			rs4785691		0.4741	3212,.	0.4223,0.3847,0.6771,0.4513,0.5677	0.2300			0.01,0.19	8.16		4.51>8.68	0.000/0.048		2.0442	0.0004	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SPG7 (inh=AR+AD oe_syn=1.38 oe_mis=1.11 oe_lof=1.30)
chr16	89598369	89598369	G	A	het		QUAL=199;DP=43;AF=0.28;MQM=60;SAP=4;ABP=21	SPG7	missense	SPG7:ENST00000268704.2:missense_variant:MODERATE:exon8/17:c.1045G>A:p.Gly349Ser:PF00004 [ATPase family associated with various cellular activities (AAA)],SPG7:ENST00000341316.2:missense_variant:MODERATE:exon8/10:c.1045G>A:p.Gly349Ser:PF00004 [ATPase family associated with various cellular activities (AAA)]	SPG7:NM_001363850.1:missense_variant:MODERATE:exon8/18:c.1045G>A:p.Gly349Ser:,SPG7:NM_003119.4:missense_variant:MODERATE:exon8/17:c.1045G>A:p.Gly349Ser:,SPG7:NM_199367.3:missense_variant:MODERATE:exon8/10:c.1045G>A:p.Gly349Ser:		602783 [GENE=SPG7 PHENOS=Spastic paraplegia 7,autosomal recessive,607259,Autosomal recessive,Autosomal dominant];	6819 [pathogenic/likely pathogenic DISEASE=Hereditary spastic paraplegia 7,not provided];	CM085724 [CLASS=DM MUT=ALT PHEN="Spastic paraplegia" GENE=SPG7];		rs141659620	0.0008	0.0008	0,.	0.0002,0.0001,0.0002,0.0016,0.0001	9.4080	D(0.00),D(0.00)	D(1.00),D(1.00)	0.98,0.98	26.40	0.95				-0.0292	0.2889	0	0	53	0 / 20	5	"Klasse 5 best., NDE, 15.11.18%0Apathogen, MR, 03.06.2016, [5] old entry - no details available"			SPG7 (inh=AR+AD oe_syn=1.38 oe_mis=1.11 oe_lof=1.30)
chr16	89611199	89611199	G	A	het	off-target	QUAL=2304;DP=185;AF=0.48;MQM=60;SAP=7;ABP=4	SPG7	intron	SPG7:ENST00000268704.2:intron_variant:MODIFIER:intron10/16:c.1449+19G>A::	SPG7:NM_001363850.1:intron_variant:MODIFIER:intron10/17:c.1449+19G>A::,SPG7:NM_003119.4:intron_variant:MODIFIER:intron10/16:c.1449+19G>A::		602783 [GENE=SPG7 PHENOS=Spastic paraplegia 7,autosomal recessive,607259,Autosomal recessive,Autosomal dominant];	258907 [benign DISEASE=not specified];			rs79201073	0.1460	0.1020	157,.	0.0662,0.1061,0.3251,0.0584,0.1541	-0.6690			0.01,0.20	3.88					0.1564	0.2927	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SPG7 (inh=AR+AD oe_syn=1.38 oe_mis=1.11 oe_lof=1.30)
chr16	89613007	89613007	G	C	het	off-target	QUAL=13;DP=6;AF=0.67;MQM=60;SAP=12;ABP=4	SPG7	intron	SPG7:ENST00000268704.2:intron_variant:MODIFIER:intron10/16:c.1450-59G>C::	SPG7:NM_001363850.1:intron_variant:MODIFIER:intron10/17:c.1450-59G>C::,SPG7:NM_003119.4:intron_variant:MODIFIER:intron10/16:c.1450-59G>C::		602783 [GENE=SPG7 PHENOS=Spastic paraplegia 7,autosomal recessive,607259,Autosomal recessive,Autosomal dominant];									-0.9840			0.00,0.06	0.11					0.0051	0.3452	0.01	0	16	0 / 16					SPG7 (inh=AR+AD oe_syn=1.38 oe_mis=1.11 oe_lof=1.30)
chr17	4907989	4907989	A	G	hom	off-target	QUAL=2245;DP=72;AF=1.00;MQM=60;SAP=3;ABP=0	KIF1C	intron	KIF1C:ENST00000320785.5:intron_variant:MODIFIER:intron12/22:c.1019+49A>G::	KIF1C:NM_006612.6:intron_variant:MODIFIER:intron12/22:c.1019+49A>G::		603060 [GENE=KIF1C PHENOS=Spastic ataxia 2,autosomal recessive,611302,Autosomal recessive];				rs391271	0.0455	0.1046	217,.	0.0221,0.0691,0.0007,0.1626,0.0430	-0.1120			0.11,0.25	6.26					0.1038	0.2003	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1C (inh=AR oe_syn=1.10 oe_mis=0.85 oe_lof=0.21)
chr17	4926882	4926882	A	G	hom		QUAL=11752;DP=375;AF=1.00;MQM=60;SAP=3;ABP=0	KIF1C	synonymous	KIF1C:ENST00000320785.5:synonymous_variant:LOW:exon23/23:c.2748A>G:p.Pro916=:	KIF1C:NM_006612.6:synonymous_variant:LOW:exon23/23:c.2748A>G:p.Pro916=:		603060 [GENE=KIF1C PHENOS=Spastic ataxia 2,autosomal recessive,611302,Autosomal recessive];	380827 [benign DISEASE=not specified];			rs346828		0.7171	6990,.	0.5513,0.7700,0.6654,0.7185,0.8120	-2.1520			0.01,0.11	0.79					0.003	0.9061	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1C (inh=AR oe_syn=1.10 oe_mis=0.85 oe_lof=0.21)
chr17	19561012	19561019	ACTGAATT	-	het	off-target;low_conf_region	QUAL=950;DP=111;AF=0.38;MQM=60;SAP=5;ABP=17	ALDH3A2	intron	ALDH3A2:ENST00000176643.6:intron_variant:MODIFIER:intron4/9:c.681-37_681-30del::,ALDH3A2:ENST00000339618.4:intron_variant:MODIFIER:intron4/10:c.681-37_681-30del::,ALDH3A2:ENST00000395575.2:intron_variant:MODIFIER:intron5/10:c.681-37_681-30del::,ALDH3A2:ENST00000579855.1:intron_variant:MODIFIER:intron5/10:c.681-37_681-30del::,ALDH3A2:ENST00000581518.1:intron_variant:MODIFIER:intron4/11:c.681-37_681-30del::	ALDH3A2:NM_000382.3:intron_variant:MODIFIER:intron4/9:c.681-37_681-30del::,ALDH3A2:NM_001031806.2:intron_variant:MODIFIER:intron4/10:c.681-37_681-30del::,ALDH3A2:NM_001369136.1:intron_variant:MODIFIER:intron5/11:c.681-37_681-30del::,ALDH3A2:NM_001369137.1:intron_variant:MODIFIER:intron5/11:c.681-37_681-30del::,ALDH3A2:NM_001369138.1:intron_variant:MODIFIER:intron5/10:c.681-37_681-30del::,ALDH3A2:NM_001369139.1:intron_variant:MODIFIER:intron5/10:c.681-37_681-30del::,ALDH3A2:NM_001369146.1:intron_variant:MODIFIER:intron5/9:c.681-37_681-30del::,ALDH3A2:NM_001369148.1:intron_variant:MODIFIER:intron6/11:c.102-37_102-30del::		609523 [GENE=ALDH3A2 PHENOS=Sjogren-Larsson syndrome,270200,Autosomal recessive];				rs3034928		0.5838	4045,.	0.3755,0.7207,0.9127,0.5308,0.6540	2.9620				6.64					-0.2826	0.653	0.04	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH3A2 (inh=AR oe_syn=0.81 oe_mis=0.88 oe_lof=0.51), SNORA31 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr17	19564634	19564634	C	G	het		QUAL=876;DP=95;AF=0.42;MQM=60;SAP=11;ABP=8	ALDH3A2	intron	ALDH3A2:ENST00000176643.6:intron_variant:MODIFIER:intron6/9:c.940+53C>G::,ALDH3A2:ENST00000339618.4:intron_variant:MODIFIER:intron6/10:c.940+53C>G::,ALDH3A2:ENST00000395575.2:intron_variant:MODIFIER:intron7/10:c.940+53C>G::,ALDH3A2:ENST00000579855.1:intron_variant:MODIFIER:intron7/10:c.940+53C>G::,ALDH3A2:ENST00000581518.1:intron_variant:MODIFIER:intron6/11:c.940+53C>G::	ALDH3A2:NM_000382.3:intron_variant:MODIFIER:intron6/9:c.940+53C>G::,ALDH3A2:NM_001031806.2:intron_variant:MODIFIER:intron6/10:c.940+53C>G::,ALDH3A2:NM_001369136.1:intron_variant:MODIFIER:intron7/11:c.940+53C>G::,ALDH3A2:NM_001369137.1:intron_variant:MODIFIER:intron7/11:c.940+53C>G::,ALDH3A2:NM_001369138.1:intron_variant:MODIFIER:intron7/10:c.940+53C>G::,ALDH3A2:NM_001369139.1:intron_variant:MODIFIER:intron7/10:c.940+53C>G::,ALDH3A2:NM_001369146.1:intron_variant:MODIFIER:intron7/9:c.940+53C>G::,ALDH3A2:NM_001369148.1:intron_variant:MODIFIER:intron8/11:c.361+53C>G::		609523 [GENE=ALDH3A2 PHENOS=Sjogren-Larsson syndrome,270200,Autosomal recessive];				rs1800869	0.2278	0.2404	772,.	0.0640,0.3051,0.3939,0.2402,0.2216	0.0300			0.07,0.22	5.09					-0.0568	0.9402	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH3A2 (inh=AR oe_syn=0.81 oe_mis=0.88 oe_lof=0.51), SNORA31 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr17	19578873	19578873	A	T	het		QUAL=400;DP=51;AF=0.39;MQM=60;SAP=19;ABP=8	ALDH3A2	splice_region&synonymous,splice_region&3'UTR,stop_gained&splice_region,splice_acceptor	ALDH3A2:ENST00000176643.6:splice_region_variant&synonymous_variant:LOW:exon10/10:c.1446A>T:p.Ala482=:,ALDH3A2:ENST00000339618.4:splice_region_variant&3_prime_UTR_variant:LOW:exon11/11:c.*44A>T::,ALDH3A2:ENST00000395575.2:splice_region_variant&synonymous_variant:LOW:exon11/11:c.1446A>T:p.Ala482=:,ALDH3A2:ENST00000571163.1:stop_gained&splice_region_variant:HIGH:exon3/3:c.229A>T:p.Arg77Ter:,ALDH3A2:ENST00000579855.1:splice_region_variant&synonymous_variant:LOW:exon11/11:c.1446A>T:p.Ala482=:,ALDH3A2:ENST00000581518.1:splice_acceptor_variant:HIGH:intron11/11:c.*46-2A>T::	ALDH3A2:NM_000382.3:splice_region_variant&synonymous_variant:LOW:exon10/10:c.1446A>T:p.Ala482=:,ALDH3A2:NM_001031806.2:splice_region_variant&3_prime_UTR_variant:LOW:exon11/11:c.*44A>T::,ALDH3A2:NM_001369136.1:splice_region_variant&3_prime_UTR_variant:LOW:exon12/12:c.*44A>T::,ALDH3A2:NM_001369137.1:splice_region_variant&3_prime_UTR_variant:LOW:exon12/12:c.*44A>T::,ALDH3A2:NM_001369138.1:splice_region_variant&synonymous_variant:LOW:exon11/11:c.1446A>T:p.Ala482=:,ALDH3A2:NM_001369139.1:splice_region_variant&synonymous_variant:LOW:exon11/11:c.1446A>T:p.Ala482=:,ALDH3A2:NM_001369146.1:stop_gained&splice_region_variant:HIGH:exon10/10:c.1210A>T:p.Arg404Ter:,ALDH3A2:NM_001369148.1:splice_region_variant&synonymous_variant:LOW:exon12/12:c.867A>T:p.Ala289=:		609523 [GENE=ALDH3A2 PHENOS=Sjogren-Larsson syndrome,270200,Autosomal recessive];	322219 [benign DISEASE=Sjoegren-Larsson syndrome,not provided];			rs7216	0.6785	0.6200	5270,.	0.5337,0.7456,0.9910,0.5574,0.6669	-0.9760			0.00,0.11	14.03		12.13>11.69,6.63>-1.74			-2.1383	1.0	0.26	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH3A2 (inh=AR oe_syn=0.81 oe_mis=0.88 oe_lof=0.51), SLC47A2 (inh=n/a oe_syn=0.98 oe_mis=0.95 oe_lof=0.81)
chr17	42990697	42990697	C	A	het		QUAL=2857;DP=245;AF=0.47;MQM=60;SAP=5;ABP=5	GFAP	synonymous,intron	GFAP:ENST00000253408.5:synonymous_variant:LOW:exon4/9:c.720G>T:p.Thr240=:PF00038 [Intermediate filament protein],GFAP:ENST00000435360.2:synonymous_variant:LOW:exon4/8:c.720G>T:p.Thr240=:PF00038 [Intermediate filament protein],GFAP:ENST00000586793.1:synonymous_variant:LOW:exon4/7:c.720G>T:p.Thr240=:PF00038 [Intermediate filament protein],GFAP:ENST00000588735.1:intron_variant:MODIFIER:intron1/2:c.82+2076G>T::	GFAP:NM_001131019.3:synonymous_variant:LOW:exon4/8:c.720G>T:p.Thr240=:,GFAP:NM_001242376.2:synonymous_variant:LOW:exon4/7:c.720G>T:p.Thr240=:,GFAP:NM_001363846.1:synonymous_variant:LOW:exon4/10:c.720G>T:p.Thr240=:,GFAP:NM_002055.5:synonymous_variant:LOW:exon4/9:c.720G>T:p.Thr240=:		137780 [GENE=GFAP PHENOS=Alexander disease,203450,Autosomal dominant];	323615 [benign DISEASE=not provided];			rs2229012	0.0030	0.0056	0,.	0.0012,0.0051,0.0001,0.0072,0.0039	-2.2450			0.04,0.19	0.36				COSV53653278	-0.1555	0.9216	0.01	1	206	0 / 65					GFAP (inh=AD oe_syn=0.73 oe_mis=0.84 oe_lof=0.63)
chr17	42990810	42990810	G	A	het	off-target	QUAL=201;DP=22;AF=0.50;MQM=60;SAP=27;ABP=3	GFAP	intron	GFAP:ENST00000253408.5:intron_variant:MODIFIER:intron3/8:c.619-12C>T::,GFAP:ENST00000435360.2:intron_variant:MODIFIER:intron3/7:c.619-12C>T::,GFAP:ENST00000586793.1:intron_variant:MODIFIER:intron3/6:c.619-12C>T::,GFAP:ENST00000588735.1:intron_variant:MODIFIER:intron1/2:c.82+1963C>T::	GFAP:NM_001131019.3:intron_variant:MODIFIER:intron3/7:c.619-12C>T::,GFAP:NM_001242376.2:intron_variant:MODIFIER:intron3/6:c.619-12C>T::,GFAP:NM_001363846.1:intron_variant:MODIFIER:intron3/9:c.619-12C>T::,GFAP:NM_002055.5:intron_variant:MODIFIER:intron3/8:c.619-12C>T::		137780 [GENE=GFAP PHENOS=Alexander disease,203450,Autosomal dominant];	66489 [benign DISEASE=not provided];			rs3744468	0.1474	0.1491	425,.	0.2510,0.0819,0.0963,0.1240,0.1167	0.2780			0.06,0.24	5.01		5.27>4.39	0.000/0.072		0.3172	0.542	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GFAP (inh=AD oe_syn=0.73 oe_mis=0.84 oe_lof=0.63)
chr18	12348285	12348285	T	C	hom		QUAL=3128;DP=98;AF=1.00;MQM=60;SAP=3;ABP=0	AFG3L2	synonymous	AFG3L2:ENST00000269143.3:synonymous_variant:LOW:exon13/17:c.1650A>G:p.Glu550=:PF01434 [Peptidase family M41]	AFG3L2:NM_006796.3:synonymous_variant:LOW:exon13/17:c.1650A>G:p.Glu550=:		604581 [GENE=AFG3L2 PHENOS=Spastic ataxia 5,autosomal recessive,614487,Autosomal recessive/Optic atrophy 12,618977,Autosomal dominant/Spinocerebellar ataxia 28,610246,Autosomal dominant];	128287 [benign DISEASE=Spinocerebellar ataxia type 28,not specified,not provided];			rs11553521		0.7762	9507,.	0.7637,0.5679,0.6107,0.7808,0.7839	-0.0740			0.59,0.96	9.33					-0.2557	0.4903	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AFG3L2 (inh=AR+AD oe_syn=1.07 oe_mis=0.73 oe_lof=0.49)
chr18	12351342	12351342	C	T	hom		QUAL=3793;DP=119;AF=1.00;MQM=60;SAP=4;ABP=0	AFG3L2	synonymous	AFG3L2:ENST00000269143.3:synonymous_variant:LOW:exon11/17:c.1389G>A:p.Leu463=:PF00004 [ATPase family associated with various cellular activities (AAA)]	AFG3L2:NM_006796.3:synonymous_variant:LOW:exon11/17:c.1389G>A:p.Leu463=:		604581 [GENE=AFG3L2 PHENOS=Spastic ataxia 5,autosomal recessive,614487,Autosomal recessive/Optic atrophy 12,618977,Autosomal dominant/Spinocerebellar ataxia 28,610246,Autosomal dominant];	128286 [benign DISEASE=Spinocerebellar ataxia type 28,not specified,not provided];			rs11080572		0.7171	7832,.	0.4841,0.5561,0.6044,0.7793,0.7815	-0.9330			0.09,0.25	3.97					-0.0854	0.287	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AFG3L2 (inh=AR+AD oe_syn=1.07 oe_mis=0.73 oe_lof=0.49)
chr18	12352952	12352952	-	A	het	off-target	QUAL=178;DP=66;AF=0.20;MQM=60;SAP=3;ABP=56	AFG3L2	intron	AFG3L2:ENST00000269143.3:intron_variant:MODIFIER:intron10/16:c.1318+51dup::	AFG3L2:NM_006796.3:intron_variant:MODIFIER:intron10/16:c.1318+51dup::		604581 [GENE=AFG3L2 PHENOS=Spastic ataxia 5,autosomal recessive,614487,Autosomal recessive/Optic atrophy 12,618977,Autosomal dominant/Spinocerebellar ataxia 28,610246,Autosomal dominant];			AluSx3 (SINE/Alu)	rs1388615371		0.0054	0,.						2.38					0.0674	0.3032	0	0	499	0 / 320					AFG3L2 (inh=AR+AD oe_syn=1.07 oe_mis=0.73 oe_lof=0.49)
chr18	12358997	12358997	A	G	hom	off-target	QUAL=5552;DP=165;AF=1.00;MQM=60;SAP=16;ABP=0	AFG3L2	intron	AFG3L2:ENST00000269143.3:intron_variant:MODIFIER:intron7/16:c.753-55T>C::	AFG3L2:NM_006796.3:intron_variant:MODIFIER:intron7/16:c.753-55T>C::		604581 [GENE=AFG3L2 PHENOS=Spastic ataxia 5,autosomal recessive,614487,Autosomal recessive/Optic atrophy 12,618977,Autosomal dominant/Spinocerebellar ataxia 28,610246,Autosomal dominant];				rs7407640	0.6302	0.7046	8081,.		-1.9010			0.00,0.02	0.01					-0.0055	0.8724	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AFG3L2 (inh=AR+AD oe_syn=1.07 oe_mis=0.73 oe_lof=0.49)
chr18	12359920	12359920	G	A	hom	low_conf_region	QUAL=3200;DP=104;AF=0.99;MQM=60;SAP=3;ABP=0	AFG3L2	splice_region&intron	AFG3L2:ENST00000269143.3:splice_region_variant&intron_variant:LOW:intron7/16:c.752+6C>T::	AFG3L2:NM_006796.3:splice_region_variant&intron_variant:LOW:intron7/16:c.752+6C>T::		604581 [GENE=AFG3L2 PHENOS=Spastic ataxia 5,autosomal recessive,614487,Autosomal recessive/Optic atrophy 12,618977,Autosomal dominant/Spinocerebellar ataxia 28,610246,Autosomal dominant];	136312 [benign DISEASE=Spinocerebellar ataxia type 28,not specified,not provided];			rs8097342	0.6196	0.7145	7788,.	0.4824,0.5558,0.6056,0.7770,0.7708	-0.5940			0.01,0.07	2.52		4.20>6.19	0.000/0.000		0.2641	0.5043	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AFG3L2 (inh=AR+AD oe_syn=1.07 oe_mis=0.73 oe_lof=0.49)
chr19	7606908	7606908	G	C	het		QUAL=967;DP=86;AF=0.45;MQM=60;SAP=10;ABP=5	PNPLA6	missense	PNPLA6:ENST00000221249.6:missense_variant:MODERATE:exon13/35:c.1090G>C:p.Ala364Pro:,PNPLA6:ENST00000414982.3:missense_variant:MODERATE:exon12/34:c.1234G>C:p.Ala412Pro:,PNPLA6:ENST00000450331.3:missense_variant:MODERATE:exon13/35:c.1090G>C:p.Ala364Pro:,PNPLA6:ENST00000545201.2:missense_variant:MODERATE:exon13/34:c.1090G>C:p.Ala364Pro:,PNPLA6:ENST00000600737.1:missense_variant:MODERATE:exon10/32:c.1207G>C:p.Ala403Pro:	PNPLA6:NM_001166111.2:missense_variant:MODERATE:exon12/34:c.1234G>C:p.Ala412Pro:,PNPLA6:NM_001166112.1:missense_variant:MODERATE:exon13/34:c.1090G>C:p.Ala364Pro:,PNPLA6:NM_001166113.1:missense_variant:MODERATE:exon13/35:c.1090G>C:p.Ala364Pro:,PNPLA6:NM_001166114.2:missense_variant:MODERATE:exon10/32:c.1207G>C:p.Ala403Pro:,PNPLA6:NM_006702.5:missense_variant:MODERATE:exon13/35:c.1090G>C:p.Ala364Pro:		603197 [GENE=PNPLA6 PHENOS=Spastic paraplegia 39,autosomal recessive,612020,Autosomal recessive/Boucher-Neuhauser syndrome,215470,Autosomal recessive/Oliver-McFarlane syndrome,275400,Autosomal recessive/Laurence-Moon syndrome,245800,Autosomal recessive];	129977 [benign DISEASE=Hereditary spastic paraplegia 39,not specified,not provided];			rs17854645	0.1184	0.1653	496,.	0.1043,0.0947,0.0005,0.2140,0.1404	2.8170	T(0.26),T(0.22),T(0.26),T(0.28),T(0.22)	B(0.00),D(1.00),B(0.00),B(0.01),B(0.01)	0.49,0.97	24.40	0.03				-0.2413	0.4135	0.15	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PNPLA6 (inh=AR oe_syn=1.01 oe_mis=0.59 oe_lof=0.48)
chr19	7606970	7606970	C	A	het	off-target	QUAL=207;DP=23;AF=0.52;MQM=60;SAP=29;ABP=3	PNPLA6	intron	PNPLA6:ENST00000221249.6:intron_variant:MODIFIER:intron13/34:c.1135+17C>A::,PNPLA6:ENST00000414982.3:intron_variant:MODIFIER:intron12/33:c.1279+17C>A::,PNPLA6:ENST00000450331.3:intron_variant:MODIFIER:intron13/34:c.1135+17C>A::,PNPLA6:ENST00000545201.2:intron_variant:MODIFIER:intron13/33:c.1135+17C>A::,PNPLA6:ENST00000600737.1:intron_variant:MODIFIER:intron10/31:c.1252+17C>A::	PNPLA6:NM_001166111.2:intron_variant:MODIFIER:intron12/33:c.1279+17C>A::,PNPLA6:NM_001166112.1:intron_variant:MODIFIER:intron13/33:c.1135+17C>A::,PNPLA6:NM_001166113.1:intron_variant:MODIFIER:intron13/34:c.1135+17C>A::,PNPLA6:NM_001166114.2:intron_variant:MODIFIER:intron10/31:c.1252+17C>A::,PNPLA6:NM_006702.5:intron_variant:MODIFIER:intron13/34:c.1135+17C>A::		603197 [GENE=PNPLA6 PHENOS=Spastic paraplegia 39,autosomal recessive,612020,Autosomal recessive/Boucher-Neuhauser syndrome,215470,Autosomal recessive/Oliver-McFarlane syndrome,275400,Autosomal recessive/Laurence-Moon syndrome,245800,Autosomal recessive];	385065 [benign DISEASE=not specified];			rs117630756	0.0104	0.0256	21,.	0.0052,0.0080,0.0004,0.0320,0.0090	-2.6760			0.02,0.22	7.71					0.1735	0.4241	0.2	17	634	9 / 227					PNPLA6 (inh=AR oe_syn=1.01 oe_mis=0.59 oe_lof=0.48)
chr19	7607441	7607441	C	T	het		QUAL=884;DP=83;AF=0.46;MQM=60;SAP=11;ABP=4	PNPLA6	splice_region&intron	PNPLA6:ENST00000221249.6:splice_region_variant&intron_variant:LOW:intron13/34:c.1136-6C>T::,PNPLA6:ENST00000414982.3:splice_region_variant&intron_variant:LOW:intron12/33:c.1280-6C>T::,PNPLA6:ENST00000450331.3:splice_region_variant&intron_variant:LOW:intron13/34:c.1136-6C>T::,PNPLA6:ENST00000545201.2:splice_region_variant&intron_variant:LOW:intron13/33:c.1136-6C>T::,PNPLA6:ENST00000600737.1:splice_region_variant&intron_variant:LOW:intron10/31:c.1253-6C>T::	PNPLA6:NM_001166111.2:splice_region_variant&intron_variant:LOW:intron12/33:c.1280-6C>T::,PNPLA6:NM_001166112.1:splice_region_variant&intron_variant:LOW:intron13/33:c.1136-6C>T::,PNPLA6:NM_001166113.1:splice_region_variant&intron_variant:LOW:intron13/34:c.1136-6C>T::,PNPLA6:NM_001166114.2:splice_region_variant&intron_variant:LOW:intron10/31:c.1253-6C>T::,PNPLA6:NM_006702.5:splice_region_variant&intron_variant:LOW:intron13/34:c.1136-6C>T::		603197 [GENE=PNPLA6 PHENOS=Spastic paraplegia 39,autosomal recessive,612020,Autosomal recessive/Boucher-Neuhauser syndrome,215470,Autosomal recessive/Oliver-McFarlane syndrome,275400,Autosomal recessive/Laurence-Moon syndrome,245800,Autosomal recessive];	330520 [benign DISEASE=Hereditary spastic paraplegia 39,not specified];			rs574930	0.2438	0.3087	1578,.	0.3406,0.1763,0.0010,0.3471,0.1792	-0.4640			0.01,0.16	3.50		10.00>9.42	0.000/0.000		-0.2271	0.916	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PNPLA6 (inh=AR oe_syn=1.01 oe_mis=0.59 oe_lof=0.48)
chr19	7607564	7607564	T	C	het		QUAL=938;DP=104;AF=0.40;MQM=60;SAP=10;ABP=11	PNPLA6	splice_region&intron	PNPLA6:ENST00000221249.6:splice_region_variant&intron_variant:LOW:intron14/34:c.1245+8T>C::,PNPLA6:ENST00000414982.3:splice_region_variant&intron_variant:LOW:intron13/33:c.1389+8T>C::,PNPLA6:ENST00000450331.3:splice_region_variant&intron_variant:LOW:intron14/34:c.1245+8T>C::,PNPLA6:ENST00000545201.2:splice_region_variant&intron_variant:LOW:intron14/33:c.1245+8T>C::,PNPLA6:ENST00000600737.1:splice_region_variant&intron_variant:LOW:intron11/31:c.1362+8T>C::	PNPLA6:NM_001166111.2:splice_region_variant&intron_variant:LOW:intron13/33:c.1389+8T>C::,PNPLA6:NM_001166112.1:splice_region_variant&intron_variant:LOW:intron14/33:c.1245+8T>C::,PNPLA6:NM_001166113.1:splice_region_variant&intron_variant:LOW:intron14/34:c.1245+8T>C::,PNPLA6:NM_001166114.2:splice_region_variant&intron_variant:LOW:intron11/31:c.1362+8T>C::,PNPLA6:NM_006702.5:splice_region_variant&intron_variant:LOW:intron14/34:c.1245+8T>C::		603197 [GENE=PNPLA6 PHENOS=Spastic paraplegia 39,autosomal recessive,612020,Autosomal recessive/Boucher-Neuhauser syndrome,215470,Autosomal recessive/Oliver-McFarlane syndrome,275400,Autosomal recessive/Laurence-Moon syndrome,245800,Autosomal recessive];	330522 [benign DISEASE=Hereditary spastic paraplegia 39,not specified,not provided];			rs620744	0.6945	0.6733	7239,.	0.8363,0.7545,0.5239,0.6263,0.5538	1.0180			0.00,0.06	6.19			0.000/0.002		0.1379	0.5822	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PNPLA6 (inh=AR oe_syn=1.01 oe_mis=0.59 oe_lof=0.48)
chr19	7615585	7615585	T	G	het	off-target	QUAL=2693;DP=195;AF=0.54;MQM=60;SAP=13;ABP=6	PNPLA6	intron	PNPLA6:ENST00000221249.6:intron_variant:MODIFIER:intron19/34:c.1953+59T>G::,PNPLA6:ENST00000414982.3:intron_variant:MODIFIER:intron18/33:c.2097+59T>G::,PNPLA6:ENST00000450331.3:intron_variant:MODIFIER:intron19/34:c.1953+59T>G::,PNPLA6:ENST00000545201.2:intron_variant:MODIFIER:intron18/33:c.1875+59T>G::,PNPLA6:ENST00000600737.1:intron_variant:MODIFIER:intron16/31:c.2070+59T>G::	PNPLA6:NM_001166111.2:intron_variant:MODIFIER:intron18/33:c.2097+59T>G::,PNPLA6:NM_001166112.1:intron_variant:MODIFIER:intron18/33:c.1875+59T>G::,PNPLA6:NM_001166113.1:intron_variant:MODIFIER:intron19/34:c.1953+59T>G::,PNPLA6:NM_001166114.2:intron_variant:MODIFIER:intron16/31:c.2070+59T>G::,PNPLA6:NM_006702.5:intron_variant:MODIFIER:intron19/34:c.1953+59T>G::		603197 [GENE=PNPLA6 PHENOS=Spastic paraplegia 39,autosomal recessive,612020,Autosomal recessive/Boucher-Neuhauser syndrome,215470,Autosomal recessive/Oliver-McFarlane syndrome,275400,Autosomal recessive/Laurence-Moon syndrome,245800,Autosomal recessive];				rs577219	0.6685	0.6693	7165,.		-1.9590			0.00,0.04	0.10					-0.2682	0.2275	0.1	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PNPLA6 (inh=AR oe_syn=1.01 oe_mis=0.59 oe_lof=0.48)
chr19	7616347	7616347	G	A	het	off-target	QUAL=1687;DP=156;AF=0.44;MQM=60;SAP=3;ABP=9	PNPLA6	intron	PNPLA6:ENST00000221249.6:intron_variant:MODIFIER:intron21/34:c.2143+24G>A::,PNPLA6:ENST00000414982.3:intron_variant:MODIFIER:intron20/33:c.2287+24G>A::,PNPLA6:ENST00000450331.3:intron_variant:MODIFIER:intron21/34:c.2143+24G>A::,PNPLA6:ENST00000545201.2:intron_variant:MODIFIER:intron20/33:c.2065+24G>A::,PNPLA6:ENST00000600737.1:intron_variant:MODIFIER:intron18/31:c.2260+24G>A::	PNPLA6:NM_001166111.2:intron_variant:MODIFIER:intron20/33:c.2287+24G>A::,PNPLA6:NM_001166112.1:intron_variant:MODIFIER:intron20/33:c.2065+24G>A::,PNPLA6:NM_001166113.1:intron_variant:MODIFIER:intron21/34:c.2143+24G>A::,PNPLA6:NM_001166114.2:intron_variant:MODIFIER:intron18/31:c.2260+24G>A::,PNPLA6:NM_006702.5:intron_variant:MODIFIER:intron21/34:c.2143+24G>A::	regulatory_region_variant:promoter,TF_binding_site_variant	603197 [GENE=PNPLA6 PHENOS=Spastic paraplegia 39,autosomal recessive,612020,Autosomal recessive/Boucher-Neuhauser syndrome,215470,Autosomal recessive/Oliver-McFarlane syndrome,275400,Autosomal recessive/Laurence-Moon syndrome,245800,Autosomal recessive];				rs473899		0.5598	4002,.	0.4312,0.7362,0.5582,0.5159,0.6534	0.0040			0.02,0.15	4.15					0.0404	0.0887	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PNPLA6 (inh=AR oe_syn=1.01 oe_mis=0.59 oe_lof=0.48)
chr19	7619199	7619199	C	G	het	off-target	QUAL=1157;DP=79;AF=0.58;MQM=60;SAP=3;ABP=8	PNPLA6	intron	PNPLA6:ENST00000221249.6:intron_variant:MODIFIER:intron23/34:c.2351+41C>G::,PNPLA6:ENST00000414982.3:intron_variant:MODIFIER:intron22/33:c.2495+41C>G::,PNPLA6:ENST00000450331.3:intron_variant:MODIFIER:intron23/34:c.2351+41C>G::,PNPLA6:ENST00000545201.2:intron_variant:MODIFIER:intron22/33:c.2270+41C>G::,PNPLA6:ENST00000600737.1:intron_variant:MODIFIER:intron20/31:c.2465+41C>G::	PNPLA6:NM_001166111.2:intron_variant:MODIFIER:intron22/33:c.2495+41C>G::,PNPLA6:NM_001166112.1:intron_variant:MODIFIER:intron22/33:c.2270+41C>G::,PNPLA6:NM_001166113.1:intron_variant:MODIFIER:intron23/34:c.2351+41C>G::,PNPLA6:NM_001166114.2:intron_variant:MODIFIER:intron20/31:c.2465+41C>G::,PNPLA6:NM_006702.5:intron_variant:MODIFIER:intron23/34:c.2351+41C>G::		603197 [GENE=PNPLA6 PHENOS=Spastic paraplegia 39,autosomal recessive,612020,Autosomal recessive/Boucher-Neuhauser syndrome,215470,Autosomal recessive/Oliver-McFarlane syndrome,275400,Autosomal recessive/Laurence-Moon syndrome,245800,Autosomal recessive];				rs534464	0.7534	0.7911	8810,.	0.6912,0.8833,0.5903,0.7934,0.8497	0.4350			0.04,0.17	6.86					0.118	0.5335	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PNPLA6 (inh=AR oe_syn=1.01 oe_mis=0.59 oe_lof=0.48)
chr19	7619647	7619647	G	C	het	off-target	QUAL=1068;DP=91;AF=0.53;MQM=60;SAP=3;ABP=4	PNPLA6	intron	PNPLA6:ENST00000221249.6:intron_variant:MODIFIER:intron24/34:c.2520+38G>C::,PNPLA6:ENST00000414982.3:intron_variant:MODIFIER:intron23/33:c.2664+38G>C::,PNPLA6:ENST00000450331.3:intron_variant:MODIFIER:intron24/34:c.2520+38G>C::,PNPLA6:ENST00000545201.2:intron_variant:MODIFIER:intron23/33:c.2439+38G>C::,PNPLA6:ENST00000600737.1:intron_variant:MODIFIER:intron21/31:c.2634+38G>C::	PNPLA6:NM_001166111.2:intron_variant:MODIFIER:intron23/33:c.2664+38G>C::,PNPLA6:NM_001166112.1:intron_variant:MODIFIER:intron23/33:c.2439+38G>C::,PNPLA6:NM_001166113.1:intron_variant:MODIFIER:intron24/34:c.2520+38G>C::,PNPLA6:NM_001166114.2:intron_variant:MODIFIER:intron21/31:c.2634+38G>C::,PNPLA6:NM_006702.5:intron_variant:MODIFIER:intron24/34:c.2520+38G>C::		603197 [GENE=PNPLA6 PHENOS=Spastic paraplegia 39,autosomal recessive,612020,Autosomal recessive/Boucher-Neuhauser syndrome,215470,Autosomal recessive/Oliver-McFarlane syndrome,275400,Autosomal recessive/Laurence-Moon syndrome,245800,Autosomal recessive];				rs599328		0.7896	8761,.	0.6881,0.8814,0.5854,0.7901,0.8485	-0.7050			0.03,0.16	3.22					-0.1367	0.4831	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PNPLA6 (inh=AR oe_syn=1.01 oe_mis=0.59 oe_lof=0.48)
chr19	7619648	7619648	T	C	het	off-target	QUAL=1068;DP=91;AF=0.53;MQM=60;SAP=3;ABP=4	PNPLA6	intron	PNPLA6:ENST00000221249.6:intron_variant:MODIFIER:intron24/34:c.2520+39T>C::,PNPLA6:ENST00000414982.3:intron_variant:MODIFIER:intron23/33:c.2664+39T>C::,PNPLA6:ENST00000450331.3:intron_variant:MODIFIER:intron24/34:c.2520+39T>C::,PNPLA6:ENST00000545201.2:intron_variant:MODIFIER:intron23/33:c.2439+39T>C::,PNPLA6:ENST00000600737.1:intron_variant:MODIFIER:intron21/31:c.2634+39T>C::	PNPLA6:NM_001166111.2:intron_variant:MODIFIER:intron23/33:c.2664+39T>C::,PNPLA6:NM_001166112.1:intron_variant:MODIFIER:intron23/33:c.2439+39T>C::,PNPLA6:NM_001166113.1:intron_variant:MODIFIER:intron24/34:c.2520+39T>C::,PNPLA6:NM_001166114.2:intron_variant:MODIFIER:intron21/31:c.2634+39T>C::,PNPLA6:NM_006702.5:intron_variant:MODIFIER:intron24/34:c.2520+39T>C::		603197 [GENE=PNPLA6 PHENOS=Spastic paraplegia 39,autosomal recessive,612020,Autosomal recessive/Boucher-Neuhauser syndrome,215470,Autosomal recessive/Oliver-McFarlane syndrome,275400,Autosomal recessive/Laurence-Moon syndrome,245800,Autosomal recessive];				rs599330	0.7536	0.7899	8763,.	0.6892,0.8812,0.5855,0.7903,0.8486	-3.1760			0.00,0.09	3.84					-0.0288	0.482	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PNPLA6 (inh=AR oe_syn=1.01 oe_mis=0.59 oe_lof=0.48)
chr19	7621648	7621648	C	T	het	off-target	QUAL=2298;DP=175;AF=0.54;MQM=60;SAP=3;ABP=5	PNPLA6	intron	PNPLA6:ENST00000221249.6:intron_variant:MODIFIER:intron29/34:c.3166+38C>T::,PNPLA6:ENST00000414982.3:intron_variant:MODIFIER:intron28/33:c.3310+38C>T::,PNPLA6:ENST00000450331.3:intron_variant:MODIFIER:intron29/34:c.3166+38C>T::,PNPLA6:ENST00000545201.2:intron_variant:MODIFIER:intron28/33:c.3085+38C>T::,PNPLA6:ENST00000600737.1:intron_variant:MODIFIER:intron26/31:c.3280+38C>T::	PNPLA6:NM_001166111.2:intron_variant:MODIFIER:intron28/33:c.3310+38C>T::,PNPLA6:NM_001166112.1:intron_variant:MODIFIER:intron28/33:c.3085+38C>T::,PNPLA6:NM_001166113.1:intron_variant:MODIFIER:intron29/34:c.3166+38C>T::,PNPLA6:NM_001166114.2:intron_variant:MODIFIER:intron26/31:c.3280+38C>T::,PNPLA6:NM_006702.5:intron_variant:MODIFIER:intron29/34:c.3166+38C>T::		603197 [GENE=PNPLA6 PHENOS=Spastic paraplegia 39,autosomal recessive,612020,Autosomal recessive/Boucher-Neuhauser syndrome,215470,Autosomal recessive/Oliver-McFarlane syndrome,275400,Autosomal recessive/Laurence-Moon syndrome,245800,Autosomal recessive];				rs489056	0.3796	0.5116	3901,.	0.2896,0.4671,0.1878,0.5910,0.5337	0.0510			0.07,0.18	7.50					0.0927	0.2455	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PNPLA6 (inh=AR oe_syn=1.01 oe_mis=0.59 oe_lof=0.48)
chr19	7622226	7622226	G	A	het	off-target	QUAL=1278;DP=83;AF=0.65;MQM=60;SAP=3;ABP=19	PNPLA6	intron	PNPLA6:ENST00000221249.6:intron_variant:MODIFIER:intron30/34:c.3283+56G>A::,PNPLA6:ENST00000414982.3:intron_variant:MODIFIER:intron29/33:c.3427+56G>A::,PNPLA6:ENST00000450331.3:intron_variant:MODIFIER:intron30/34:c.3283+56G>A::,PNPLA6:ENST00000545201.2:intron_variant:MODIFIER:intron29/33:c.3202+56G>A::,PNPLA6:ENST00000600737.1:intron_variant:MODIFIER:intron27/31:c.3397+56G>A::	PNPLA6:NM_001166111.2:intron_variant:MODIFIER:intron29/33:c.3427+56G>A::,PNPLA6:NM_001166112.1:intron_variant:MODIFIER:intron29/33:c.3202+56G>A::,PNPLA6:NM_001166113.1:intron_variant:MODIFIER:intron30/34:c.3283+56G>A::,PNPLA6:NM_001166114.2:intron_variant:MODIFIER:intron27/31:c.3397+56G>A::,PNPLA6:NM_006702.5:intron_variant:MODIFIER:intron30/34:c.3283+56G>A::		603197 [GENE=PNPLA6 PHENOS=Spastic paraplegia 39,autosomal recessive,612020,Autosomal recessive/Boucher-Neuhauser syndrome,215470,Autosomal recessive/Oliver-McFarlane syndrome,275400,Autosomal recessive/Laurence-Moon syndrome,245800,Autosomal recessive];			(CACGCA)n (Simple_repeat)	rs1645800	0.5333	0.5599	4958,.		-0.3260			0.08,0.11	5.63					0.1439	0.9172	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PNPLA6 (inh=AR oe_syn=1.01 oe_mis=0.59 oe_lof=0.48)
chr19	7623700	7623700	G	A	het	off-target	QUAL=1265;DP=101;AF=0.53;MQM=60;SAP=4;ABP=4	PNPLA6	intron	PNPLA6:ENST00000221249.6:intron_variant:MODIFIER:intron30/34:c.3284-36G>A::,PNPLA6:ENST00000414982.3:intron_variant:MODIFIER:intron29/33:c.3428-36G>A::,PNPLA6:ENST00000450331.3:intron_variant:MODIFIER:intron30/34:c.3284-36G>A::,PNPLA6:ENST00000545201.2:intron_variant:MODIFIER:intron29/33:c.3203-36G>A::,PNPLA6:ENST00000600737.1:intron_variant:MODIFIER:intron27/31:c.3398-36G>A::	PNPLA6:NM_001166111.2:intron_variant:MODIFIER:intron29/33:c.3428-36G>A::,PNPLA6:NM_001166112.1:intron_variant:MODIFIER:intron29/33:c.3203-36G>A::,PNPLA6:NM_001166113.1:intron_variant:MODIFIER:intron30/34:c.3284-36G>A::,PNPLA6:NM_001166114.2:intron_variant:MODIFIER:intron27/31:c.3398-36G>A::,PNPLA6:NM_006702.5:intron_variant:MODIFIER:intron30/34:c.3284-36G>A::		603197 [GENE=PNPLA6 PHENOS=Spastic paraplegia 39,autosomal recessive,612020,Autosomal recessive/Boucher-Neuhauser syndrome,215470,Autosomal recessive/Oliver-McFarlane syndrome,275400,Autosomal recessive/Laurence-Moon syndrome,245800,Autosomal recessive];				rs535208		0.5952	5091,.	0.5433,0.6950,0.3365,0.6005,0.6358	-0.1320			0.07,0.15	6.66					-0.2961	0.3292	0.39	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PNPLA6 (inh=AR oe_syn=1.01 oe_mis=0.59 oe_lof=0.48)
chr19	7624078	7624078	C	T	het	off-target	QUAL=2254;DP=155;AF=0.57;MQM=60;SAP=18;ABP=10	PNPLA6	intron	PNPLA6:ENST00000221249.6:intron_variant:MODIFIER:intron31/34:c.3585+41C>T::,PNPLA6:ENST00000414982.3:intron_variant:MODIFIER:intron30/33:c.3729+41C>T::,PNPLA6:ENST00000450331.3:intron_variant:MODIFIER:intron31/34:c.3585+41C>T::,PNPLA6:ENST00000545201.2:intron_variant:MODIFIER:intron30/33:c.3504+41C>T::,PNPLA6:ENST00000600737.1:intron_variant:MODIFIER:intron28/31:c.3699+41C>T::	PNPLA6:NM_001166111.2:intron_variant:MODIFIER:intron30/33:c.3729+41C>T::,PNPLA6:NM_001166112.1:intron_variant:MODIFIER:intron30/33:c.3504+41C>T::,PNPLA6:NM_001166113.1:intron_variant:MODIFIER:intron31/34:c.3585+41C>T::,PNPLA6:NM_001166114.2:intron_variant:MODIFIER:intron28/31:c.3699+41C>T::,PNPLA6:NM_006702.5:intron_variant:MODIFIER:intron31/34:c.3585+41C>T::		603197 [GENE=PNPLA6 PHENOS=Spastic paraplegia 39,autosomal recessive,612020,Autosomal recessive/Boucher-Neuhauser syndrome,215470,Autosomal recessive/Oliver-McFarlane syndrome,275400,Autosomal recessive/Laurence-Moon syndrome,245800,Autosomal recessive];				rs538850	0.4127	0.4671	2771,.	0.2946,0.6022,0.3334,0.4542,0.5463	-3.6100			0.00,0.07	0.32					0.1209	0.2892	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PNPLA6 (inh=AR oe_syn=1.01 oe_mis=0.59 oe_lof=0.48)
chr19	7625864	7625864	-	C	het	off-target	QUAL=559;DP=57;AF=0.46;MQM=60;SAP=3;ABP=4	PNPLA6	intron	PNPLA6:ENST00000221249.6:intron_variant:MODIFIER:intron32/34:c.3703-29dup::,PNPLA6:ENST00000414982.3:intron_variant:MODIFIER:intron31/33:c.3847-29dup::,PNPLA6:ENST00000450331.3:intron_variant:MODIFIER:intron32/34:c.3703-29dup::,PNPLA6:ENST00000545201.2:intron_variant:MODIFIER:intron31/33:c.3622-29dup::,PNPLA6:ENST00000600737.1:intron_variant:MODIFIER:intron29/31:c.3817-29dup::	PNPLA6:NM_001166111.2:intron_variant:MODIFIER:intron31/33:c.3847-29dup::,PNPLA6:NM_001166112.1:intron_variant:MODIFIER:intron31/33:c.3622-29dup::,PNPLA6:NM_001166113.1:intron_variant:MODIFIER:intron32/34:c.3703-29dup::,PNPLA6:NM_001166114.2:intron_variant:MODIFIER:intron29/31:c.3817-29dup::,PNPLA6:NM_006702.5:intron_variant:MODIFIER:intron32/34:c.3703-29dup::		603197 [GENE=PNPLA6 PHENOS=Spastic paraplegia 39,autosomal recessive,612020,Autosomal recessive/Boucher-Neuhauser syndrome,215470,Autosomal recessive/Oliver-McFarlane syndrome,275400,Autosomal recessive/Laurence-Moon syndrome,245800,Autosomal recessive];				rs35902090		0.1905	687,.	0.0781,0.1067,0.3981,0.2035,0.1488					0.32					0.1957	0.0278	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PNPLA6 (inh=AR oe_syn=1.01 oe_mis=0.59 oe_lof=0.48)
chr19	7626669	7626669	G	A	het	off-target	QUAL=1626;DP=130;AF=0.51;MQM=60;SAP=25;ABP=3	PNPLA6	downstream_gene	PNPLA6:ENST00000221249.6:downstream_gene_variant:MODIFIER::::,PNPLA6:ENST00000414982.3:downstream_gene_variant:MODIFIER::::,PNPLA6:ENST00000450331.3:downstream_gene_variant:MODIFIER::::,PNPLA6:ENST00000545201.2:downstream_gene_variant:MODIFIER::::,PNPLA6:ENST00000600737.1:downstream_gene_variant:MODIFIER::::			603197 [GENE=PNPLA6 PHENOS=Spastic paraplegia 39,autosomal recessive,612020,Autosomal recessive/Boucher-Neuhauser syndrome,215470,Autosomal recessive/Oliver-McFarlane syndrome,275400,Autosomal recessive/Laurence-Moon syndrome,245800,Autosomal recessive];				rs2303178	0.3073	0.3518	1958,.		1.1540			0.38,0.77	9.22								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PNPLA6 (inh=AR oe_syn=1.01 oe_mis=0.59 oe_lof=0.48)
chr19	30193721	30193721	G	A	het		QUAL=129;DP=12;AF=0.67;MQM=60;SAP=20;ABP=6	C19orf12	synonymous,intron	C19orf12:ENST00000323670.9:synonymous_variant:LOW:exon3/3:c.324C>T:p.Thr108=:,C19orf12:ENST00000392276.1:synonymous_variant:LOW:exon2/2:c.132C>T:p.Thr44=:,C19orf12:ENST00000392278.2:synonymous_variant:LOW:exon3/3:c.357C>T:p.Thr119=:,C19orf12:ENST00000592153.1:intron_variant:MODIFIER:intron3/3:c.291-22C>T::	C19orf12:NM_001031726.3:synonymous_variant:LOW:exon3/3:c.357C>T:p.Thr119=:,C19orf12:NM_001256046.2:intron_variant:MODIFIER:intron3/3:c.291-22C>T::,C19orf12:NM_001256047.1:synonymous_variant:LOW:exon3/3:c.324C>T:p.Thr108=:,C19orf12:NM_001282929.1:synonymous_variant:LOW:exon2/2:c.132C>T:p.Thr44=:,C19orf12:NM_001282930.2:synonymous_variant:LOW:exon2/2:c.132C>T:p.Thr44=:,C19orf12:NM_001282931.2:synonymous_variant:LOW:exon4/4:c.132C>T:p.Thr44=:,C19orf12:NM_031448.5:synonymous_variant:LOW:exon3/3:c.324C>T:p.Thr108=:	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	614297 [GENE=C19ORF12 PHENOS=Neurodegeneration with brain iron accumulation 4,614298,Autosomal recessive,Autosomal dominant/Spastic paraplegia 43,autosomal recessive,615043,Autosomal recessive];	128537 [benign DISEASE=Neurodegeneration with brain iron accumulation 4,not specified];			rs10424582		0.7176	8196,.	0.7766,0.4518,0.3019,0.7516,0.6448	0.1170			0.04,0.21	1.18					-0.2421	0.9596	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C19ORF12 (inh=AR oe_syn=1.15 oe_mis=0.89 oe_lof=0.22)
chr19	30196310	30196314	AAAAA	-	het	low_conf_region	QUAL=88;DP=10;AF=0.30;MQM=60;SAP=4;ABP=6	C19orf12	intron	C19orf12:ENST00000323670.9:intron_variant:MODIFIER:intron2/2:c.161-2430_161-2426del::,C19orf12:ENST00000392276.1:intron_variant:MODIFIER:intron1/1:c.-32-2430_-32-2426del::,C19orf12:ENST00000392278.2:intron_variant:MODIFIER:intron2/2:c.194-2430_194-2426del::,C19orf12:ENST00000592153.1:intron_variant:MODIFIER:intron2/3:c.161-2430_161-2426del::	C19orf12:NM_001031726.3:intron_variant:MODIFIER:intron2/2:c.194-2430_194-2426del::,C19orf12:NM_001256046.2:intron_variant:MODIFIER:intron2/3:c.161-2430_161-2426del::,C19orf12:NM_001256047.1:intron_variant:MODIFIER:intron2/2:c.161-2430_161-2426del::,C19orf12:NM_001282929.1:intron_variant:MODIFIER:intron1/1:c.-32-2430_-32-2426del::,C19orf12:NM_001282930.2:intron_variant:MODIFIER:intron1/1:c.-32-2430_-32-2426del::,C19orf12:NM_001282931.2:intron_variant:MODIFIER:intron2/3:c.-153-13_-153-9del::,C19orf12:NM_031448.5:intron_variant:MODIFIER:intron2/2:c.161-2430_161-2426del::		614297 [GENE=C19ORF12 PHENOS=Neurodegeneration with brain iron accumulation 4,614298,Autosomal recessive,Autosomal dominant/Spastic paraplegia 43,autosomal recessive,615043,Autosomal recessive];			L1MD3 (LINE/L1)	rs34101444					1.5250				1.22					0.1793	0.0917	0.01	11	9	11 / 4	2	"VUS2 best., MR, 24.10.2016%0A[2] ahrautm1 16.12.2015%0A[n/a] comment imported from detected variant: VUS2, MR, 16.12.2015"			C19ORF12 (inh=AR oe_syn=1.15 oe_mis=0.89 oe_lof=0.22)
chr19	30196310	30196316	AAAAAAA	-	het	low_conf_region	QUAL=88;DP=10;AF=0.20;MQM=60;SAP=3;ABP=11	C19orf12	intron	C19orf12:ENST00000323670.9:intron_variant:MODIFIER:intron2/2:c.161-2432_161-2426del::,C19orf12:ENST00000392276.1:intron_variant:MODIFIER:intron1/1:c.-32-2432_-32-2426del::,C19orf12:ENST00000392278.2:intron_variant:MODIFIER:intron2/2:c.194-2432_194-2426del::,C19orf12:ENST00000592153.1:intron_variant:MODIFIER:intron2/3:c.161-2432_161-2426del::	C19orf12:NM_001031726.3:intron_variant:MODIFIER:intron2/2:c.194-2432_194-2426del::,C19orf12:NM_001256046.2:intron_variant:MODIFIER:intron2/3:c.161-2432_161-2426del::,C19orf12:NM_001256047.1:intron_variant:MODIFIER:intron2/2:c.161-2432_161-2426del::,C19orf12:NM_001282929.1:intron_variant:MODIFIER:intron1/1:c.-32-2432_-32-2426del::,C19orf12:NM_001282930.2:intron_variant:MODIFIER:intron1/1:c.-32-2432_-32-2426del::,C19orf12:NM_001282931.2:intron_variant:MODIFIER:intron2/3:c.-153-15_-153-9del::,C19orf12:NM_031448.5:intron_variant:MODIFIER:intron2/2:c.161-2432_161-2426del::		614297 [GENE=C19ORF12 PHENOS=Neurodegeneration with brain iron accumulation 4,614298,Autosomal recessive,Autosomal dominant/Spastic paraplegia 43,autosomal recessive,615043,Autosomal recessive];			L1MD3 (LINE/L1)	rs34101444					1.5250									0.0219	0.1233	0.01	0	1	0 / 0					C19ORF12 (inh=AR oe_syn=1.15 oe_mis=0.89 oe_lof=0.22)
chr19	45992544	45992544	G	A	het	off-target	QUAL=911;DP=62;AF=0.58;MQM=60;SAP=38;ABP=7	RTN2,PPM1N	intron	RTN2:ENST00000245923.4:intron_variant:MODIFIER:intron6/10:c.1241+60C>T::,RTN2:ENST00000344680.4:intron_variant:MODIFIER:intron5/9:c.1022+60C>T::,PPM1N:ENST00000401705.1:intron_variant:MODIFIER:intron1/4:c.-16+307G>A::,RTN2:ENST00000430715.2:intron_variant:MODIFIER:intron2/6:c.221+60C>T::,RTN2:ENST00000590526.1:intron_variant:MODIFIER:intron6/10:c.419+60C>T::	RTN2:NM_005619.5:intron_variant:MODIFIER:intron6/10:c.1241+60C>T::,RTN2:NM_206900.3:intron_variant:MODIFIER:intron5/9:c.1022+60C>T::,RTN2:NM_206901.3:intron_variant:MODIFIER:intron2/6:c.221+60C>T::		603183 [GENE=RTN2 PHENOS=Spastic paraplegia 12,autosomal dominant,604805,Autosomal dominant];	677524 [benign DISEASE=not provided];		G-rich (Low_complexity)	rs45548637	0.1270	0.1020	175,.		0.0820			0.10,0.17	4.89					0.1726	0.4497	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RTN2 (inh=AD oe_syn=0.93 oe_mis=0.89 oe_lof=0.22), PPM1N (inh=n/a oe_syn=0.85 oe_mis=0.76 oe_lof=0.82)
chr19	45998247	45998247	A	G	het		QUAL=2145;DP=165;AF=0.48;MQM=60;SAP=3;ABP=3	RTN2,PPM1N	synonymous,intron,5'UTR	RTN2:ENST00000245923.4:synonymous_variant:LOW:exon3/11:c.96T>C:p.Ser32=:,RTN2:ENST00000344680.4:synonymous_variant:LOW:exon3/10:c.96T>C:p.Ser32=:,PPM1N:ENST00000401705.1:intron_variant:MODIFIER:intron1/4:c.-15-4960A>G::,RTN2:ENST00000590526.1:5_prime_UTR_variant:MODIFIER:exon3/11:c.-727T>C::	RTN2:NM_005619.5:synonymous_variant:LOW:exon3/11:c.96T>C:p.Ser32=:,RTN2:NM_206900.3:synonymous_variant:LOW:exon3/10:c.96T>C:p.Ser32=:		603183 [GENE=RTN2 PHENOS=Spastic paraplegia 12,autosomal dominant,604805,Autosomal dominant];	130163 [benign DISEASE=not specified];			rs10401270	0.1528	0.1310	250,.	0.1419,0.1779,0.2066,0.1032,0.1556	-7.0790			0.01,0.07	0.16					0.0353	0.8836	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RTN2 (inh=AD oe_syn=0.93 oe_mis=0.89 oe_lof=0.22), PPM1N (inh=n/a oe_syn=0.85 oe_mis=0.76 oe_lof=0.82)
chr19	46032736	46032737	AG	-	het	off-target	QUAL=734;DP=96;AF=0.40;MQM=60;SAP=5;ABP=12	OPA3	intron	OPA3:ENST00000323060.3:intron_variant:MODIFIER:intron1/1:c.143-23_143-22del::	OPA3:NM_001017989.3:intron_variant:MODIFIER:intron1/1:c.143-23_143-22del::	regulatory_region_variant:CTCF_binding_site	606580 [GENE=OPA3 PHENOS=3-methylglutaconic aciduria,type III,258501,Autosomal recessive/Optic atrophy 3 with cataract,165300,Autosomal dominant];				rs149252540	0.1480	0.1395	253,.	0.1301,0.0803,0.1308,0.1350,0.2415	4.1900				10.88					-0.7636	0.9872		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					VASP (inh=n/a oe_syn=1.05 oe_mis=0.78 oe_lof=0.13), OPA3 (inh=AR+AD oe_syn=0.98 oe_mis=0.99 oe_lof=0.00)
chr19	46057081	46057081	A	G	hom		QUAL=2335;DP=77;AF=1.00;MQM=60;SAP=6;ABP=0	OPA3	synonymous,intron	OPA3:ENST00000263275.4:synonymous_variant:LOW:exon2/2:c.231T>C:p.Ala77=:PF07047 [Optic atrophy 3 protein (OPA3)],OPA3:ENST00000323060.3:intron_variant:MODIFIER:intron1/1:c.143-24367T>C::,OPA3:ENST00000544371.1:synonymous_variant:LOW:exon2/2:c.72T>C:p.Ala24=:PF07047 [Optic atrophy 3 protein (OPA3)]	OPA3:NM_001017989.3:intron_variant:MODIFIER:intron1/1:c.143-24367T>C::,OPA3:NM_025136.4:synonymous_variant:LOW:exon2/2:c.231T>C:p.Ala77=:	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	606580 [GENE=OPA3 PHENOS=3-methylglutaconic aciduria,type III,258501,Autosomal recessive/Optic atrophy 3 with cataract,165300,Autosomal dominant];	21709 [benign DISEASE=Optic atrophy 3,3-Methylglutaconic aciduria type 3,not specified,not provided];			rs3826860	0.7670	0.7096	7940,.	0.7753,0.8304,0.8748,0.6490,0.6788	-0.9240			0.09,0.69	15.76					0.0079	0.8914	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					OPA3 (inh=AR+AD oe_syn=0.98 oe_mis=0.99 oe_lof=0.00)
chr20	1961134	1961134	A	G	het		QUAL=850;DP=102;AF=0.38;MQM=60;SAP=38;ABP=15	PDYN,RP4-684O24.5	synonymous,intron&non_coding_transcript	PDYN:ENST00000217305.2:synonymous_variant:LOW:exon4/4:c.600T>C:p.His200=:,RP4-684O24.5:ENST00000446562.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/3:n.1216+14145A>G::,PDYN:ENST00000539905.1:synonymous_variant:LOW:exon3/3:c.600T>C:p.His200=:,PDYN:ENST00000540134.1:synonymous_variant:LOW:exon4/4:c.600T>C:p.His200=:	PDYN:NM_001190892.1:synonymous_variant:LOW:exon3/3:c.600T>C:p.His200=:,PDYN:NM_001190898.3:synonymous_variant:LOW:exon4/4:c.600T>C:p.His200=:,PDYN:NM_001190899.2:synonymous_variant:LOW:exon3/3:c.600T>C:p.His200=:,PDYN:NM_001190900.1:synonymous_variant:LOW:exon4/4:c.600T>C:p.His200=:,PDYN:NM_024411.5:synonymous_variant:LOW:exon4/4:c.600T>C:p.His200=:,LOC727993:NR_134520.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/3:n.1252+14145A>G::		131340 [GENE=PDYN PHENOS=Spinocerebellar ataxia 23,610245,Autosomal dominant];	337834 [benign DISEASE=Spinocerebellar ataxia type 23];			rs6045819	0.1302	0.1472	487,.	0.2848,0.0784,0.0002,0.1193,0.0661	-1.7530			0.03,0.83	0.22					0.0028	0.9299	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PDYN (inh=AD oe_syn=1.10 oe_mis=1.12 oe_lof=0.88)
chr20	1961159	1961159	T	A	het		QUAL=563;DP=88;AF=0.35;MQM=60;SAP=15;ABP=20	PDYN,RP4-684O24.5	missense,intron&non_coding_transcript	PDYN:ENST00000217305.2:missense_variant:MODERATE:exon4/4:c.575A>T:p.Glu192Val:,RP4-684O24.5:ENST00000446562.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/3:n.1216+14170T>A::,PDYN:ENST00000539905.1:missense_variant:MODERATE:exon3/3:c.575A>T:p.Glu192Val:,PDYN:ENST00000540134.1:missense_variant:MODERATE:exon4/4:c.575A>T:p.Glu192Val:	PDYN:NM_001190892.1:missense_variant:MODERATE:exon3/3:c.575A>T:p.Glu192Val:,PDYN:NM_001190898.3:missense_variant:MODERATE:exon4/4:c.575A>T:p.Glu192Val:,PDYN:NM_001190899.2:missense_variant:MODERATE:exon3/3:c.575A>T:p.Glu192Val:,PDYN:NM_001190900.1:missense_variant:MODERATE:exon4/4:c.575A>T:p.Glu192Val:,PDYN:NM_024411.5:missense_variant:MODERATE:exon4/4:c.575A>T:p.Glu192Val:,LOC727993:NR_134520.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/3:n.1252+14170T>A::		131340 [GENE=PDYN PHENOS=Spinocerebellar ataxia 23,610245,Autosomal dominant];	337835 [benign/likely benign DISEASE=Spinocerebellar ataxia type 23,not provided];			rs45469293	0.0026	0.0096	4,.	0.0011,0.0031,0.0000,0.0107,0.0007	2.6480	D(0.03), ,D(0.03),D(0.03)	B(0.08), ,B(0.08),B(0.08)	0.84,0.98	22.50	0.21				-0.0067	0.9298	0	2	221	1 / 79	1	"VUS1, MR, 13.02.2017%0A[1] ahrautm1 13.02.2017"			PDYN (inh=AD oe_syn=1.10 oe_mis=1.12 oe_lof=0.88)
chr20	2375262	2375262	A	G	het		QUAL=899;DP=76;AF=0.54;MQM=60;SAP=68;ABP=4	TGM6	missense	TGM6:ENST00000202625.2:missense_variant:MODERATE:exon2/13:c.172A>G:p.Met58Val:PF00868 [Transglutaminase family],TGM6:ENST00000381423.1:missense_variant:MODERATE:exon2/12:c.172A>G:p.Met58Val:PF00868 [Transglutaminase family]	TGM6:NM_001254734.2:missense_variant:MODERATE:exon2/12:c.172A>G:p.Met58Val:,TGM6:NM_198994.3:missense_variant:MODERATE:exon2/13:c.172A>G:p.Met58Val:		613900 [GENE=TGM6 PHENOS=Spinocerebellar ataxia 35,613908,Autosomal dominant];	130585 [benign DISEASE=Spinocerebellar ataxia 35,not specified,not provided];			rs2076405	0.8780	0.9240	13446,.	0.9559,0.9433,0.6721,0.9311,0.8763	2.2530	T(1.00),T(1.00)	B(0.00),B(0.00)	0.00,0.89	10.28	0.14				-0.0805	0.192	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TGM6 (inh=AD oe_syn=1.03 oe_mis=1.11 oe_lof=1.03)
chr20	2380396	2380396	G	A	hom	off-target	QUAL=520;DP=20;AF=1.00;MQM=60;SAP=46;ABP=0	TGM6	intron	TGM6:ENST00000202625.2:intron_variant:MODIFIER:intron6/12:c.850+12G>A::,TGM6:ENST00000381423.1:intron_variant:MODIFIER:intron6/11:c.850+12G>A::	TGM6:NM_001254734.2:intron_variant:MODIFIER:intron6/11:c.850+12G>A::,TGM6:NM_198994.3:intron_variant:MODIFIER:intron6/12:c.850+12G>A::		613900 [GENE=TGM6 PHENOS=Spinocerebellar ataxia 35,613908,Autosomal dominant];	337914 [benign DISEASE=Spinocerebellar ataxia 35];			rs2076404		0.6573	6388,.	0.4174,0.6081,0.6598,0.7086,0.6241	0.0020			0.01,0.23	13.55					-0.1717	0.3623	0.03	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TGM6 (inh=AD oe_syn=1.03 oe_mis=1.11 oe_lof=1.03)
chr20	2413125	2413125	C	T	het	off-target	QUAL=3766;DP=131;AF=0.47;MQM=60;SAP=4;ABP=4	TGM6	intron	TGM6:ENST00000202625.2:intron_variant:MODIFIER:intron12/12:c.1968-11C>T::,TGM6:ENST00000381423.1:intron_variant:MODIFIER:intron11/11:c.1834-11C>T::	TGM6:NM_001254734.2:intron_variant:MODIFIER:intron11/11:c.1834-11C>T::,TGM6:NM_198994.3:intron_variant:MODIFIER:intron12/12:c.1968-11C>T::		613900 [GENE=TGM6 PHENOS=Spinocerebellar ataxia 35,613908,Autosomal dominant];	337938 [benign DISEASE=Spinocerebellar ataxia 35];			rs2076653	0.5132	0.4401	3266,.	0.6365,0.4312,0.5155,0.3497,0.4940	-1.9280			0.01,0.10	0.29		10.64>10.77	0.000/0.000		0.398	0.5362	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TGM6 (inh=AD oe_syn=1.03 oe_mis=1.11 oe_lof=1.03)
chr20	2413126	2413126	C	T	hom		QUAL=3766;DP=131;AF=0.47;MQM=60;SAP=3;ABP=4	TGM6	intron	TGM6:ENST00000202625.2:intron_variant:MODIFIER:intron12/12:c.1968-10C>T::,TGM6:ENST00000381423.1:intron_variant:MODIFIER:intron11/11:c.1834-10C>T::	TGM6:NM_001254734.2:intron_variant:MODIFIER:intron11/11:c.1834-10C>T::,TGM6:NM_198994.3:intron_variant:MODIFIER:intron12/12:c.1968-10C>T::		613900 [GENE=TGM6 PHENOS=Spinocerebellar ataxia 35,613908,Autosomal dominant];	337939 [benign DISEASE=Spinocerebellar ataxia 35,not provided];			rs6036467	0.9958	0.9874	15290,.	0.9974,0.9962,0.9999,0.9795,0.9962	-0.3990			0.00,0.09	2.86		10.64>10.78	0.000/0.000		0.2232	0.7395	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TGM6 (inh=AD oe_syn=1.03 oe_mis=1.11 oe_lof=1.03)
chr20	2413320	2413320	T	C	het	off-target	QUAL=203;DP=20;AF=0.60;MQM=60;SAP=29;ABP=5	TGM6	3'UTR	TGM6:ENST00000202625.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*31T>C::,TGM6:ENST00000381423.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*140T>C::	TGM6:NM_001254734.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*140T>C::,TGM6:NM_198994.3:3_prime_UTR_variant:MODIFIER:exon13/13:c.*31T>C::		613900 [GENE=TGM6 PHENOS=Spinocerebellar ataxia 35,613908,Autosomal dominant];	337941 [benign DISEASE=Spinocerebellar ataxia 35];			rs2076652	0.5132	0.4398	3250,.	0.6368,0.4312,0.5159,0.3497,0.4942	-3.3240			0.01,0.11	0.11					0.134	0.9005	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TGM6 (inh=AD oe_syn=1.03 oe_mis=1.11 oe_lof=1.03)
chr20	3870124	3870124	G	C	hom	low_conf_region	QUAL=6806;DP=236;AF=1.00;MQM=60;SAP=3;ABP=0	PANK2	missense,intron	PANK2:ENST00000316562.4:missense_variant:MODERATE:exon1/7:c.377G>C:p.Gly126Ala:,PANK2:ENST00000497424.1:intron_variant:MODIFIER:intron1/6:c.-246+573G>C::,PANK2:ENST00000610179.1:missense_variant:MODERATE:exon1/7:c.8G>C:p.Gly3Ala:	PANK2:NM_001324191.2:5_prime_UTR_variant:MODIFIER:exon1/8:c.-665G>C::,PANK2:NM_001324192.1:missense_variant:MODERATE:exon1/2:c.377G>C:p.Gly126Ala:,PANK2:NM_024960.6:intron_variant:MODIFIER:intron1/6:c.-246+573G>C::,PANK2:NM_153638.3:missense_variant:MODERATE:exon1/7:c.377G>C:p.Gly126Ala:,PANK2:NR_136715.2:non_coding_transcript_exon_variant:MODIFIER:exon1/7:n.91G>C::	regulatory_region_variant:promoter	606157 [GENE=PANK2 PHENOS=HARP syndrome,607236,Autosomal recessive/Neurodegeneration with brain iron accumulation 1,234200,Autosomal recessive];	96526 [benign DISEASE=Pigmentary pallidal degeneration,not specified,not provided];			rs3737084		0.8965	12648,.	0.9830,0.9319,0.8025,0.8754,0.7596	1.0190	T(1.00), ,T(1.00)	B(0.00), ,B(0.00)	0.03,0.98	20.30	0.27				0.2378	0.1295	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PANK2 (inh=AR oe_syn=1.26 oe_mis=0.97 oe_lof=0.61)
chr20	3897559	3897559	-	TTCCCC	het	off-target	QUAL=434;DP=28;AF=0.75;MQM=60;SAP=33;ABP=18	PANK2	intron	PANK2:ENST00000316562.4:intron_variant:MODIFIER:intron4/6:c.1413-14_1413-9dup::,PANK2:ENST00000497424.1:intron_variant:MODIFIER:intron4/6:c.540-14_540-9dup::,PANK2:ENST00000610179.1:intron_variant:MODIFIER:intron4/6:c.1044-14_1044-9dup::	PANK2:NM_001324191.2:intron_variant:MODIFIER:intron5/7:c.540-14_540-9dup::,PANK2:NM_001324193.2:intron_variant:MODIFIER:intron4/6:c.105-14_105-9dup::,PANK2:NM_024960.6:intron_variant:MODIFIER:intron4/6:c.540-14_540-9dup::,PANK2:NM_153638.3:intron_variant:MODIFIER:intron4/6:c.1413-14_1413-9dup::,PANK2:NM_153640.3:intron_variant:MODIFIER:intron4/6:c.540-14_540-9dup::,PANK2:NR_136715.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/6:n.984-14_984-9dup::		606157 [GENE=PANK2 PHENOS=HARP syndrome,607236,Autosomal recessive/Neurodegeneration with brain iron accumulation 1,234200,Autosomal recessive];	96525 [benign DISEASE=Pigmentary pallidal degeneration,not specified,not provided];	CI057047 [CLASS=R MUT=ALT PHEN="Pantothenate kinase-associated neurodegeneration" GENE=PANK2];		rs10679953		0.1513	393,.						7.01					0.5566	0.1251	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PANK2 (inh=AR oe_syn=1.26 oe_mis=0.97 oe_lof=0.61), MIR103A2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr20	25288632	25288632	G	A	hom		QUAL=6043;DP=198;AF=0.99;MQM=60;SAP=3;ABP=0	ABHD12	synonymous	ABHD12:ENST00000339157.5:synonymous_variant:LOW:exon9/13:c.837C>T:p.Arg279=:PF12695 [Alpha/beta hydrolase family],ABHD12:ENST00000376542.3:synonymous_variant:LOW:exon9/13:c.837C>T:p.Arg279=:PF12695 [Alpha/beta hydrolase family]	ABHD12:NM_001042472.3:synonymous_variant:LOW:exon9/13:c.837C>T:p.Arg279=:,ABHD12:NM_015600.5:synonymous_variant:LOW:exon9/13:c.837C>T:p.Arg279=:		613599 [GENE=ABHD12 PHENOS=Polyneuropathy,hearing loss,ataxia,retinitis pigmentosa,and cataract,612674,Autosomal recessive];	128255 [benign DISEASE=Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract,not specified];			rs6107027	0.3361	0.4780	2961,.	0.2521,0.6383,0.0108,0.5158,0.4972	-2.1680			0.04,0.10	0.39					-0.1323	0.3463	0.08	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ABHD12 (inh=AR oe_syn=1.01 oe_mis=0.96 oe_lof=0.47)
chr20	25320228	25320228	T	A	hom	off-target	QUAL=2667;DP=80;AF=1.00;MQM=60;SAP=8;ABP=0	ABHD12	intron	ABHD12:ENST00000339157.5:intron_variant:MODIFIER:intron1/12:c.192-241A>T::,ABHD12:ENST00000376542.3:intron_variant:MODIFIER:intron1/12:c.192-241A>T::	ABHD12:NM_001042472.3:intron_variant:MODIFIER:intron1/12:c.192-241A>T::,ABHD12:NM_015600.5:intron_variant:MODIFIER:intron1/12:c.192-241A>T::	regulatory_region_variant:promoter_flanking_region	613599 [GENE=ABHD12 PHENOS=Polyneuropathy,hearing loss,ataxia,retinitis pigmentosa,and cataract,612674,Autosomal recessive];				rs6050544	0.4852	0.5519	4997,.	0.6339,0.6925,0.0756,0.5640,0.5336	0.3640			0.00,0.05	4.12					0.0565	0.2822	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ABHD12 (inh=AR oe_syn=1.01 oe_mis=0.96 oe_lof=0.47)
chr20	25371113	25371118	GCCCCC	-	hom	off-target;low_conf_region	QUAL=96;DP=4;AF=1.00;MQM=60;SAP=5;ABP=0	ABHD12	intron	ABHD12:ENST00000339157.5:intron_variant:MODIFIER:intron1/12:c.191+31_191+36del::,ABHD12:ENST00000376542.3:intron_variant:MODIFIER:intron1/12:c.191+31_191+36del::	ABHD12:NM_001042472.3:intron_variant:MODIFIER:intron1/12:c.191+31_191+36del::,ABHD12:NM_015600.5:intron_variant:MODIFIER:intron1/12:c.191+31_191+36del::	regulatory_region_variant:promoter	613599 [GENE=ABHD12 PHENOS=Polyneuropathy,hearing loss,ataxia,retinitis pigmentosa,and cataract,612674,Autosomal recessive];				rs139848340		0.7547		0.5849,0.8186,0.5154,0.7372,0.7314	0.3890				8.37								n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ABHD12 (inh=AR oe_syn=1.01 oe_mis=0.96 oe_lof=0.47)
chr20	25371125	25371125	C	G	hom	off-target;low_conf_region	QUAL=200;DP=7;AF=1.00;MQM=60;SAP=3;ABP=0	ABHD12	intron	ABHD12:ENST00000339157.5:intron_variant:MODIFIER:intron1/12:c.191+24G>C::,ABHD12:ENST00000376542.3:intron_variant:MODIFIER:intron1/12:c.191+24G>C::	ABHD12:NM_001042472.3:intron_variant:MODIFIER:intron1/12:c.191+24G>C::,ABHD12:NM_015600.5:intron_variant:MODIFIER:intron1/12:c.191+24G>C::	regulatory_region_variant:promoter,TF_binding_site_variant	613599 [GENE=ABHD12 PHENOS=Polyneuropathy,hearing loss,ataxia,retinitis pigmentosa,and cataract,612674,Autosomal recessive];				rs77202707	0.3367	0.6010	3866,.	0.2672,0.7010,0.0170,0.5907,0.5827	-0.6800			0.01,0.27	1.52					0.003	0.1292	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ABHD12 (inh=AR oe_syn=1.01 oe_mis=0.96 oe_lof=0.47)
chr20	25371378	25371378	-	GCCTCCGCC	hom	off-target;low_conf_region	QUAL=942;DP=33;AF=1.00;MQM=60;SAP=5;ABP=0	ABHD12	5'UTR	ABHD12:ENST00000339157.5:5_prime_UTR_variant:MODIFIER:exon1/13:c.-40_-39insGGCGGAGGC::,ABHD12:ENST00000376542.3:5_prime_UTR_variant:MODIFIER:exon1/13:c.-40_-39insGGCGGAGGC::	ABHD12:NM_001042472.3:5_prime_UTR_variant:MODIFIER:exon1/13:c.-40_-39insGGCGGAGGC::,ABHD12:NM_015600.5:5_prime_UTR_variant:MODIFIER:exon1/13:c.-40_-39insGGCGGAGGC::	regulatory_region_variant:promoter,TF_binding_site_variant	613599 [GENE=ABHD12 PHENOS=Polyneuropathy,hearing loss,ataxia,retinitis pigmentosa,and cataract,612674,Autosomal recessive];	337999 [benign DISEASE=Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract,not provided];		(CCG)n (Simple_repeat)	rs3833297		0.5652	4983,.	0.3472,0.2613,0.0069,0.2663,0.1859					15.48					0.0908	0.1311	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ABHD12 (inh=AR oe_syn=1.01 oe_mis=0.96 oe_lof=0.47)
chr22	38369976	38369976	A	G	het		QUAL=462;DP=36;AF=0.64;MQM=60;SAP=24;ABP=9	SOX10,POLR2F	synonymous,intron	SOX10:ENST00000360880.2:synonymous_variant:LOW:exon5/5:c.927T>C:p.His309=:,SOX10:ENST00000396884.2:synonymous_variant:LOW:exon4/4:c.927T>C:p.His309=:,POLR2F:ENST00000405557.1:intron_variant:MODIFIER:intron4/4:c.293+6799A>G::,POLR2F:ENST00000407936.1:intron_variant:MODIFIER:intron4/5:c.293+6799A>G::	POLR2F:NM_001301130.2:intron_variant:MODIFIER:intron4/5:c.293+6799A>G::,POLR2F:NM_001301131.2:intron_variant:MODIFIER:intron4/4:c.293+6799A>G::,POLR2F:NM_001363825.1:intron_variant:MODIFIER:intron5/5:c.*38+1659A>G::,SOX10:NM_006941.4:synonymous_variant:LOW:exon4/4:c.927T>C:p.His309=:		602229 [GENE=SOX10 PHENOS=Waardenburg syndrome,type 2E,with or without neurologic involvement,611584,Autosomal dominant/PCWH syndrome,609136,Autosomal dominant/Waardenburg syndrome,type 4C,613266,Autosomal dominant];	227081 [benign DISEASE=Peripheral demyelinating neuropathy, central dysmyelination, Waardenburg syndrome, and Hirschsprung disease,Waardenburg syndrome,not specified];			rs139884	0.7133	0.6911	7610,.	0.8257,0.6227,0.7600,0.6291,0.6340	-1.3370			0.01,0.60	0.38					-0.2118	0.8877	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					POLR2F (inh=n/a oe_syn=0.90 oe_mis=0.73 oe_lof=0.42), SOX10 (inh=AD oe_syn=0.89 oe_mis=0.55 oe_lof=0.00)
chr22	38512355	38512355	C	T	het		QUAL=2464;DP=161;AF=0.60;MQM=60;SAP=90;ABP=16	PLA2G6	intron	PLA2G6:ENST00000332509.3:intron_variant:MODIFIER:intron12/16:c.1743-137G>A::,PLA2G6:ENST00000335539.3:intron_variant:MODIFIER:intron11/15:c.1581-137G>A::,PLA2G6:ENST00000402064.1:intron_variant:MODIFIER:intron11/15:c.1581-137G>A::	PLA2G6:NM_001004426.2:intron_variant:MODIFIER:intron11/15:c.1581-137G>A::,PLA2G6:NM_001199562.3:intron_variant:MODIFIER:intron11/15:c.1581-137G>A::,PLA2G6:NM_001349864.2:intron_variant:MODIFIER:intron12/16:c.1743-137G>A::,PLA2G6:NM_001349865.2:intron_variant:MODIFIER:intron11/15:c.1581-137G>A::,PLA2G6:NM_001349866.2:intron_variant:MODIFIER:intron11/15:c.1581-137G>A::,PLA2G6:NM_001349867.2:intron_variant:MODIFIER:intron13/17:c.1209-137G>A::,PLA2G6:NM_001349868.2:intron_variant:MODIFIER:intron11/15:c.1065-137G>A::,PLA2G6:NM_001349869.2:intron_variant:MODIFIER:intron12/16:c.1047-137G>A::,PLA2G6:NM_003560.4:intron_variant:MODIFIER:intron12/16:c.1743-137G>A::		603604 [GENE=PLA2G6 PHENOS=Infantile neuroaxonal dystrophy 1,256600,Autosomal recessive/Parkinson disease 14,autosomal recessive,612953,Autosomal recessive/Neurodegeneration with brain iron accumulation 2B,610217,Autosomal recessive];				rs55679135	0.0042	0.0104	2,.	0.0022,0.0067,0.0000,0.0154,0.0013	-0.2950			0.01,0.30	9.98					0.2051	0.7747	0	3	446	1 / 156					PLA2G6 (inh=AR oe_syn=0.84 oe_mis=0.85 oe_lof=0.60)
chr22	38512402	38512402	G	A	het		QUAL=2186;DP=254;AF=0.35;MQM=60;SAP=8;ABP=50	PLA2G6	intron	PLA2G6:ENST00000332509.3:intron_variant:MODIFIER:intron12/16:c.1743-184C>T::,PLA2G6:ENST00000335539.3:intron_variant:MODIFIER:intron11/15:c.1581-184C>T::,PLA2G6:ENST00000402064.1:intron_variant:MODIFIER:intron11/15:c.1581-184C>T::	PLA2G6:NM_001004426.2:intron_variant:MODIFIER:intron11/15:c.1581-184C>T::,PLA2G6:NM_001199562.3:intron_variant:MODIFIER:intron11/15:c.1581-184C>T::,PLA2G6:NM_001349864.2:intron_variant:MODIFIER:intron12/16:c.1743-184C>T::,PLA2G6:NM_001349865.2:intron_variant:MODIFIER:intron11/15:c.1581-184C>T::,PLA2G6:NM_001349866.2:intron_variant:MODIFIER:intron11/15:c.1581-184C>T::,PLA2G6:NM_001349867.2:intron_variant:MODIFIER:intron13/17:c.1209-184C>T::,PLA2G6:NM_001349868.2:intron_variant:MODIFIER:intron11/15:c.1065-184C>T::,PLA2G6:NM_001349869.2:intron_variant:MODIFIER:intron12/16:c.1047-184C>T::,PLA2G6:NM_003560.4:intron_variant:MODIFIER:intron12/16:c.1743-184C>T::		603604 [GENE=PLA2G6 PHENOS=Infantile neuroaxonal dystrophy 1,256600,Autosomal recessive/Parkinson disease 14,autosomal recessive,612953,Autosomal recessive/Neurodegeneration with brain iron accumulation 2B,610217,Autosomal recessive];			L1ME4b (LINE/L1)	rs11089863	0.3001	0.3587	1659,.	0.2413,0.4221,0.1362,0.3662,0.4204	1.3780			0.02,0.11	6.64					-0.013	0.7667	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLA2G6 (inh=AR oe_syn=0.84 oe_mis=0.85 oe_lof=0.60)
chr22	38535946	38535946	G	A	het	off-target	QUAL=448;DP=38;AF=0.55;MQM=60;SAP=4;ABP=4	PLA2G6	intron	PLA2G6:ENST00000332509.3:intron_variant:MODIFIER:intron5/16:c.797+43C>T::,PLA2G6:ENST00000335539.3:intron_variant:MODIFIER:intron5/15:c.797+43C>T::,PLA2G6:ENST00000402064.1:intron_variant:MODIFIER:intron5/15:c.797+43C>T::	PLA2G6:NM_001004426.2:intron_variant:MODIFIER:intron5/15:c.797+43C>T::,PLA2G6:NM_001199562.3:intron_variant:MODIFIER:intron5/15:c.797+43C>T::,PLA2G6:NM_001349864.2:intron_variant:MODIFIER:intron5/16:c.797+43C>T::,PLA2G6:NM_001349865.2:intron_variant:MODIFIER:intron5/15:c.797+43C>T::,PLA2G6:NM_001349866.2:intron_variant:MODIFIER:intron5/15:c.797+43C>T::,PLA2G6:NM_001349867.2:intron_variant:MODIFIER:intron6/17:c.263+43C>T::,PLA2G6:NM_001349868.2:intron_variant:MODIFIER:intron4/15:c.119+3166C>T::,PLA2G6:NM_001349869.2:intron_variant:MODIFIER:intron6/16:c.263+43C>T::,PLA2G6:NM_003560.4:intron_variant:MODIFIER:intron5/16:c.797+43C>T::		603604 [GENE=PLA2G6 PHENOS=Infantile neuroaxonal dystrophy 1,256600,Autosomal recessive/Parkinson disease 14,autosomal recessive,612953,Autosomal recessive/Neurodegeneration with brain iron accumulation 2B,610217,Autosomal recessive];				rs12329956	0.2798	0.3471	1472,.	0.1565,0.4157,0.1357,0.3607,0.4163	-0.2760			0.03,0.25	12.41					0.2546	0.2832	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLA2G6 (inh=AR oe_syn=0.84 oe_mis=0.85 oe_lof=0.60)
chr22	38541040	38541040	T	-	het	off-target;low_conf_region	QUAL=49;DP=32;AF=0.16;MQM=60;SAP=14;ABP=36	PLA2G6	intron	PLA2G6:ENST00000332509.3:intron_variant:MODIFIER:intron3/16:c.425+405del::,PLA2G6:ENST00000335539.3:intron_variant:MODIFIER:intron3/15:c.425+405del::,PLA2G6:ENST00000402064.1:intron_variant:MODIFIER:intron3/15:c.425+405del::,PLA2G6:ENST00000436218.1:intron_variant:MODIFIER:intron3/3:c.425+405del::	PLA2G6:NM_001004426.2:intron_variant:MODIFIER:intron3/15:c.425+405del::,PLA2G6:NM_001199562.3:intron_variant:MODIFIER:intron3/15:c.425+405del::,PLA2G6:NM_001349864.2:intron_variant:MODIFIER:intron3/16:c.425+405del::,PLA2G6:NM_001349865.2:intron_variant:MODIFIER:intron3/15:c.425+405del::,PLA2G6:NM_001349866.2:intron_variant:MODIFIER:intron3/15:c.425+405del::,PLA2G6:NM_001349867.2:intron_variant:MODIFIER:intron4/17:c.-110+405del::,PLA2G6:NM_001349868.2:intron_variant:MODIFIER:intron3/15:c.-66+405del::,PLA2G6:NM_001349869.2:intron_variant:MODIFIER:intron4/16:c.-110+405del::,PLA2G6:NM_003560.4:intron_variant:MODIFIER:intron3/16:c.425+405del::	regulatory_region_variant:promoter_flanking_region	603604 [GENE=PLA2G6 PHENOS=Infantile neuroaxonal dystrophy 1,256600,Autosomal recessive/Parkinson disease 14,autosomal recessive,612953,Autosomal recessive/Neurodegeneration with brain iron accumulation 2B,610217,Autosomal recessive];			AluJr4 (SINE/Alu)	rs968832533					0.2800									0.0169	0.3597	0	81	1004	25 / 684	2	"[2] auto-classification 25.11.2017%0A%0A"			PLA2G6 (inh=AR oe_syn=0.84 oe_mis=0.85 oe_lof=0.60)
chr22	38543453	38543453	T	C	het	off-target	QUAL=1692;DP=131;AF=0.53;MQM=60;SAP=3;ABP=4	PLA2G6	intron	PLA2G6:ENST00000332509.3:intron_variant:MODIFIER:intron2/16:c.210-1793A>G::,PLA2G6:ENST00000335539.3:intron_variant:MODIFIER:intron2/15:c.210-1793A>G::,PLA2G6:ENST00000402064.1:intron_variant:MODIFIER:intron2/15:c.210-1793A>G::,PLA2G6:ENST00000417303.2:intron_variant:MODIFIER:intron3/3:c.*40+1047A>G::,PLA2G6:ENST00000435484.1:intron_variant:MODIFIER:intron3/3:c.*40+1047A>G::,PLA2G6:ENST00000436218.1:intron_variant:MODIFIER:intron2/3:c.210-1793A>G::,PLA2G6:ENST00000447598.2:intron_variant:MODIFIER:intron3/3:c.*40+1047A>G::	PLA2G6:NM_001004426.2:intron_variant:MODIFIER:intron2/15:c.210-1793A>G::,PLA2G6:NM_001199562.3:intron_variant:MODIFIER:intron2/15:c.210-1793A>G::,PLA2G6:NM_001349864.2:intron_variant:MODIFIER:intron2/16:c.210-1793A>G::,PLA2G6:NM_001349865.2:intron_variant:MODIFIER:intron2/15:c.210-1793A>G::,PLA2G6:NM_001349866.2:intron_variant:MODIFIER:intron2/15:c.210-1793A>G::,PLA2G6:NM_001349867.2:intron_variant:MODIFIER:intron3/17:c.-326+1047A>G::,PLA2G6:NM_001349868.2:intron_variant:MODIFIER:intron2/15:c.-281-1793A>G::,PLA2G6:NM_001349869.2:intron_variant:MODIFIER:intron3/16:c.-326+1047A>G::,PLA2G6:NM_003560.4:intron_variant:MODIFIER:intron2/16:c.210-1793A>G::	regulatory_region_variant:promoter_flanking_region	603604 [GENE=PLA2G6 PHENOS=Infantile neuroaxonal dystrophy 1,256600,Autosomal recessive/Parkinson disease 14,autosomal recessive,612953,Autosomal recessive/Neurodegeneration with brain iron accumulation 2B,610217,Autosomal recessive];				rs2284060	0.4201	0.4101	2668,.		-0.8520			0.00,0.07	4.76					0.1958	0.942	0.12	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLA2G6 (inh=AR oe_syn=0.84 oe_mis=0.85 oe_lof=0.60)
chr22	38559448	38559448	C	A	het		QUAL=3994;DP=284;AF=0.51;MQM=60;SAP=3;ABP=3	PLA2G6	intron	PLA2G6:ENST00000332509.3:intron_variant:MODIFIER:intron2/16:c.209+5777G>T::,PLA2G6:ENST00000335539.3:intron_variant:MODIFIER:intron2/15:c.209+5777G>T::,PLA2G6:ENST00000402064.1:intron_variant:MODIFIER:intron2/15:c.209+5777G>T::,PLA2G6:ENST00000417303.2:intron_variant:MODIFIER:intron2/3:c.209+5777G>T::,PLA2G6:ENST00000435484.1:intron_variant:MODIFIER:intron2/3:c.209+5777G>T::,PLA2G6:ENST00000436218.1:intron_variant:MODIFIER:intron2/3:c.209+5777G>T::,PLA2G6:ENST00000447598.2:intron_variant:MODIFIER:intron2/3:c.209+5777G>T::	PLA2G6:NM_001004426.2:intron_variant:MODIFIER:intron2/15:c.209+5777G>T::,PLA2G6:NM_001199562.3:intron_variant:MODIFIER:intron2/15:c.209+5777G>T::,PLA2G6:NM_001349864.2:intron_variant:MODIFIER:intron2/16:c.209+5777G>T::,PLA2G6:NM_001349865.2:intron_variant:MODIFIER:intron2/15:c.209+5777G>T::,PLA2G6:NM_001349866.2:intron_variant:MODIFIER:intron2/15:c.209+5777G>T::,PLA2G6:NM_001349867.2:intron_variant:MODIFIER:intron2/17:c.-457+5777G>T::,PLA2G6:NM_001349868.2:intron_variant:MODIFIER:intron2/15:c.-282+5777G>T::,PLA2G6:NM_001349869.2:intron_variant:MODIFIER:intron2/16:c.-457+5777G>T::,PLA2G6:NM_003560.4:intron_variant:MODIFIER:intron2/16:c.209+5777G>T::	regulatory_region_variant:promoter_flanking_region	603604 [GENE=PLA2G6 PHENOS=Infantile neuroaxonal dystrophy 1,256600,Autosomal recessive/Parkinson disease 14,autosomal recessive,612953,Autosomal recessive/Neurodegeneration with brain iron accumulation 2B,610217,Autosomal recessive];			L2b (LINE/L2)	rs731821	0.4147	0.3847	2387,.		-0.7940			0.00,0.07	2.61					-0.0212	0.217	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLA2G6 (inh=AR oe_syn=0.84 oe_mis=0.85 oe_lof=0.60)
chr22	38564041	38564041	C	G	het	off-target	QUAL=930;DP=74;AF=0.51;MQM=60;SAP=11;ABP=3	PLA2G6	intron	PLA2G6:ENST00000332509.3:intron_variant:MODIFIER:intron2/16:c.209+1184G>C::,PLA2G6:ENST00000335539.3:intron_variant:MODIFIER:intron2/15:c.209+1184G>C::,PLA2G6:ENST00000402064.1:intron_variant:MODIFIER:intron2/15:c.209+1184G>C::,PLA2G6:ENST00000417303.2:intron_variant:MODIFIER:intron2/3:c.209+1184G>C::,PLA2G6:ENST00000435484.1:intron_variant:MODIFIER:intron2/3:c.209+1184G>C::,PLA2G6:ENST00000436218.1:intron_variant:MODIFIER:intron2/3:c.209+1184G>C::,PLA2G6:ENST00000447598.2:intron_variant:MODIFIER:intron2/3:c.209+1184G>C::	PLA2G6:NM_001004426.2:intron_variant:MODIFIER:intron2/15:c.209+1184G>C::,PLA2G6:NM_001199562.3:intron_variant:MODIFIER:intron2/15:c.209+1184G>C::,PLA2G6:NM_001349864.2:intron_variant:MODIFIER:intron2/16:c.209+1184G>C::,PLA2G6:NM_001349865.2:intron_variant:MODIFIER:intron2/15:c.209+1184G>C::,PLA2G6:NM_001349866.2:intron_variant:MODIFIER:intron2/15:c.209+1184G>C::,PLA2G6:NM_001349867.2:intron_variant:MODIFIER:intron2/17:c.-457+1184G>C::,PLA2G6:NM_001349868.2:intron_variant:MODIFIER:intron2/15:c.-282+1184G>C::,PLA2G6:NM_001349869.2:intron_variant:MODIFIER:intron2/16:c.-457+1184G>C::,PLA2G6:NM_003560.4:intron_variant:MODIFIER:intron2/16:c.209+1184G>C::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	603604 [GENE=PLA2G6 PHENOS=Infantile neuroaxonal dystrophy 1,256600,Autosomal recessive/Parkinson disease 14,autosomal recessive,612953,Autosomal recessive/Neurodegeneration with brain iron accumulation 2B,610217,Autosomal recessive];			L2b (LINE/L2)	rs9622746	0.2951	0.2987	1514,.		0.0510			0.01,0.10	1.32					-0.0077	0.3741	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLA2G6 (inh=AR oe_syn=0.84 oe_mis=0.85 oe_lof=0.60)
chr22	50499967	50499967	T	C	het	off-target	QUAL=431;DP=48;AF=0.50;MQM=60;SAP=55;ABP=3	MLC1	3'UTR	MLC1:ENST00000311597.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*45A>G::,MLC1:ENST00000395876.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*45A>G::,MLC1:ENST00000431262.2:3_prime_UTR_variant:MODIFIER:exon11/11:c.*45A>G::,MLC1:ENST00000450140.2:3_prime_UTR_variant:MODIFIER:exon10/10:c.*45A>G::,MLC1:ENST00000535444.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*45A>G::,MLC1:ENST00000538737.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*45A>G::	MLC1:NM_015166.3:3_prime_UTR_variant:MODIFIER:exon12/12:c.*45A>G::,MLC1:NM_139202.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*45A>G::	regulatory_region_variant:promoter_flanking_region	605908 [GENE=MLC1 PHENOS=Megalencephalic leukoencephalopathy with subcortical cysts,604004,Autosomal recessive];	260572 [benign DISEASE=Megalencephalic leukoencephalopathy with subcortical cysts 1,not specified];			rs2072873	0.1504	0.1487	373,.	0.1772,0.1599,0.1955,0.1320,0.1384	-0.7860			0.01,0.08	1.19					-0.001	0.8833	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MLC1 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.74)
chr22	50512617	50512617	C	T	het	off-target	QUAL=857;DP=78;AF=0.60;MQM=60;SAP=97;ABP=10	MLC1	intron	MLC1:ENST00000311597.5:intron_variant:MODIFIER:intron8/11:c.714+28G>A::,MLC1:ENST00000395876.2:intron_variant:MODIFIER:intron8/11:c.714+28G>A::,MLC1:ENST00000431262.2:intron_variant:MODIFIER:intron7/10:c.624+28G>A::,MLC1:ENST00000450140.2:intron_variant:MODIFIER:intron6/9:c.558+28G>A::,MLC1:ENST00000535444.1:intron_variant:MODIFIER:intron7/10:c.477+28G>A::,MLC1:ENST00000538737.1:intron_variant:MODIFIER:intron7/10:c.612+28G>A::	MLC1:NM_015166.3:intron_variant:MODIFIER:intron8/11:c.714+28G>A::,MLC1:NM_139202.2:intron_variant:MODIFIER:intron8/11:c.714+28G>A::	regulatory_region_variant:promoter_flanking_region	605908 [GENE=MLC1 PHENOS=Megalencephalic leukoencephalopathy with subcortical cysts,604004,Autosomal recessive];	262458 [benign DISEASE=not specified];			rs2038048	0.2877	0.4047	2488,.	0.2148,0.4756,0.2095,0.4535,0.3393	-1.1050			0.01,0.11	0.60					0.1388	0.1305	0.02	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MLC1 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.74)
chr22	50515808	50515808	C	T	het	off-target	QUAL=5392;DP=341;AF=0.59;MQM=60;SAP=3;ABP=27	MLC1	intron	MLC1:ENST00000311597.5:intron_variant:MODIFIER:intron6/11:c.525+22G>A::,MLC1:ENST00000395876.2:intron_variant:MODIFIER:intron6/11:c.525+22G>A::,MLC1:ENST00000431262.2:intron_variant:MODIFIER:intron5/10:c.435+22G>A::,MLC1:ENST00000450140.2:intron_variant:MODIFIER:intron4/9:c.369+22G>A::,MLC1:ENST00000535444.1:intron_variant:MODIFIER:intron5/10:c.288+22G>A::,MLC1:ENST00000538737.1:intron_variant:MODIFIER:intron5/10:c.423+22G>A::	MLC1:NM_015166.3:intron_variant:MODIFIER:intron6/11:c.525+22G>A::,MLC1:NM_139202.2:intron_variant:MODIFIER:intron6/11:c.525+22G>A::		605908 [GENE=MLC1 PHENOS=Megalencephalic leukoencephalopathy with subcortical cysts,604004,Autosomal recessive];	260574 [benign DISEASE=not specified];			rs2072874	0.1528	0.1669	357,.	0.1123,0.2925,0.2031,0.1428,0.1501	-1.3810			0.00,0.08	0.41					0.0987	0.1924	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MLC1 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.74)
chr22	50518723	50518723	A	G	hom	off-target	QUAL=4806;DP=153;AF=1.00;MQM=60;SAP=4;ABP=0	MLC1	intron	MLC1:ENST00000311597.5:intron_variant:MODIFIER:intron4/11:c.321+50T>C::,MLC1:ENST00000395876.2:intron_variant:MODIFIER:intron4/11:c.321+50T>C::,MLC1:ENST00000431262.2:intron_variant:MODIFIER:intron3/10:c.231+50T>C::,MLC1:ENST00000450140.2:intron_variant:MODIFIER:intron3/9:c.267+2790T>C::,MLC1:ENST00000535444.1:intron_variant:MODIFIER:intron3/10:c.84+50T>C::,MLC1:ENST00000538737.1:intron_variant:MODIFIER:intron4/10:c.321+50T>C::	MLC1:NM_015166.3:intron_variant:MODIFIER:intron4/11:c.321+50T>C::,MLC1:NM_139202.2:intron_variant:MODIFIER:intron4/11:c.321+50T>C::		605908 [GENE=MLC1 PHENOS=Megalencephalic leukoencephalopathy with subcortical cysts,604004,Autosomal recessive];	260573 [benign DISEASE=not specified];			rs79301	0.9736	0.9524	14247,.	0.9886,0.9574,0.9987,0.9243,0.9827	-2.5680			0.00,0.07	2.35					-0.2047	0.3116	0.01	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MLC1 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.74)
chrX	73641265	73641265	A	G	het		QUAL=26;DP=63;AF=0.30;MQM=60;SAP=44;ABP=25	SLC16A2	synonymous	SLC16A2:ENST00000276033.5:synonymous_variant:LOW:exon1/6:c.15A>G:p.Gly5=:		regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site	300095 [GENE=SLC16A2 PHENOS=Allan-Herndon-Dudley syndrome,300523,X-linked];			GA-rich (Low_complexity)	rs1313235844		0.0014	0,0		1.4850			0.31,0.46	10.34					-0.1399	0.0312		0	115	0 / 99					SLC16A2 (inh=XLD oe_syn=0.88 oe_mis=0.56 oe_lof=0.00)
chrX	73641569	73641569	T	C	het	low_conf_region	QUAL=1164;DP=72;AF=0.64;MQM=60;SAP=5;ABP=15	SLC16A2	missense	SLC16A2:ENST00000276033.5:missense_variant:MODERATE:exon1/6:c.319T>C:p.Ser107Pro:,SLC16A2:ENST00000587091.1:missense_variant:MODERATE:exon1/6:c.97T>C:p.Ser33Pro:	SLC16A2:NM_006517.5:missense_variant:MODERATE:exon1/6:c.97T>C:p.Ser33Pro:	regulatory_region_variant:promoter,regulatory_region_variant:CTCF_binding_site	300095 [GENE=SLC16A2 PHENOS=Allan-Herndon-Dudley syndrome,300523,X-linked];	21462 [benign DISEASE=Spastic paraplegia,Allan-Herndon-Dudley syndrome,History of neurodevelopmental disorder,not specified,not provided];		(AGCCGG)n (Simple_repeat)	rs6647476	0.6638	0.5405	2129,3968	0.6863,0.3358,0.9587,0.4064,0.6345	-0.3900	T(0.44),T(0.29)	B(0.00),B(0.40)	0.04,0.34	9.11	0.09			COSV52082293	0.0154	0.0322	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC16A2 (inh=XLD oe_syn=0.88 oe_mis=0.56 oe_lof=0.00)
chrX	73749319	73749319	T	G	het	off-target	QUAL=1009;DP=80;AF=0.49;MQM=60;SAP=6;ABP=3	SLC16A2	intron	SLC16A2:ENST00000276033.5:intron_variant:MODIFIER:intron5/5:c.1621+43T>G::,SLC16A2:ENST00000587091.1:intron_variant:MODIFIER:intron5/5:c.1399+43T>G::	SLC16A2:NM_006517.5:intron_variant:MODIFIER:intron5/5:c.1399+43T>G::		300095 [GENE=SLC16A2 PHENOS=Allan-Herndon-Dudley syndrome,300523,X-linked];	159903 [likely benign DISEASE=not specified];			rs5937843	0.3438	0.6056	3021,4488	0.2084,0.4747,0.0318,0.8099,0.5055	0.3890			0.00,0.08	5.72				COSV52084469	-0.0163	0.15	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC16A2 (inh=XLD oe_syn=0.88 oe_mis=0.56 oe_lof=0.00)
chrX	153009197	153009197	G	C	hom		QUAL=3869;DP=132;AF=1.00;MQM=60;SAP=18;ABP=0	ABCD1,U52111.14	3'UTR,intron&non_coding_transcript	ABCD1:ENST00000218104.3:3_prime_UTR_variant:MODIFIER:exon10/10:c.*8G>C::,U52111.14:ENST00000434284.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/2:n.72-5165C>G::	ABCD1:NM_000033.4:3_prime_UTR_variant:MODIFIER:exon10/10:c.*8G>C::		300371 [GENE=ABCD1 PHENOS=Adrenomyeloneuropathy,adult,300100,X-linked recessive/Adrenoleukodystrophy,300100,X-linked recessive];	92313 [benign DISEASE=Adrenoleukodystrophy,History of neurodevelopmental disorder,not specified,not provided];			rs2229539	0.7404	0.7001	3456,4721	0.8474,0.6959,0.5772,0.6413,0.7640	-0.1780			0.02,0.13	0.10					-0.0167	0.9066	0	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ABCD1 (inh=XLR oe_syn=0.96 oe_mis=0.72 oe_lof=0.00)
